"ProtocolName","LabelName","GroupValues","Size","Estimator","ROC_AUC","ClassificationPointType","Direction","Threshold","Accuracy","Precision","Recall"
"5-HT6","Ki","NA","163","Weka RF classification","0.89076852418861","Minimum","UP","6.148264209326978","0.8159509202453987","0.7887323943661971","0.7887323943661971"
"5-HT6","Ki","NA","163","Smile Bernoulli NB classification","0.8811236987140233","Minimum","UP","6.148264209326978","0.7300613496932515","0.6336633663366337","0.9014084507042254"
"5-HT6","Ki","NA","163","Smile SVC RBF classification","0.8743110838946733","Minimum","UP","6.148264209326978","0.8098159509202454","0.9","0.6338028169014085"
"5-HT6","Ki","NA","163","Smile SVC Tanimoto classification","0.8651255358236376","Minimum","UP","6.148264209326978","0.7668711656441718","0.7088607594936709","0.7887323943661971"
"5-HT6","Ki","NA","163","Weka RF on folded fp classification","0.8648958971218617","Minimum","UP","6.148264209326978","0.7914110429447853","0.8032786885245902","0.6901408450704225"
"5-HT6","Ki","NA","163","Smile SVC Poly classification","0.8508879363135348","Minimum","UP","6.148264209326978","0.5828220858895705","1.0","0.04225352112676056"
"DOPAMINE D3","Ki","NA","173","Weka RF on folded fp classification","0.8380217785843915","Proportion","UP","8.012098319436179","0.7687861271676301","0.7575757575757576","0.43859649122807015"
"DOPAMINE D3","Ki","NA","173","Smile Bernoulli NB classification","0.8378705384150029","Proportion","UP","8.012098319436179","0.6473988439306358","0.4818181818181818","0.9298245614035088"
"DOPAMINE D3","Ki","NA","173","Smile SVC Poly classification","0.8053539019963711","Proportion","UP","8.012098319436179","0.6705202312138728","NaN","0.0"
"DOPAMINE D3","Ki","NA","173","Smile SVC Tanimoto classification","0.8053539019963701","Proportion","UP","8.012098319436179","0.7572254335260116","0.6363636363636364","0.6140350877192983"
"DOPAMINE D3","Ki","NA","173","Smile SVC RBF classification","0.7781306715063523","Proportion","UP","8.012098319436179","0.7398843930635838","0.8","0.2807017543859649"
"DOPAMINE D3","Ki","NA","173","Weka RF classification","0.7776769509981851","Proportion","UP","8.012098319436179","0.7514450867052023","0.64","0.5614035087719298"
"DOPAMINE D4","Ki","NA","137","Weka RF on folded fp classification","0.7819197446420428","Proportion","UP","7.520088284001859","0.7299270072992701","0.7058823529411765","0.47058823529411764"
"DOPAMINE D4","Ki","NA","137","Smile SVC Tanimoto classification","0.7731418148654808","Proportion","UP","7.520088284001859","0.7299270072992701","0.6458333333333334","0.6078431372549019"
"DOPAMINE D4","Ki","NA","137","Weka RF classification","0.7720018239854082","Proportion","UP","7.520088284001859","0.6715328467153284","0.5652173913043478","0.5098039215686274"
"DOPAMINE D4","Ki","NA","137","Smile SVC RBF classification","0.7528499772001824","Proportion","UP","7.520088284001859","0.7372262773722628","0.7586206896551724","0.43137254901960786"
"DOPAMINE D4","Ki","NA","137","Smile Bernoulli NB classification","0.7395120839033286","Proportion","UP","7.520088284001859","0.5985401459854015","0.4772727272727273","0.8235294117647058"
"DOPAMINE D4","Ki","NA","137","Smile SVC Poly classification","0.738486092111263","Proportion","UP","7.520088284001859","0.6277372262773723","NaN","0.0"
"5-HT Transporter","Ki","NA","166","Smile Bernoulli NB classification","0.8528097062579814","Inflection","UP","6.090346152915738","0.7349397590361446","0.5777777777777777","0.896551724137931"
"5-HT Transporter","Ki","NA","166","Smile SVC Tanimoto classification","0.8443486590038313","Inflection","UP","6.090346152915738","0.7891566265060241","0.6885245901639344","0.7241379310344828"
"5-HT Transporter","Ki","NA","166","Weka RF on folded fp classification","0.8333333333333327","Inflection","UP","6.090346152915738","0.7469879518072289","0.7105263157894737","0.46551724137931033"
"5-HT Transporter","Ki","NA","166","Weka RF classification","0.8300606641123882","Inflection","UP","6.090346152915738","0.7590361445783133","0.6875","0.5689655172413793"
"5-HT Transporter","Ki","NA","166","Smile SVC Poly classification","0.8239144316730522","Inflection","UP","6.090346152915738","0.6506024096385542","NaN","0.0"
"5-HT Transporter","Ki","NA","166","Smile SVC RBF classification","0.7450510855683268","Inflection","UP","6.090346152915738","0.7530120481927711","0.717948717948718","0.4827586206896552"
"HISTAMINE H1","Ki","NA","215","Smile SVC Tanimoto classification","0.9402021336327908","Minimum","UP","6.83703147675769","0.8837209302325582","0.8192771084337349","0.8717948717948718"
"HISTAMINE H1","Ki","NA","215","Weka RF on folded fp classification","0.9137188845218045","Minimum","UP","6.83703147675769","0.8604651162790697","0.9","0.6923076923076923"
"HISTAMINE H1","Ki","NA","215","Weka RF classification","0.911800486618005","Minimum","UP","6.83703147675769","0.8325581395348837","0.7916666666666666","0.7307692307692307"
"HISTAMINE H1","Ki","NA","215","Smile Bernoulli NB classification","0.9043140557739107","Minimum","UP","6.83703147675769","0.7534883720930232","0.6086956521739131","0.8974358974358975"
"HISTAMINE H1","Ki","NA","215","Smile SVC Poly classification","0.8965936739659379","Minimum","UP","6.83703147675769","0.6372093023255814","NaN","0.0"
"HISTAMINE H1","Ki","NA","215","Smile SVC RBF classification","0.8858319296275508","Minimum","UP","6.83703147675769","0.827906976744186","0.8727272727272727","0.6153846153846154"
"5-HT1B","Ki","NA","201","Smile Bernoulli NB classification","0.8611672278338951","Inflection","UP","6.24601350311662","0.6567164179104478","0.488","0.9242424242424242"
"5-HT1B","Ki","NA","201","Weka RF on folded fp classification","0.8448933782267115","Inflection","UP","6.24601350311662","0.7910447761194029","0.8","0.48484848484848486"
"5-HT1B","Ki","NA","201","Smile SVC Tanimoto classification","0.8406285072951748","Inflection","UP","6.24601350311662","0.8208955223880597","0.7586206896551724","0.6666666666666666"
"5-HT1B","Ki","NA","201","Smile SVC Poly classification","0.8300785634118968","Inflection","UP","6.24601350311662","0.6716417910447762","NaN","0.0"
"5-HT1B","Ki","NA","201","Weka RF classification","0.7791806958473627","Inflection","UP","6.24601350311662","0.7910447761194029","0.7608695652173914","0.5303030303030303"
"5-HT1B","Ki","NA","201","Smile SVC RBF classification","0.7379349046015725","Inflection","UP","6.24601350311662","0.7213930348258707","0.8125","0.19696969696969696"
"OPIATE Delta","Ki","NA","110","Weka RF on folded fp classification","0.9093507554103716","Inflection","UP","7.378572019113603","0.8363636363636363","0.782608695652174","0.5806451612903226"
"OPIATE Delta","Ki","NA","110","Smile SVC Tanimoto classification","0.8975091874234374","Inflection","UP","7.378572019113603","0.8636363636363636","0.75","0.7741935483870968"
"OPIATE Delta","Ki","NA","110","Smile Bernoulli NB classification","0.8971008574928537","Inflection","UP","7.378572019113603","0.7","0.4838709677419355","0.967741935483871"
"OPIATE Delta","Ki","NA","110","Smile SVC Poly classification","0.890159248672928","Inflection","UP","7.378572019113603","0.7181818181818181","NaN","0.0"
"OPIATE Delta","Ki","NA","110","Smile SVC RBF classification","0.8419763168640259","Inflection","UP","7.378572019113603","0.8363636363636363","0.8421052631578947","0.5161290322580645"
"OPIATE Delta","Ki","NA","110","Weka RF classification","0.8336055532870559","Inflection","UP","7.378572019113603","0.7909090909090909","0.6538461538461539","0.5483870967741935"
"Cholinergic, muscarinic M5","Ki","NA","117","Smile SVC Tanimoto classification","0.8777777777777785","Minimum","UP","6.337321764442645","0.8290598290598291","0.775","0.7380952380952381"
"Cholinergic, muscarinic M5","Ki","NA","117","Weka RF classification","0.8755555555555556","Minimum","UP","6.337321764442645","0.8376068376068376","0.8709677419354839","0.6428571428571429"
"Cholinergic, muscarinic M5","Ki","NA","117","Weka RF on folded fp classification","0.8658730158730168","Minimum","UP","6.337321764442645","0.7863247863247863","0.8148148148148148","0.5238095238095238"
"Cholinergic, muscarinic M5","Ki","NA","117","Smile Bernoulli NB classification","0.8573015873015869","Minimum","UP","6.337321764442645","0.7435897435897436","0.603448275862069","0.8333333333333334"
"Cholinergic, muscarinic M5","Ki","NA","117","Smile SVC RBF classification","0.8552380952380966","Minimum","UP","6.337321764442645","0.8034188034188035","0.9130434782608695","0.5"
"Cholinergic, muscarinic M5","Ki","NA","117","Smile SVC Poly classification","0.8460317460317455","Minimum","UP","6.337321764442645","0.6495726495726496","1.0","0.023809523809523808"
"Cholinergic, muscarinic M1","Ki","NA","134","Weka RF on folded fp classification","0.9324837916387211","Minimum","UP","6.340823629731827","0.8582089552238806","0.8333333333333334","0.873015873015873"
"Cholinergic, muscarinic M1","Ki","NA","134","Smile SVC Poly classification","0.9213056114464555","Minimum","UP","6.340823629731827","0.5373134328358209","1.0","0.015873015873015872"
"Cholinergic, muscarinic M1","Ki","NA","134","Smile Bernoulli NB classification","0.9206349206349208","Minimum","UP","6.340823629731827","0.8432835820895522","0.7916666666666666","0.9047619047619048"
"Cholinergic, muscarinic M1","Ki","NA","134","Smile SVC Tanimoto classification","0.9130337581041809","Minimum","UP","6.340823629731827","0.8059701492537313","0.7761194029850746","0.8253968253968254"
"Cholinergic, muscarinic M1","Ki","NA","134","Weka RF classification","0.9114688128772636","Minimum","UP","6.340823629731827","0.8134328358208955","0.8275862068965517","0.7619047619047619"
"Cholinergic, muscarinic M1","Ki","NA","134","Smile SVC RBF classification","0.8685446009389673","Minimum","UP","6.340823629731827","0.7835820895522388","0.84","0.6666666666666666"
"OPIATE Mu","Ki","NA","144","Weka RF on folded fp classification","0.8604702750665484","Proportion","UP","8.043675246272999","0.8125","0.7209302325581395","0.6739130434782609"
"OPIATE Mu","Ki","NA","144","Smile SVC Tanimoto classification","0.8549245785270626","Proportion","UP","8.043675246272999","0.8263888888888888","0.7058823529411765","0.782608695652174"
"OPIATE Mu","Ki","NA","144","Smile Bernoulli NB classification","0.8438331854480923","Proportion","UP","8.043675246272999","0.7152777777777778","0.5308641975308642","0.9347826086956522"
"OPIATE Mu","Ki","NA","144","Smile SVC Poly classification","0.8420585625554563","Proportion","UP","8.043675246272999","0.6875","1.0","0.021739130434782608"
"OPIATE Mu","Ki","NA","144","Smile SVC RBF classification","0.7999112688553686","Proportion","UP","8.043675246272999","0.7291666666666666","0.6296296296296297","0.3695652173913043"
"OPIATE Mu","Ki","NA","144","Weka RF classification","0.7767302573203194","Proportion","UP","8.043675246272999","0.7569444444444444","0.627906976744186","0.5869565217391305"
"adrenergic Alpha1A","Ki","NA","111","Smile SVC Tanimoto classification","0.8943763518385004","Minimum","UP","6.7507133985118175","0.8018018018018018","0.7352941176470589","0.6578947368421053"
"adrenergic Alpha1A","Ki","NA","111","Weka RF classification","0.8895097332372025","Minimum","UP","6.7507133985118175","0.8198198198198198","0.8","0.631578947368421"
"adrenergic Alpha1A","Ki","NA","111","Smile SVC RBF classification","0.8723864455659699","Minimum","UP","6.7507133985118175","0.7297297297297297","1.0","0.21052631578947367"
"adrenergic Alpha1A","Ki","NA","111","Weka RF on folded fp classification","0.8704037490987743","Minimum","UP","6.7507133985118175","0.7567567567567568","0.8235294117647058","0.3684210526315789"
"adrenergic Alpha1A","Ki","NA","111","Smile Bernoulli NB classification","0.8626532083633743","Minimum","UP","6.7507133985118175","0.6846846846846847","0.5217391304347826","0.9473684210526315"
"adrenergic Alpha1A","Ki","NA","111","Smile SVC Poly classification","0.8536409516943043","Minimum","UP","6.7507133985118175","0.6576576576576577","NaN","0.0"
"Norepinephrine transporter","Ki","NA","159","Weka RF on folded fp classification","0.7952531645569619","Minimum","UP","5.814168151638226","0.6918238993710691","0.6530612244897959","0.810126582278481"
"Norepinephrine transporter","Ki","NA","159","Smile SVC Tanimoto classification","0.7856012658227847","Minimum","UP","5.814168151638226","0.6729559748427673","0.6451612903225806","0.759493670886076"
"Norepinephrine transporter","Ki","NA","159","Smile SVC Poly classification","0.7829113924050631","Minimum","UP","5.814168151638226","0.4716981132075472","0.4528301886792453","0.3037974683544304"
"Norepinephrine transporter","Ki","NA","159","Smile Bernoulli NB classification","0.7753164556962024","Minimum","UP","5.814168151638226","0.710691823899371","0.6853932584269663","0.7721518987341772"
"Norepinephrine transporter","Ki","NA","159","Weka RF classification","0.767879746835443","Minimum","UP","5.814168151638226","0.7232704402515723","0.7058823529411765","0.759493670886076"
"Norepinephrine transporter","Ki","NA","159","Smile SVC RBF classification","0.7428797468354429","Minimum","UP","5.814168151638226","0.6855345911949685","0.6790123456790124","0.6962025316455697"
"DOPAMINE D1","Ki","NA","233","Weka RF on folded fp classification","0.8771224984839299","Minimum","UP","5.761438765653894","0.7939914163090128","0.855072463768116","0.6082474226804123"
"DOPAMINE D1","Ki","NA","233","Smile Bernoulli NB classification","0.8770466949666467","Minimum","UP","5.761438765653894","0.7253218884120172","0.6170212765957447","0.8969072164948454"
"DOPAMINE D1","Ki","NA","233","Smile SVC Tanimoto classification","0.8750000000000002","Minimum","UP","5.761438765653894","0.8283261802575107","0.7878787878787878","0.8041237113402062"
"DOPAMINE D1","Ki","NA","233","Smile SVC Poly classification","0.8600288053365679","Minimum","UP","5.761438765653894","0.5965665236051502","0.8","0.041237113402061855"
"DOPAMINE D1","Ki","NA","233","Weka RF classification","0.8198150394178291","Minimum","UP","5.761438765653894","0.7510729613733905","0.696969696969697","0.711340206185567"
"DOPAMINE D1","Ki","NA","233","Smile SVC RBF classification","0.7769860521528201","Minimum","UP","5.761438765653894","0.7467811158798283","0.7714285714285715","0.5567010309278351"
"adrenergic Alpha1B","Ki","NA","104","Weka RF classification","0.9003906249999999","Inflection","UP","6.597062693889956","0.8269230769230769","0.7692307692307693","0.625"
"adrenergic Alpha1B","Ki","NA","104","Smile SVC RBF classification","0.8789062499999998","Inflection","UP","6.597062693889956","0.7596153846153846","0.8888888888888888","0.25"
"adrenergic Alpha1B","Ki","NA","104","Weka RF on folded fp classification","0.8667534722222221","Inflection","UP","6.597062693889956","0.7980769230769231","1.0","0.34375"
"adrenergic Alpha1B","Ki","NA","104","Smile SVC Tanimoto classification","0.8615451388888891","Inflection","UP","6.597062693889956","0.8173076923076923","0.7096774193548387","0.6875"
"adrenergic Alpha1B","Ki","NA","104","Smile Bernoulli NB classification","0.8164062499999997","Inflection","UP","6.597062693889956","0.5865384615384616","0.4126984126984127","0.8125"
"adrenergic Alpha1B","Ki","NA","104","Smile SVC Poly classification","0.8151041666666663","Inflection","UP","6.597062693889956","0.6923076923076923","NaN","0.0"
"Cholinergic, muscarinic M4","Ki","NA","117","Smile Bernoulli NB classification","0.8952087007642564","Minimum","UP","6.332912354009978","0.8205128205128205","0.7391304347826086","0.9444444444444444"
"Cholinergic, muscarinic M4","Ki","NA","117","Weka RF on folded fp classification","0.8880070546737215","Minimum","UP","6.332912354009978","0.7606837606837606","0.7708333333333334","0.6851851851851852"
"Cholinergic, muscarinic M4","Ki","NA","117","Smile SVC Poly classification","0.8868312757201647","Minimum","UP","6.332912354009978","0.4700854700854701","0.39473684210526316","0.2777777777777778"
"Cholinergic, muscarinic M4","Ki","NA","117","Smile SVC Tanimoto classification","0.8539094650205763","Minimum","UP","6.332912354009978","0.7692307692307693","0.7142857142857143","0.8333333333333334"
"Cholinergic, muscarinic M4","Ki","NA","117","Weka RF classification","0.8461199294532631","Minimum","UP","6.332912354009978","0.7606837606837606","0.7166666666666667","0.7962962962962963"
"Cholinergic, muscarinic M4","Ki","NA","117","Smile SVC RBF classification","0.8012933568489129","Minimum","UP","6.332912354009978","0.7606837606837606","0.825","0.6111111111111112"
"5-HT2","Ki","NA","121","Smile Bernoulli NB classification","0.9389709906951286","Minimum","UP","7.040404040404041","0.8016528925619835","0.717948717948718","0.9655172413793104"
"5-HT2","Ki","NA","121","Weka RF on folded fp classification","0.9148877941981391","Minimum","UP","7.040404040404041","0.8429752066115702","0.8421052631578947","0.8275862068965517"
"5-HT2","Ki","NA","121","Smile SVC Tanimoto classification","0.9107827038861522","Minimum","UP","7.040404040404041","0.8099173553719008","0.7966101694915254","0.8103448275862069"
"5-HT2","Ki","NA","121","Smile SVC Poly classification","0.9105090311986862","Minimum","UP","7.040404040404041","0.47107438016528924","0.425","0.29310344827586204"
"5-HT2","Ki","NA","121","Weka RF classification","0.8565955117679256","Minimum","UP","7.040404040404041","0.7520661157024794","0.71875","0.7931034482758621"
"5-HT2","Ki","NA","121","Smile SVC RBF classification","0.8399014778325121","Minimum","UP","7.040404040404041","0.71900826446281","0.75","0.6206896551724138"
"adrenergic Alpha2C","Ki","NA","129","Smile SVC Tanimoto classification","0.7725797728501893","Proportion","UP","7.249022968317128","0.7596899224806202","0.6666666666666666","0.5581395348837209"
"adrenergic Alpha2C","Ki","NA","129","Smile SVC Poly classification","0.7479718766901023","Proportion","UP","7.249022968317128","0.6666666666666666","NaN","0.0"
"adrenergic Alpha2C","Ki","NA","129","Weka RF on folded fp classification","0.7425635478637098","Proportion","UP","7.249022968317128","0.6976744186046512","0.625","0.23255813953488372"
"adrenergic Alpha2C","Ki","NA","129","Smile Bernoulli NB classification","0.7389129259058946","Proportion","UP","7.249022968317128","0.5891472868217055","0.43902439024390244","0.8372093023255814"
"adrenergic Alpha2C","Ki","NA","129","Weka RF classification","0.718361276365603","Proportion","UP","7.249022968317128","0.6744186046511628","0.5185185185185185","0.32558139534883723"
"adrenergic Alpha2C","Ki","NA","129","Smile SVC RBF classification","0.6995673336938882","Proportion","UP","7.249022968317128","0.6744186046511628","0.5454545454545454","0.13953488372093023"
"adrenergic Alpha2","Ki","NA","153","Weka RF classification","0.7366981132075474","Proportion","UP","6.546654976049467","0.7189542483660131","0.6470588235294118","0.41509433962264153"
"adrenergic Alpha2","Ki","NA","153","Smile Bernoulli NB classification","0.7167924528301884","Proportion","UP","6.546654976049467","0.6013071895424836","0.45121951219512196","0.6981132075471698"
"adrenergic Alpha2","Ki","NA","153","Smile SVC Tanimoto classification","0.6951886792452826","Proportion","UP","6.546654976049467","0.7124183006535948","0.6153846153846154","0.4528301886792453"
"adrenergic Alpha2","Ki","NA","153","Smile SVC Poly classification","0.6950000000000001","Proportion","UP","6.546654976049467","0.6535947712418301","NaN","0.0"
"adrenergic Alpha2","Ki","NA","153","Smile SVC RBF classification","0.6756603773584906","Proportion","UP","6.546654976049467","0.6993464052287581","0.7333333333333333","0.20754716981132076"
"adrenergic Alpha2","Ki","NA","153","Weka RF on folded fp classification","0.675","Proportion","UP","6.546654976049467","0.7124183006535948","0.68","0.32075471698113206"
"adrenergic Alpha1","Ki","NA","146","Weka RF on folded fp classification","0.9052177572059753","Proportion","UP","7.28453083208872","0.7876712328767124","0.75","0.5510204081632653"
"adrenergic Alpha1","Ki","NA","146","Smile SVC Tanimoto classification","0.9042709867452133","Proportion","UP","7.28453083208872","0.8561643835616438","0.78","0.7959183673469388"
"adrenergic Alpha1","Ki","NA","146","Weka RF classification","0.8992215442878182","Proportion","UP","7.28453083208872","0.815068493150685","0.7115384615384616","0.7551020408163265"
"adrenergic Alpha1","Ki","NA","146","Smile SVC RBF classification","0.8876499053229537","Proportion","UP","7.28453083208872","0.7602739726027398","1.0","0.2857142857142857"
"adrenergic Alpha1","Ki","NA","146","Smile Bernoulli NB classification","0.886071954555017","Proportion","UP","7.28453083208872","0.678082191780822","0.5113636363636364","0.9183673469387755"
"adrenergic Alpha1","Ki","NA","146","Smile SVC Poly classification","0.8786029875867866","Proportion","UP","7.28453083208872","0.6643835616438356","NaN","0.0"
"Cholinergic, muscarinic M3","Ki","NA","130","Weka RF on folded fp classification","0.9011015325670493","Minimum","UP","6.329359193909465","0.8461538461538461","0.8166666666666667","0.8448275862068966"
"Cholinergic, muscarinic M3","Ki","NA","130","Weka RF classification","0.9006226053639845","Minimum","UP","6.329359193909465","0.8076923076923077","0.8","0.7586206896551724"
"Cholinergic, muscarinic M3","Ki","NA","130","Smile SVC Tanimoto classification","0.8891283524904209","Minimum","UP","6.329359193909465","0.8","0.7424242424242424","0.8448275862068966"
"Cholinergic, muscarinic M3","Ki","NA","130","Smile SVC Poly classification","0.8826628352490428","Minimum","UP","6.329359193909465","0.5615384615384615","1.0","0.017241379310344827"
"Cholinergic, muscarinic M3","Ki","NA","130","Smile Bernoulli NB classification","0.8826628352490425","Minimum","UP","6.329359193909465","0.823076923076923","0.7333333333333333","0.9482758620689655"
"Cholinergic, muscarinic M3","Ki","NA","130","Smile SVC RBF classification","0.8527298850574723","Minimum","UP","6.329359193909465","0.7769230769230769","0.8372093023255814","0.6206896551724138"
"5-HT2B","Ki","NA","123","Smile Bernoulli NB classification","0.7561852704257767","Proportion","UP","7.459683468206588","0.6666666666666666","0.5245901639344263","0.7272727272727273"
"5-HT2B","Ki","NA","123","Weka RF on folded fp classification","0.7302934407364791","Proportion","UP","7.459683468206588","0.7235772357723578","0.7083333333333334","0.38636363636363635"
"5-HT2B","Ki","NA","123","Smile SVC Poly classification","0.7232451093210586","Proportion","UP","7.459683468206588","0.6341463414634146","0.0","0.0"
"5-HT2B","Ki","NA","123","Smile SVC Tanimoto classification","0.7195051783659381","Proportion","UP","7.459683468206588","0.6747967479674797","0.5555555555555556","0.45454545454545453"
"5-HT2B","Ki","NA","123","Weka RF classification","0.70066168009206","Proportion","UP","7.459683468206588","0.7073170731707317","0.625","0.45454545454545453"
"5-HT2B","Ki","NA","123","Smile SVC RBF classification","0.6697353279631757","Proportion","UP","7.459683468206588","0.6422764227642277","0.5","0.11363636363636363"
"OPIATE Kappa","Ki","NA","122","Weka RF on folded fp classification","0.9430842607313195","Inflection","UP","6.420413294158891","0.8852459016393442","0.8484848484848485","0.7567567567567568"
"OPIATE Kappa","Ki","NA","122","Smile Bernoulli NB classification","0.9408585055643879","Inflection","UP","6.420413294158891","0.8688524590163934","0.723404255319149","0.918918918918919"
"OPIATE Kappa","Ki","NA","122","Smile SVC Poly classification","0.9379968203497605","Inflection","UP","6.420413294158891","0.7131147540983607","1.0","0.05405405405405406"
"OPIATE Kappa","Ki","NA","122","Smile SVC Tanimoto classification","0.9252782193958653","Inflection","UP","6.420413294158891","0.8770491803278688","0.8055555555555556","0.7837837837837838"
"OPIATE Kappa","Ki","NA","122","Weka RF classification","0.9068362480127184","Inflection","UP","6.420413294158891","0.8278688524590164","0.7857142857142857","0.5945945945945946"
"OPIATE Kappa","Ki","NA","122","Smile SVC RBF classification","0.8848966613672494","Inflection","UP","6.420413294158891","0.8442622950819673","0.8214285714285714","0.6216216216216216"
"DOPAMINE D2","Ki","NA","291","Weka RF on folded fp classification","0.8947604120017911","Minimum","UP","7.533854446502959","0.8213058419243986","0.8333333333333334","0.5113636363636364"
"DOPAMINE D2","Ki","NA","291","Smile SVC Tanimoto classification","0.8823331840573233","Minimum","UP","7.533854446502959","0.8281786941580757","0.7261904761904762","0.6931818181818182"
"DOPAMINE D2","Ki","NA","291","Smile SVC Poly classification","0.8728168383340799","Minimum","UP","7.533854446502959","0.7044673539518901","1.0","0.022727272727272728"
"DOPAMINE D2","Ki","NA","291","Smile Bernoulli NB classification","0.8726209135691925","Minimum","UP","7.533854446502959","0.6185567010309279","0.4385026737967914","0.9318181818181818"
"DOPAMINE D2","Ki","NA","291","Weka RF classification","0.8526085982982534","Minimum","UP","7.533854446502959","0.8109965635738832","0.7391304347826086","0.5795454545454546"
"DOPAMINE D2","Ki","NA","291","Smile SVC RBF classification","0.8524966412897433","Minimum","UP","7.533854446502959","0.8109965635738832","0.9024390243902439","0.42045454545454547"
"5-HT7","Ki","NA","169","Smile Bernoulli NB classification","0.8559633027522939","Minimum","UP","6.889027530226635","0.7041420118343196","0.5471698113207547","0.9666666666666667"
"5-HT7","Ki","NA","169","Weka RF on folded fp classification","0.8470948012232418","Minimum","UP","6.889027530226635","0.7396449704142012","0.6818181818181818","0.5"
"5-HT7","Ki","NA","169","Weka RF classification","0.8444954128440367","Minimum","UP","6.889027530226635","0.7514792899408284","0.6323529411764706","0.7166666666666667"
"5-HT7","Ki","NA","169","Smile SVC Poly classification","0.8358562691131504","Minimum","UP","6.889027530226635","0.6449704142011834","0.5","0.016666666666666666"
"5-HT7","Ki","NA","169","Smile SVC Tanimoto classification","0.8327217125382267","Minimum","UP","6.889027530226635","0.7751479289940828","0.6571428571428571","0.7666666666666667"
"5-HT7","Ki","NA","169","Smile SVC RBF classification","0.7931192660550466","Minimum","UP","6.889027530226635","0.7041420118343196","0.65625","0.35"
"5-HT3","Ki","NA","211","Smile SVC RBF classification","0.8233184725722028","Proportion","UP","5.515974884032238","0.6919431279620853","0.6875","0.2857142857142857"
"5-HT3","Ki","NA","211","Weka RF classification","0.8057278542353168","Proportion","UP","5.515974884032238","0.7819905213270142","0.7818181818181819","0.5584415584415584"
"5-HT3","Ki","NA","211","Smile SVC Tanimoto classification","0.7884279899205269","Proportion","UP","5.515974884032238","0.7725118483412322","0.7230769230769231","0.6103896103896104"
"5-HT3","Ki","NA","211","Smile Bernoulli NB classification","0.785617367706919","Proportion","UP","5.515974884032238","0.6540284360189573","0.5181818181818182","0.7402597402597403"
"5-HT3","Ki","NA","211","Smile SVC Poly classification","0.7778639271176578","Proportion","UP","5.515974884032238","0.6350710900473934","NaN","0.0"
"5-HT3","Ki","NA","211","Weka RF on folded fp classification","0.7400659042450081","Proportion","UP","5.515974884032238","0.7298578199052133","0.7777777777777778","0.36363636363636365"
"adrenergic Alpha2A","Ki","NA","141","Smile Bernoulli NB classification","0.8095604395604391","Proportion","UP","7.047424690414974","0.6666666666666666","0.5194805194805194","0.8"
"adrenergic Alpha2A","Ki","NA","141","Smile SVC RBF classification","0.8006593406593412","Proportion","UP","7.047424690414974","0.723404255319149","0.7391304347826086","0.34"
"adrenergic Alpha2A","Ki","NA","141","Smile SVC Poly classification","0.7949450549450551","Proportion","UP","7.047424690414974","0.6453900709219859","NaN","0.0"
"adrenergic Alpha2A","Ki","NA","141","Weka RF on folded fp classification","0.7826373626373624","Proportion","UP","7.047424690414974","0.7446808510638298","0.7692307692307693","0.4"
"adrenergic Alpha2A","Ki","NA","141","Smile SVC Tanimoto classification","0.7705494505494503","Proportion","UP","7.047424690414974","0.7730496453900709","0.7045454545454546","0.62"
"adrenergic Alpha2A","Ki","NA","141","Weka RF classification","0.7557142857142857","Proportion","UP","7.047424690414974","0.7304964539007093","0.6666666666666666","0.48"
"5-HT2C","Ki","NA","282","Smile Bernoulli NB classification","0.8703787535838228","Minimum","UP","5.937200865754152","0.7695035460992907","0.7209302325581395","0.8794326241134752"
"5-HT2C","Ki","NA","282","Smile SVC Tanimoto classification","0.8583572254916741","Minimum","UP","5.937200865754152","0.7446808510638298","0.7197452229299363","0.8014184397163121"
"5-HT2C","Ki","NA","282","Smile SVC Poly classification","0.852572808208842","Minimum","UP","5.937200865754152","0.4787234042553192","0.46938775510204084","0.3262411347517731"
"5-HT2C","Ki","NA","282","Weka RF on folded fp classification","0.8522710125245201","Minimum","UP","5.937200865754152","0.776595744680851","0.8046875","0.7304964539007093"
"5-HT2C","Ki","NA","282","Smile SVC RBF classification","0.8175142095468024","Minimum","UP","5.937200865754152","0.7304964539007093","0.751937984496124","0.6879432624113475"
"5-HT2C","Ki","NA","282","Weka RF classification","0.8103214124038023","Minimum","UP","5.937200865754152","0.7163120567375887","0.7103448275862069","0.7304964539007093"
"Cholinergic, muscarinic M2","Ki","NA","149","Weka RF on folded fp classification","0.9415726246814705","Minimum","UP","6.115800400989309","0.8657718120805369","0.8507462686567164","0.8507462686567164"
"Cholinergic, muscarinic M2","Ki","NA","149","Smile Bernoulli NB classification","0.9018019657808508","Minimum","UP","6.115800400989309","0.8322147651006712","0.7692307692307693","0.8955223880597015"
"Cholinergic, muscarinic M2","Ki","NA","149","Weka RF classification","0.8947033127047688","Minimum","UP","6.115800400989309","0.7919463087248322","0.7903225806451613","0.7313432835820896"
"Cholinergic, muscarinic M2","Ki","NA","149","Smile SVC Poly classification","0.8937022206042947","Minimum","UP","6.115800400989309","0.5570469798657718","1.0","0.014925373134328358"
"Cholinergic, muscarinic M2","Ki","NA","149","Smile SVC Tanimoto classification","0.8824171823807786","Minimum","UP","6.115800400989309","0.8322147651006712","0.8","0.835820895522388"
"Cholinergic, muscarinic M2","Ki","NA","149","Smile SVC RBF classification","0.8662176920276651","Minimum","UP","6.115800400989309","0.7718120805369127","0.8367346938775511","0.6119402985074627"
"5-HT1A","Ki","NA","265","Smile SVC Poly classification","0.8601132909643547","Inflection","UP","6.6858585854472015","0.720754716981132","1.0","0.03896103896103896"
"5-HT1A","Ki","NA","265","Weka RF on folded fp classification","0.8580408952749387","Inflection","UP","6.6858585854472015","0.8226415094339623","0.8260869565217391","0.4935064935064935"
"5-HT1A","Ki","NA","265","Smile SVC Tanimoto classification","0.8393202542138721","Inflection","UP","6.6858585854472015","0.8037735849056604","0.7049180327868853","0.5584415584415584"
"5-HT1A","Ki","NA","265","Smile Bernoulli NB classification","0.8208068527217457","Inflection","UP","6.6858585854472015","0.6226415094339622","0.4258064516129032","0.8571428571428571"
"5-HT1A","Ki","NA","265","Weka RF classification","0.8179400386847194","Inflection","UP","6.6858585854472015","0.7849056603773585","0.6851851851851852","0.4805194805194805"
"5-HT1A","Ki","NA","265","Smile SVC RBF classification","0.7625725338491294","Inflection","UP","6.6858585854472015","0.7660377358490567","0.8260869565217391","0.24675324675324675"
"adrenergic Beta2","Ki","NA","111","Smile Bernoulli NB classification","0.8080985915492954","Proportion","UP","5.484299121472576","0.7657657657657657","0.6296296296296297","0.85"
"adrenergic Beta2","Ki","NA","111","Smile SVC RBF classification","0.7996478873239435","Proportion","UP","5.484299121472576","0.7567567567567568","0.8095238095238095","0.425"
"adrenergic Beta2","Ki","NA","111","Weka RF on folded fp classification","0.798943661971831","Proportion","UP","5.484299121472576","0.7567567567567568","0.7241379310344828","0.525"
"adrenergic Beta2","Ki","NA","111","Weka RF classification","0.7941901408450706","Proportion","UP","5.484299121472576","0.7657657657657657","0.71875","0.575"
"adrenergic Beta2","Ki","NA","111","Smile SVC Tanimoto classification","0.789788732394366","Proportion","UP","5.484299121472576","0.7567567567567568","0.6585365853658537","0.675"
"adrenergic Beta2","Ki","NA","111","Smile SVC Poly classification","0.7894366197183095","Proportion","UP","5.484299121472576","0.6396396396396397","NaN","0.0"
"Dopamine Transporter","Ki","NA","148","Smile SVC Tanimoto classification","0.7659824046920822","Proportion","UP","5.646241627796357","0.722972972972973","0.675","0.4909090909090909"
"Dopamine Transporter","Ki","NA","148","Smile Bernoulli NB classification","0.7548387096774193","Proportion","UP","5.646241627796357","0.6959459459459459","0.5806451612903226","0.6545454545454545"
"Dopamine Transporter","Ki","NA","148","Weka RF on folded fp classification","0.7509286412512218","Proportion","UP","5.646241627796357","0.722972972972973","0.71875","0.41818181818181815"
"Dopamine Transporter","Ki","NA","148","Smile SVC Poly classification","0.7311827956989249","Proportion","UP","5.646241627796357","0.6283783783783784","NaN","0.0"
"Dopamine Transporter","Ki","NA","148","Smile SVC RBF classification","0.7292277614858258","Proportion","UP","5.646241627796357","0.6824324324324325","0.625","0.36363636363636365"
"Dopamine Transporter","Ki","NA","148","Weka RF classification","0.6941348973607038","Proportion","UP","5.646241627796357","0.6621621621621622","0.5609756097560976","0.41818181818181815"
"Cholinergic, muscarinic","Ki","NA","105","Smile Bernoulli NB classification","0.8022496371552974","Inflection","UP","5.6408750319132235","0.7238095238095238","0.7017543859649122","0.7692307692307693"
"Cholinergic, muscarinic","Ki","NA","105","Smile SVC Poly classification","0.7910014513788098","Inflection","UP","5.6408750319132235","0.4857142857142857","0.4852941176470588","0.6346153846153846"
"Cholinergic, muscarinic","Ki","NA","105","Weka RF on folded fp classification","0.7558055152394777","Inflection","UP","5.6408750319132235","0.6571428571428571","0.6428571428571429","0.6923076923076923"
"Cholinergic, muscarinic","Ki","NA","105","Smile SVC Tanimoto classification","0.7558055152394771","Inflection","UP","5.6408750319132235","0.6761904761904762","0.6666666666666666","0.6923076923076923"
"Cholinergic, muscarinic","Ki","NA","105","Smile SVC RBF classification","0.7503628447024672","Inflection","UP","5.6408750319132235","0.6952380952380952","0.8333333333333334","0.4807692307692308"
"Cholinergic, muscarinic","Ki","NA","105","Weka RF classification","0.7322206095791001","Inflection","UP","5.6408750319132235","0.638095238095238","0.6296296296296297","0.6538461538461539"
"adrenergic Beta1","Ki","NA","107","Smile Bernoulli NB classification","0.8744343891402716","Proportion","UP","5.558202270414537","0.7476635514018691","0.603448275862069","0.8974358974358975"
"adrenergic Beta1","Ki","NA","107","Weka RF on folded fp classification","0.8731146304675718","Proportion","UP","5.558202270414537","0.7850467289719626","0.8636363636363636","0.48717948717948717"
"adrenergic Beta1","Ki","NA","107","Smile SVC Poly classification","0.8208898944193064","Proportion","UP","5.558202270414537","0.6448598130841121","1.0","0.02564102564102564"
"adrenergic Beta1","Ki","NA","107","Weka RF classification","0.8146681749622927","Proportion","UP","5.558202270414537","0.7570093457943925","0.7096774193548387","0.5641025641025641"
"adrenergic Beta1","Ki","NA","107","Smile SVC Tanimoto classification","0.8024132730015084","Proportion","UP","5.558202270414537","0.7570093457943925","0.6756756756756757","0.6410256410256411"
"adrenergic Beta1","Ki","NA","107","Smile SVC RBF classification","0.7858220211161389","Proportion","UP","5.558202270414537","0.719626168224299","0.7368421052631579","0.358974358974359"
"adrenergic Alpha2B","Ki","NA","130","Weka RF classification","0.7786733615221988","Proportion","UP","7.187155795627568","0.6846153846153846","0.56","0.3181818181818182"
"adrenergic Alpha2B","Ki","NA","130","Smile SVC RBF classification","0.767177589852008","Proportion","UP","7.187155795627568","0.7384615384615385","0.8571428571428571","0.2727272727272727"
"adrenergic Alpha2B","Ki","NA","130","Smile SVC Poly classification","0.7328224101479914","Proportion","UP","7.187155795627568","0.6615384615384615","NaN","0.0"
"adrenergic Alpha2B","Ki","NA","130","Smile SVC Tanimoto classification","0.7037526427061308","Proportion","UP","7.187155795627568","0.6923076923076923","0.5625","0.4090909090909091"
"adrenergic Alpha2B","Ki","NA","130","Weka RF on folded fp classification","0.7026955602537","Proportion","UP","7.187155795627568","0.6692307692307692","0.5384615384615384","0.1590909090909091"
"adrenergic Alpha2B","Ki","NA","130","Smile Bernoulli NB classification","0.6956923890063427","Proportion","UP","7.187155795627568","0.6230769230769231","0.4666666666666667","0.7954545454545454"
"5-HT2A","Ki","NA","319","Smile SVC RBF classification","0.8928365819557535","Minimum","UP","6.908200405170315","0.8244514106583072","0.9069767441860465","0.6190476190476191"
"5-HT2A","Ki","NA","319","Weka RF on folded fp classification","0.8812607944732296","Minimum","UP","6.908200405170315","0.8369905956112853","0.8490566037735849","0.7142857142857143"
"5-HT2A","Ki","NA","319","Smile SVC Tanimoto classification","0.880417797516242","Minimum","UP","6.908200405170315","0.8526645768025078","0.8110236220472441","0.8174603174603174"
"5-HT2A","Ki","NA","319","Smile Bernoulli NB classification","0.8798420922773261","Minimum","UP","6.908200405170315","0.7523510971786834","0.6312849162011173","0.8968253968253969"
"5-HT2A","Ki","NA","319","Smile SVC Poly classification","0.8744551361131669","Minimum","UP","6.908200405170315","0.6050156739811913","0.5","0.007936507936507936"
"5-HT2A","Ki","NA","319","Weka RF classification","0.8726046549880747","Minimum","UP","6.908200405170315","0.8087774294670846","0.7443609022556391","0.7857142857142857"
"5-HT1D","Ki","NA","168","Smile SVC Poly classification","0.8068181818181805","Inflection","UP","6.488046596903814","0.7440476190476191","1.0","0.022727272727272728"
"5-HT1D","Ki","NA","168","Smile SVC Tanimoto classification","0.785373900293255","Inflection","UP","6.488046596903814","0.8214285714285714","0.7333333333333333","0.5"
"5-HT1D","Ki","NA","168","Smile Bernoulli NB classification","0.7842741935483876","Inflection","UP","6.488046596903814","0.6130952380952381","0.38202247191011235","0.7727272727272727"
"5-HT1D","Ki","NA","168","Weka RF classification","0.7807001466275659","Inflection","UP","6.488046596903814","0.8035714285714286","0.7391304347826086","0.38636363636363635"
"5-HT1D","Ki","NA","168","Weka RF on folded fp classification","0.7666788856304986","Inflection","UP","6.488046596903814","0.8333333333333334","0.8333333333333334","0.45454545454545453"
"5-HT1D","Ki","NA","168","Smile SVC RBF classification","0.6972140762463338","Inflection","UP","6.488046596903814","0.7738095238095238","0.7142857142857143","0.22727272727272727"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2/Cyclin A|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","171","Smile SVC Poly classification","0.8524904214559389","Minimum","UP","5.820933140620905","0.783625730994152","0.7659574468085106","0.8275862068965517"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2/Cyclin A|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","171","Smile Bernoulli NB classification","0.8477695675971543","Minimum","UP","5.820933140620905","0.7602339181286549","0.73","0.8390804597701149"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2/Cyclin A|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","171","Weka RF on folded fp classification","0.8446907498631637","Minimum","UP","5.820933140620905","0.7426900584795322","0.7415730337078652","0.7586206896551724"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2/Cyclin A|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","171","Smile SVC Tanimoto classification","0.818281335522715","Minimum","UP","5.820933140620905","0.7602339181286549","0.75","0.7931034482758621"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2/Cyclin A|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","171","Smile SVC RBF classification","0.811781609195403","Minimum","UP","5.820933140620905","0.7485380116959064","0.782051282051282","0.7011494252873564"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2/Cyclin A|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","171","Weka RF classification","0.8034345922276959","Minimum","UP","5.820933140620905","0.7368421052631579","0.7625","0.7011494252873564"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","412","Weka RF on folded fp classification","0.9021928065249366","Proportion","DOWN","7.541542084934767","0.8228155339805825","0.8617021276595744","0.8772563176895307"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","412","Smile SVC Tanimoto classification","0.8848108035833668","Proportion","DOWN","7.541542084934767","0.8276699029126213","0.8872180451127819","0.851985559566787"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","412","Smile SVC RBF classification","0.8810001337077152","Proportion","DOWN","7.541542084934767","0.837378640776699","0.8595890410958904","0.9061371841155235"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","412","Weka RF classification","0.8800106966171948","Proportion","DOWN","7.541542084934767","0.8228155339805825","0.8669064748201439","0.8700361010830325"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","412","Smile Bernoulli NB classification","0.8754646343094007","Proportion","DOWN","7.541542084934767","0.7912621359223301","0.9170305676855895","0.7581227436823105"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","412","Smile SVC Poly classification","0.8694344163658247","Proportion","DOWN","7.541542084934767","0.7985436893203883","0.8129032258064516","0.9097472924187726"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","181","Weka RF on folded fp classification","0.8540998931623928","Proportion","DOWN","7.437912731212775","0.8011049723756906","0.8347107438016529","0.8632478632478633"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","181","Weka RF classification","0.8225827991452992","Proportion","DOWN","7.437912731212775","0.8011049723756906","0.824","0.8803418803418803"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","181","Smile Bernoulli NB classification","0.8032852564102564","Proportion","DOWN","7.437912731212775","0.6906077348066298","0.8279569892473119","0.6581196581196581"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","181","Smile SVC Poly classification","0.8023504273504272","Proportion","DOWN","7.437912731212775","0.6464088397790055","0.6568047337278107","0.9487179487179487"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","181","Smile SVC Tanimoto classification","0.7891292735042736","Proportion","DOWN","7.437912731212775","0.7237569060773481","0.7481481481481481","0.8632478632478633"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","181","Smile SVC RBF classification","0.7259615384615382","Proportion","DOWN","7.437912731212775","0.6408839779005525","0.6645569620253164","0.8974358974358975"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1 in presence of 9.5 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","103","Smile SVC Tanimoto classification","0.8552416052416051","Proportion","DOWN","7.092903477928976","0.7961165048543689","0.8082191780821918","0.8939393939393939"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1 in presence of 9.5 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","103","Weka RF classification","0.824938574938575","Proportion","DOWN","7.092903477928976","0.7281553398058253","0.7878787878787878","0.7878787878787878"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1 in presence of 9.5 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","103","Smile SVC Poly classification","0.8101965601965602","Proportion","DOWN","7.092903477928976","0.6407766990291263","0.6407766990291263","1.0"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1 in presence of 9.5 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","103","Smile Bernoulli NB classification","0.7907452907452908","Proportion","DOWN","7.092903477928976","0.7378640776699029","0.8545454545454545","0.7121212121212122"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1 in presence of 9.5 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","103","Weka RF on folded fp classification","0.7841932841932842","Proportion","DOWN","7.092903477928976","0.7766990291262136","0.8524590163934426","0.7878787878787878"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1 in presence of 9.5 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","103","Smile SVC RBF classification","0.7416052416052414","Proportion","DOWN","7.092903477928976","0.6796116504854369","0.7037037037037037","0.8636363636363636"
"DYRK1A","Activity Value","Assay Description:PubChem BioAssay. Assay for Inhibitors of Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (Kinase-Glo assay): round 2 SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1770, AID1970, AID2705, AID488872]|Activity Type:Potency|Target Accession Numbers:NP_001387, NP_567824, NP_569120, NP_569121, NP_569122, SK234, Q13627|Standard Unit:uM","141","Weka RF on folded fp classification","0.9288087327954437","Minimum","UP","5.74647637619052","0.900709219858156","0.8536585365853658","0.813953488372093"
"DYRK1A","Activity Value","Assay Description:PubChem BioAssay. Assay for Inhibitors of Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (Kinase-Glo assay): round 2 SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1770, AID1970, AID2705, AID488872]|Activity Type:Potency|Target Accession Numbers:NP_001387, NP_567824, NP_569120, NP_569121, NP_569122, SK234, Q13627|Standard Unit:uM","141","Smile SVC Poly classification","0.8927384907451353","Minimum","UP","5.74647637619052","0.8226950354609929","0.8","0.5581395348837209"
"DYRK1A","Activity Value","Assay Description:PubChem BioAssay. Assay for Inhibitors of Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (Kinase-Glo assay): round 2 SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1770, AID1970, AID2705, AID488872]|Activity Type:Potency|Target Accession Numbers:NP_001387, NP_567824, NP_569120, NP_569121, NP_569122, SK234, Q13627|Standard Unit:uM","141","Smile Bernoulli NB classification","0.892501186521121","Minimum","UP","5.74647637619052","0.8226950354609929","0.6551724137931034","0.8837209302325582"
"DYRK1A","Activity Value","Assay Description:PubChem BioAssay. Assay for Inhibitors of Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (Kinase-Glo assay): round 2 SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1770, AID1970, AID2705, AID488872]|Activity Type:Potency|Target Accession Numbers:NP_001387, NP_567824, NP_569120, NP_569121, NP_569122, SK234, Q13627|Standard Unit:uM","141","Smile SVC Tanimoto classification","0.8849074513526346","Minimum","UP","5.74647637619052","0.851063829787234","0.75","0.7674418604651163"
"DYRK1A","Activity Value","Assay Description:PubChem BioAssay. Assay for Inhibitors of Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (Kinase-Glo assay): round 2 SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1770, AID1970, AID2705, AID488872]|Activity Type:Potency|Target Accession Numbers:NP_001387, NP_567824, NP_569120, NP_569121, NP_569122, SK234, Q13627|Standard Unit:uM","141","Weka RF classification","0.872093023255814","Minimum","UP","5.74647637619052","0.8014184397163121","0.6923076923076923","0.627906976744186"
"DYRK1A","Activity Value","Assay Description:PubChem BioAssay. Assay for Inhibitors of Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (Kinase-Glo assay): round 2 SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1770, AID1970, AID2705, AID488872]|Activity Type:Potency|Target Accession Numbers:NP_001387, NP_567824, NP_569120, NP_569121, NP_569122, SK234, Q13627|Standard Unit:uM","141","Smile SVC RBF classification","0.8113431419079264","Minimum","UP","5.74647637619052","0.7375886524822695","0.6666666666666666","0.27906976744186046"
"LCK","Activity Value","Assay Description:Inhibition of LCK|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","243","Weka RF on folded fp classification","0.8329041054385697","Proportion","UP","7.234377514600048","0.7736625514403292","0.6626506024096386","0.6707317073170732"
"LCK","Activity Value","Assay Description:Inhibition of LCK|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","243","Weka RF classification","0.8241933040448417","Proportion","UP","7.234377514600048","0.7942386831275721","0.7285714285714285","0.6219512195121951"
"LCK","Activity Value","Assay Description:Inhibition of LCK|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","243","Smile SVC Tanimoto classification","0.822148159369792","Proportion","UP","7.234377514600048","0.7983539094650206","0.72","0.6585365853658537"
"LCK","Activity Value","Assay Description:Inhibition of LCK|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","243","Smile SVC Poly classification","0.8207847295864266","Proportion","UP","7.234377514600048","0.7407407407407407","0.6507936507936508","0.5"
"LCK","Activity Value","Assay Description:Inhibition of LCK|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","243","Smile SVC RBF classification","0.8135888501742158","Proportion","UP","7.234377514600048","0.7736625514403292","0.7368421052631579","0.5121951219512195"
"LCK","Activity Value","Assay Description:Inhibition of LCK|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","243","Smile Bernoulli NB classification","0.8009392516285408","Proportion","UP","7.234377514600048","0.7078189300411523","0.5426356589147286","0.8536585365853658"
"LCK","Activity Value","Assay Description:Inhibition of Lck|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","356","Smile SVC Tanimoto classification","0.8849281738492835","Minimum","UP","7.171729997580284","0.8258426966292135","0.8","0.7299270072992701"
"LCK","Activity Value","Assay Description:Inhibition of Lck|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","356","Weka RF classification","0.8814618538146185","Minimum","UP","7.171729997580284","0.8286516853932584","0.8166666666666667","0.7153284671532847"
"LCK","Activity Value","Assay Description:Inhibition of Lck|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","356","Weka RF on folded fp classification","0.878978768789787","Minimum","UP","7.171729997580284","0.8061797752808989","0.7931034482758621","0.6715328467153284"
"LCK","Activity Value","Assay Description:Inhibition of Lck|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","356","Smile SVC Poly classification","0.8664300236643003","Minimum","UP","7.171729997580284","0.797752808988764","0.8350515463917526","0.5912408759124088"
"LCK","Activity Value","Assay Description:Inhibition of Lck|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","356","Smile SVC RBF classification","0.858730793587308","Minimum","UP","7.171729997580284","0.800561797752809","0.8235294117647058","0.6131386861313869"
"LCK","Activity Value","Assay Description:Inhibition of Lck|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","356","Smile Bernoulli NB classification","0.8556810985568092","Minimum","UP","7.171729997580284","0.7275280898876404","0.6075268817204301","0.8248175182481752"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. Confirmation Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1379, AID1770, AID1983, AID1997, AID2710, AID488872, AID488883, AID488887, AID493206, AID504421, AID504424, AID504427, AID504428, AID504429, AID504430]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:uM","167","Weka RF on folded fp classification","0.8939065883080731","Minimum","UP","6.450374997668138","0.8383233532934131","0.7931034482758621","0.7540983606557377"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. Confirmation Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1379, AID1770, AID1983, AID1997, AID2710, AID488872, AID488883, AID488887, AID493206, AID504421, AID504424, AID504427, AID504428, AID504429, AID504430]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:uM","167","Smile SVC Tanimoto classification","0.8751159913393135","Minimum","UP","6.450374997668138","0.8323353293413174","0.7894736842105263","0.7377049180327869"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. Confirmation Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1379, AID1770, AID1983, AID1997, AID2710, AID488872, AID488883, AID488887, AID493206, AID504421, AID504424, AID504427, AID504428, AID504429, AID504430]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:uM","167","Smile Bernoulli NB classification","0.8392360037117234","Minimum","UP","6.450374997668138","0.7664670658682635","0.6486486486486487","0.7868852459016393"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. Confirmation Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1379, AID1770, AID1983, AID1997, AID2710, AID488872, AID488883, AID488887, AID493206, AID504421, AID504424, AID504427, AID504428, AID504429, AID504430]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:uM","167","Smile SVC Poly classification","0.8079956696566647","Minimum","UP","6.450374997668138","0.7125748502994012","0.6666666666666666","0.4262295081967213"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. Confirmation Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1379, AID1770, AID1983, AID1997, AID2710, AID488872, AID488883, AID488887, AID493206, AID504421, AID504424, AID504427, AID504428, AID504429, AID504430]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:uM","167","Weka RF classification","0.8032786885245901","Minimum","UP","6.450374997668138","0.7245508982035929","0.6470588235294118","0.5409836065573771"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. Confirmation Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1379, AID1770, AID1983, AID1997, AID2710, AID488872, AID488883, AID488887, AID493206, AID504421, AID504424, AID504427, AID504428, AID504429, AID504430]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:uM","167","Smile SVC RBF classification","0.7698731828023504","Minimum","UP","6.450374997668138","0.7425149700598802","0.6956521739130435","0.5245901639344263"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","558","Weka RF on folded fp classification","0.8072754075615648","Proportion","UP","4.900318785003531","0.7956989247311828","0.7769230769230769","0.543010752688172"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","558","Smile SVC Tanimoto classification","0.8044716152156319","Proportion","UP","4.900318785003531","0.7885304659498208","0.7151898734177216","0.6075268817204301"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","558","Smile SVC Poly classification","0.7835154353104407","Proportion","UP","4.900318785003531","0.7544802867383512","0.7207207207207207","0.43010752688172044"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","558","Smile Bernoulli NB classification","0.7764842756388014","Proportion","UP","4.900318785003531","0.7275985663082437","0.5702479338842975","0.7419354838709677"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","558","Weka RF classification","0.7416970169961841","Proportion","UP","4.900318785003531","0.7168458781362007","0.6060606060606061","0.43010752688172044"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","558","Smile SVC RBF classification","0.6671146953405026","Proportion","UP","4.900318785003531","0.6899641577060932","0.5670103092783505","0.2956989247311828"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","605","Weka RF on folded fp classification","0.7879218394824268","Minimum","UP","4.793954909736444","0.715702479338843","0.7311827956989247","0.6777408637873754"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","605","Smile SVC Tanimoto classification","0.763146966252842","Minimum","UP","4.793954909736444","0.7041322314049587","0.7163120567375887","0.6710963455149501"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","605","Smile Bernoulli NB classification","0.7436778720055954","Minimum","UP","4.793954909736444","0.6743801652892562","0.6830985915492958","0.6445182724252492"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","605","Smile SVC Poly classification","0.7294872355306871","Minimum","UP","4.793954909736444","0.6628099173553719","0.7342995169082126","0.5049833887043189"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","605","Weka RF classification","0.660894605700297","Minimum","UP","4.793954909736444","0.6264462809917355","0.6288659793814433","0.6079734219269103"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","605","Smile SVC RBF classification","0.6114158943871308","Minimum","UP","4.793954909736444","0.6033057851239669","0.6168582375478927","0.5348837209302325"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-FP Assay). (Class of assay: confirmatory) [Related pubchem assays: 1771 , 1770 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","364","Smile SVC Tanimoto classification","0.8026885395306443","Proportion","UP","5.136853429502994","0.7692307692307693","0.7333333333333333","0.5789473684210527"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-FP Assay). (Class of assay: confirmatory) [Related pubchem assays: 1771 , 1770 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","364","Smile SVC Poly classification","0.7851446798815215","Proportion","UP","5.136853429502994","0.7060439560439561","0.8611111111111112","0.23308270676691728"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-FP Assay). (Class of assay: confirmatory) [Related pubchem assays: 1771 , 1770 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","364","Weka RF on folded fp classification","0.7692608143735964","Proportion","UP","5.136853429502994","0.760989010989011","0.7053571428571429","0.5939849624060151"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-FP Assay). (Class of assay: confirmatory) [Related pubchem assays: 1771 , 1770 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","364","Smile Bernoulli NB classification","0.7596588874784365","Proportion","UP","5.136853429502994","0.6785714285714286","0.5449438202247191","0.7293233082706767"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-FP Assay). (Class of assay: confirmatory) [Related pubchem assays: 1771 , 1770 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","364","Weka RF classification","0.7314878104351789","Proportion","UP","5.136853429502994","0.6758241758241759","0.5728155339805825","0.44360902255639095"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-FP Assay). (Class of assay: confirmatory) [Related pubchem assays: 1771 , 1770 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","364","Smile SVC RBF classification","0.6646160856687169","Proportion","UP","5.136853429502994","0.6428571428571429","0.5272727272727272","0.21804511278195488"
"CDK4","Activity Value","Assay Description:Inhibition of Cyclin-dependent kinase 4-cyclin D1|Activity Type:IC50|Target Accession Numbers:NP_000066, SK069, P11802, Q6FG61|Standard Unit:nM","115","Smile Bernoulli NB classification","0.843118069145466","Proportion","UP","5.383119505399446","0.7043478260869566","0.5625","0.8571428571428571"
"CDK4","Activity Value","Assay Description:Inhibition of Cyclin-dependent kinase 4-cyclin D1|Activity Type:IC50|Target Accession Numbers:NP_000066, SK069, P11802, Q6FG61|Standard Unit:nM","115","Weka RF on folded fp classification","0.8411611219830396","Proportion","UP","5.383119505399446","0.7565217391304347","0.6521739130434783","0.7142857142857143"
"CDK4","Activity Value","Assay Description:Inhibition of Cyclin-dependent kinase 4-cyclin D1|Activity Type:IC50|Target Accession Numbers:NP_000066, SK069, P11802, Q6FG61|Standard Unit:nM","115","Smile SVC Poly classification","0.8281148075668618","Proportion","UP","5.383119505399446","0.7478260869565218","0.6857142857142857","0.5714285714285714"
"CDK4","Activity Value","Assay Description:Inhibition of Cyclin-dependent kinase 4-cyclin D1|Activity Type:IC50|Target Accession Numbers:NP_000066, SK069, P11802, Q6FG61|Standard Unit:nM","115","Smile SVC Tanimoto classification","0.8258317025440308","Proportion","UP","5.383119505399446","0.7391304347826086","0.62","0.7380952380952381"
"CDK4","Activity Value","Assay Description:Inhibition of Cyclin-dependent kinase 4-cyclin D1|Activity Type:IC50|Target Accession Numbers:NP_000066, SK069, P11802, Q6FG61|Standard Unit:nM","115","Weka RF classification","0.8131115459882583","Proportion","UP","5.383119505399446","0.7739130434782608","0.6904761904761905","0.6904761904761905"
"CDK4","Activity Value","Assay Description:Inhibition of Cyclin-dependent kinase 4-cyclin D1|Activity Type:IC50|Target Accession Numbers:NP_000066, SK069, P11802, Q6FG61|Standard Unit:nM","115","Smile SVC RBF classification","0.7759295499021523","Proportion","UP","5.383119505399446","0.7391304347826086","0.75","0.42857142857142855"
"SRC","Activity Value","Assay Description:Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","171","Weka RF on folded fp classification","0.9055538602380225","Proportion","DOWN","7.145213969225381","0.8187134502923976","0.8596491228070176","0.8672566371681416"
"SRC","Activity Value","Assay Description:Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","171","Weka RF classification","0.8927372596887398","Proportion","DOWN","7.145213969225381","0.8187134502923976","0.853448275862069","0.8761061946902655"
"SRC","Activity Value","Assay Description:Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","171","Smile SVC RBF classification","0.8802258162953916","Proportion","DOWN","7.145213969225381","0.8362573099415205","0.8102189781021898","0.9823008849557522"
"SRC","Activity Value","Assay Description:Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","171","Smile Bernoulli NB classification","0.859627708269759","Proportion","DOWN","7.145213969225381","0.7660818713450293","0.9294117647058824","0.6991150442477876"
"SRC","Activity Value","Assay Description:Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","171","Smile SVC Poly classification","0.8513884650595057","Proportion","DOWN","7.145213969225381","0.7134502923976608","0.6975308641975309","1.0"
"SRC","Activity Value","Assay Description:Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","171","Smile SVC Tanimoto classification","0.8489472078120232","Proportion","DOWN","7.145213969225381","0.7894736842105263","0.8130081300813008","0.8849557522123894"
"SRC","Activity Value","Assay Description:Inhibition of Src|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","227","Weka RF on folded fp classification","0.9303743398570986","Minimum","UP","6.454230725803608","0.8590308370044053","0.8761904761904762","0.8288288288288288"
"SRC","Activity Value","Assay Description:Inhibition of Src|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","227","Smile SVC Poly classification","0.9300248524386452","Minimum","UP","6.454230725803608","0.8546255506607929","0.8679245283018868","0.8288288288288288"
"SRC","Activity Value","Assay Description:Inhibition of Src|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","227","Smile SVC RBF classification","0.9245883814849318","Minimum","UP","6.454230725803608","0.8634361233480177","0.925531914893617","0.7837837837837838"
"SRC","Activity Value","Assay Description:Inhibition of Src|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","227","Weka RF classification","0.9226856166511339","Minimum","UP","6.454230725803608","0.8678414096916299","0.9090909090909091","0.8108108108108109"
"SRC","Activity Value","Assay Description:Inhibition of Src|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","227","Smile SVC Tanimoto classification","0.9138707673190428","Minimum","UP","6.454230725803608","0.8370044052863436","0.8135593220338984","0.8648648648648649"
"SRC","Activity Value","Assay Description:Inhibition of Src|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","227","Smile Bernoulli NB classification","0.9001242621932279","Minimum","UP","6.454230725803608","0.8370044052863436","0.7936507936507936","0.9009009009009009"
"VEGFR2","Activity Value","Assay Description:Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","169","Smile SVC Tanimoto classification","0.8129984051036696","Proportion","UP","6.109838139149719","0.7810650887573964","0.7368421052631579","0.509090909090909"
"VEGFR2","Activity Value","Assay Description:Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","169","Weka RF on folded fp classification","0.8037480063795859","Proportion","UP","6.109838139149719","0.7633136094674556","0.6595744680851063","0.5636363636363636"
"VEGFR2","Activity Value","Assay Description:Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","169","Smile Bernoulli NB classification","0.7989633173843707","Proportion","UP","6.109838139149719","0.727810650887574","0.5542168674698795","0.8363636363636363"
"VEGFR2","Activity Value","Assay Description:Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","169","Smile SVC Poly classification","0.7924242424242428","Proportion","UP","6.109838139149719","0.6745562130177515","NaN","0.0"
"VEGFR2","Activity Value","Assay Description:Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","169","Weka RF classification","0.784768740031898","Proportion","UP","6.109838139149719","0.8047337278106509","0.775","0.5636363636363636"
"VEGFR2","Activity Value","Assay Description:Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","169","Smile SVC RBF classification","0.7630781499202554","Proportion","UP","6.109838139149719","0.7455621301775148","0.7727272727272727","0.3090909090909091"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","473","Smile SVC Tanimoto classification","0.9068325418939577","Minimum","UP","7.127399007355367","0.8477801268498943","0.8092105263157895","0.7409638554216867"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","473","Weka RF on folded fp classification","0.9045269023978647","Minimum","UP","7.127399007355367","0.8372093023255814","0.8068965517241379","0.7048192771084337"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","473","Smile SVC RBF classification","0.8998076998547945","Minimum","UP","7.127399007355367","0.8393234672304439","0.8214285714285714","0.6927710843373494"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","473","Smile SVC Poly classification","0.8937247360778617","Minimum","UP","7.127399007355367","0.828752642706131","0.8632478632478633","0.608433734939759"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","473","Weka RF classification","0.8884757270122836","Minimum","UP","7.127399007355367","0.8224101479915433","0.7928571428571428","0.6686746987951807"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","473","Smile Bernoulli NB classification","0.886336878458459","Minimum","UP","7.127399007355367","0.8202959830866807","0.7035175879396985","0.8433734939759037"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR by HTRF assay|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","365","Weka RF on folded fp classification","0.886075734995258","Proportion","DOWN","7.764021748313225","0.8136986301369863","0.8358778625954199","0.8975409836065574"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR by HTRF assay|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","365","Weka RF classification","0.8853813846362278","Proportion","DOWN","7.764021748313225","0.8465753424657534","0.8700787401574803","0.9057377049180327"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR by HTRF assay|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","365","Smile SVC Tanimoto classification","0.874745969380842","Proportion","DOWN","7.764021748313225","0.8082191780821918","0.8222222222222222","0.9098360655737705"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR by HTRF assay|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","365","Smile Bernoulli NB classification","0.8647540983606555","Proportion","DOWN","7.764021748313225","0.736986301369863","0.9252873563218391","0.6598360655737705"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR by HTRF assay|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","365","Smile SVC RBF classification","0.8590130063677018","Proportion","DOWN","7.764021748313225","0.7863013698630137","0.7964285714285714","0.9139344262295082"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR by HTRF assay|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","365","Smile SVC Poly classification","0.8445332610757346","Proportion","DOWN","7.764021748313225","0.7671232876712328","0.7572815533980582","0.9590163934426229"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","428","Weka RF on folded fp classification","0.8765109890109891","Inflection","UP","7.259762880211319","0.7920560747663551","0.7841726618705036","0.6488095238095238"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","428","Smile SVC Tanimoto classification","0.8619391025641028","Inflection","UP","7.259762880211319","0.7733644859813084","0.7320261437908496","0.6666666666666666"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","428","Smile Bernoulli NB classification","0.8592719780219781","Inflection","UP","7.259762880211319","0.7476635514018691","0.6363636363636364","0.8333333333333334"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","428","Weka RF classification","0.8574290293040293","Inflection","UP","7.259762880211319","0.8130841121495327","0.8235294117647058","0.6666666666666666"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","428","Smile SVC Poly classification","0.8391369047619048","Inflection","UP","7.259762880211319","0.7710280373831776","0.8365384615384616","0.5178571428571429"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","428","Smile SVC RBF classification","0.8349816849816852","Inflection","UP","7.259762880211319","0.7967289719626168","0.8292682926829268","0.6071428571428571"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","451","Weka RF on folded fp classification","0.8627262979916699","Inflection","UP","7.259762880211319","0.7804878048780488","0.7708333333333334","0.6271186440677966"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","451","Smile SVC Tanimoto classification","0.8283640562497435","Inflection","UP","7.259762880211319","0.7671840354767184","0.7222222222222222","0.6610169491525424"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","451","Smile Bernoulli NB classification","0.8232504433172513","Inflection","UP","7.259762880211319","0.7272727272727273","0.618421052631579","0.7966101694915254"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","451","Smile SVC Poly classification","0.8196832859086984","Inflection","UP","7.259762880211319","0.7649667405764967","0.8736842105263158","0.4689265536723164"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","451","Weka RF classification","0.8187760320013195","Inflection","UP","7.259762880211319","0.7893569844789357","0.7808219178082192","0.6440677966101694"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","451","Smile SVC RBF classification","0.810775702090807","Inflection","UP","7.259762880211319","0.7760532150776053","0.7794117647058824","0.5988700564971752"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","105","Smile SVC Tanimoto classification","0.9807168784029038","Inflection","UP","8.013985810861993","0.9523809523809523","0.8529411764705882","1.0"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","105","Smile SVC Poly classification","0.9807168784029038","Inflection","UP","8.013985810861993","0.9523809523809523","0.8529411764705882","1.0"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","105","Weka RF classification","0.978448275862069","Inflection","UP","8.013985810861993","0.9238095238095239","0.8888888888888888","0.8275862068965517"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","105","Weka RF on folded fp classification","0.9668784029038113","Inflection","UP","8.013985810861993","0.9333333333333333","0.8235294117647058","0.9655172413793104"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","105","Smile Bernoulli NB classification","0.9605263157894737","Inflection","UP","8.013985810861993","0.9428571428571428","0.8285714285714286","1.0"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","105","Smile SVC RBF classification","0.8879310344827578","Inflection","UP","8.013985810861993","0.9047619047619048","0.88","0.7586206896551724"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","105","Smile SVC Poly classification","0.9807168784029038","Inflection","UP","8.013985810861993","0.9523809523809523","0.8529411764705882","1.0"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","105","Smile SVC Tanimoto classification","0.9798094373865699","Inflection","UP","8.013985810861993","0.9523809523809523","0.8529411764705882","1.0"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","105","Weka RF classification","0.978448275862069","Inflection","UP","8.013985810861993","0.9238095238095239","0.8888888888888888","0.8275862068965517"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","105","Weka RF on folded fp classification","0.9668784029038113","Inflection","UP","8.013985810861993","0.9333333333333333","0.8235294117647058","0.9655172413793104"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","105","Smile Bernoulli NB classification","0.9605263157894737","Inflection","UP","8.013985810861993","0.9428571428571428","0.8285714285714286","1.0"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","105","Smile SVC RBF classification","0.8879310344827578","Inflection","UP","8.013985810861993","0.9047619047619048","0.88","0.7586206896551724"
"FLT3","Activity Value","Assay Description:Inhibition of FLT3|Activity Type:IC50|Target Accession Numbers:NP_004110, SK149, P36888|Standard Unit:nM","106","Smile SVC Poly classification","0.8958333333333334","Proportion","UP","7.0195278356916315","0.7924528301886793","0.8","0.47058823529411764"
"FLT3","Activity Value","Assay Description:Inhibition of FLT3|Activity Type:IC50|Target Accession Numbers:NP_004110, SK149, P36888|Standard Unit:nM","106","Smile Bernoulli NB classification","0.8950163398692811","Proportion","UP","7.0195278356916315","0.8301886792452831","0.6818181818181818","0.8823529411764706"
"FLT3","Activity Value","Assay Description:Inhibition of FLT3|Activity Type:IC50|Target Accession Numbers:NP_004110, SK149, P36888|Standard Unit:nM","106","Smile SVC Tanimoto classification","0.8823529411764707","Proportion","UP","7.0195278356916315","0.8490566037735849","0.8","0.7058823529411765"
"FLT3","Activity Value","Assay Description:Inhibition of FLT3|Activity Type:IC50|Target Accession Numbers:NP_004110, SK149, P36888|Standard Unit:nM","106","Smile SVC RBF classification","0.8794934640522877","Proportion","UP","7.0195278356916315","0.7924528301886793","0.875","0.4117647058823529"
"FLT3","Activity Value","Assay Description:Inhibition of FLT3|Activity Type:IC50|Target Accession Numbers:NP_004110, SK149, P36888|Standard Unit:nM","106","Weka RF on folded fp classification","0.8678513071895425","Proportion","UP","7.0195278356916315","0.8018867924528302","0.7407407407407407","0.5882352941176471"
"FLT3","Activity Value","Assay Description:Inhibition of FLT3|Activity Type:IC50|Target Accession Numbers:NP_004110, SK149, P36888|Standard Unit:nM","106","Weka RF classification","0.8415032679738563","Proportion","UP","7.0195278356916315","0.7641509433962265","0.6363636363636364","0.6176470588235294"
"AKT1","Activity Value","Assay Description:Inhibition of Akt1|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","135","Smile SVC Tanimoto classification","0.796096743295019","Proportion","DOWN","8.069956278935347","0.7111111111111111","0.75","0.8275862068965517"
"AKT1","Activity Value","Assay Description:Inhibition of Akt1|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","135","Smile Bernoulli NB classification","0.7865181992337165","Proportion","DOWN","8.069956278935347","0.7185185185185186","0.8769230769230769","0.6551724137931034"
"AKT1","Activity Value","Assay Description:Inhibition of Akt1|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","135","Smile SVC Poly classification","0.7793342911877393","Proportion","DOWN","8.069956278935347","0.725925925925926","0.7551020408163265","0.8505747126436781"
"AKT1","Activity Value","Assay Description:Inhibition of Akt1|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","135","Smile SVC RBF classification","0.7717911877394641","Proportion","DOWN","8.069956278935347","0.762962962962963","0.7619047619047619","0.9195402298850575"
"AKT1","Activity Value","Assay Description:Inhibition of Akt1|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","135","Weka RF on folded fp classification","0.768079501915709","Proportion","DOWN","8.069956278935347","0.725925925925926","0.7604166666666666","0.8390804597701149"
"AKT1","Activity Value","Assay Description:Inhibition of Akt1|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","135","Weka RF classification","0.7620929118773949","Proportion","DOWN","8.069956278935347","0.725925925925926","0.7717391304347826","0.8160919540229885"
"AKT1","Activity Value","Assay Description:Inhibition of Akt|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","152","Smile Bernoulli NB classification","0.8748860944049568","Minimum","UP","7.454110313366671","0.756578947368421","0.6170212765957447","0.9830508474576272"
"AKT1","Activity Value","Assay Description:Inhibition of Akt|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","152","Weka RF on folded fp classification","0.8726079825041004","Minimum","UP","7.454110313366671","0.756578947368421","0.7115384615384616","0.6271186440677966"
"AKT1","Activity Value","Assay Description:Inhibition of Akt|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","152","Smile SVC Tanimoto classification","0.8720612356478948","Minimum","UP","7.454110313366671","0.743421052631579","0.625","0.847457627118644"
"AKT1","Activity Value","Assay Description:Inhibition of Akt|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","152","Weka RF classification","0.849553490067432","Minimum","UP","7.454110313366671","0.7960526315789473","0.7333333333333333","0.7457627118644068"
"AKT1","Activity Value","Assay Description:Inhibition of Akt|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","152","Smile SVC Poly classification","0.844723892837616","Minimum","UP","7.454110313366671","0.7368421052631579","0.6507936507936508","0.6949152542372882"
"AKT1","Activity Value","Assay Description:Inhibition of Akt|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","152","Smile SVC RBF classification","0.7727355567705485","Minimum","UP","7.454110313366671","0.7236842105263158","0.7073170731707317","0.4915254237288136"
"CDK5","Activity Value","Assay Description:Inhibition of human cdk5/p25 by SPA|Activity Type:IC50|Target Accession Numbers:NP_004926, SK070, Q00535|Standard Unit:nM","124","Smile SVC Tanimoto classification","0.8157738095238096","Proportion","DOWN","6.401576729695526","0.7580645161290323","0.7647058823529411","0.9285714285714286"
"CDK5","Activity Value","Assay Description:Inhibition of human cdk5/p25 by SPA|Activity Type:IC50|Target Accession Numbers:NP_004926, SK070, Q00535|Standard Unit:nM","124","Weka RF on folded fp classification","0.7397321428571427","Proportion","DOWN","6.401576729695526","0.7096774193548387","0.7553191489361702","0.8452380952380952"
"CDK5","Activity Value","Assay Description:Inhibition of human cdk5/p25 by SPA|Activity Type:IC50|Target Accession Numbers:NP_004926, SK070, Q00535|Standard Unit:nM","124","Smile SVC Poly classification","0.7354166666666667","Proportion","DOWN","6.401576729695526","0.6774193548387096","0.6774193548387096","1.0"
"CDK5","Activity Value","Assay Description:Inhibition of human cdk5/p25 by SPA|Activity Type:IC50|Target Accession Numbers:NP_004926, SK070, Q00535|Standard Unit:nM","124","Weka RF classification","0.7014880952380951","Proportion","DOWN","6.401576729695526","0.7096774193548387","0.74","0.8809523809523809"
"CDK5","Activity Value","Assay Description:Inhibition of human cdk5/p25 by SPA|Activity Type:IC50|Target Accession Numbers:NP_004926, SK070, Q00535|Standard Unit:nM","124","Smile Bernoulli NB classification","0.6443452380952381","Proportion","DOWN","6.401576729695526","0.5645161290322581","0.75","0.5357142857142857"
"CDK5","Activity Value","Assay Description:Inhibition of human cdk5/p25 by SPA|Activity Type:IC50|Target Accession Numbers:NP_004926, SK070, Q00535|Standard Unit:nM","124","Smile SVC RBF classification","0.6315476190476191","Proportion","DOWN","6.401576729695526","0.6854838709677419","0.6991150442477876","0.9404761904761905"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1 by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","114","Smile Bernoulli NB classification","0.828505392912173","Minimum","UP","4.8509473228859274","0.7456140350877193","0.7083333333333334","0.864406779661017"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1 by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","114","Smile SVC Tanimoto classification","0.8221879815100156","Minimum","UP","4.8509473228859274","0.7982456140350878","0.7727272727272727","0.864406779661017"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1 by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","114","Weka RF on folded fp classification","0.8001540832049308","Minimum","UP","4.8509473228859274","0.7105263157894737","0.6857142857142857","0.8135593220338984"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1 by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","114","Weka RF classification","0.7730354391371339","Minimum","UP","4.8509473228859274","0.7192982456140351","0.7288135593220338","0.7288135593220338"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1 by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","114","Smile SVC Poly classification","0.763944530046225","Minimum","UP","4.8509473228859274","0.7017543859649122","0.654320987654321","0.8983050847457628"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1 by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","114","Smile SVC RBF classification","0.7500770416024651","Minimum","UP","4.8509473228859274","0.6842105263157895","0.676923076923077","0.7457627118644068"
"JNK1","Activity Value","Assay Description:Inhibition of recombinant JNK1 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","115","Weka RF on folded fp classification","0.8776666666666667","Proportion","UP","6.309654781038412","0.8434782608695652","0.84375","0.675"
"JNK1","Activity Value","Assay Description:Inhibition of recombinant JNK1 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","115","Smile SVC Tanimoto classification","0.8671666666666666","Proportion","UP","6.309654781038412","0.8173913043478261","0.7878787878787878","0.65"
"JNK1","Activity Value","Assay Description:Inhibition of recombinant JNK1 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","115","Smile Bernoulli NB classification","0.8584999999999997","Proportion","UP","6.309654781038412","0.782608695652174","0.6415094339622641","0.85"
"JNK1","Activity Value","Assay Description:Inhibition of recombinant JNK1 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","115","Smile SVC Poly classification","0.8438333333333334","Proportion","UP","6.309654781038412","0.8","1.0","0.425"
"JNK1","Activity Value","Assay Description:Inhibition of recombinant JNK1 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","115","Smile SVC RBF classification","0.8236666666666667","Proportion","UP","6.309654781038412","0.782608695652174","0.9411764705882353","0.4"
"JNK1","Activity Value","Assay Description:Inhibition of recombinant JNK1 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","115","Weka RF classification","0.8196666666666665","Proportion","UP","6.309654781038412","0.8","0.7297297297297297","0.675"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","143","Smile Bernoulli NB classification","0.842032967032967","Proportion","UP","6.796294668981709","0.7342657342657343","0.5813953488372093","0.9615384615384616"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","143","Weka RF on folded fp classification","0.8291420118343195","Proportion","UP","6.796294668981709","0.7552447552447552","0.6666666666666666","0.6538461538461539"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","143","Weka RF classification","0.8290363482671175","Proportion","UP","6.796294668981709","0.7622377622377622","0.6666666666666666","0.6923076923076923"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","143","Smile SVC Poly classification","0.8273457311918848","Proportion","UP","6.796294668981709","0.7342657342657343","0.6944444444444444","0.4807692307692308"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","143","Smile SVC Tanimoto classification","0.8146661031276414","Proportion","UP","6.796294668981709","0.7482517482517482","0.6290322580645161","0.75"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","143","Smile SVC RBF classification","0.8108622147083683","Proportion","UP","6.796294668981709","0.7342657342657343","0.7058823529411765","0.46153846153846156"
"AURb","Activity Value","Assay Description:Inhibition of Aurora B|Activity Type:IC50|Target Accession Numbers:NP_004208, SK406, Q96GD4|Standard Unit:nM","132","Weka RF on folded fp classification","0.935906432748538","Proportion","DOWN","7.738785361895846","0.8939393939393939","0.8961038961038961","0.92"
"AURb","Activity Value","Assay Description:Inhibition of Aurora B|Activity Type:IC50|Target Accession Numbers:NP_004208, SK406, Q96GD4|Standard Unit:nM","132","Weka RF classification","0.9272514619883041","Proportion","DOWN","7.738785361895846","0.9090909090909091","0.8795180722891566","0.9733333333333334"
"AURb","Activity Value","Assay Description:Inhibition of Aurora B|Activity Type:IC50|Target Accession Numbers:NP_004208, SK406, Q96GD4|Standard Unit:nM","132","Smile SVC Tanimoto classification","0.9174269005847953","Proportion","DOWN","7.738785361895846","0.9090909090909091","0.8987341772151899","0.9466666666666667"
"AURb","Activity Value","Assay Description:Inhibition of Aurora B|Activity Type:IC50|Target Accession Numbers:NP_004208, SK406, Q96GD4|Standard Unit:nM","132","Smile Bernoulli NB classification","0.911461988304094","Proportion","DOWN","7.738785361895846","0.8787878787878788","0.8933333333333333","0.8933333333333333"
"AURb","Activity Value","Assay Description:Inhibition of Aurora B|Activity Type:IC50|Target Accession Numbers:NP_004208, SK406, Q96GD4|Standard Unit:nM","132","Smile SVC RBF classification","0.9099415204678362","Proportion","DOWN","7.738785361895846","0.8636363636363636","0.8202247191011236","0.9733333333333334"
"AURb","Activity Value","Assay Description:Inhibition of Aurora B|Activity Type:IC50|Target Accession Numbers:NP_004208, SK406, Q96GD4|Standard Unit:nM","132","Smile SVC Poly classification","0.8879532163742694","Proportion","DOWN","7.738785361895846","0.9015151515151515","0.8604651162790697","0.9866666666666667"
"PKCt","Activity Value","Assay Description:Inhibition of PKCtheta|Activity Type:IC50|Target Accession Numbers:NP_006248, SK310, Q04759, Q3MJF1, Q5JUN8|Standard Unit:nM","119","Smile SVC RBF classification","0.8829847371396268","Inflection","UP","7.658651022583489","0.8487394957983193","0.8846153846153846","0.7931034482758621"
"PKCt","Activity Value","Assay Description:Inhibition of PKCtheta|Activity Type:IC50|Target Accession Numbers:NP_006248, SK310, Q04759, Q3MJF1, Q5JUN8|Standard Unit:nM","119","Smile SVC Tanimoto classification","0.8725268513284337","Inflection","UP","7.658651022583489","0.8487394957983193","0.8703703703703703","0.8103448275862069"
"PKCt","Activity Value","Assay Description:Inhibition of PKCtheta|Activity Type:IC50|Target Accession Numbers:NP_006248, SK310, Q04759, Q3MJF1, Q5JUN8|Standard Unit:nM","119","Weka RF on folded fp classification","0.8713962690785754","Inflection","UP","7.658651022583489","0.7899159663865546","0.7619047619047619","0.8275862068965517"
"PKCt","Activity Value","Assay Description:Inhibition of PKCtheta|Activity Type:IC50|Target Accession Numbers:NP_006248, SK310, Q04759, Q3MJF1, Q5JUN8|Standard Unit:nM","119","Smile Bernoulli NB classification","0.8706896551724134","Inflection","UP","7.658651022583489","0.8235294117647058","0.8245614035087719","0.8103448275862069"
"PKCt","Activity Value","Assay Description:Inhibition of PKCtheta|Activity Type:IC50|Target Accession Numbers:NP_006248, SK310, Q04759, Q3MJF1, Q5JUN8|Standard Unit:nM","119","Smile SVC Poly classification","0.8538722442057665","Inflection","UP","7.658651022583489","0.8487394957983193","0.8703703703703703","0.8103448275862069"
"PKCt","Activity Value","Assay Description:Inhibition of PKCtheta|Activity Type:IC50|Target Accession Numbers:NP_006248, SK310, Q04759, Q3MJF1, Q5JUN8|Standard Unit:nM","119","Weka RF classification","0.8526003391746749","Inflection","UP","7.658651022583489","0.7983193277310925","0.8035714285714286","0.7758620689655172"
"ABL1","Activity Value","Assay Description:Inhibition of recombinant c-Abl by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005148, NP_009297, SK006, P00519, Q45F09, Q59FK4|Standard Unit:nM","171","Weka RF on folded fp classification","0.8543637473298755","Proportion","UP","6.417093329263688","0.8070175438596491","0.7450980392156863","0.6551724137931034"
"ABL1","Activity Value","Assay Description:Inhibition of recombinant c-Abl by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005148, NP_009297, SK006, P00519, Q45F09, Q59FK4|Standard Unit:nM","171","Smile SVC Tanimoto classification","0.8397162038449794","Proportion","UP","6.417093329263688","0.7777777777777778","0.7380952380952381","0.5344827586206896"
"ABL1","Activity Value","Assay Description:Inhibition of recombinant c-Abl by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005148, NP_009297, SK006, P00519, Q45F09, Q59FK4|Standard Unit:nM","171","Smile SVC Poly classification","0.8317821177906617","Proportion","UP","6.417093329263688","0.6549707602339181","0.4","0.034482758620689655"
"ABL1","Activity Value","Assay Description:Inhibition of recombinant c-Abl by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005148, NP_009297, SK006, P00519, Q45F09, Q59FK4|Standard Unit:nM","171","Smile Bernoulli NB classification","0.8290357033872443","Proportion","UP","6.417093329263688","0.7192982456140351","0.5568181818181818","0.8448275862068966"
"ABL1","Activity Value","Assay Description:Inhibition of recombinant c-Abl by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005148, NP_009297, SK006, P00519, Q45F09, Q59FK4|Standard Unit:nM","171","Weka RF classification","0.7961550198352151","Proportion","UP","6.417093329263688","0.7485380116959064","0.6271186440677966","0.6379310344827587"
"ABL1","Activity Value","Assay Description:Inhibition of recombinant c-Abl by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005148, NP_009297, SK006, P00519, Q45F09, Q59FK4|Standard Unit:nM","171","Smile SVC RBF classification","0.7116264876411353","Proportion","UP","6.417093329263688","0.6900584795321637","0.5925925925925926","0.27586206896551724"
"ITK","Activity Value","Assay Description:Inhibition of Itk|Activity Type:IC50|Target Accession Numbers:NP_005537, SK184, Q08881, Q32ML7|Standard Unit:nM","103","Smile Bernoulli NB classification","0.9433221099887767","Inflection","UP","7.053523969398224","0.7864077669902912","0.5","0.9545454545454546"
"ITK","Activity Value","Assay Description:Inhibition of Itk|Activity Type:IC50|Target Accession Numbers:NP_005537, SK184, Q08881, Q32ML7|Standard Unit:nM","103","Smile SVC Poly classification","0.9343434343434345","Inflection","UP","7.053523969398224","0.7961165048543689","0.6666666666666666","0.09090909090909091"
"ITK","Activity Value","Assay Description:Inhibition of Itk|Activity Type:IC50|Target Accession Numbers:NP_005537, SK184, Q08881, Q32ML7|Standard Unit:nM","103","Smile SVC Tanimoto classification","0.9287317620650953","Inflection","UP","7.053523969398224","0.8640776699029126","0.75","0.5454545454545454"
"ITK","Activity Value","Assay Description:Inhibition of Itk|Activity Type:IC50|Target Accession Numbers:NP_005537, SK184, Q08881, Q32ML7|Standard Unit:nM","103","Weka RF on folded fp classification","0.9225589225589226","Inflection","UP","7.053523969398224","0.883495145631068","0.75","0.6818181818181818"
"ITK","Activity Value","Assay Description:Inhibition of Itk|Activity Type:IC50|Target Accession Numbers:NP_005537, SK184, Q08881, Q32ML7|Standard Unit:nM","103","Weka RF classification","0.9163860830527497","Inflection","UP","7.053523969398224","0.883495145631068","0.75","0.6818181818181818"
"ITK","Activity Value","Assay Description:Inhibition of Itk|Activity Type:IC50|Target Accession Numbers:NP_005537, SK184, Q08881, Q32ML7|Standard Unit:nM","103","Smile SVC RBF classification","0.8580246913580248","Inflection","UP","7.053523969398224","0.8446601941747572","1.0","0.2727272727272727"
"EGFR","Value","Assay Description:Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","170","Weka RF classification","0.8401680915809303","Inflection","UP","5.590909090909092","0.7588235294117647","0.7166666666666667","0.6417910447761194"
"EGFR","Value","Assay Description:Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","170","Smile SVC RBF classification","0.8349514563106797","Inflection","UP","5.590909090909092","0.7352941176470589","0.775","0.4626865671641791"
"EGFR","Value","Assay Description:Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","170","Smile SVC Tanimoto classification","0.8287204752934361","Inflection","UP","5.590909090909092","0.7588235294117647","0.7954545454545454","0.5223880597014925"
"EGFR","Value","Assay Description:Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","170","Weka RF on folded fp classification","0.8214026952615565","Inflection","UP","5.590909090909092","0.788235294117647","0.7540983606557377","0.6865671641791045"
"EGFR","Value","Assay Description:Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","170","Smile SVC Poly classification","0.8159687001883784","Inflection","UP","5.590909090909092","0.6529411764705882","1.0","0.11940298507462686"
"EGFR","Value","Assay Description:Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","170","Smile Bernoulli NB classification","0.791189682654687","Inflection","UP","5.590909090909092","0.7470588235294118","0.6363636363636364","0.835820895522388"
"EGFR","Value","Assay Description:Inhibition of EGFR|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","506","Smile SVC Tanimoto classification","0.9291307201800436","Minimum","UP","6.5580704101903935","0.8774703557312253","0.8345323741007195","0.9354838709677419"
"EGFR","Value","Assay Description:Inhibition of EGFR|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","506","Weka RF on folded fp classification","0.9262628157039254","Minimum","UP","6.5580704101903935","0.8695652173913043","0.85","0.8911290322580645"
"EGFR","Value","Assay Description:Inhibition of EGFR|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","506","Smile SVC Poly classification","0.9229573018254573","Minimum","UP","6.5580704101903935","0.8636363636363636","0.8352059925093633","0.8991935483870968"
"EGFR","Value","Assay Description:Inhibition of EGFR|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","506","Weka RF classification","0.9161743560890219","Minimum","UP","6.5580704101903935","0.8656126482213439","0.86","0.8669354838709677"
"EGFR","Value","Assay Description:Inhibition of EGFR|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","506","Smile SVC RBF classification","0.9160805826456604","Minimum","UP","6.5580704101903935","0.8478260869565217","0.8547717842323651","0.8306451612903226"
"EGFR","Value","Assay Description:Inhibition of EGFR|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","506","Smile Bernoulli NB classification","0.9079066641660419","Minimum","UP","6.5580704101903935","0.8478260869565217","0.7840531561461794","0.9516129032258065"
"TGFbR1","Activity Value","Assay Description:Inhibition of TGFR1|Activity Type:IC50|Target Accession Numbers:NP_004603, SK029, P36897, Q5T7S2, Q6IR47|Standard Unit:nM","104","Weka RF on folded fp classification","0.7546977124183009","Proportion","DOWN","7.252151300435472","0.7115384615384616","0.7638888888888888","0.8088235294117647"
"TGFbR1","Activity Value","Assay Description:Inhibition of TGFR1|Activity Type:IC50|Target Accession Numbers:NP_004603, SK029, P36897, Q5T7S2, Q6IR47|Standard Unit:nM","104","Smile SVC Tanimoto classification","0.7446895424836601","Proportion","DOWN","7.252151300435472","0.7211538461538461","0.7407407407407407","0.8823529411764706"
"TGFbR1","Activity Value","Assay Description:Inhibition of TGFR1|Activity Type:IC50|Target Accession Numbers:NP_004603, SK029, P36897, Q5T7S2, Q6IR47|Standard Unit:nM","104","Smile SVC Poly classification","0.6960784313725492","Proportion","DOWN","7.252151300435472","0.6538461538461539","0.6538461538461539","1.0"
"TGFbR1","Activity Value","Assay Description:Inhibition of TGFR1|Activity Type:IC50|Target Accession Numbers:NP_004603, SK029, P36897, Q5T7S2, Q6IR47|Standard Unit:nM","104","Smile Bernoulli NB classification","0.6883169934640525","Proportion","DOWN","7.252151300435472","0.6634615384615384","0.8113207547169812","0.6323529411764706"
"TGFbR1","Activity Value","Assay Description:Inhibition of TGFR1|Activity Type:IC50|Target Accession Numbers:NP_004603, SK029, P36897, Q5T7S2, Q6IR47|Standard Unit:nM","104","Weka RF classification","0.6345996732026145","Proportion","DOWN","7.252151300435472","0.6153846153846154","0.6666666666666666","0.8235294117647058"
"TGFbR1","Activity Value","Assay Description:Inhibition of TGFR1|Activity Type:IC50|Target Accession Numbers:NP_004603, SK029, P36897, Q5T7S2, Q6IR47|Standard Unit:nM","104","Smile SVC RBF classification","0.547794117647059","Proportion","DOWN","7.252151300435472","0.6346153846153846","0.6530612244897959","0.9411764705882353"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Accession Numbers:NP_002728, SK3003, P17252, Q32M72|Standard Unit:nM","103","Smile SVC RBF classification","0.9153846153846154","Proportion","UP","6.229730148799936","0.8252427184466019","0.7777777777777778","0.7368421052631579"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Accession Numbers:NP_002728, SK3003, P17252, Q32M72|Standard Unit:nM","103","Weka RF on folded fp classification","0.8860323886639676","Proportion","UP","6.229730148799936","0.8058252427184466","0.68","0.8947368421052632"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Accession Numbers:NP_002728, SK3003, P17252, Q32M72|Standard Unit:nM","103","Weka RF classification","0.8842105263157894","Proportion","UP","6.229730148799936","0.7766990291262136","0.6923076923076923","0.7105263157894737"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Accession Numbers:NP_002728, SK3003, P17252, Q32M72|Standard Unit:nM","103","Smile Bernoulli NB classification","0.8582995951417004","Proportion","UP","6.229730148799936","0.7378640776699029","0.5873015873015873","0.9736842105263158"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Accession Numbers:NP_002728, SK3003, P17252, Q32M72|Standard Unit:nM","103","Smile SVC Tanimoto classification","0.8441295546558704","Proportion","UP","6.229730148799936","0.7766990291262136","0.6415094339622641","0.8947368421052632"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Accession Numbers:NP_002728, SK3003, P17252, Q32M72|Standard Unit:nM","103","Smile SVC Poly classification","0.8072874493927127","Proportion","UP","6.229730148799936","0.6310679611650486","0.5","0.18421052631578946"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Name:PKCa|Standard Unit:nM","105","Weka RF on folded fp classification","0.8902486402486401","Proportion","UP","6.2582610583611515","0.8095238095238095","0.7021276595744681","0.8461538461538461"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Name:PKCa|Standard Unit:nM","105","Smile Bernoulli NB classification","0.8636363636363636","Proportion","UP","6.2582610583611515","0.7428571428571429","0.59375","0.9743589743589743"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Name:PKCa|Standard Unit:nM","105","Smile SVC RBF classification","0.8570318570318569","Proportion","UP","6.2582610583611515","0.8285714285714286","0.8620689655172413","0.6410256410256411"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Name:PKCa|Standard Unit:nM","105","Weka RF classification","0.8560606060606061","Proportion","UP","6.2582610583611515","0.819047619047619","0.7777777777777778","0.717948717948718"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Name:PKCa|Standard Unit:nM","105","Smile SVC Poly classification","0.8395493395493395","Proportion","UP","6.2582610583611515","0.6285714285714286","0.5","0.05128205128205128"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Name:PKCa|Standard Unit:nM","105","Smile SVC Tanimoto classification","0.8228438228438228","Proportion","UP","6.2582610583611515","0.7428571428571429","0.62","0.7948717948717948"
"EPHB4","Activity Value","Assay Description:Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_004435, SK130, P54760, Q541P7, Q59F17, Q7Z635, Q96L35|Standard Unit:nM","170","Smile SVC Tanimoto classification","0.7514887769125058","Proportion","UP","5.874282282431891","0.7411764705882353","0.6744186046511628","0.4915254237288136"
"EPHB4","Activity Value","Assay Description:Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_004435, SK130, P54760, Q541P7, Q59F17, Q7Z635, Q96L35|Standard Unit:nM","170","Smile SVC Poly classification","0.7366773553214236","Proportion","UP","5.874282282431891","0.6529411764705882","NaN","0.0"
"EPHB4","Activity Value","Assay Description:Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_004435, SK130, P54760, Q541P7, Q59F17, Q7Z635, Q96L35|Standard Unit:nM","170","Weka RF on folded fp classification","0.7327836310887155","Proportion","UP","5.874282282431891","0.7058823529411765","0.5957446808510638","0.4745762711864407"
"EPHB4","Activity Value","Assay Description:Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_004435, SK130, P54760, Q541P7, Q59F17, Q7Z635, Q96L35|Standard Unit:nM","170","Smile Bernoulli NB classification","0.711482669109788","Proportion","UP","5.874282282431891","0.6529411764705882","0.5","0.7457627118644068"
"EPHB4","Activity Value","Assay Description:Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_004435, SK130, P54760, Q541P7, Q59F17, Q7Z635, Q96L35|Standard Unit:nM","170","Weka RF classification","0.699572453809742","Proportion","UP","5.874282282431891","0.7470588235294118","0.6739130434782609","0.5254237288135594"
"EPHB4","Activity Value","Assay Description:Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_004435, SK130, P54760, Q541P7, Q59F17, Q7Z635, Q96L35|Standard Unit:nM","170","Smile SVC RBF classification","0.6743777675981064","Proportion","UP","5.874282282431891","0.7058823529411765","0.6551724137931034","0.3220338983050847"
"HCK","Activity Value","Assay Description:Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002101, SK164, P08631, Q504R5|Standard Unit:nM","171","Weka RF on folded fp classification","0.879170113041082","Minimum","UP","6.785322421768094","0.7719298245614035","0.7532467532467533","0.7435897435897436"
"HCK","Activity Value","Assay Description:Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002101, SK164, P08631, Q504R5|Standard Unit:nM","171","Smile SVC Tanimoto classification","0.8696581196581196","Minimum","UP","6.785322421768094","0.7719298245614035","0.76","0.7307692307692307"
"HCK","Activity Value","Assay Description:Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002101, SK164, P08631, Q504R5|Standard Unit:nM","171","Weka RF classification","0.8582161566032532","Minimum","UP","6.785322421768094","0.7953216374269005","0.7866666666666666","0.7564102564102564"
"HCK","Activity Value","Assay Description:Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002101, SK164, P08631, Q504R5|Standard Unit:nM","171","Smile Bernoulli NB classification","0.8243038323683489","Minimum","UP","6.785322421768094","0.7485380116959064","0.6881720430107527","0.8205128205128205"
"HCK","Activity Value","Assay Description:Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002101, SK164, P08631, Q504R5|Standard Unit:nM","171","Smile SVC Poly classification","0.8218224427901856","Minimum","UP","6.785322421768094","0.672514619883041","0.7894736842105263","0.38461538461538464"
"HCK","Activity Value","Assay Description:Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002101, SK164, P08631, Q504R5|Standard Unit:nM","171","Smile SVC RBF classification","0.817411083540116","Minimum","UP","6.785322421768094","0.7660818713450293","0.796875","0.6538461538461539"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:nM","107","Smile Bernoulli NB classification","0.7097222222222224","Proportion","UP","5.459771897546844","0.6261682242990654","0.4528301886792453","0.6857142857142857"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:nM","107","Smile SVC Poly classification","0.6805555555555558","Proportion","UP","5.459771897546844","0.6728971962616822","NaN","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:nM","107","Smile SVC Tanimoto classification","0.6559523809523808","Proportion","UP","5.459771897546844","0.6822429906542056","0.5263157894736842","0.2857142857142857"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:nM","107","Weka RF classification","0.6482142857142857","Proportion","UP","5.459771897546844","0.719626168224299","0.631578947368421","0.34285714285714286"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:nM","107","Weka RF on folded fp classification","0.6321428571428571","Proportion","UP","5.459771897546844","0.719626168224299","0.6923076923076923","0.2571428571428571"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:nM","107","Smile SVC RBF classification","0.5488095238095237","Proportion","UP","5.459771897546844","0.6822429906542056","0.5714285714285714","0.11428571428571428"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:nM","107","Smile Bernoulli NB classification","0.7097222222222224","Proportion","UP","5.459771897546844","0.6261682242990654","0.4528301886792453","0.6857142857142857"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:nM","107","Smile SVC Poly classification","0.679761904761905","Proportion","UP","5.459771897546844","0.6728971962616822","NaN","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:nM","107","Smile SVC Tanimoto classification","0.6527777777777777","Proportion","UP","5.459771897546844","0.6822429906542056","0.5263157894736842","0.2857142857142857"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:nM","107","Weka RF classification","0.6482142857142857","Proportion","UP","5.459771897546844","0.719626168224299","0.631578947368421","0.34285714285714286"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:nM","107","Weka RF on folded fp classification","0.6321428571428571","Proportion","UP","5.459771897546844","0.719626168224299","0.6923076923076923","0.2571428571428571"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:nM","107","Smile SVC RBF classification","0.5488095238095237","Proportion","UP","5.459771897546844","0.6822429906542056","0.5714285714285714","0.11428571428571428"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:nM","107","Smile Bernoulli NB classification","0.7097222222222224","Proportion","UP","5.459771897546844","0.6261682242990654","0.4528301886792453","0.6857142857142857"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:nM","107","Smile SVC Poly classification","0.6805555555555558","Proportion","UP","5.459771897546844","0.6728971962616822","NaN","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:nM","107","Smile SVC Tanimoto classification","0.6531746031746031","Proportion","UP","5.459771897546844","0.6822429906542056","0.5263157894736842","0.2857142857142857"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:nM","107","Weka RF classification","0.6482142857142857","Proportion","UP","5.459771897546844","0.719626168224299","0.631578947368421","0.34285714285714286"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:nM","107","Weka RF on folded fp classification","0.6321428571428571","Proportion","UP","5.459771897546844","0.719626168224299","0.6923076923076923","0.2571428571428571"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:nM","107","Smile SVC RBF classification","0.5488095238095237","Proportion","UP","5.459771897546844","0.6822429906542056","0.5714285714285714","0.11428571428571428"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","137","Smile SVC Tanimoto classification","0.7236781609195401","Proportion","UP","5.552462005059991","0.6788321167883211","0.575","0.46"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","137","Smile SVC Poly classification","0.6963218390804595","Proportion","UP","5.552462005059991","0.635036496350365","NaN","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","137","Smile Bernoulli NB classification","0.694942528735632","Proportion","UP","5.552462005059991","0.6204379562043796","0.4861111111111111","0.7"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","137","Smile SVC RBF classification","0.6835632183908044","Proportion","UP","5.552462005059991","0.6934306569343066","0.8333333333333334","0.2"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","137","Weka RF on folded fp classification","0.6682758620689656","Proportion","UP","5.552462005059991","0.6934306569343066","0.6666666666666666","0.32"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","137","Weka RF classification","0.6506896551724137","Proportion","UP","5.552462005059991","0.6277372262773723","0.4838709677419355","0.3"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","137","Smile SVC Tanimoto classification","0.7202298850574712","Proportion","UP","5.552462005059991","0.6934306569343066","0.6052631578947368","0.46"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","137","Smile Bernoulli NB classification","0.694942528735632","Proportion","UP","5.552462005059991","0.6204379562043796","0.4861111111111111","0.7"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","137","Smile SVC Poly classification","0.6947126436781605","Proportion","UP","5.552462005059991","0.635036496350365","NaN","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","137","Smile SVC RBF classification","0.6835632183908044","Proportion","UP","5.552462005059991","0.6934306569343066","0.8333333333333334","0.2"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","137","Weka RF on folded fp classification","0.6682758620689656","Proportion","UP","5.552462005059991","0.6934306569343066","0.6666666666666666","0.32"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","137","Weka RF classification","0.6506896551724137","Proportion","UP","5.552462005059991","0.6277372262773723","0.4838709677419355","0.3"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","137","Smile SVC Tanimoto classification","0.7211494252873564","Proportion","UP","5.552462005059991","0.6861313868613139","0.5897435897435898","0.46"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","137","Smile SVC Poly classification","0.7004597701149421","Proportion","UP","5.552462005059991","0.635036496350365","NaN","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","137","Smile Bernoulli NB classification","0.694942528735632","Proportion","UP","5.552462005059991","0.6204379562043796","0.4861111111111111","0.7"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","137","Smile SVC RBF classification","0.6835632183908044","Proportion","UP","5.552462005059991","0.6934306569343066","0.8333333333333334","0.2"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","137","Weka RF on folded fp classification","0.6682758620689656","Proportion","UP","5.552462005059991","0.6934306569343066","0.6666666666666666","0.32"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","137","Weka RF classification","0.6506896551724137","Proportion","UP","5.552462005059991","0.6277372262773723","0.4838709677419355","0.3"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","164","Weka RF on folded fp classification","0.7185633575464083","Proportion","UP","5.224958586519195","0.7134146341463414","0.7","0.3559322033898305"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","164","Smile Bernoulli NB classification","0.6732041969330103","Proportion","UP","5.224958586519195","0.573170731707317","0.43956043956043955","0.6779661016949152"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","164","Smile SVC RBF classification","0.6624697336561743","Proportion","UP","5.224958586519195","0.7134146341463414","0.75","0.3050847457627119"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","164","Smile SVC Tanimoto classification","0.6320419693301046","Proportion","UP","5.224958586519195","0.6646341463414634","0.5555555555555556","0.3389830508474576"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","164","Smile SVC Poly classification","0.6192897497982243","Proportion","UP","5.224958586519195","0.6402439024390244","NaN","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","164","Weka RF classification","0.5918482647296207","Proportion","UP","5.224958586519195","0.6524390243902439","0.5333333333333333","0.2711864406779661"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","164","Weka RF on folded fp classification","0.7185633575464083","Proportion","UP","5.224958586519195","0.7134146341463414","0.7","0.3559322033898305"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","164","Smile Bernoulli NB classification","0.6732041969330103","Proportion","UP","5.224958586519195","0.573170731707317","0.43956043956043955","0.6779661016949152"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","164","Smile SVC RBF classification","0.6626311541565779","Proportion","UP","5.224958586519195","0.7134146341463414","0.75","0.3050847457627119"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","164","Smile SVC Tanimoto classification","0.628006456820016","Proportion","UP","5.224958586519195","0.6585365853658537","0.5405405405405406","0.3389830508474576"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","164","Smile SVC Poly classification","0.6189669087974172","Proportion","UP","5.224958586519195","0.6402439024390244","NaN","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","164","Weka RF classification","0.5918482647296207","Proportion","UP","5.224958586519195","0.6524390243902439","0.5333333333333333","0.2711864406779661"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","164","Weka RF on folded fp classification","0.7185633575464083","Proportion","UP","5.224958586519195","0.7134146341463414","0.7","0.3559322033898305"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","164","Smile Bernoulli NB classification","0.6732041969330103","Proportion","UP","5.224958586519195","0.573170731707317","0.43956043956043955","0.6779661016949152"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","164","Smile SVC RBF classification","0.6626311541565779","Proportion","UP","5.224958586519195","0.7134146341463414","0.75","0.3050847457627119"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","164","Smile SVC Tanimoto classification","0.634624697336561","Proportion","UP","5.224958586519195","0.6585365853658537","0.5428571428571428","0.3220338983050847"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","164","Smile SVC Poly classification","0.6194511702986277","Proportion","UP","5.224958586519195","0.6402439024390244","NaN","0.0"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","164","Weka RF classification","0.5918482647296207","Proportion","UP","5.224958586519195","0.6524390243902439","0.5333333333333333","0.2711864406779661"
"Chk1","Activity Value","Assay Description:Inhibition of CHK1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","115","Smile SVC Tanimoto classification","0.978246539222149","Proportion","UP","5.57599949705094","0.9304347826086956","0.9230769230769231","0.8780487804878049"
"Chk1","Activity Value","Assay Description:Inhibition of CHK1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","115","Weka RF on folded fp classification","0.9746209624258404","Proportion","UP","5.57599949705094","0.9130434782608695","0.918918918918919","0.8292682926829268"
"Chk1","Activity Value","Assay Description:Inhibition of CHK1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","115","Smile SVC Poly classification","0.9739617666446934","Proportion","UP","5.57599949705094","0.8956521739130435","0.9142857142857143","0.7804878048780488"
"Chk1","Activity Value","Assay Description:Inhibition of CHK1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","115","Weka RF classification","0.96044825313118","Proportion","UP","5.57599949705094","0.8956521739130435","0.9142857142857143","0.7804878048780488"
"Chk1","Activity Value","Assay Description:Inhibition of CHK1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","115","Smile Bernoulli NB classification","0.9487475280158205","Proportion","UP","5.57599949705094","0.9217391304347826","0.8478260869565217","0.9512195121951219"
"Chk1","Activity Value","Assay Description:Inhibition of CHK1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","115","Smile SVC RBF classification","0.9334212261041528","Proportion","UP","5.57599949705094","0.8260869565217391","0.9565217391304348","0.5365853658536586"
"Chk1","Activity Value","Assay Description:Inhibition at human Chk1 in presence of 4 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","103","Weka RF on folded fp classification","0.7619747899159666","Proportion","UP","6.36110759985932","0.6990291262135923","0.5714285714285714","0.45714285714285713"
"Chk1","Activity Value","Assay Description:Inhibition at human Chk1 in presence of 4 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","103","Smile SVC Tanimoto classification","0.7472689075630253","Proportion","UP","6.36110759985932","0.6504854368932039","0.0","0.0"
"Chk1","Activity Value","Assay Description:Inhibition at human Chk1 in presence of 4 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","103","Smile Bernoulli NB classification","0.7422268907563028","Proportion","UP","6.36110759985932","0.6893203883495146","0.5428571428571428","0.5428571428571428"
"Chk1","Activity Value","Assay Description:Inhibition at human Chk1 in presence of 4 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","103","Smile SVC Poly classification","0.7153361344537816","Proportion","UP","6.36110759985932","0.6601941747572816","NaN","0.0"
"Chk1","Activity Value","Assay Description:Inhibition at human Chk1 in presence of 4 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","103","Weka RF classification","0.6094537815126051","Proportion","UP","6.36110759985932","0.6407766990291263","0.4666666666666667","0.4"
"Chk1","Activity Value","Assay Description:Inhibition at human Chk1 in presence of 4 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","103","Smile SVC RBF classification","0.5172268907563027","Proportion","UP","6.36110759985932","0.6407766990291263","0.42857142857142855","0.17142857142857143"
"Chk1","Activity Value","Assay Description:Inhibition of Chk1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","291","Weka RF on folded fp classification","0.8653664921465961","Proportion","DOWN","8.134668340185751","0.8419243986254296","0.864321608040201","0.900523560209424"
"Chk1","Activity Value","Assay Description:Inhibition of Chk1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","291","Smile SVC Tanimoto classification","0.8623560209424083","Proportion","DOWN","8.134668340185751","0.865979381443299","0.8653846153846154","0.9424083769633508"
"Chk1","Activity Value","Assay Description:Inhibition of Chk1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","291","Smile SVC RBF classification","0.856858638743455","Proportion","DOWN","8.134668340185751","0.8350515463917526","0.8294930875576036","0.9424083769633508"
"Chk1","Activity Value","Assay Description:Inhibition of Chk1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","291","Weka RF classification","0.8442670157068062","Proportion","DOWN","8.134668340185751","0.845360824742268","0.8613861386138614","0.9109947643979057"
"Chk1","Activity Value","Assay Description:Inhibition of Chk1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","291","Smile Bernoulli NB classification","0.8439790575916231","Proportion","DOWN","8.134668340185751","0.7250859106529209","0.8675496688741722","0.6858638743455497"
"Chk1","Activity Value","Assay Description:Inhibition of Chk1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","291","Smile SVC Poly classification","0.8391099476439791","Proportion","DOWN","8.134668340185751","0.7731958762886598","0.775330396475771","0.9214659685863874"
"AURa","Activity Value","Assay Description:Inhibition of Aurora A|Activity Type:IC50|Target Accession Numbers:NP_003591, NP_940835, NP_940836, NP_940837, NP_940838, NP_940839, SK407, O14965|Standard Unit:nM","330","Weka RF on folded fp classification","0.9568645016797311","Minimum","UP","7.515151515151516","0.9151515151515152","0.9240506329113924","0.7684210526315789"
"AURa","Activity Value","Assay Description:Inhibition of Aurora A|Activity Type:IC50|Target Accession Numbers:NP_003591, NP_940835, NP_940836, NP_940837, NP_940838, NP_940839, SK407, O14965|Standard Unit:nM","330","Smile SVC Tanimoto classification","0.9510862262038046","Minimum","UP","7.515151515151516","0.9090909090909091","0.8823529411764706","0.7894736842105263"
"AURa","Activity Value","Assay Description:Inhibition of Aurora A|Activity Type:IC50|Target Accession Numbers:NP_003591, NP_940835, NP_940836, NP_940837, NP_940838, NP_940839, SK407, O14965|Standard Unit:nM","330","Weka RF classification","0.9409406494960806","Minimum","UP","7.515151515151516","0.8818181818181818","0.85","0.7157894736842105"
"AURa","Activity Value","Assay Description:Inhibition of Aurora A|Activity Type:IC50|Target Accession Numbers:NP_003591, NP_940835, NP_940836, NP_940837, NP_940838, NP_940839, SK407, O14965|Standard Unit:nM","330","Smile Bernoulli NB classification","0.9346024636058204","Minimum","UP","7.515151515151516","0.8303030303030303","0.6535433070866141","0.8736842105263158"
"AURa","Activity Value","Assay Description:Inhibition of Aurora A|Activity Type:IC50|Target Accession Numbers:NP_003591, NP_940835, NP_940836, NP_940837, NP_940838, NP_940839, SK407, O14965|Standard Unit:nM","330","Smile SVC Poly classification","0.9289137737961916","Minimum","UP","7.515151515151516","0.9151515151515152","0.958904109589041","0.7368421052631579"
"AURa","Activity Value","Assay Description:Inhibition of Aurora A|Activity Type:IC50|Target Accession Numbers:NP_003591, NP_940835, NP_940836, NP_940837, NP_940838, NP_940839, SK407, O14965|Standard Unit:nM","330","Smile SVC RBF classification","0.9177827547592404","Minimum","UP","7.515151515151516","0.8666666666666667","0.8923076923076924","0.6105263157894737"
"HER2","Activity Value","Assay Description:Inhibition of HER2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","138","Weka RF on folded fp classification","0.890491452991453","Minimum","UP","6.392989902927164","0.7971014492753623","0.7857142857142857","0.7333333333333333"
"HER2","Activity Value","Assay Description:Inhibition of HER2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","138","Smile SVC Poly classification","0.8875000000000001","Minimum","UP","6.392989902927164","0.8188405797101449","0.8301886792452831","0.7333333333333333"
"HER2","Activity Value","Assay Description:Inhibition of HER2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","138","Smile SVC Tanimoto classification","0.8686965811965813","Minimum","UP","6.392989902927164","0.8188405797101449","0.7868852459016393","0.8"
"HER2","Activity Value","Assay Description:Inhibition of HER2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","138","Smile Bernoulli NB classification","0.8683760683760685","Minimum","UP","6.392989902927164","0.7681159420289855","0.6842105263157895","0.8666666666666667"
"HER2","Activity Value","Assay Description:Inhibition of HER2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","138","Weka RF classification","0.8596153846153847","Minimum","UP","6.392989902927164","0.7898550724637681","0.7627118644067796","0.75"
"HER2","Activity Value","Assay Description:Inhibition of HER2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","138","Smile SVC RBF classification","0.8381410256410259","Minimum","UP","6.392989902927164","0.7463768115942029","0.8205128205128205","0.5333333333333333"
"HER2","Activity Value","Assay Description:Inhibition of ErbB2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","121","Smile SVC Poly classification","0.7039355992844365","Proportion","DOWN","7.497459456026151","0.6363636363636364","0.673469387755102","0.8461538461538461"
"HER2","Activity Value","Assay Description:Inhibition of ErbB2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","121","Smile Bernoulli NB classification","0.6964818127608825","Proportion","DOWN","7.497459456026151","0.6363636363636364","0.8541666666666666","0.5256410256410257"
"HER2","Activity Value","Assay Description:Inhibition of ErbB2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","121","Weka RF on folded fp classification","0.6771019677996422","Proportion","DOWN","7.497459456026151","0.6776859504132231","0.7468354430379747","0.7564102564102564"
"HER2","Activity Value","Assay Description:Inhibition of ErbB2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","121","Smile SVC RBF classification","0.6739713774597497","Proportion","DOWN","7.497459456026151","0.6859504132231405","0.6923076923076923","0.9230769230769231"
"HER2","Activity Value","Assay Description:Inhibition of ErbB2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","121","Smile SVC Tanimoto classification","0.6550387596899223","Proportion","DOWN","7.497459456026151","0.6198347107438017","0.6568627450980392","0.8589743589743589"
"HER2","Activity Value","Assay Description:Inhibition of ErbB2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","121","Weka RF classification","0.6079308288610614","Proportion","DOWN","7.497459456026151","0.6198347107438017","0.7","0.717948717948718"
"SYK","Activity Value","Assay Description:Inhibition of recombinant Syk|Activity Type:IC50|Target Accession Numbers:NP_003168, SK363, P43405, Q5T6N7, Q5T6N8|Standard Unit:nM","141","Weka RF on folded fp classification","0.8992374727668845","Inflection","UP","6.703713429908824","0.8226950354609929","0.76","0.7450980392156863"
"SYK","Activity Value","Assay Description:Inhibition of recombinant Syk|Activity Type:IC50|Target Accession Numbers:NP_003168, SK363, P43405, Q5T6N7, Q5T6N8|Standard Unit:nM","141","Smile SVC Tanimoto classification","0.8845315904139431","Inflection","UP","6.703713429908824","0.8156028368794326","0.7358490566037735","0.7647058823529411"
"SYK","Activity Value","Assay Description:Inhibition of recombinant Syk|Activity Type:IC50|Target Accession Numbers:NP_003168, SK363, P43405, Q5T6N7, Q5T6N8|Standard Unit:nM","141","Weka RF classification","0.8770152505446623","Inflection","UP","6.703713429908824","0.7801418439716312","0.7272727272727273","0.6274509803921569"
"SYK","Activity Value","Assay Description:Inhibition of recombinant Syk|Activity Type:IC50|Target Accession Numbers:NP_003168, SK363, P43405, Q5T6N7, Q5T6N8|Standard Unit:nM","141","Smile Bernoulli NB classification","0.8555555555555558","Inflection","UP","6.703713429908824","0.7375886524822695","0.5897435897435898","0.9019607843137255"
"SYK","Activity Value","Assay Description:Inhibition of recombinant Syk|Activity Type:IC50|Target Accession Numbers:NP_003168, SK363, P43405, Q5T6N7, Q5T6N8|Standard Unit:nM","141","Smile SVC RBF classification","0.8376906318082789","Inflection","UP","6.703713429908824","0.7375886524822695","0.7333333333333333","0.43137254901960786"
"SYK","Activity Value","Assay Description:Inhibition of recombinant Syk|Activity Type:IC50|Target Accession Numbers:NP_003168, SK363, P43405, Q5T6N7, Q5T6N8|Standard Unit:nM","141","Smile SVC Poly classification","0.8357298474945535","Inflection","UP","6.703713429908824","0.723404255319149","0.8","0.3137254901960784"
"JNK2","Activity Value","Assay Description:Inhibition of recombinant JNK2 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","117","Weka RF on folded fp classification","0.9285714285714286","Proportion","UP","6.199019227905245","0.8547008547008547","0.7674418604651163","0.825"
"JNK2","Activity Value","Assay Description:Inhibition of recombinant JNK2 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","117","Weka RF classification","0.9219155844155844","Proportion","UP","6.199019227905245","0.8461538461538461","0.7619047619047619","0.8"
"JNK2","Activity Value","Assay Description:Inhibition of recombinant JNK2 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","117","Smile Bernoulli NB classification","0.9011363636363642","Proportion","UP","6.199019227905245","0.8547008547008547","0.7254901960784313","0.925"
"JNK2","Activity Value","Assay Description:Inhibition of recombinant JNK2 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","117","Smile SVC Poly classification","0.8998376623376628","Proportion","UP","6.199019227905245","0.8290598290598291","0.7631578947368421","0.725"
"JNK2","Activity Value","Assay Description:Inhibition of recombinant JNK2 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","117","Smile SVC Tanimoto classification","0.8975649350649358","Proportion","UP","6.199019227905245","0.8376068376068376","0.7441860465116279","0.8"
"JNK2","Activity Value","Assay Description:Inhibition of recombinant JNK2 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","117","Smile SVC RBF classification","0.8866883116883122","Proportion","UP","6.199019227905245","0.8034188034188035","0.8695652173913043","0.5"
"JNK2","Activity Value","Assay Description:Inhibition of JNK2|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","130","Weka RF on folded fp classification","0.9811656005685856","Minimum","UP","4.907591820240333","0.9230769230769231","0.8840579710144928","0.9682539682539683"
"JNK2","Activity Value","Assay Description:Inhibition of JNK2|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","130","Smile SVC Poly classification","0.9779673063255152","Minimum","UP","4.907591820240333","0.9230769230769231","0.8840579710144928","0.9682539682539683"
"JNK2","Activity Value","Assay Description:Inhibition of JNK2|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","130","Smile SVC Tanimoto classification","0.9725183605780621","Minimum","UP","4.907591820240333","0.9384615384615385","0.8985507246376812","0.9841269841269841"
"JNK2","Activity Value","Assay Description:Inhibition of JNK2|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","130","Smile Bernoulli NB classification","0.9703861644160152","Minimum","UP","4.907591820240333","0.9076923076923077","0.8805970149253731","0.9365079365079365"
"JNK2","Activity Value","Assay Description:Inhibition of JNK2|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","130","Weka RF classification","0.9702677090736793","Minimum","UP","4.907591820240333","0.9076923076923077","0.9047619047619048","0.9047619047619048"
"JNK2","Activity Value","Assay Description:Inhibition of JNK2|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","130","Smile SVC RBF classification","0.9696754323619996","Minimum","UP","4.907591820240333","0.9","0.8378378378378378","0.9841269841269841"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory)|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","7167","Weka RF on folded fp classification","0.5856166290769617","Proportion","UP","4.885061592130468","0.6137854053299846","0.6170212765957447","0.041251778093883355"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory)|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","7167","Smile SVC Poly classification","0.5790413562998048","Proportion","UP","4.885061592130468","0.6076461559927445","0.5","3.5561877667140827E-4"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory)|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","7167","Smile SVC Tanimoto classification","0.5786767551889328","Proportion","UP","4.885061592130468","0.6102971954792801","0.5075098814229249","0.2283072546230441"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory)|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","7167","Smile Bernoulli NB classification","0.573186262581393","Proportion","UP","4.885061592130468","0.5564392353844008","0.44267416432364887","0.5039118065433855"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory)|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","7167","Weka RF classification","0.5700599203348609","Proportion","UP","4.885061592130468","0.606529928840519","0.4953810623556582","0.15256045519203415"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory)|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","7167","Smile SVC RBF classification","0.5689327190505505","Proportion","UP","4.885061592130468","0.6094600251151109","0.5098934550989346","0.11913229018492176"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","6398","Smile SVC Tanimoto classification","0.6062398157660505","Proportion","UP","4.728413980590172","0.6461394185683026","0.5372005044136192","0.18338355574687903"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","6398","Smile SVC RBF classification","0.6039177708114919","Proportion","UP","4.728413980590172","0.6428571428571429","0.5407725321888412","0.10848041325871717"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","6398","Weka RF classification","0.6018443466112403","Proportion","UP","4.728413980590172","0.6511409815567365","0.5696784073506891","0.16013775290572535"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","6398","Smile SVC Poly classification","0.5997180502259305","Proportion","UP","4.728413980590172","0.6369177868083776","NaN","0.0"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","6398","Smile Bernoulli NB classification","0.5945635667861258","Proportion","UP","4.728413980590172","0.5909659268521413","0.4399018806214227","0.46319414550150667"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","6398","Weka RF on folded fp classification","0.5809962260563224","Proportion","UP","4.728413980590172","0.6384807752422632","0.5833333333333334","0.015066724063710719"
"CDK1","Activity Value","Assay Description:Inhibition of CDK1|Activity Type:IC50|Target Accession Numbers:NP_001777, SK065, P06493|Standard Unit:nM","248","Weka RF on folded fp classification","0.8066323980866712","Proportion","DOWN","7.089243523931646","0.782258064516129","0.7955801104972375","0.8944099378881988"
"CDK1","Activity Value","Assay Description:Inhibition of CDK1|Activity Type:IC50|Target Accession Numbers:NP_001777, SK065, P06493|Standard Unit:nM","248","Smile Bernoulli NB classification","0.7917112872135369","Proportion","DOWN","7.089243523931646","0.7016129032258065","0.8536585365853658","0.6521739130434783"
"CDK1","Activity Value","Assay Description:Inhibition of CDK1|Activity Type:IC50|Target Accession Numbers:NP_001777, SK065, P06493|Standard Unit:nM","248","Smile SVC Poly classification","0.7890340544013713","Proportion","DOWN","7.089243523931646","0.7217741935483871","0.719047619047619","0.937888198757764"
"CDK1","Activity Value","Assay Description:Inhibition of CDK1|Activity Type:IC50|Target Accession Numbers:NP_001777, SK065, P06493|Standard Unit:nM","248","Smile SVC Tanimoto classification","0.784250731776969","Proportion","DOWN","7.089243523931646","0.75","0.776536312849162","0.8633540372670807"
"CDK1","Activity Value","Assay Description:Inhibition of CDK1|Activity Type:IC50|Target Accession Numbers:NP_001777, SK065, P06493|Standard Unit:nM","248","Weka RF classification","0.7717926750910257","Proportion","DOWN","7.089243523931646","0.7419354838709677","0.783625730994152","0.8322981366459627"
"CDK1","Activity Value","Assay Description:Inhibition of CDK1|Activity Type:IC50|Target Accession Numbers:NP_001777, SK065, P06493|Standard Unit:nM","248","Smile SVC RBF classification","0.7575497965303066","Proportion","DOWN","7.089243523931646","0.7338709677419355","0.7411167512690355","0.906832298136646"
"TIE2","Activity Value","Assay Description:Inhibition of Tie2|Activity Type:IC50|Target Accession Numbers:NP_000450, SK367, Q02763, Q59HG2, Q5TCU2|Standard Unit:nM","166","Weka RF on folded fp classification","0.8786375661375662","Minimum","UP","7.338747978265044","0.8313253012048193","0.782608695652174","0.6666666666666666"
"TIE2","Activity Value","Assay Description:Inhibition of Tie2|Activity Type:IC50|Target Accession Numbers:NP_000450, SK367, Q02763, Q59HG2, Q5TCU2|Standard Unit:nM","166","Smile SVC Tanimoto classification","0.8779761904761908","Minimum","UP","7.338747978265044","0.8373493975903614","0.8461538461538461","0.6111111111111112"
"TIE2","Activity Value","Assay Description:Inhibition of Tie2|Activity Type:IC50|Target Accession Numbers:NP_000450, SK367, Q02763, Q59HG2, Q5TCU2|Standard Unit:nM","166","Smile SVC Poly classification","0.874338624338625","Minimum","UP","7.338747978265044","0.8313253012048193","0.8823529411764706","0.5555555555555556"
"TIE2","Activity Value","Assay Description:Inhibition of Tie2|Activity Type:IC50|Target Accession Numbers:NP_000450, SK367, Q02763, Q59HG2, Q5TCU2|Standard Unit:nM","166","Smile Bernoulli NB classification","0.8555720899470916","Minimum","UP","7.338747978265044","0.8072289156626506","0.671875","0.7962962962962963"
"TIE2","Activity Value","Assay Description:Inhibition of Tie2|Activity Type:IC50|Target Accession Numbers:NP_000450, SK367, Q02763, Q59HG2, Q5TCU2|Standard Unit:nM","166","Weka RF classification","0.841765873015873","Minimum","UP","7.338747978265044","0.7891566265060241","0.7209302325581395","0.5740740740740741"
"TIE2","Activity Value","Assay Description:Inhibition of Tie2|Activity Type:IC50|Target Accession Numbers:NP_000450, SK367, Q02763, Q59HG2, Q5TCU2|Standard Unit:nM","166","Smile SVC RBF classification","0.796957671957672","Minimum","UP","7.338747978265044","0.8313253012048193","0.8823529411764706","0.5555555555555556"
"IGF1R","Activity Value","Assay Description:Inhibition of IGF1R|Activity Type:IC50|Target Accession Numbers:NP_000866, SK174, P08069|Standard Unit:nM","221","Smile Bernoulli NB classification","0.9194704908990615","Proportion","UP","7.211185051674074","0.8054298642533937","0.6534653465346535","0.8918918918918919"
"IGF1R","Activity Value","Assay Description:Inhibition of IGF1R|Activity Type:IC50|Target Accession Numbers:NP_000866, SK174, P08069|Standard Unit:nM","221","Weka RF on folded fp classification","0.8976833976833979","Proportion","UP","7.211185051674074","0.8552036199095022","0.7837837837837838","0.7837837837837838"
"IGF1R","Activity Value","Assay Description:Inhibition of IGF1R|Activity Type:IC50|Target Accession Numbers:NP_000866, SK174, P08069|Standard Unit:nM","221","Smile SVC Tanimoto classification","0.8953392167677885","Proportion","UP","7.211185051674074","0.8687782805429864","0.7922077922077922","0.8243243243243243"
"IGF1R","Activity Value","Assay Description:Inhibition of IGF1R|Activity Type:IC50|Target Accession Numbers:NP_000866, SK174, P08069|Standard Unit:nM","221","Smile SVC Poly classification","0.8946957161242871","Proportion","UP","7.211185051674074","0.8552036199095022","0.7692307692307693","0.8108108108108109"
"IGF1R","Activity Value","Assay Description:Inhibition of IGF1R|Activity Type:IC50|Target Accession Numbers:NP_000866, SK174, P08069|Standard Unit:nM","221","Weka RF classification","0.8624747196175769","Proportion","UP","7.211185051674074","0.8144796380090498","0.7323943661971831","0.7027027027027027"
"IGF1R","Activity Value","Assay Description:Inhibition of IGF1R|Activity Type:IC50|Target Accession Numbers:NP_000866, SK174, P08069|Standard Unit:nM","221","Smile SVC RBF classification","0.8507997793712091","Proportion","UP","7.211185051674074","0.8099547511312217","0.7857142857142857","0.5945945945945946"
"PLK1","Activity Value","Assay Description:Inhibition of PLK1|Activity Type:IC50|Target Accession Numbers:NP_005021, P53350|Standard Unit:nM","133","Smile Bernoulli NB classification","0.9195402298850577","Proportion","DOWN","7.200750980959092","0.8045112781954887","0.9420289855072463","0.7471264367816092"
"PLK1","Activity Value","Assay Description:Inhibition of PLK1|Activity Type:IC50|Target Accession Numbers:NP_005021, P53350|Standard Unit:nM","133","Smile SVC Tanimoto classification","0.9177911044477762","Proportion","DOWN","7.200750980959092","0.8646616541353384","0.8876404494382022","0.9080459770114943"
"PLK1","Activity Value","Assay Description:Inhibition of PLK1|Activity Type:IC50|Target Accession Numbers:NP_005021, P53350|Standard Unit:nM","133","Weka RF on folded fp classification","0.917416291854073","Proportion","DOWN","7.200750980959092","0.8421052631578947","0.875","0.8850574712643678"
"PLK1","Activity Value","Assay Description:Inhibition of PLK1|Activity Type:IC50|Target Accession Numbers:NP_005021, P53350|Standard Unit:nM","133","Smile SVC Poly classification","0.9035482258870566","Proportion","DOWN","7.200750980959092","0.8045112781954887","0.8144329896907216","0.9080459770114943"
"PLK1","Activity Value","Assay Description:Inhibition of PLK1|Activity Type:IC50|Target Accession Numbers:NP_005021, P53350|Standard Unit:nM","133","Weka RF classification","0.8856821589205397","Proportion","DOWN","7.200750980959092","0.7669172932330827","0.8111111111111111","0.8390804597701149"
"PLK1","Activity Value","Assay Description:Inhibition of PLK1|Activity Type:IC50|Target Accession Numbers:NP_005021, P53350|Standard Unit:nM","133","Smile SVC RBF classification","0.8770614692653674","Proportion","DOWN","7.200750980959092","0.8421052631578947","0.83","0.9540229885057471"
"JNK3","Activity Value","Assay Description:Inhibition of recombinant JNK3 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","121","Smile SVC Tanimoto classification","0.9339130434782609","Inflection","UP","6.6165587947113025","0.8842975206611571","0.82","0.8913043478260869"
"JNK3","Activity Value","Assay Description:Inhibition of recombinant JNK3 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","121","Weka RF on folded fp classification","0.9246376811594202","Inflection","UP","6.6165587947113025","0.859504132231405","0.8372093023255814","0.782608695652174"
"JNK3","Activity Value","Assay Description:Inhibition of recombinant JNK3 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","121","Smile Bernoulli NB classification","0.9231884057971015","Inflection","UP","6.6165587947113025","0.8760330578512396","0.7924528301886793","0.9130434782608695"
"JNK3","Activity Value","Assay Description:Inhibition of recombinant JNK3 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","121","Smile SVC Poly classification","0.9202898550724639","Inflection","UP","6.6165587947113025","0.8264462809917356","0.7906976744186046","0.7391304347826086"
"JNK3","Activity Value","Assay Description:Inhibition of recombinant JNK3 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","121","Weka RF classification","0.9175362318840579","Inflection","UP","6.6165587947113025","0.8347107438016529","0.76","0.8260869565217391"
"JNK3","Activity Value","Assay Description:Inhibition of recombinant JNK3 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","121","Smile SVC RBF classification","0.8907246376811582","Inflection","UP","6.6165587947113025","0.7603305785123967","0.8148148148148148","0.4782608695652174"
"JNK3","Activity Value","Assay Description:PubChem BioAssay. Dose response biochemical screening assay for inhibitors of c-Jun N-Terminal Kinase 3 (JNK3). (Class of assay: confirmatory) [Related pubchem assays: 746 ]|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","362","Smile Bernoulli NB classification","0.7058433629862204","Proportion","UP","4.574178805882413","0.6049723756906077","0.4322916666666667","0.7094017094017094"
"JNK3","Activity Value","Assay Description:PubChem BioAssay. Dose response biochemical screening assay for inhibitors of c-Jun N-Terminal Kinase 3 (JNK3). (Class of assay: confirmatory) [Related pubchem assays: 746 ]|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","362","Weka RF on folded fp classification","0.6821210535496255","Proportion","UP","4.574178805882413","0.7182320441988951","0.7027027027027027","0.2222222222222222"
"JNK3","Activity Value","Assay Description:PubChem BioAssay. Dose response biochemical screening assay for inhibitors of c-Jun N-Terminal Kinase 3 (JNK3). (Class of assay: confirmatory) [Related pubchem assays: 746 ]|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","362","Smile SVC Poly classification","0.6814233385661957","Proportion","UP","4.574178805882413","0.6767955801104972","NaN","0.0"
"JNK3","Activity Value","Assay Description:PubChem BioAssay. Dose response biochemical screening assay for inhibitors of c-Jun N-Terminal Kinase 3 (JNK3). (Class of assay: confirmatory) [Related pubchem assays: 746 ]|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","362","Smile SVC Tanimoto classification","0.6725623582766445","Proportion","UP","4.574178805882413","0.7182320441988951","0.6271186440677966","0.3162393162393162"
"JNK3","Activity Value","Assay Description:PubChem BioAssay. Dose response biochemical screening assay for inhibitors of c-Jun N-Terminal Kinase 3 (JNK3). (Class of assay: confirmatory) [Related pubchem assays: 746 ]|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","362","Smile SVC RBF classification","0.6425954997383576","Proportion","UP","4.574178805882413","0.7016574585635359","0.6666666666666666","0.15384615384615385"
"JNK3","Activity Value","Assay Description:PubChem BioAssay. Dose response biochemical screening assay for inhibitors of c-Jun N-Terminal Kinase 3 (JNK3). (Class of assay: confirmatory) [Related pubchem assays: 746 ]|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","362","Weka RF classification","0.6160997732426302","Proportion","UP","4.574178805882413","0.7292817679558011","0.6792452830188679","0.3076923076923077"
"JNK3","Activity Value","Assay Description:Inhibition of JNK3|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","122","Smile Bernoulli NB classification","0.8521529659741043","Proportion","UP","7.1140398466597405","0.7131147540983607","0.546875","0.8536585365853658"
"JNK3","Activity Value","Assay Description:Inhibition of JNK3|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","122","Weka RF on folded fp classification","0.8414634146341463","Proportion","UP","7.1140398466597405","0.7459016393442623","0.6923076923076923","0.43902439024390244"
"JNK3","Activity Value","Assay Description:Inhibition of JNK3|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","122","Smile SVC Poly classification","0.7964468533574229","Proportion","UP","7.1140398466597405","0.680327868852459","0.75","0.07317073170731707"
"JNK3","Activity Value","Assay Description:Inhibition of JNK3|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","122","Smile SVC Tanimoto classification","0.7807889190003015","Proportion","UP","7.1140398466597405","0.7459016393442623","0.6923076923076923","0.43902439024390244"
"JNK3","Activity Value","Assay Description:Inhibition of JNK3|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","122","Weka RF classification","0.7565492321589882","Proportion","UP","7.1140398466597405","0.7377049180327869","0.68","0.4146341463414634"
"JNK3","Activity Value","Assay Description:Inhibition of JNK3|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","122","Smile SVC RBF classification","0.6763023185787411","Proportion","UP","7.1140398466597405","0.6885245901639344","0.5882352941176471","0.24390243902439024"
"GSK3b","Activity Value","Assay Description:Inhibition of recombinant GSK3-beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","150","Weka RF classification","0.8889910130718954","Proportion","DOWN","7.129117220960602","0.8266666666666667","0.88","0.8627450980392157"
"GSK3b","Activity Value","Assay Description:Inhibition of recombinant GSK3-beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","150","Weka RF on folded fp classification","0.8741830065359477","Proportion","DOWN","7.129117220960602","0.82","0.8504672897196262","0.8921568627450981"
"GSK3b","Activity Value","Assay Description:Inhibition of recombinant GSK3-beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","150","Smile SVC Tanimoto classification","0.8725490196078431","Proportion","DOWN","7.129117220960602","0.8333333333333334","0.8407079646017699","0.9313725490196079"
"GSK3b","Activity Value","Assay Description:Inhibition of recombinant GSK3-beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","150","Smile SVC RBF classification","0.8525326797385622","Proportion","DOWN","7.129117220960602","0.76","0.7661290322580645","0.9313725490196079"
"GSK3b","Activity Value","Assay Description:Inhibition of recombinant GSK3-beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","150","Smile Bernoulli NB classification","0.8377246732026145","Proportion","DOWN","7.129117220960602","0.7","0.8904109589041096","0.6372549019607843"
"GSK3b","Activity Value","Assay Description:Inhibition of recombinant GSK3-beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","150","Smile SVC Poly classification","0.8255718954248367","Proportion","DOWN","7.129117220960602","0.7133333333333334","0.736","0.9019607843137255"
"GSK3b","Activity Value","Assay Description:Inhibition of GSK3beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","157","Weka RF on folded fp classification","0.9273403838621229","Minimum","UP","6.0237924879694855","0.821656050955414","0.78125","0.5434782608695652"
"GSK3b","Activity Value","Assay Description:Inhibition of GSK3beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","157","Smile SVC Poly classification","0.9142185663924794","Minimum","UP","6.0237924879694855","0.7070063694267515","NaN","0.0"
"GSK3b","Activity Value","Assay Description:Inhibition of GSK3beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","157","Weka RF classification","0.9129455542499022","Minimum","UP","6.0237924879694855","0.8280254777070064","0.8064516129032258","0.5434782608695652"
"GSK3b","Activity Value","Assay Description:Inhibition of GSK3beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","157","Smile SVC Tanimoto classification","0.9124559341950647","Minimum","UP","6.0237924879694855","0.8152866242038217","0.6976744186046512","0.6521739130434783"
"GSK3b","Activity Value","Assay Description:Inhibition of GSK3beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","157","Smile SVC RBF classification","0.9020759890325112","Minimum","UP","6.0237924879694855","0.7452229299363057","0.8","0.17391304347826086"
"GSK3b","Activity Value","Assay Description:Inhibition of GSK3beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","157","Smile Bernoulli NB classification","0.8975714845280065","Minimum","UP","6.0237924879694855","0.8280254777070064","0.6417910447761194","0.9347826086956522"
"MK2","Activity Value","Assay Description:Inhibition of MK2|Activity Type:IC50|Target Accession Numbers:NP_004750, NP_116584, SK212, P49137, Q5SY30, Q5SY41|Standard Unit:nM","205","Smile Bernoulli NB classification","0.9457337546908939","Minimum","UP","6.319535771613926","0.8585365853658536","0.7596153846153846","0.9518072289156626"
"MK2","Activity Value","Assay Description:Inhibition of MK2|Activity Type:IC50|Target Accession Numbers:NP_004750, NP_116584, SK212, P49137, Q5SY30, Q5SY41|Standard Unit:nM","205","Weka RF classification","0.9450424649417342","Minimum","UP","6.319535771613926","0.8731707317073171","0.88","0.7951807228915663"
"MK2","Activity Value","Assay Description:Inhibition of MK2|Activity Type:IC50|Target Accession Numbers:NP_004750, NP_116584, SK212, P49137, Q5SY30, Q5SY41|Standard Unit:nM","205","Weka RF on folded fp classification","0.9432648627296069","Minimum","UP","6.319535771613926","0.8926829268292683","0.9066666666666666","0.8192771084337349"
"MK2","Activity Value","Assay Description:Inhibition of MK2|Activity Type:IC50|Target Accession Numbers:NP_004750, NP_116584, SK212, P49137, Q5SY30, Q5SY41|Standard Unit:nM","205","Smile SVC Poly classification","0.9431167292119297","Minimum","UP","6.319535771613926","0.8585365853658536","0.921875","0.7108433734939759"
"MK2","Activity Value","Assay Description:Inhibition of MK2|Activity Type:IC50|Target Accession Numbers:NP_004750, NP_116584, SK212, P49137, Q5SY30, Q5SY41|Standard Unit:nM","205","Smile SVC Tanimoto classification","0.9395615247876747","Minimum","UP","6.319535771613926","0.8731707317073171","0.8433734939759037","0.8433734939759037"
"MK2","Activity Value","Assay Description:Inhibition of MK2|Activity Type:IC50|Target Accession Numbers:NP_004750, NP_116584, SK212, P49137, Q5SY30, Q5SY41|Standard Unit:nM","205","Smile SVC RBF classification","0.9288959115149116","Minimum","UP","6.319535771613926","0.8585365853658536","0.9090909090909091","0.7228915662650602"
"IRAK4","Activity Value","Assay Description:Inhibition of IRAK4|Activity Type:IC50|Target Accession Numbers:Q9NWZ3, Q69FE1, Q69FE3|Standard Unit:nM","117","Weka RF classification","0.8825782811459028","Proportion","UP","6.422506959207412","0.7863247863247863","0.6585365853658537","0.7105263157894737"
"IRAK4","Activity Value","Assay Description:Inhibition of IRAK4|Activity Type:IC50|Target Accession Numbers:Q9NWZ3, Q69FE1, Q69FE3|Standard Unit:nM","117","Smile SVC Tanimoto classification","0.8767488341105921","Proportion","UP","6.422506959207412","0.8034188034188035","0.6829268292682927","0.7368421052631579"
"IRAK4","Activity Value","Assay Description:Inhibition of IRAK4|Activity Type:IC50|Target Accession Numbers:Q9NWZ3, Q69FE1, Q69FE3|Standard Unit:nM","117","Weka RF on folded fp classification","0.8752498334443705","Proportion","UP","6.422506959207412","0.8034188034188035","0.6923076923076923","0.7105263157894737"
"IRAK4","Activity Value","Assay Description:Inhibition of IRAK4|Activity Type:IC50|Target Accession Numbers:Q9NWZ3, Q69FE1, Q69FE3|Standard Unit:nM","117","Smile SVC Poly classification","0.8730846102598262","Proportion","UP","6.422506959207412","0.8205128205128205","0.7575757575757576","0.6578947368421053"
"IRAK4","Activity Value","Assay Description:Inhibition of IRAK4|Activity Type:IC50|Target Accession Numbers:Q9NWZ3, Q69FE1, Q69FE3|Standard Unit:nM","117","Smile SVC RBF classification","0.8497668221185871","Proportion","UP","6.422506959207412","0.7863247863247863","0.76","0.5"
"IRAK4","Activity Value","Assay Description:Inhibition of IRAK4|Activity Type:IC50|Target Accession Numbers:Q9NWZ3, Q69FE1, Q69FE3|Standard Unit:nM","117","Smile Bernoulli NB classification","0.8391072618254493","Proportion","UP","6.422506959207412","0.7606837606837606","0.5925925925925926","0.8421052631578947"
"p38a","Activity Value","Assay Description:Inhibition of p38alpha|Activity Type:IC50|Target Accession Numbers:NP_620581, Q16539|Standard Unit:nM","639","Weka RF on folded fp classification","0.920195261079422","Proportion","DOWN","7.827397589969481","0.863849765258216","0.8769574944071589","0.9245283018867925"
"p38a","Activity Value","Assay Description:Inhibition of p38alpha|Activity Type:IC50|Target Accession Numbers:NP_620581, Q16539|Standard Unit:nM","639","Smile SVC Tanimoto classification","0.9088086880210628","Proportion","DOWN","7.827397589969481","0.8513302034428795","0.8781609195402299","0.9009433962264151"
"p38a","Activity Value","Assay Description:Inhibition of p38alpha|Activity Type:IC50|Target Accession Numbers:NP_620581, Q16539|Standard Unit:nM","639","Smile Bernoulli NB classification","0.8954091706889","Proportion","DOWN","7.827397589969481","0.810641627543036","0.8976377952755905","0.8066037735849056"
"p38a","Activity Value","Assay Description:Inhibition of p38alpha|Activity Type:IC50|Target Accession Numbers:NP_620581, Q16539|Standard Unit:nM","639","Smile SVC Poly classification","0.8793001316366843","Proportion","DOWN","7.827397589969481","0.8137715179968701","0.8322440087145969","0.9009433962264151"
"p38a","Activity Value","Assay Description:Inhibition of p38alpha|Activity Type:IC50|Target Accession Numbers:NP_620581, Q16539|Standard Unit:nM","639","Weka RF classification","0.878148310662571","Proportion","DOWN","7.827397589969481","0.8137715179968701","0.8458049886621315","0.8797169811320755"
"p38a","Activity Value","Assay Description:Inhibition of p38alpha|Activity Type:IC50|Target Accession Numbers:NP_620581, Q16539|Standard Unit:nM","639","Smile SVC RBF classification","0.8678312856516025","Proportion","DOWN","7.827397589969481","0.8231611893583725","0.8526077097505669","0.8867924528301887"
"VEGFR1","Activity Value","Assay Description:Inhibition of VEGFR1 by HTRF assay|Activity type:IC50|Target Accession Numbers:NP_002010, SK150, P17948, Q59GQ9, Q5TAR1|Standard unit:nM","102","Weka RF on folded fp classification","0.7584541062801934","Proportion","UP","6.3098351269849","0.7647058823529411","0.7142857142857143","0.45454545454545453"
"VEGFR1","Activity Value","Assay Description:Inhibition of VEGFR1 by HTRF assay|Activity type:IC50|Target Accession Numbers:NP_002010, SK150, P17948, Q59GQ9, Q5TAR1|Standard unit:nM","102","Smile SVC Poly classification","0.7347386912604302","Proportion","UP","6.3098351269849","0.6764705882352942","NaN","0.0"
"VEGFR1","Activity Value","Assay Description:Inhibition of VEGFR1 by HTRF assay|Activity type:IC50|Target Accession Numbers:NP_002010, SK150, P17948, Q59GQ9, Q5TAR1|Standard unit:nM","102","Smile SVC Tanimoto classification","0.7312252964426877","Proportion","UP","6.3098351269849","0.7352941176470589","0.8","0.24242424242424243"
"VEGFR1","Activity Value","Assay Description:Inhibition of VEGFR1 by HTRF assay|Activity type:IC50|Target Accession Numbers:NP_002010, SK150, P17948, Q59GQ9, Q5TAR1|Standard unit:nM","102","Smile Bernoulli NB classification","0.7140974967061924","Proportion","UP","6.3098351269849","0.696078431372549","0.5238095238095238","0.6666666666666666"
"VEGFR1","Activity Value","Assay Description:Inhibition of VEGFR1 by HTRF assay|Activity type:IC50|Target Accession Numbers:NP_002010, SK150, P17948, Q59GQ9, Q5TAR1|Standard unit:nM","102","Weka RF classification","0.7013614404918752","Proportion","UP","6.3098351269849","0.7745098039215687","0.7083333333333334","0.5151515151515151"
"VEGFR1","Activity Value","Assay Description:Inhibition of VEGFR1 by HTRF assay|Activity type:IC50|Target Accession Numbers:NP_002010, SK150, P17948, Q59GQ9, Q5TAR1|Standard unit:nM","102","Smile SVC RBF classification","0.6916996047430835","Proportion","UP","6.3098351269849","0.7156862745098039","0.6428571428571429","0.2727272727272727"
"Kinase Assay","Inhibition","Target (full name):Unchecked","364","Smile SVC Tanimoto classification","0.8040836820083685","Proportion","UP","27.633000019810254","0.7747252747252747","0.7216494845360825","0.56"
"Kinase Assay","Inhibition","Target (full name):Unchecked","364","Smile Bernoulli NB classification","0.7953974895397485","Proportion","UP","27.633000019810254","0.717032967032967","0.5561224489795918","0.872"
"Kinase Assay","Inhibition","Target (full name):Unchecked","364","Weka RF on folded fp classification","0.7872635983263602","Proportion","UP","27.633000019810254","0.7527472527472527","0.7011494252873564","0.488"
"Kinase Assay","Inhibition","Target (full name):Unchecked","364","Weka RF classification","0.7742928870292887","Proportion","UP","27.633000019810254","0.7417582417582418","0.6597938144329897","0.512"
"Kinase Assay","Inhibition","Target (full name):Unchecked","364","Smile SVC RBF classification","0.7658912133891218","Proportion","UP","27.633000019810254","0.728021978021978","0.696969696969697","0.368"
"Kinase Assay","Inhibition","Target (full name):Unchecked","364","Smile SVC Poly classification","0.7579246861924684","Proportion","UP","27.633000019810254","0.6730769230769231","0.7142857142857143","0.08"
"Kinase Assay","Inhibition","Target (full name):Leucine-rich repeat serine/threonine-protein kinase 2","364","Weka RF on folded fp classification","0.8690992767915856","Proportion","UP","8.675249373182755","0.7857142857142857","0.76","0.5846153846153846"
"Kinase Assay","Inhibition","Target (full name):Leucine-rich repeat serine/threonine-protein kinase 2","364","Smile Bernoulli NB classification","0.8603879026955967","Proportion","UP","8.675249373182755","0.7774725274725275","0.6560509554140127","0.7923076923076923"
"Kinase Assay","Inhibition","Target (full name):Leucine-rich repeat serine/threonine-protein kinase 2","364","Smile SVC Tanimoto classification","0.8486850756081535","Proportion","UP","8.675249373182755","0.7692307692307693","0.6949152542372882","0.6307692307692307"
"Kinase Assay","Inhibition","Target (full name):Leucine-rich repeat serine/threonine-protein kinase 2","364","Smile SVC Poly classification","0.8449046679815924","Proportion","UP","8.675249373182755","0.6978021978021978","0.8125","0.2"
"Kinase Assay","Inhibition","Target (full name):Leucine-rich repeat serine/threonine-protein kinase 2","364","Weka RF classification","0.8390368178829718","Proportion","UP","8.675249373182755","0.760989010989011","0.7047619047619048","0.5692307692307692"
"Kinase Assay","Inhibition","Target (full name):Leucine-rich repeat serine/threonine-protein kinase 2","364","Smile SVC RBF classification","0.7850756081525315","Proportion","UP","8.675249373182755","0.7252747252747253","0.7142857142857143","0.38461538461538464"
"Kinase Assay","Inhibition","Target (full name):Interleukin-1 receptor-associated kinase 4","364","Weka RF on folded fp classification","0.543895656779661","Proportion","UP","1.8337498560366163","0.5851648351648352","0.2830188679245283","0.1171875"
"Kinase Assay","Inhibition","Target (full name):Interleukin-1 receptor-associated kinase 4","364","Smile Bernoulli NB classification","0.524347854872881","Proportion","UP","1.8337498560366163","0.5","0.3532608695652174","0.5078125"
"Kinase Assay","Inhibition","Target (full name):Interleukin-1 receptor-associated kinase 4","364","Smile SVC Tanimoto classification","0.5132415254237293","Proportion","UP","1.8337498560366163","0.6043956043956044","0.2777777777777778","0.078125"
"Kinase Assay","Inhibition","Target (full name):Interleukin-1 receptor-associated kinase 4","364","Smile SVC RBF classification","0.5114539194915255","Proportion","UP","1.8337498560366163","0.6208791208791209","0.375","0.1171875"
"Kinase Assay","Inhibition","Target (full name):Interleukin-1 receptor-associated kinase 4","364","Smile SVC Poly classification","0.509004237288135","Proportion","UP","1.8337498560366163","0.6401098901098901","0.0","0.0"
"Kinase Assay","Inhibition","Target (full name):Interleukin-1 receptor-associated kinase 4","364","Weka RF classification","0.5075311175847458","Proportion","UP","1.8337498560366163","0.5769230769230769","0.3522727272727273","0.2421875"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase RAF","364","Smile SVC Tanimoto classification","0.5581414664939035","Proportion","UP","1.3724825311362885","0.6675824175824175","0.5652173913043478","0.2047244094488189"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase RAF","364","Smile Bernoulli NB classification","0.5547194258945478","Proportion","UP","1.3724825311362885","0.5521978021978022","0.38461538461538464","0.47244094488188976"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase RAF","364","Weka RF on folded fp classification","0.5523273198445131","Proportion","UP","1.3724825311362885","0.6593406593406593","0.5254237288135594","0.2440944881889764"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase RAF","364","Smile SVC Poly classification","0.5404332369846173","Proportion","UP","1.3724825311362885","0.6510989010989011","NaN","0.0"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase RAF","364","Weka RF classification","0.5384896508189643","Proportion","UP","1.3724825311362885","0.6291208791208791","0.45454545454545453","0.31496062992125984"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase RAF","364","Smile SVC RBF classification","0.5345526429449484","Proportion","UP","1.3724825311362885","0.6098901098901099","0.2972972972972973","0.08661417322834646"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase B-raf","364","Smile Bernoulli NB classification","0.6585820895522392","Proportion","UP","6.239649633796628","0.6236263736263736","0.4915254237288136","0.6492537313432836"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase B-raf","364","Smile SVC RBF classification","0.6576249188838432","Proportion","UP","6.239649633796628","0.6510989010989011","0.574468085106383","0.20149253731343283"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase B-raf","364","Weka RF classification","0.6575924724205067","Proportion","UP","6.239649633796628","0.6510989010989011","0.5411764705882353","0.34328358208955223"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase B-raf","364","Weka RF on folded fp classification","0.65734912394549","Proportion","UP","6.239649633796628","0.6675824175824175","0.6065573770491803","0.27611940298507465"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase B-raf","364","Smile SVC Poly classification","0.6408825438027256","Proportion","UP","6.239649633796628","0.6291208791208791","0.3333333333333333","0.007462686567164179"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase B-raf","364","Smile SVC Tanimoto classification","0.6170992861778063","Proportion","UP","6.239649633796628","0.6291208791208791","0.49206349206349204","0.23134328358208955"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase ZAP-70","364","Smile Bernoulli NB classification","0.5442431602739265","Proportion","DOWN","0.34020319863378745","0.5357142857142857","0.385","0.6260162601626016"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase ZAP-70","364","Weka RF classification","0.5209155618527143","Proportion","DOWN","0.34020319863378745","0.6208791208791209","0.391304347826087","0.21951219512195122"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase ZAP-70","364","Smile SVC RBF classification","0.5098336875484939","Proportion","DOWN","0.34020319863378745","0.6483516483516484","0.43902439024390244","0.14634146341463414"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase ZAP-70","364","Smile SVC Poly classification","0.4991397631818642","Proportion","DOWN","0.34020319863378745","0.6428571428571429","0.26666666666666666","0.032520325203252036"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase ZAP-70","364","Weka RF on folded fp classification","0.49063859933205156","Proportion","DOWN","0.34020319863378745","0.6181318681318682","0.375","0.1951219512195122"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase ZAP-70","364","Smile SVC Tanimoto classification","0.4898626994568699","Proportion","DOWN","0.34020319863378745","0.6263736263736264","0.37735849056603776","0.16260162601626016"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase YES","364","Weka RF on folded fp classification","0.830475370762711","Proportion","UP","7.855531822471439","0.75","0.6907216494845361","0.5234375"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase YES","364","Smile Bernoulli NB classification","0.825344279661018","Proportion","UP","7.855531822471439","0.728021978021978","0.5792349726775956","0.828125"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase YES","364","Smile SVC Tanimoto classification","0.82130561440678","Proportion","UP","7.855531822471439","0.7582417582417582","0.6785714285714286","0.59375"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase YES","364","Smile SVC Poly classification","0.8105799788135594","Proportion","UP","7.855531822471439","0.7005494505494505","0.8518518518518519","0.1796875"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase YES","364","Weka RF classification","0.8105634269067796","Proportion","UP","7.855531822471439","0.7252747252747253","0.6590909090909091","0.453125"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase YES","364","Smile SVC RBF classification","0.8090903072033895","Proportion","UP","7.855531822471439","0.7445054945054945","0.7611940298507462","0.3984375"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase receptor TYRO3","364","Smile Bernoulli NB classification","0.7762539184952975","Proportion","UP","4.311001564067155","0.7115384615384616","0.5737704918032787","0.7954545454545454"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase receptor TYRO3","364","Smile SVC Tanimoto classification","0.7644657784743979","Proportion","UP","4.311001564067155","0.7087912087912088","0.6083333333333333","0.553030303030303"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase receptor TYRO3","364","Smile SVC Poly classification","0.7475509404388712","Proportion","UP","4.311001564067155","0.6346153846153846","0.46153846153846156","0.045454545454545456"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase receptor TYRO3","364","Weka RF on folded fp classification","0.7294278996865201","Proportion","UP","4.311001564067155","0.6978021978021978","0.6222222222222222","0.42424242424242425"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase receptor TYRO3","364","Weka RF classification","0.7251991901776383","Proportion","UP","4.311001564067155","0.7060439560439561","0.6288659793814433","0.4621212121212121"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase receptor TYRO3","364","Smile SVC RBF classification","0.7069945141065836","Proportion","UP","4.311001564067155","0.6785714285714286","0.6229508196721312","0.2878787878787879"
"Kinase Assay","Inhibition","Target (full name):Vascular endothelial growth factor receptor 1","364","Weka RF on folded fp classification","0.9037017635760445","Proportion","UP","4.509398509151122","0.8489010989010989","0.8260869565217391","0.6608695652173913"
"Kinase Assay","Inhibition","Target (full name):Vascular endothelial growth factor receptor 1","364","Smile Bernoulli NB classification","0.888370874803566","Proportion","UP","4.509398509151122","0.7857142857142857","0.6225165562913907","0.8173913043478261"
"Kinase Assay","Inhibition","Target (full name):Vascular endothelial growth factor receptor 1","364","Smile SVC Tanimoto classification","0.8859437751004029","Proportion","UP","4.509398509151122","0.8379120879120879","0.7745098039215687","0.6869565217391305"
"Kinase Assay","Inhibition","Target (full name):Vascular endothelial growth factor receptor 1","364","Smile SVC Poly classification","0.8800768290553538","Proportion","UP","4.509398509151122","0.7252747252747253","0.9411764705882353","0.1391304347826087"
"Kinase Assay","Inhibition","Target (full name):Vascular endothelial growth factor receptor 1","364","Weka RF classification","0.8704906582853154","Proportion","UP","4.509398509151122","0.8159340659340659","0.7926829268292683","0.5652173913043478"
"Kinase Assay","Inhibition","Target (full name):Vascular endothelial growth factor receptor 1","364","Smile SVC RBF classification","0.8539898725336122","Proportion","UP","4.509398509151122","0.7939560439560439","0.8571428571428571","0.41739130434782606"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FGR","364","Smile Bernoulli NB classification","0.8208594566353163","Proportion","UP","7.378567143113104","0.760989010989011","0.6415094339622641","0.7727272727272727"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FGR","364","Smile SVC Tanimoto classification","0.8185410135841172","Proportion","UP","7.378567143113104","0.7912087912087912","0.7258064516129032","0.6818181818181818"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FGR","364","Smile SVC Poly classification","0.8095611285266443","Proportion","UP","7.378567143113104","0.6895604395604396","0.8064516129032258","0.1893939393939394"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FGR","364","Weka RF on folded fp classification","0.8062793887147314","Proportion","UP","7.378567143113104","0.7445054945054945","0.6857142857142857","0.5454545454545454"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FGR","364","Weka RF classification","0.8013812695924764","Proportion","UP","7.378567143113104","0.7692307692307693","0.7352941176470589","0.5681818181818182"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FGR","364","Smile SVC RBF classification","0.7916340125391842","Proportion","UP","7.378567143113104","0.7307692307692307","0.7236842105263158","0.4166666666666667"
"Kinase Assay","Inhibition","Target (full name):Fibroblast growth factor receptor 4","364","Smile Bernoulli NB classification","0.6340869681205812","Proportion","UP","1.6631582327346752","0.5796703296703297","0.4245810055865922","0.6031746031746031"
"Kinase Assay","Inhibition","Target (full name):Fibroblast growth factor receptor 4","364","Smile SVC Poly classification","0.6267840469521132","Proportion","UP","1.6631582327346752","0.6538461538461539","NaN","0.0"
"Kinase Assay","Inhibition","Target (full name):Fibroblast growth factor receptor 4","364","Smile SVC Tanimoto classification","0.6079098305989061","Proportion","UP","1.6631582327346752","0.6648351648351648","0.5476190476190477","0.18253968253968253"
"Kinase Assay","Inhibition","Target (full name):Fibroblast growth factor receptor 4","364","Weka RF on folded fp classification","0.5993063892223555","Proportion","UP","1.6631582327346752","0.6675824175824175","0.5384615384615384","0.2777777777777778"
"Kinase Assay","Inhibition","Target (full name):Fibroblast growth factor receptor 4","364","Smile SVC RBF classification","0.5942043484060293","Proportion","UP","1.6631582327346752","0.6593406593406593","0.55","0.0873015873015873"
"Kinase Assay","Inhibition","Target (full name):Fibroblast growth factor receptor 4","364","Weka RF classification","0.5849506469254367","Proportion","UP","1.6631582327346752","0.6291208791208791","0.42857142857142855","0.21428571428571427"
"Kinase Assay","Inhibition","Target (full name):Fibroblast growth factor receptor 3","364","Smile Bernoulli NB classification","0.7241588310454423","Proportion","UP","6.19688996862415","0.6840659340659341","0.551948051948052","0.648854961832061"
"Kinase Assay","Inhibition","Target (full name):Fibroblast growth factor receptor 3","364","Smile SVC Poly classification","0.7018314058251153","Proportion","UP","6.19688996862415","0.6428571428571429","1.0","0.007633587786259542"
"Kinase Assay","Inhibition","Target (full name):Fibroblast growth factor receptor 3","364","Weka RF on folded fp classification","0.6959669757232249","Proportion","UP","6.19688996862415","0.7005494505494505","0.627906976744186","0.4122137404580153"
"Kinase Assay","Inhibition","Target (full name):Fibroblast growth factor receptor 3","364","Smile SVC Tanimoto classification","0.6706418110932745","Proportion","UP","6.19688996862415","0.6758241758241759","0.5656565656565656","0.42748091603053434"
"Kinase Assay","Inhibition","Target (full name):Fibroblast growth factor receptor 3","364","Weka RF classification","0.6627625069619633","Proportion","UP","6.19688996862415","0.6675824175824175","0.5568181818181818","0.37404580152671757"
"Kinase Assay","Inhibition","Target (full name):Fibroblast growth factor receptor 3","364","Smile SVC RBF classification","0.6627461258722932","Proportion","UP","6.19688996862415","0.6456043956043956","0.5208333333333334","0.19083969465648856"
"Kinase Assay","Inhibition","Target (full name):Fibroblast growth factor receptor 2","364","Smile Bernoulli NB classification","0.739299802761342","Proportion","UP","6.761944921324143","0.6895604395604396","0.5555555555555556","0.6538461538461539"
"Kinase Assay","Inhibition","Target (full name):Fibroblast growth factor receptor 2","364","Smile SVC Poly classification","0.7205785667324124","Proportion","UP","6.761944921324143","0.6538461538461539","1.0","0.03076923076923077"
"Kinase Assay","Inhibition","Target (full name):Fibroblast growth factor receptor 2","364","Smile SVC Tanimoto classification","0.7111111111111112","Proportion","UP","6.761944921324143","0.717032967032967","0.6451612903225806","0.46153846153846156"
"Kinase Assay","Inhibition","Target (full name):Fibroblast growth factor receptor 2","364","Weka RF on folded fp classification","0.710979618671927","Proportion","UP","6.761944921324143","0.6868131868131868","0.5952380952380952","0.38461538461538464"
"Kinase Assay","Inhibition","Target (full name):Fibroblast growth factor receptor 2","364","Weka RF classification","0.696153846153846","Proportion","UP","6.761944921324143","0.7060439560439561","0.6292134831460674","0.4307692307692308"
"Kinase Assay","Inhibition","Target (full name):Fibroblast growth factor receptor 2","364","Smile SVC RBF classification","0.6470742932281393","Proportion","UP","6.761944921324143","0.6730769230769231","0.6222222222222222","0.2153846153846154"
"Kinase Assay","Inhibition","Target (full name):Fibroblast growth factor receptor 1","364","Smile Bernoulli NB classification","0.5737258782780801","Proportion","UP","4.584086862764334","0.5741758241758241","0.41975308641975306","0.5271317829457365"
"Kinase Assay","Inhibition","Target (full name):Fibroblast growth factor receptor 1","364","Weka RF on folded fp classification","0.5483259112650505","Proportion","UP","4.584086862764334","0.6126373626373627","0.4032258064516129","0.1937984496124031"
"Kinase Assay","Inhibition","Target (full name):Fibroblast growth factor receptor 1","364","Smile SVC Tanimoto classification","0.5317499587662874","Proportion","UP","4.584086862764334","0.6208791208791209","0.40816326530612246","0.15503875968992248"
"Kinase Assay","Inhibition","Target (full name):Fibroblast growth factor receptor 1","364","Smile SVC Poly classification","0.5200725713343226","Proportion","UP","4.584086862764334","0.6456043956043956","NaN","0.0"
"Kinase Assay","Inhibition","Target (full name):Fibroblast growth factor receptor 1","364","Weka RF classification","0.4987794821045685","Proportion","UP","4.584086862764334","0.6016483516483516","0.3918918918918919","0.2248062015503876"
"Kinase Assay","Inhibition","Target (full name):Fibroblast growth factor receptor 1","364","Smile SVC RBF classification","0.4981362361867066","Proportion","UP","4.584086862764334","0.6208791208791209","0.37142857142857144","0.10077519379844961"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FES","364","Smile SVC Poly classification","0.7044853855721401","Proportion","UP","3.8923954506528418","0.7802197802197802","1.0","0.16666666666666666"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FES","364","Smile SVC RBF classification","0.6864894278606971","Proportion","UP","3.8923954506528418","0.7554945054945055","0.7333333333333333","0.11458333333333333"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FES","364","Smile SVC Tanimoto classification","0.6841962064676622","Proportion","UP","3.8923954506528418","0.8104395604395604","0.8292682926829268","0.3541666666666667"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FES","364","Smile Bernoulli NB classification","0.6817086442786072","Proportion","UP","3.8923954506528418","0.6318681318681318","0.3698630136986301","0.5625"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FES","364","Weka RF classification","0.6714085820895522","Proportion","UP","3.8923954506528418","0.7664835164835165","0.6222222222222222","0.2916666666666667"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FES","364","Weka RF on folded fp classification","0.6603700248756219","Proportion","UP","3.8923954506528418","0.804945054945055","0.7777777777777778","0.3645833333333333"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FER","364","Smile SVC Tanimoto classification","0.7435906760245834","Proportion","UP","5.5177150981810215","0.7994505494505495","0.8541666666666666","0.38317757009345793"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FER","364","Smile SVC Poly classification","0.729953816502419","Proportion","UP","5.5177150981810215","0.7527472527472527","1.0","0.1588785046728972"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FER","364","Smile Bernoulli NB classification","0.722189897814466","Proportion","UP","5.5177150981810215","0.6840659340659341","0.47297297297297297","0.6542056074766355"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FER","364","Weka RF on folded fp classification","0.7137714098694499","Proportion","UP","5.5177150981810215","0.804945054945055","0.8333333333333334","0.4205607476635514"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FER","364","Weka RF classification","0.6911160405832941","Proportion","UP","5.5177150981810215","0.7554945054945055","0.6551724137931034","0.35514018691588783"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FER","364","Smile SVC RBF classification","0.6879886541328781","Proportion","UP","5.5177150981810215","0.739010989010989","0.8333333333333334","0.14018691588785046"
"Kinase Assay","Inhibition","Target (full name):Receptor protein-tyrosine kinase erbB-4","364","Weka RF on folded fp classification","0.7600167364016737","Proportion","UP","13.567070483378442","0.7857142857142857","0.7831325301204819","0.52"
"Kinase Assay","Inhibition","Target (full name):Receptor protein-tyrosine kinase erbB-4","364","Smile SVC Tanimoto classification","0.7556652719665283","Proportion","UP","13.567070483378442","0.7802197802197802","0.7528089887640449","0.536"
"Kinase Assay","Inhibition","Target (full name):Receptor protein-tyrosine kinase erbB-4","364","Smile SVC Poly classification","0.7497238493723852","Proportion","UP","13.567070483378442","0.7527472527472527","0.926829268292683","0.304"
"Kinase Assay","Inhibition","Target (full name):Receptor protein-tyrosine kinase erbB-4","364","Smile Bernoulli NB classification","0.7463096234309629","Proportion","UP","13.567070483378442","0.6428571428571429","0.4857142857142857","0.68"
"Kinase Assay","Inhibition","Target (full name):Receptor protein-tyrosine kinase erbB-4","364","Weka RF classification","0.722962343096234","Proportion","UP","13.567070483378442","0.7307692307692307","0.6451612903225806","0.48"
"Kinase Assay","Inhibition","Target (full name):Receptor protein-tyrosine kinase erbB-4","364","Smile SVC RBF classification","0.7218577405857743","Proportion","UP","13.567070483378442","0.7472527472527473","0.8","0.352"
"Kinase Assay","Inhibition","Target (full name):Receptor protein-tyrosine kinase erbB-2","364","Smile SVC Poly classification","0.7202873088052899","Proportion","UP","3.874549195349884","0.75","0.9354838709677419","0.2457627118644068"
"Kinase Assay","Inhibition","Target (full name):Receptor protein-tyrosine kinase erbB-2","364","Weka RF on folded fp classification","0.717290202563041","Proportion","UP","3.874549195349884","0.7637362637362637","0.7222222222222222","0.4406779661016949"
"Kinase Assay","Inhibition","Target (full name):Receptor protein-tyrosine kinase erbB-2","364","Smile SVC Tanimoto classification","0.7105381011437225","Proportion","UP","3.874549195349884","0.7527472527472527","0.6891891891891891","0.4322033898305085"
"Kinase Assay","Inhibition","Target (full name):Receptor protein-tyrosine kinase erbB-2","364","Smile Bernoulli NB classification","0.7062146892655354","Proportion","UP","3.874549195349884","0.5961538461538461","0.4180790960451977","0.6271186440677966"
"Kinase Assay","Inhibition","Target (full name):Receptor protein-tyrosine kinase erbB-2","364","Weka RF classification","0.701839603141794","Proportion","UP","3.874549195349884","0.7087912087912088","0.575","0.3898305084745763"
"Kinase Assay","Inhibition","Target (full name):Receptor protein-tyrosine kinase erbB-2","364","Smile SVC RBF classification","0.7010300399614157","Proportion","UP","3.874549195349884","0.7307692307692307","0.7631578947368421","0.2457627118644068"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-B receptor 4","364","Smile Bernoulli NB classification","0.8024589535062163","Proportion","UP","3.6546512527209223","0.7087912087912088","0.474025974025974","0.7448979591836735"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-B receptor 4","364","Weka RF on folded fp classification","0.784486727021635","Proportion","UP","3.6546512527209223","0.7994505494505495","0.7272727272727273","0.40816326530612246"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-B receptor 4","364","Smile SVC Poly classification","0.7668405708147925","Proportion","UP","3.6546512527209223","0.7335164835164835","0.6666666666666666","0.02040816326530612"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-B receptor 4","364","Smile SVC Tanimoto classification","0.7636949516648757","Proportion","UP","3.6546512527209223","0.7912087912087912","0.6833333333333333","0.41836734693877553"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-B receptor 4","364","Smile SVC RBF classification","0.7515344483658126","Proportion","UP","3.6546512527209223","0.7417582417582418","0.6","0.12244897959183673"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-B receptor 4","364","Weka RF classification","0.7499424581862822","Proportion","UP","3.6546512527209223","0.7417582417582418","0.5434782608695652","0.25510204081632654"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-B receptor 3","364","Smile SVC RBF classification","0.617984967788118","Proportion","UP","4.300094281580785","0.695054945054945","0.4782608695652174","0.1"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-B receptor 3","364","Weka RF on folded fp classification","0.6067465998568359","Proportion","UP","4.300094281580785","0.7142857142857143","0.59375","0.17272727272727273"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-B receptor 3","364","Smile SVC Poly classification","0.6048854688618469","Proportion","UP","4.300094281580785","0.6978021978021978","NaN","0.0"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-B receptor 3","364","Smile Bernoulli NB classification","0.602845382963494","Proportion","UP","4.300094281580785","0.5302197802197802","0.34196891191709844","0.6"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-B receptor 3","364","Smile SVC Tanimoto classification","0.5862383679312819","Proportion","UP","4.300094281580785","0.7005494505494505","0.5161290322580645","0.14545454545454545"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-B receptor 3","364","Weka RF classification","0.5803328561202576","Proportion","UP","4.300094281580785","0.6813186813186813","0.44642857142857145","0.22727272727272727"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-B receptor 2","364","Smile Bernoulli NB classification","0.730033193334236","Proportion","UP","9.62100862059577","0.6923076923076923","0.5362318840579711","0.6065573770491803"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-B receptor 2","364","Smile SVC Poly classification","0.7126744343584873","Proportion","UP","9.62100862059577","0.6895604395604396","0.6956521739130435","0.13114754098360656"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-B receptor 2","364","Smile SVC Tanimoto classification","0.7126744343584868","Proportion","UP","9.62100862059577","0.7445054945054945","0.7230769230769231","0.38524590163934425"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-B receptor 2","364","Weka RF on folded fp classification","0.711217992141986","Proportion","UP","9.62100862059577","0.7417582417582418","0.7058823529411765","0.39344262295081966"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-B receptor 2","364","Weka RF classification","0.7046131960438965","Proportion","UP","9.62100862059577","0.6978021978021978","0.5833333333333334","0.3442622950819672"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-B receptor 2","364","Smile SVC RBF classification","0.695400352255791","Proportion","UP","9.62100862059577","0.6620879120879121","0.4827586206896552","0.11475409836065574"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-A receptor 4","364","Weka RF classification","0.7093077956989249","Proportion","UP","9.847501605643489","0.7005494505494505","0.5903614457831325","0.3951612903225806"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-A receptor 4","364","Smile SVC RBF classification","0.708736559139785","Proportion","UP","9.847501605643489","0.6923076923076923","0.6363636363636364","0.22580645161290322"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-A receptor 4","364","Smile SVC Poly classification","0.7084005376344092","Proportion","UP","9.847501605643489","0.6593406593406593","0.5","0.024193548387096774"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-A receptor 4","364","Smile Bernoulli NB classification","0.6963037634408596","Proportion","UP","9.847501605643489","0.6098901098901099","0.4451219512195122","0.5887096774193549"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-A receptor 4","364","Smile SVC Tanimoto classification","0.6890793010752689","Proportion","UP","9.847501605643489","0.728021978021978","0.654320987654321","0.4274193548387097"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-A receptor 4","364","Weka RF on folded fp classification","0.6888440860215056","Proportion","UP","9.847501605643489","0.7225274725274725","0.6666666666666666","0.3709677419354839"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-A receptor 3","364","Smile SVC Tanimoto classification","0.6503221188260564","Proportion","UP","4.545507683767351","0.7225274725274725","0.6451612903225806","0.18181818181818182"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-A receptor 3","364","Smile SVC RBF classification","0.6260200429491766","Proportion","UP","4.545507683767351","0.7142857142857143","0.65","0.11818181818181818"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-A receptor 3","364","Smile Bernoulli NB classification","0.6148532569792409","Proportion","UP","4.545507683767351","0.5686813186813187","0.36257309941520466","0.5636363636363636"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-A receptor 3","364","Smile SVC Poly classification","0.6076950608446668","Proportion","UP","4.545507683767351","0.6978021978021978","NaN","0.0"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-A receptor 3","364","Weka RF classification","0.5965282748747311","Proportion","UP","4.545507683767351","0.6730769230769231","0.42105263157894735","0.21818181818181817"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-A receptor 3","364","Weka RF on folded fp classification","0.5713314244810309","Proportion","UP","4.545507683767351","0.7087912087912088","0.5416666666666666","0.23636363636363636"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-A receptor 2","364","Smile Bernoulli NB classification","0.7862687155240351","Proportion","UP","2.2250763871963954","0.7362637362637363","0.49206349206349204","0.6595744680851063"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-A receptor 2","364","Smile SVC Poly classification","0.7732663514578416","Proportion","UP","2.2250763871963954","0.7417582417582418","0.5","0.02127659574468085"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-A receptor 2","364","Weka RF on folded fp classification","0.7699763593380619","Proportion","UP","2.2250763871963954","0.7994505494505495","0.723404255319149","0.3617021276595745"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-A receptor 2","364","Smile SVC Tanimoto classification","0.756245074862096","Proportion","UP","2.2250763871963954","0.804945054945055","0.7254901960784313","0.39361702127659576"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-A receptor 2","364","Smile SVC RBF classification","0.745133963750985","Proportion","UP","2.2250763871963954","0.771978021978022","0.6896551724137931","0.2127659574468085"
"Kinase Assay","Inhibition","Target (full name):Ephrin type-A receptor 2","364","Weka RF classification","0.7381599684791174","Proportion","UP","2.2250763871963954","0.7912087912087912","0.6956521739130435","0.3404255319148936"
"Kinase Assay","Inhibition","Target (full name):Epidermal growth factor receptor erbB1","364","Smile SVC Tanimoto classification","0.8653240596560439","Proportion","UP","5.242858727113962","0.8543956043956044","0.826530612244898","0.6923076923076923"
"Kinase Assay","Inhibition","Target (full name):Epidermal growth factor receptor erbB1","364","Weka RF on folded fp classification","0.8465863870722162","Proportion","UP","5.242858727113962","0.8406593406593407","0.8172043010752689","0.6495726495726496"
"Kinase Assay","Inhibition","Target (full name):Epidermal growth factor receptor erbB1","364","Smile Bernoulli NB classification","0.8451676528599595","Proportion","UP","5.242858727113962","0.7417582417582418","0.5723270440251572","0.7777777777777778"
"Kinase Assay","Inhibition","Target (full name):Epidermal growth factor receptor erbB1","364","Smile SVC Poly classification","0.8334198415170079","Proportion","UP","5.242858727113962","0.8076923076923077","0.9272727272727272","0.4358974358974359"
"Kinase Assay","Inhibition","Target (full name):Epidermal growth factor receptor erbB1","364","Weka RF classification","0.8174677324474895","Proportion","UP","5.242858727113962","0.7692307692307693","0.6774193548387096","0.5384615384615384"
"Kinase Assay","Inhibition","Target (full name):Epidermal growth factor receptor erbB1","364","Smile SVC RBF classification","0.8131423232637803","Proportion","UP","5.242858727113962","0.7884615384615384","0.7941176470588235","0.46153846153846156"
"Kinase Assay","Inhibition","Target (full name):Discoidin domain-containing receptor 2","364","Smile Bernoulli NB classification","0.7049327190288133","Proportion","UP","4.742900479548101","0.6868131868131868","0.4726027397260274","0.6509433962264151"
"Kinase Assay","Inhibition","Target (full name):Discoidin domain-containing receptor 2","364","Smile SVC Poly classification","0.7010750329091706","Proportion","UP","4.742900479548101","0.7445054945054945","1.0","0.12264150943396226"
"Kinase Assay","Inhibition","Target (full name):Discoidin domain-containing receptor 2","364","Smile SVC RBF classification","0.6946760274974402","Proportion","UP","4.742900479548101","0.7307692307692307","0.6538461538461539","0.16037735849056603"
"Kinase Assay","Inhibition","Target (full name):Discoidin domain-containing receptor 2","364","Weka RF on folded fp classification","0.6914948076641794","Proportion","UP","4.742900479548101","0.7692307692307693","0.7115384615384616","0.3490566037735849"
"Kinase Assay","Inhibition","Target (full name):Discoidin domain-containing receptor 2","364","Smile SVC Tanimoto classification","0.689118034225537","Proportion","UP","4.742900479548101","0.7664835164835165","0.7142857142857143","0.330188679245283"
"Kinase Assay","Inhibition","Target (full name):Discoidin domain-containing receptor 2","364","Weka RF classification","0.6583845253766272","Proportion","UP","4.742900479548101","0.7335164835164835","0.5918367346938775","0.27358490566037735"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase CSK","364","Smile SVC RBF classification","0.7055903866248693","Proportion","UP","4.599490555283133","0.6593406593406593","0.5909090909090909","0.19696969696969696"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase CSK","364","Smile SVC Poly classification","0.6695075757575754","Proportion","UP","4.599490555283133","0.6291208791208791","0.0","0.0"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase CSK","364","Smile Bernoulli NB classification","0.662274686520376","Proportion","UP","4.599490555283133","0.6510989010989011","0.5165562913907285","0.5909090909090909"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase CSK","364","Smile SVC Tanimoto classification","0.6399229362591435","Proportion","UP","4.599490555283133","0.6978021978021978","0.6774193548387096","0.3181818181818182"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase CSK","364","Weka RF classification","0.6344533699059562","Proportion","UP","4.599490555283133","0.6620879120879121","0.56","0.3181818181818182"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase CSK","364","Weka RF on folded fp classification","0.6271388453500519","Proportion","UP","4.599490555283133","0.6813186813186813","0.6142857142857143","0.32575757575757575"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase BTK","364","Smile SVC Tanimoto classification","0.67688998780653","Proportion","UP","1.2100045381824174","0.7060439560439561","0.6229508196721312","0.3114754098360656"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase BTK","364","Smile Bernoulli NB classification","0.672114212166372","Proportion","UP","1.2100045381824174","0.6318681318681318","0.4620253164556962","0.5983606557377049"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase BTK","364","Weka RF on folded fp classification","0.6571772117599239","Proportion","UP","1.2100045381824174","0.695054945054945","0.5873015873015873","0.30327868852459017"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase BTK","364","Smile SVC Poly classification","0.6361434764936997","Proportion","UP","1.2100045381824174","0.6675824175824175","0.5555555555555556","0.040983606557377046"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase BTK","364","Smile SVC RBF classification","0.5864212166373116","Proportion","UP","1.2100045381824174","0.6483516483516484","0.40625","0.10655737704918032"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase BTK","364","Weka RF classification","0.5771745020999862","Proportion","UP","1.2100045381824174","0.6510989010989011","0.463768115942029","0.26229508196721313"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase BRK","364","Weka RF classification","0.7448842496899543","Proportion","UP","5.535127137897653","0.6978021978021978","0.5588235294117647","0.3220338983050847"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase BRK","364","Weka RF on folded fp classification","0.7397684993799079","Proportion","UP","5.535127137897653","0.7417582417582418","0.6538461538461539","0.4322033898305085"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase BRK","364","Smile Bernoulli NB classification","0.7271083092186843","Proportion","UP","5.535127137897653","0.6428571428571429","0.46629213483146065","0.7033898305084746"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase BRK","364","Smile SVC Poly classification","0.723215516053464","Proportion","UP","5.535127137897653","0.6840659340659341","0.6363636363636364","0.059322033898305086"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase BRK","364","Smile SVC Tanimoto classification","0.7133285104037468","Proportion","UP","5.535127137897653","0.7115384615384616","0.589041095890411","0.3644067796610169"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase BRK","364","Smile SVC RBF classification","0.6968272013228606","Proportion","UP","5.535127137897653","0.6758241758241759","0.5","0.16101694915254236"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase BMX","364","Smile SVC Tanimoto classification","0.7183435442125609","Proportion","UP","4.498196340662719","0.7307692307692307","0.72","0.4122137404580153"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase BMX","364","Smile Bernoulli NB classification","0.7093011827146743","Proportion","UP","4.498196340662719","0.6483516483516484","0.5084745762711864","0.6870229007633588"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase BMX","364","Smile SVC RBF classification","0.6980965173803358","Proportion","UP","4.498196340662719","0.695054945054945","0.6666666666666666","0.3053435114503817"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase BMX","364","Smile SVC Poly classification","0.6971791763588113","Proportion","UP","4.498196340662719","0.6675824175824175","0.9166666666666666","0.08396946564885496"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase BMX","364","Weka RF on folded fp classification","0.6855486026930512","Proportion","UP","4.498196340662719","0.7060439560439561","0.6578947368421053","0.3816793893129771"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase BMX","364","Weka RF classification","0.6706090489139338","Proportion","UP","4.498196340662719","0.6758241758241759","0.5619047619047619","0.45038167938931295"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase BLK","364","Smile Bernoulli NB classification","0.8432472876917306","Proportion","UP","5.40030951908278","0.7637362637362637","0.6047904191616766","0.8347107438016529"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase BLK","364","Smile SVC Tanimoto classification","0.8335884093459853","Proportion","UP","5.40030951908278","0.804945054945055","0.75","0.6198347107438017"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase BLK","364","Weka RF on folded fp classification","0.829762269156207","Proportion","UP","5.40030951908278","0.7802197802197802","0.7204301075268817","0.5537190082644629"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase BLK","364","Smile SVC Poly classification","0.8179437472366744","Proportion","UP","5.40030951908278","0.6923076923076923","0.8461538461538461","0.09090909090909091"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase BLK","364","Weka RF classification","0.8173145597388022","Proportion","UP","5.40030951908278","0.7967032967032966","0.7582417582417582","0.5702479338842975"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase BLK","364","Smile SVC RBF classification","0.7909056898955888","Proportion","UP","5.40030951908278","0.7225274725274725","0.6666666666666666","0.3305785123966942"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase receptor UFO","364","Smile Bernoulli NB classification","0.6139766527090469","Proportion","UP","-0.313778131002703","0.5906593406593407","0.47953216374269003","0.5774647887323944"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase receptor UFO","364","Weka RF classification","0.6126284735439663","Proportion","UP","-0.313778131002703","0.6098901098901099","0.5","0.38028169014084506"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase receptor UFO","364","Weka RF on folded fp classification","0.6115499302119015","Proportion","UP","-0.313778131002703","0.6181318681318682","0.5172413793103449","0.31690140845070425"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase receptor UFO","364","Smile SVC RBF classification","0.6000824768430403","Proportion","UP","-0.313778131002703","0.6236263736263736","0.5342465753424658","0.2746478873239437"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase receptor UFO","364","Smile SVC Poly classification","0.5992577084126378","Proportion","UP","-0.313778131002703","0.6483516483516484","0.85","0.11971830985915492"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase receptor UFO","364","Smile SVC Tanimoto classification","0.5985915492957748","Proportion","UP","-0.313778131002703","0.6483516483516484","0.5813953488372093","0.352112676056338"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase ABL2","364","Smile Bernoulli NB classification","0.836862939139042","Proportion","UP","8.34211759891894","0.728021978021978","0.5903614457831325","0.7596899224806202"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase ABL2","364","Weka RF on folded fp classification","0.8310077519379843","Proportion","UP","8.34211759891894","0.804945054945055","0.7685185185185185","0.6434108527131783"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase ABL2","364","Smile SVC Poly classification","0.8212765957446804","Proportion","UP","8.34211759891894","0.717032967032967","0.8823529411764706","0.23255813953488372"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase ABL2","364","Smile SVC Tanimoto classification","0.8039254494474709","Proportion","UP","8.34211759891894","0.7664835164835165","0.6896551724137931","0.6201550387596899"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase ABL2","364","Weka RF classification","0.7977568860300184","Proportion","UP","8.34211759891894","0.728021978021978","0.65625","0.4883720930232558"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase ABL2","364","Smile SVC RBF classification","0.7519379844961239","Proportion","UP","8.34211759891894","0.728021978021978","0.7142857142857143","0.3875968992248062"
"Kinase Assay","Inhibition","Target (full name):ALK tyrosine kinase receptor","364","Smile SVC Tanimoto classification","0.7510789641943738","Proportion","UP","5.496881266372643","0.7994505494505495","0.7878787878787878","0.2826086956521739"
"Kinase Assay","Inhibition","Target (full name):ALK tyrosine kinase receptor","364","Smile SVC Poly classification","0.74440537084399","Proportion","UP","5.496881266372643","0.7857142857142857","1.0","0.15217391304347827"
"Kinase Assay","Inhibition","Target (full name):ALK tyrosine kinase receptor","364","Smile Bernoulli NB classification","0.7400895140664961","Proportion","UP","5.496881266372643","0.6401098901098901","0.38181818181818183","0.6847826086956522"
"Kinase Assay","Inhibition","Target (full name):ALK tyrosine kinase receptor","364","Weka RF classification","0.7354739450127875","Proportion","UP","5.496881266372643","0.771978021978022","0.6153846153846154","0.2608695652173913"
"Kinase Assay","Inhibition","Target (full name):ALK tyrosine kinase receptor","364","Smile SVC RBF classification","0.7189098465473149","Proportion","UP","5.496881266372643","0.7692307692307693","0.8333333333333334","0.10869565217391304"
"Kinase Assay","Inhibition","Target (full name):ALK tyrosine kinase receptor","364","Weka RF on folded fp classification","0.7169916879795396","Proportion","UP","5.496881266372643","0.7884615384615384","0.6923076923076923","0.29347826086956524"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase ABL","364","Smile Bernoulli NB classification","0.8899555903866242","Proportion","UP","8.694134965169471","0.7884615384615384","0.6627218934911243","0.8484848484848485"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase ABL","364","Smile SVC Poly classification","0.8860370950888181","Proportion","UP","8.694134965169471","0.7307692307692307","0.9047619047619048","0.2878787878787879"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase ABL","364","Smile SVC Tanimoto classification","0.8840778474399127","Proportion","UP","8.694134965169471","0.8296703296703297","0.7651515151515151","0.7651515151515151"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase ABL","364","Weka RF on folded fp classification","0.8827390282131647","Proportion","UP","8.694134965169471","0.8214285714285714","0.8018018018018018","0.6742424242424242"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase ABL","364","Weka RF classification","0.8353742163009403","Proportion","UP","8.694134965169471","0.7445054945054945","0.6822429906542056","0.553030303030303"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase ABL","364","Smile SVC RBF classification","0.8164511494252865","Proportion","UP","8.694134965169471","0.7417582417582418","0.7567567567567568","0.42424242424242425"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK6","364","Weka RF on folded fp classification","0.5564348118279567","Proportion","UP","0.7812014452330658","0.6373626373626373","0.4375","0.22580645161290322"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK6","364","Smile Bernoulli NB classification","0.5557627688172041","Proportion","UP","0.7812014452330658","0.5247252747252747","0.3567251461988304","0.49193548387096775"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK6","364","Weka RF classification","0.5549059139784948","Proportion","UP","0.7812014452330658","0.6181318681318682","0.391304347826087","0.21774193548387097"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK6","364","Smile SVC Poly classification","0.549462365591398","Proportion","UP","0.7812014452330658","0.6620879120879121","0.6666666666666666","0.016129032258064516"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK6","364","Smile SVC RBF classification","0.5343413978494624","Proportion","UP","0.7812014452330658","0.6401098901098901","0.41025641025641024","0.12903225806451613"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK6","364","Smile SVC Tanimoto classification","0.533266129032258","Proportion","UP","0.7812014452330658","0.6538461538461539","0.48333333333333334","0.23387096774193547"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK7","364","Weka RF classification","0.6417197989407284","Proportion","UP","3.379407552244164","0.6703296703296703","0.5217391304347826","0.2926829268292683"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK7","364","Smile SVC Tanimoto classification","0.6341969436291869","Proportion","UP","3.379407552244164","0.6703296703296703","0.5283018867924528","0.22764227642276422"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK7","364","Smile SVC RBF classification","0.6252909624531934","Proportion","UP","3.379407552244164","0.695054945054945","0.6764705882352942","0.18699186991869918"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK7","364","Smile Bernoulli NB classification","0.6127753601187469","Proportion","UP","3.379407552244164","0.5906593406593407","0.4226190476190476","0.5772357723577236"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK7","364","Weka RF on folded fp classification","0.6060621394595691","Proportion","UP","3.379407552244164","0.6758241758241759","0.5471698113207547","0.23577235772357724"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK7","364","Smile SVC Poly classification","0.6024525183011163","Proportion","UP","3.379407552244164","0.6648351648351648","1.0","0.008130081300813009"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK 3","364","Smile SVC RBF classification","0.4929203272650427","Inflection","DOWN","3.1991666666666676","0.48626373626373626","0.4845360824742268","0.5193370165745856"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK 3","364","Weka RF classification","0.4787006007909913","Inflection","DOWN","3.1991666666666676","0.49175824175824173","0.4888888888888889","0.4861878453038674"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK 3","364","Smile SVC Poly classification","0.45847296440539803","Inflection","DOWN","3.1991666666666676","0.49175824175824173","0.4864864864864865","0.39779005524861877"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK 3","364","Weka RF on folded fp classification","0.4387434713039279","Inflection","DOWN","3.1991666666666676","0.45054945054945056","0.4444444444444444","0.4198895027624309"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK 3","364","Smile Bernoulli NB classification","0.4318751320834464","Inflection","DOWN","3.1991666666666676","0.43956043956043955","0.4303030303030303","0.39226519337016574"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK 3","364","Smile SVC Tanimoto classification","0.42568607915949636","Inflection","DOWN","3.1991666666666676","0.4423076923076923","0.43452380952380953","0.40331491712707185"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK 2","364","Smile SVC RBF classification","0.5591058514135433","Proportion","UP","1.763658258519567","0.6401098901098901","0.47619047619047616","0.07692307692307693"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK 2","364","Weka RF classification","0.5251643655489809","Proportion","UP","1.763658258519567","0.6318681318681318","0.46551724137931033","0.2076923076923077"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK 2","364","Smile SVC Poly classification","0.5138067061143984","Proportion","UP","1.763658258519567","0.6428571428571429","NaN","0.0"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK 2","364","Smile SVC Tanimoto classification","0.5100591715976335","Proportion","UP","1.763658258519567","0.6181318681318682","0.3448275862068966","0.07692307692307693"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK 2","364","Weka RF on folded fp classification","0.49819197896120987","Proportion","UP","1.763658258519567","0.6236263736263736","0.41025641025641024","0.12307692307692308"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK 2","364","Smile Bernoulli NB classification","0.4921268902038131","Proportion","UP","1.763658258519567","0.4945054945054945","0.3430232558139535","0.45384615384615384"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK 1","364","Smile SVC RBF classification","0.57107949790795","Proportion","UP","5.984378501734054","0.6373626373626373","0.37037037037037035","0.08"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK 1","364","Smile SVC Poly classification","0.549389121338912","Proportion","UP","5.984378501734054","0.6538461538461539","0.3333333333333333","0.008"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK 1","364","Smile Bernoulli NB classification","0.5345774058577408","Proportion","UP","5.984378501734054","0.5082417582417582","0.35638297872340424","0.536"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK 1","364","Smile SVC Tanimoto classification","0.5329539748953973","Proportion","UP","5.984378501734054","0.6428571428571429","0.44680851063829785","0.168"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK 1","364","Weka RF classification","0.5251046025104603","Proportion","UP","5.984378501734054","0.6016483516483516","0.3484848484848485","0.184"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PAK 1","364","Weka RF on folded fp classification","0.5211213389121335","Proportion","UP","5.984378501734054","0.6346153846153846","0.42592592592592593","0.184"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MST4","364","Smile SVC Tanimoto classification","0.5977369459150831","Proportion","UP","1.185228120438854","0.7142857142857143","0.6181818181818182","0.2905982905982906"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MST4","364","Weka RF on folded fp classification","0.5938267760130104","Proportion","UP","1.185228120438854","0.7115384615384616","0.6111111111111112","0.28205128205128205"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MST4","364","Smile SVC Poly classification","0.5897781930170594","Proportion","UP","1.185228120438854","0.6785714285714286","NaN","0.0"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MST4","364","Weka RF classification","0.5859545312986607","Proportion","UP","1.185228120438854","0.6840659340659341","0.5147058823529411","0.29914529914529914"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MST4","364","Smile Bernoulli NB classification","0.5832035710578217","Proportion","UP","1.185228120438854","0.5824175824175825","0.389937106918239","0.5299145299145299"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MST4","364","Smile SVC RBF classification","0.5788435586006432","Proportion","UP","1.185228120438854","0.6785714285714286","0.5","0.11965811965811966"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MST2","364","Smile SVC Tanimoto classification","0.6813421524045741","Proportion","UP","7.0758266271026855","0.7582417582417582","0.7083333333333334","0.4322033898305085"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MST2","364","Smile SVC Poly classification","0.6806876119608648","Proportion","UP","7.0758266271026855","0.6895604395604396","0.7777777777777778","0.059322033898305086"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MST2","364","Weka RF on folded fp classification","0.6758302328785997","Proportion","UP","7.0758266271026855","0.7307692307692307","0.6351351351351351","0.3983050847457627"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MST2","364","Smile Bernoulli NB classification","0.6736599145652467","Proportion","UP","7.0758266271026855","0.6868131868131868","0.5151515151515151","0.576271186440678"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MST2","364","Weka RF classification","0.6613786688714345","Proportion","UP","7.0758266271026855","0.7417582417582418","0.6538461538461539","0.4322033898305085"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MST2","364","Smile SVC RBF classification","0.6485462312250238","Proportion","UP","7.0758266271026855","0.7197802197802198","0.7105263157894737","0.2288135593220339"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MST1","364","Smile Bernoulli NB classification","0.7531591530054644","Proportion","UP","7.091509158232891","0.7142857142857143","0.5571428571428572","0.65"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MST1","364","Smile SVC Tanimoto classification","0.739310109289617","Proportion","UP","7.091509158232891","0.7582417582417582","0.6666666666666666","0.5333333333333333"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MST1","364","Weka RF on folded fp classification","0.7314719945355193","Proportion","UP","7.091509158232891","0.7582417582417582","0.7","0.4666666666666667"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MST1","364","Smile SVC Poly classification","0.7293374316939881","Proportion","UP","7.091509158232891","0.6923076923076923","0.8333333333333334","0.08333333333333333"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MST1","364","Weka RF classification","0.7245901639344261","Proportion","UP","7.091509158232891","0.7362637362637363","0.6621621621621622","0.4083333333333333"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MST1","364","Smile SVC RBF classification","0.6694330601092895","Proportion","UP","7.091509158232891","0.7142857142857143","0.6818181818181818","0.25"
"Kinase Assay","Inhibition","Target (full name):Misshapen-like kinase 1","364","Weka RF on folded fp classification","0.8495397764628524","Proportion","UP","10.657612586487051","0.7939560439560439","0.7777777777777778","0.5923076923076923"
"Kinase Assay","Inhibition","Target (full name):Misshapen-like kinase 1","364","Smile SVC Tanimoto classification","0.829815910585141","Proportion","UP","10.657612586487051","0.782967032967033","0.7297297297297297","0.6230769230769231"
"Kinase Assay","Inhibition","Target (full name):Misshapen-like kinase 1","364","Smile SVC Poly classification","0.8280736357659462","Proportion","UP","10.657612586487051","0.6620879120879121","0.7333333333333333","0.08461538461538462"
"Kinase Assay","Inhibition","Target (full name):Misshapen-like kinase 1","364","Smile Bernoulli NB classification","0.8192636423405656","Proportion","UP","10.657612586487051","0.75","0.6242038216560509","0.7538461538461538"
"Kinase Assay","Inhibition","Target (full name):Misshapen-like kinase 1","364","Weka RF classification","0.7969428007889549","Proportion","UP","10.657612586487051","0.760989010989011","0.7171717171717171","0.5461538461538461"
"Kinase Assay","Inhibition","Target (full name):Misshapen-like kinase 1","364","Smile SVC RBF classification","0.7950032873109809","Proportion","UP","10.657612586487051","0.7307692307692307","0.7352941176470589","0.38461538461538464"
"Kinase Assay","Inhibition","Target (full name):Dual specificity mitogen-activated protein kinase kinase 1","364","Smile SVC Poly classification","0.6110124917817226","Proportion","UP","4.3999925723534545","0.6456043956043956","1.0","0.007692307692307693"
"Kinase Assay","Inhibition","Target (full name):Dual specificity mitogen-activated protein kinase kinase 1","364","Smile SVC Tanimoto classification","0.6092373438527282","Proportion","UP","4.3999925723534545","0.6620879120879121","0.5636363636363636","0.23846153846153847"
"Kinase Assay","Inhibition","Target (full name):Dual specificity mitogen-activated protein kinase kinase 1","364","Smile Bernoulli NB classification","0.6078402366863901","Proportion","UP","4.3999925723534545","0.5769230769230769","0.42771084337349397","0.5461538461538461"
"Kinase Assay","Inhibition","Target (full name):Dual specificity mitogen-activated protein kinase kinase 1","364","Smile SVC RBF classification","0.6003287310979627","Proportion","UP","4.3999925723534545","0.6318681318681318","0.4230769230769231","0.08461538461538462"
"Kinase Assay","Inhibition","Target (full name):Dual specificity mitogen-activated protein kinase kinase 1","364","Weka RF classification","0.5930309007232084","Proportion","UP","4.3999925723534545","0.6318681318681318","0.47058823529411764","0.24615384615384617"
"Kinase Assay","Inhibition","Target (full name):Dual specificity mitogen-activated protein kinase kinase 1","364","Weka RF on folded fp classification","0.5753944773175541","Proportion","UP","4.3999925723534545","0.6593406593406593","0.5625","0.2076923076923077"
"Kinase Assay","Inhibition","Target (full name):Mitogen-activated protein kinase kinase kinase kinase 4","364","Weka RF on folded fp classification","0.8583854798021171","Proportion","UP","11.85751967430346","0.782967032967033","0.7452830188679245","0.6030534351145038"
"Kinase Assay","Inhibition","Target (full name):Mitogen-activated protein kinase kinase kinase kinase 4","364","Smile SVC Tanimoto classification","0.8406447596894155","Proportion","UP","11.85751967430346","0.7857142857142857","0.7226890756302521","0.6564885496183206"
"Kinase Assay","Inhibition","Target (full name):Mitogen-activated protein kinase kinase kinase kinase 4","364","Smile SVC Poly classification","0.8377944500868203","Proportion","UP","11.85751967430346","0.6620879120879121","0.75","0.0916030534351145"
"Kinase Assay","Inhibition","Target (full name):Mitogen-activated protein kinase kinase kinase kinase 4","364","Smile Bernoulli NB classification","0.8359597680437705","Proportion","UP","11.85751967430346","0.7664835164835165","0.6493506493506493","0.7633587786259542"
"Kinase Assay","Inhibition","Target (full name):Mitogen-activated protein kinase kinase kinase kinase 4","364","Weka RF classification","0.7981522130852143","Proportion","UP","11.85751967430346","0.7554945054945055","0.7019230769230769","0.5572519083969466"
"Kinase Assay","Inhibition","Target (full name):Mitogen-activated protein kinase kinase kinase kinase 4","364","Smile SVC RBF classification","0.7860629689086935","Proportion","UP","11.85751967430346","0.728021978021978","0.7222222222222222","0.3969465648854962"
"Kinase Assay","Inhibition","Target (full name):Mitogen-activated protein kinase kinase kinase kinase 2","364","Weka RF on folded fp classification","0.7507117319915241","Proportion","UP","4.0698502792822415","0.75","0.7126436781609196","0.484375"
"Kinase Assay","Inhibition","Target (full name):Mitogen-activated protein kinase kinase kinase kinase 2","364","Smile Bernoulli NB classification","0.7440247616525428","Proportion","UP","4.0698502792822415","0.6675824175824175","0.5207100591715976","0.6875"
"Kinase Assay","Inhibition","Target (full name):Mitogen-activated protein kinase kinase kinase kinase 2","364","Smile SVC Tanimoto classification","0.7348384533898303","Proportion","UP","4.0698502792822415","0.7362637362637363","0.6666666666666666","0.5"
"Kinase Assay","Inhibition","Target (full name):Mitogen-activated protein kinase kinase kinase kinase 2","364","Weka RF classification","0.731610831567796","Proportion","UP","4.0698502792822415","0.7005494505494505","0.6233766233766234","0.375"
"Kinase Assay","Inhibition","Target (full name):Mitogen-activated protein kinase kinase kinase kinase 2","364","Smile SVC Poly classification","0.731031514830508","Proportion","UP","4.0698502792822415","0.6675824175824175","0.6842105263157895","0.1015625"
"Kinase Assay","Inhibition","Target (full name):Mitogen-activated protein kinase kinase kinase kinase 2","364","Smile SVC RBF classification","0.7306673728813564","Proportion","UP","4.0698502792822415","0.695054945054945","0.7073170731707317","0.2265625"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase 10","364","Smile Bernoulli NB classification","0.8236961451247167","Proportion","UP","10.108954027354219","0.7252747252747253","0.5764705882352941","0.7777777777777778"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase 10","364","Weka RF on folded fp classification","0.8183940242763776","Proportion","UP","10.108954027354219","0.7692307692307693","0.7441860465116279","0.5079365079365079"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase 10","364","Smile SVC RBF classification","0.803954915299452","Proportion","UP","10.108954027354219","0.7335164835164835","0.7735849056603774","0.3253968253968254"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase 10","364","Smile SVC Poly classification","0.7982192877150861","Proportion","UP","10.108954027354219","0.7225274725274725","0.9032258064516129","0.2222222222222222"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase 10","364","Smile SVC Tanimoto classification","0.7978191276510618","Proportion","UP","10.108954027354219","0.7554945054945055","0.7032967032967034","0.5079365079365079"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase 10","364","Weka RF classification","0.7968354008269977","Proportion","UP","10.108954027354219","0.7417582417582418","0.7","0.4444444444444444"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Aurora-C","364","Weka RF on folded fp classification","0.8376725838264293","Proportion","UP","7.217455901638834","0.7692307692307693","0.75","0.5307692307692308"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Aurora-C","364","Smile Bernoulli NB classification","0.8237672583826446","Proportion","UP","7.217455901638834","0.7802197802197802","0.6582278481012658","0.8"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Aurora-C","364","Smile SVC Poly classification","0.8234056541748853","Proportion","UP","7.217455901638834","0.6868131868131868","0.7857142857142857","0.16923076923076924"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Aurora-C","364","Smile SVC Tanimoto classification","0.8206771860618011","Proportion","UP","7.217455901638834","0.7802197802197802","0.7232142857142857","0.6230769230769231"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Aurora-C","364","Weka RF classification","0.7999835634451018","Proportion","UP","7.217455901638834","0.7774725274725275","0.7578947368421053","0.5538461538461539"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Aurora-C","364","Smile SVC RBF classification","0.7801446416831038","Proportion","UP","7.217455901638834","0.7087912087912088","0.6818181818181818","0.34615384615384615"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Aurora-B","364","Smile SVC Tanimoto classification","0.8038599046610161","Proportion","UP","6.951159507254286","0.7637362637362637","0.6909090909090909","0.59375"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Aurora-B","364","Smile Bernoulli NB classification","0.7978681144067793","Proportion","UP","6.951159507254286","0.7582417582417582","0.6219512195121951","0.796875"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Aurora-B","364","Weka RF classification","0.7974212129237288","Proportion","UP","6.951159507254286","0.75","0.6989247311827957","0.5078125"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Aurora-B","364","Smile SVC Poly classification","0.7941604872881369","Proportion","UP","6.951159507254286","0.6868131868131868","0.85","0.1328125"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Aurora-B","364","Weka RF on folded fp classification","0.788731461864407","Proportion","UP","6.951159507254286","0.75","0.7126436781609196","0.484375"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Aurora-B","364","Smile SVC RBF classification","0.7756223516949141","Proportion","UP","6.951159507254286","0.7087912087912088","0.6833333333333333","0.3203125"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Aurora-A","364","Weka RF on folded fp classification","0.8613924486702493","Proportion","UP","7.641566012380774","0.8241758241758241","0.8","0.6101694915254238"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Aurora-A","364","Smile Bernoulli NB classification","0.8552432134490838","Proportion","UP","7.641566012380774","0.7857142857142857","0.6428571428571429","0.7627118644067796"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Aurora-A","364","Smile SVC Tanimoto classification","0.8452528593082537","Proportion","UP","7.641566012380774","0.8104395604395604","0.7474747474747475","0.6271186440677966"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Aurora-A","364","Smile SVC Poly classification","0.8447016673556562","Proportion","UP","7.641566012380774","0.6978021978021978","0.6818181818181818","0.1271186440677966"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Aurora-A","364","Weka RF classification","0.7953183133526249","Proportion","UP","7.641566012380774","0.7582417582417582","0.6744186046511628","0.4915254237288136"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Aurora-A","364","Smile SVC RBF classification","0.7787997795232176","Proportion","UP","7.641566012380774","0.7307692307692307","0.6851851851851852","0.3135593220338983"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase TYK2","364","Smile Bernoulli NB classification","0.6168397144711232","Proportion","UP","-0.5540711713101469","0.6043956043956044","0.4675324675324675","0.5373134328358209"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase TYK2","364","Smile SVC Tanimoto classification","0.5960415314730699","Proportion","UP","-0.5540711713101469","0.6208791208791209","0.47674418604651164","0.30597014925373134"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase TYK2","364","Smile SVC Poly classification","0.5860804672290715","Proportion","UP","-0.5540711713101469","0.6263736263736264","0.25","0.007462686567164179"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase TYK2","364","Weka RF on folded fp classification","0.5683646982478915","Proportion","UP","-0.5540711713101469","0.6263736263736264","0.4880952380952381","0.30597014925373134"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase TYK2","364","Smile SVC RBF classification","0.556327060350422","Proportion","UP","-0.5540711713101469","0.6263736263736264","0.4852941176470588","0.2462686567164179"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase TYK2","364","Weka RF classification","0.5498539909149901","Proportion","UP","-0.5540711713101469","0.5989010989010989","0.43478260869565216","0.29850746268656714"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase TXK","364","Smile SVC Tanimoto classification","0.6695341227271191","Proportion","UP","5.010650681464151","0.6840659340659341","0.5666666666666667","0.2764227642276423"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase TXK","364","Weka RF on folded fp classification","0.6636305367203049","Proportion","UP","5.010650681464151","0.7087912087912088","0.639344262295082","0.3170731707317073"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase TXK","364","Smile SVC Poly classification","0.6584016462571265","Proportion","UP","5.010650681464151","0.6538461538461539","0.2","0.008130081300813009"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase TXK","364","Smile Bernoulli NB classification","0.6540835947778562","Proportion","UP","5.010650681464151","0.6346153846153846","0.4666666666666667","0.5691056910569106"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase TXK","364","Smile SVC RBF classification","0.6490233782005872","Proportion","UP","5.010650681464151","0.6730769230769231","0.5625","0.14634146341463414"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase TXK","364","Weka RF classification","0.6256957797793747","Proportion","UP","5.010650681464151","0.6675824175824175","0.5161290322580645","0.2601626016260163"
"Kinase Assay","Inhibition","Target (full name):NT-3 growth factor receptor","364","Weka RF on folded fp classification","0.8782675194660725","Proportion","UP","5.389106726384213","0.8598901098901099","0.8282828282828283","0.7068965517241379"
"Kinase Assay","Inhibition","Target (full name):NT-3 growth factor receptor","364","Smile SVC Tanimoto classification","0.8780589543937707","Proportion","UP","5.389106726384213","0.8461538461538461","0.7727272727272727","0.7327586206896551"
"Kinase Assay","Inhibition","Target (full name):NT-3 growth factor receptor","364","Smile Bernoulli NB classification","0.8760602057842037","Proportion","UP","5.389106726384213","0.8241758241758241","0.6857142857142857","0.8275862068965517"
"Kinase Assay","Inhibition","Target (full name):NT-3 growth factor receptor","364","Smile SVC Poly classification","0.8656145717463849","Proportion","UP","5.389106726384213","0.7307692307692307","0.875","0.1810344827586207"
"Kinase Assay","Inhibition","Target (full name):NT-3 growth factor receptor","364","Weka RF classification","0.8600702169076753","Proportion","UP","5.389106726384213","0.804945054945055","0.7319587628865979","0.6120689655172413"
"Kinase Assay","Inhibition","Target (full name):NT-3 growth factor receptor","364","Smile SVC RBF classification","0.8483731924360403","Proportion","UP","5.389106726384213","0.7884615384615384","0.8305084745762712","0.4224137931034483"
"Kinase Assay","Inhibition","Target (full name):Neurotrophic tyrosine kinase receptor type 2","364","Weka RF on folded fp classification","0.9048771929824558","Proportion","UP","5.022996985755608","0.8461538461538461","0.7959183673469388","0.6842105263157895"
"Kinase Assay","Inhibition","Target (full name):Neurotrophic tyrosine kinase receptor type 2","364","Smile SVC RBF classification","0.8963508771929827","Proportion","UP","5.022996985755608","0.7994505494505495","0.8727272727272727","0.42105263157894735"
"Kinase Assay","Inhibition","Target (full name):Neurotrophic tyrosine kinase receptor type 2","364","Weka RF classification","0.8918245614035089","Proportion","UP","5.022996985755608","0.8379120879120879","0.8021978021978022","0.6403508771929824"
"Kinase Assay","Inhibition","Target (full name):Neurotrophic tyrosine kinase receptor type 2","364","Smile Bernoulli NB classification","0.8909824561403511","Proportion","UP","5.022996985755608","0.7994505494505495","0.6289308176100629","0.8771929824561403"
"Kinase Assay","Inhibition","Target (full name):Neurotrophic tyrosine kinase receptor type 2","364","Smile SVC Tanimoto classification","0.8897894736842115","Proportion","UP","5.022996985755608","0.8516483516483516","0.7941176470588235","0.7105263157894737"
"Kinase Assay","Inhibition","Target (full name):Neurotrophic tyrosine kinase receptor type 2","364","Smile SVC Poly classification","0.8879999999999987","Proportion","UP","5.022996985755608","0.7252747252747253","0.8181818181818182","0.15789473684210525"
"Kinase Assay","Inhibition","Target (full name):Nerve growth factor receptor Trk-A","364","Smile Bernoulli NB classification","0.8295410034540474","Proportion","UP","4.343977021315165","0.7692307692307693","0.5882352941176471","0.8108108108108109"
"Kinase Assay","Inhibition","Target (full name):Nerve growth factor receptor Trk-A","364","Smile SVC Tanimoto classification","0.8197129936260369","Proportion","UP","4.343977021315165","0.8104395604395604","0.7625","0.5495495495495496"
"Kinase Assay","Inhibition","Target (full name):Nerve growth factor receptor Trk-A","364","Weka RF on folded fp classification","0.8186625360538411","Proportion","UP","4.343977021315165","0.7967032967032966","0.7176470588235294","0.5495495495495496"
"Kinase Assay","Inhibition","Target (full name):Nerve growth factor receptor Trk-A","364","Smile SVC Poly classification","0.8145141188619446","Proportion","UP","4.343977021315165","0.7142857142857143","0.7692307692307693","0.09009009009009009"
"Kinase Assay","Inhibition","Target (full name):Nerve growth factor receptor Trk-A","364","Smile SVC RBF classification","0.7465014421536161","Proportion","UP","4.343977021315165","0.739010989010989","0.7","0.25225225225225223"
"Kinase Assay","Inhibition","Target (full name):Nerve growth factor receptor Trk-A","364","Weka RF classification","0.743154221415091","Proportion","UP","4.343977021315165","0.760989010989011","0.6621621621621622","0.44144144144144143"
"Kinase Assay","Inhibition","Target (full name):Tyrosine kinase non-receptor protein 2","364","Weka RF classification","0.760241204026712","Proportion","UP","2.2161354385282914","0.7307692307692307","0.6746987951807228","0.4409448818897638"
"Kinase Assay","Inhibition","Target (full name):Tyrosine kinase non-receptor protein 2","364","Smile SVC RBF classification","0.7519685039370081","Proportion","UP","2.2161354385282914","0.6868131868131868","0.6326530612244898","0.2440944881889764"
"Kinase Assay","Inhibition","Target (full name):Tyrosine kinase non-receptor protein 2","364","Smile SVC Tanimoto classification","0.7497425163626696","Proportion","UP","2.2161354385282914","0.7362637362637363","0.7012987012987013","0.4251968503937008"
"Kinase Assay","Inhibition","Target (full name):Tyrosine kinase non-receptor protein 2","364","Smile SVC Poly classification","0.7367520515631749","Proportion","UP","2.2161354385282914","0.6868131868131868","0.8095238095238095","0.13385826771653545"
"Kinase Assay","Inhibition","Target (full name):Tyrosine kinase non-receptor protein 2","364","Weka RF on folded fp classification","0.7293099438519552","Proportion","UP","2.2161354385282914","0.7197802197802198","0.6623376623376623","0.4015748031496063"
"Kinase Assay","Inhibition","Target (full name):Tyrosine kinase non-receptor protein 2","364","Smile Bernoulli NB classification","0.7254227715206487","Proportion","UP","2.2161354385282914","0.6620879120879121","0.5126582278481012","0.6377952755905512"
"Kinase Assay","Inhibition","Target (full name):Non-receptor tyrosine-protein kinase TNK1","364","Smile SVC Tanimoto classification","0.8214085436252676","Proportion","UP","9.599005403508416","0.782967032967033","0.7403846153846154","0.5968992248062015"
"Kinase Assay","Inhibition","Target (full name):Non-receptor tyrosine-protein kinase TNK1","364","Weka RF classification","0.8211941283193139","Proportion","UP","9.599005403508416","0.771978021978022","0.7346938775510204","0.5581395348837209"
"Kinase Assay","Inhibition","Target (full name):Non-receptor tyrosine-protein kinase TNK1","364","Smile Bernoulli NB classification","0.8180108857001485","Proportion","UP","9.599005403508416","0.7307692307692307","0.5837837837837838","0.8372093023255814"
"Kinase Assay","Inhibition","Target (full name):Non-receptor tyrosine-protein kinase TNK1","364","Weka RF on folded fp classification","0.8132277750288633","Proportion","UP","9.599005403508416","0.760989010989011","0.723404255319149","0.5271317829457365"
"Kinase Assay","Inhibition","Target (full name):Non-receptor tyrosine-protein kinase TNK1","364","Smile SVC RBF classification","0.8013194788058712","Proportion","UP","9.599005403508416","0.7060439560439561","0.6774193548387096","0.32558139534883723"
"Kinase Assay","Inhibition","Target (full name):Non-receptor tyrosine-protein kinase TNK1","364","Smile SVC Poly classification","0.8006267524327897","Proportion","UP","9.599005403508416","0.7005494505494505","0.8125","0.20155038759689922"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase TIE-2","364","Weka RF on folded fp classification","0.7526485325697928","Proportion","UP","6.051513577776449","0.7802197802197802","0.7083333333333334","0.4636363636363636"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase TIE-2","364","Weka RF classification","0.7489978525411591","Proportion","UP","6.051513577776449","0.7472527472527473","0.640625","0.37272727272727274"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase TIE-2","364","Smile SVC Tanimoto classification","0.73734788833214","Proportion","UP","6.051513577776449","0.75","0.620253164556962","0.44545454545454544"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase TIE-2","364","Smile SVC RBF classification","0.7310486757337141","Proportion","UP","6.051513577776449","0.7307692307692307","0.6875","0.2"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase TIE-2","364","Smile Bernoulli NB classification","0.7300823192555468","Proportion","UP","6.051513577776449","0.6483516483516484","0.449438202247191","0.7272727272727273"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase TIE-2","364","Smile SVC Poly classification","0.7156227630637074","Proportion","UP","6.051513577776449","0.717032967032967","0.7692307692307693","0.09090909090909091"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase TEC","364","Smile Bernoulli NB classification","0.6865104602510458","Proportion","UP","5.525639590554524","0.6703296703296703","0.5159235668789809","0.648"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase TEC","364","Smile SVC Poly classification","0.6642008368200844","Proportion","UP","5.525639590554524","0.6565934065934066","NaN","0.0"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase TEC","364","Smile SVC Tanimoto classification","0.6629958158995827","Proportion","UP","5.525639590554524","0.6813186813186813","0.5692307692307692","0.296"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase TEC","364","Weka RF on folded fp classification","0.6332719665271968","Proportion","UP","5.525639590554524","0.6730769230769231","0.5428571428571428","0.304"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase TEC","364","Smile SVC RBF classification","0.618209205020921","Proportion","UP","5.525639590554524","0.6483516483516484","0.45161290322580644","0.112"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase TEC","364","Weka RF classification","0.5937071129707113","Proportion","UP","5.525639590554524","0.6456043956043956","0.4714285714285714","0.264"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase SYK","364","Smile Bernoulli NB classification","0.5692876344086014","Proportion","UP","0.5041663995945065","0.5686813186813187","0.4088397790055249","0.5967741935483871"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase SYK","364","Weka RF on folded fp classification","0.5542338709677418","Proportion","UP","0.5041663995945065","0.5989010989010989","0.328125","0.1693548387096774"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase SYK","364","Smile SVC Poly classification","0.552116935483871","Proportion","UP","0.5041663995945065","0.6428571428571429","0.125","0.008064516129032258"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase SYK","364","Smile SVC Tanimoto classification","0.5494959677419354","Proportion","UP","0.5041663995945065","0.5934065934065934","0.3064516129032258","0.1532258064516129"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase SYK","364","Smile SVC RBF classification","0.5254032258064514","Proportion","UP","0.5041663995945065","0.6236263736263736","0.3673469387755102","0.14516129032258066"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase SYK","364","Weka RF classification","0.5075436827956988","Proportion","UP","0.5041663995945065","0.5824175824175825","0.32926829268292684","0.21774193548387097"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase Srms","364","Smile SVC Poly classification","0.6897112912150504","Proportion","UP","1.3604196346719135","0.6346153846153846","0.5","0.015037593984962405"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase Srms","364","Smile Bernoulli NB classification","0.6756338899196042","Proportion","UP","1.3604196346719135","0.6071428571428571","0.46987951807228917","0.5864661654135338"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase Srms","364","Weka RF on folded fp classification","0.6718093936139043","Proportion","UP","1.3604196346719135","0.6868131868131868","0.620253164556962","0.3684210526315789"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase Srms","364","Smile SVC Tanimoto classification","0.6589200273410792","Proportion","UP","1.3604196346719135","0.6840659340659341","0.5957446808510638","0.42105263157894735"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase Srms","364","Smile SVC RBF classification","0.6548514142499106","Proportion","UP","1.3604196346719135","0.6730769230769231","0.6296296296296297","0.2556390977443609"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase Srms","364","Weka RF classification","0.6510920157536696","Proportion","UP","1.3604196346719135","0.6703296703296703","0.5764705882352941","0.3684210526315789"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase SRC","364","Smile Bernoulli NB classification","0.8055150953389834","Proportion","UP","10.112398798466016","0.7582417582417582","0.6298701298701299","0.7578125"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase SRC","364","Weka RF on folded fp classification","0.7990598516949158","Proportion","UP","10.112398798466016","0.7445054945054945","0.7160493827160493","0.453125"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase SRC","364","Weka RF classification","0.7909659692796607","Proportion","UP","10.112398798466016","0.75","0.6907216494845361","0.5234375"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase SRC","364","Smile SVC Tanimoto classification","0.7883011122881356","Proportion","UP","10.112398798466016","0.7582417582417582","0.7","0.546875"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase SRC","364","Smile SVC Poly classification","0.7845934851694909","Proportion","UP","10.112398798466016","0.6730769230769231","0.8461538461538461","0.0859375"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase SRC","364","Smile SVC RBF classification","0.7681077860169491","Proportion","UP","10.112398798466016","0.7225274725274725","0.7454545454545455","0.3203125"
"Kinase Assay","Inhibition","Target (full name):Proto-oncogene tyrosine-protein kinase ROS","364","Weka RF on folded fp classification","0.7773845007451552","Proportion","UP","8.594627081239759","0.760989010989011","0.7611940298507462","0.4180327868852459"
"Kinase Assay","Inhibition","Target (full name):Proto-oncogene tyrosine-protein kinase ROS","364","Smile Bernoulli NB classification","0.7675789188456851","Proportion","UP","8.594627081239759","0.6730769230769231","0.5094339622641509","0.6639344262295082"
"Kinase Assay","Inhibition","Target (full name):Proto-oncogene tyrosine-protein kinase ROS","364","Smile SVC Poly classification","0.7653773201463212","Proportion","UP","8.594627081239759","0.7115384615384616","0.9047619047619048","0.1557377049180328"
"Kinase Assay","Inhibition","Target (full name):Proto-oncogene tyrosine-protein kinase ROS","364","Smile SVC Tanimoto classification","0.7471209863162178","Proportion","UP","8.594627081239759","0.7527472527472527","0.7222222222222222","0.4262295081967213"
"Kinase Assay","Inhibition","Target (full name):Proto-oncogene tyrosine-protein kinase ROS","364","Smile SVC RBF classification","0.7188389107167049","Proportion","UP","8.594627081239759","0.7032967032967034","0.6590909090909091","0.23770491803278687"
"Kinase Assay","Inhibition","Target (full name):Proto-oncogene tyrosine-protein kinase ROS","364","Weka RF classification","0.7148252269340195","Proportion","UP","8.594627081239759","0.7417582417582418","0.6842105263157895","0.4262295081967213"
"Kinase Assay","Inhibition","Target (full name):Macrophage-stimulating protein receptor","364","Smile SVC Poly classification","0.6104177701271186","Proportion","UP","4.807595078961322","0.6675824175824175","0.8888888888888888","0.0625"
"Kinase Assay","Inhibition","Target (full name):Macrophage-stimulating protein receptor","364","Smile Bernoulli NB classification","0.60353217690678","Proportion","UP","4.807595078961322","0.5659340659340659","0.4117647058823529","0.546875"
"Kinase Assay","Inhibition","Target (full name):Macrophage-stimulating protein receptor","364","Smile SVC Tanimoto classification","0.5816671080508472","Proportion","UP","4.807595078961322","0.6593406593406593","0.53125","0.265625"
"Kinase Assay","Inhibition","Target (full name):Macrophage-stimulating protein receptor","364","Weka RF on folded fp classification","0.563426906779661","Proportion","UP","4.807595078961322","0.6291208791208791","0.4567901234567901","0.2890625"
"Kinase Assay","Inhibition","Target (full name):Macrophage-stimulating protein receptor","364","Smile SVC RBF classification","0.5487619173728813","Proportion","UP","4.807595078961322","0.6401098901098901","0.4594594594594595","0.1328125"
"Kinase Assay","Inhibition","Target (full name):Macrophage-stimulating protein receptor","364","Weka RF classification","0.5376886917372883","Proportion","UP","4.807595078961322","0.6071428571428571","0.40963855421686746","0.265625"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase receptor RET","364","Weka RF on folded fp classification","0.8708927206883954","Proportion","UP","11.280905585463088","0.7857142857142857","0.7692307692307693","0.5511811023622047"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase receptor RET","364","Smile Bernoulli NB classification","0.8550117944117748","Proportion","UP","11.280905585463088","0.7664835164835165","0.622093023255814","0.84251968503937"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase receptor RET","364","Smile SVC Tanimoto classification","0.8533506096548056","Proportion","UP","11.280905585463088","0.7939560439560439","0.7407407407407407","0.6299212598425197"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase receptor RET","364","Weka RF classification","0.8520050500016613","Proportion","UP","11.280905585463088","0.7939560439560439","0.76","0.5984251968503937"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase receptor RET","364","Smile SVC Poly classification","0.8494634373234986","Proportion","UP","11.280905585463088","0.7142857142857143","0.8709677419354839","0.2125984251968504"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase receptor RET","364","Smile SVC RBF classification","0.8251769161766188","Proportion","UP","11.280905585463088","0.75","0.78125","0.3937007874015748"
"Kinase Assay","Inhibition","Target (full name):Protein tyrosine kinase 2 beta","364","Weka RF classification","0.7347772442310261","Proportion","UP","9.9020602789587","0.7554945054945055","0.7341772151898734","0.4603174603174603"
"Kinase Assay","Inhibition","Target (full name):Protein tyrosine kinase 2 beta","364","Smile SVC Tanimoto classification","0.7326930772308928","Proportion","UP","9.9020602789587","0.7335164835164835","0.7377049180327869","0.35714285714285715"
"Kinase Assay","Inhibition","Target (full name):Protein tyrosine kinase 2 beta","364","Smile SVC Poly classification","0.7245898359343738","Proportion","UP","9.9020602789587","0.7087912087912088","1.0","0.15873015873015872"
"Kinase Assay","Inhibition","Target (full name):Protein tyrosine kinase 2 beta","364","Weka RF on folded fp classification","0.7149526477257566","Proportion","UP","9.9020602789587","0.728021978021978","0.6956521739130435","0.38095238095238093"
"Kinase Assay","Inhibition","Target (full name):Protein tyrosine kinase 2 beta","364","Smile SVC RBF classification","0.7108843537414957","Proportion","UP","9.9020602789587","0.6868131868131868","0.6578947368421053","0.1984126984126984"
"Kinase Assay","Inhibition","Target (full name):Protein tyrosine kinase 2 beta","364","Smile Bernoulli NB classification","0.7085000666933448","Proportion","UP","9.9020602789587","0.6648351648351648","0.5135135135135135","0.6031746031746031"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FRK","364","Weka RF on folded fp classification","0.717054712537164","Proportion","UP","3.029426754358065","0.7527472527472527","0.6","0.21649484536082475"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FRK","364","Smile Bernoulli NB classification","0.6947951658365199","Proportion","UP","3.029426754358065","0.6401098901098901","0.4011627906976744","0.711340206185567"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FRK","364","Smile SVC RBF classification","0.6717633885478205","Proportion","UP","3.029426754358065","0.7445054945054945","0.6428571428571429","0.09278350515463918"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FRK","364","Smile SVC Poly classification","0.6613382756090965","Proportion","UP","3.029426754358065","0.7335164835164835","NaN","0.0"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FRK","364","Smile SVC Tanimoto classification","0.6455075485539989","Proportion","UP","3.029426754358065","0.7417582417582418","0.5384615384615384","0.21649484536082475"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FRK","364","Weka RF classification","0.6237306459708871","Proportion","UP","3.029426754358065","0.7472527472527473","0.5806451612903226","0.18556701030927836"
"Kinase Assay","Inhibition","Target (full name):Platelet-derived growth factor receptor beta","364","Weka RF on folded fp classification","0.8702161703239293","Proportion","UP","17.391421899648396","0.8076923076923077","0.7540983606557377","0.696969696969697"
"Kinase Assay","Inhibition","Target (full name):Platelet-derived growth factor receptor beta","364","Smile SVC Tanimoto classification","0.8651711076280021","Proportion","UP","17.391421899648396","0.8131868131868132","0.7318840579710145","0.7651515151515151"
"Kinase Assay","Inhibition","Target (full name):Platelet-derived growth factor receptor beta","364","Smile Bernoulli NB classification","0.8618403866248687","Proportion","UP","17.391421899648396","0.7912087912087912","0.6686746987951807","0.8409090909090909"
"Kinase Assay","Inhibition","Target (full name):Platelet-derived growth factor receptor beta","364","Smile SVC RBF classification","0.8515869905956099","Proportion","UP","17.391421899648396","0.7582417582417582","0.7444444444444445","0.5075757575757576"
"Kinase Assay","Inhibition","Target (full name):Platelet-derived growth factor receptor beta","364","Smile SVC Poly classification","0.8488766980146286","Proportion","UP","17.391421899648396","0.6758241758241759","0.6842105263157895","0.19696969696969696"
"Kinase Assay","Inhibition","Target (full name):Platelet-derived growth factor receptor beta","364","Weka RF classification","0.8404356060606061","Proportion","UP","17.391421899648396","0.771978021978022","0.7058823529411765","0.6363636363636364"
"Kinase Assay","Inhibition","Target (full name):Platelet-derived growth factor receptor alpha","364","Weka RF on folded fp classification","0.9126712886111374","Proportion","UP","14.496743047986007","0.8489010989010989","0.8095238095238095","0.7669172932330827"
"Kinase Assay","Inhibition","Target (full name):Platelet-derived growth factor receptor alpha","364","Smile SVC Tanimoto classification","0.902613677049768","Proportion","UP","14.496743047986007","0.8406593406593407","0.8048780487804879","0.7443609022556391"
"Kinase Assay","Inhibition","Target (full name):Platelet-derived growth factor receptor alpha","364","Smile Bernoulli NB classification","0.8986752595775145","Proportion","UP","14.496743047986007","0.8104395604395604","0.7","0.8421052631578947"
"Kinase Assay","Inhibition","Target (full name):Platelet-derived growth factor receptor alpha","364","Smile SVC Poly classification","0.8952576245809324","Proportion","UP","14.496743047986007","0.7307692307692307","0.8070175438596491","0.3458646616541353"
"Kinase Assay","Inhibition","Target (full name):Platelet-derived growth factor receptor alpha","364","Weka RF classification","0.8770302379324934","Proportion","UP","14.496743047986007","0.7884615384615384","0.75","0.631578947368421"
"Kinase Assay","Inhibition","Target (full name):Platelet-derived growth factor receptor alpha","364","Smile SVC RBF classification","0.8711063372717497","Proportion","UP","14.496743047986007","0.7884615384615384","0.8181818181818182","0.5413533834586466"
"Kinase Assay","Inhibition","Target (full name):Muscle, skeletal receptor tyrosine protein kinase","364","Weka RF on folded fp classification","0.8312329234972673","Proportion","UP","5.949733592490433","0.7884615384615384","0.7171717171717171","0.5916666666666667"
"Kinase Assay","Inhibition","Target (full name):Muscle, skeletal receptor tyrosine protein kinase","364","Smile SVC Tanimoto classification","0.8264685792349725","Proportion","UP","5.949733592490433","0.8159340659340659","0.7264957264957265","0.7083333333333334"
"Kinase Assay","Inhibition","Target (full name):Muscle, skeletal receptor tyrosine protein kinase","364","Weka RF classification","0.8235826502732242","Proportion","UP","5.949733592490433","0.7857142857142857","0.723404255319149","0.5666666666666667"
"Kinase Assay","Inhibition","Target (full name):Muscle, skeletal receptor tyrosine protein kinase","364","Smile SVC Poly classification","0.8194330601092902","Proportion","UP","5.949733592490433","0.7307692307692307","0.7894736842105263","0.25"
"Kinase Assay","Inhibition","Target (full name):Muscle, skeletal receptor tyrosine protein kinase","364","Smile Bernoulli NB classification","0.8188524590163933","Proportion","UP","5.949733592490433","0.75","0.5923566878980892","0.775"
"Kinase Assay","Inhibition","Target (full name):Muscle, skeletal receptor tyrosine protein kinase","364","Smile SVC RBF classification","0.8080942622950817","Proportion","UP","5.949733592490433","0.771978021978022","0.7605633802816901","0.45"
"Kinase Assay","Inhibition","Target (full name):Hepatocyte growth factor receptor","364","Smile Bernoulli NB classification","0.6706182472989193","Proportion","UP","6.220110867885323","0.6236263736263736","0.46994535519125685","0.6825396825396826"
"Kinase Assay","Inhibition","Target (full name):Hepatocyte growth factor receptor","364","Weka RF on folded fp classification","0.6529778578097907","Proportion","UP","6.220110867885323","0.6785714285714286","0.5633802816901409","0.31746031746031744"
"Kinase Assay","Inhibition","Target (full name):Hepatocyte growth factor receptor","364","Smile SVC Poly classification","0.6484260370814982","Proportion","UP","6.220110867885323","0.6565934065934066","0.5714285714285714","0.031746031746031744"
"Kinase Assay","Inhibition","Target (full name):Hepatocyte growth factor receptor","364","Smile SVC Tanimoto classification","0.6296185140722956","Proportion","UP","6.220110867885323","0.6373626373626373","0.4642857142857143","0.30952380952380953"
"Kinase Assay","Inhibition","Target (full name):Hepatocyte growth factor receptor","364","Weka RF classification","0.620831665999733","Proportion","UP","6.220110867885323","0.6346153846153846","0.4533333333333333","0.2698412698412698"
"Kinase Assay","Inhibition","Target (full name):Hepatocyte growth factor receptor","364","Smile SVC RBF classification","0.602274243030546","Proportion","UP","6.220110867885323","0.6373626373626373","0.4318181818181818","0.15079365079365079"
"Kinase Assay","Inhibition","Target (full name):Proto-oncogene tyrosine-protein kinase MER","364","Weka RF on folded fp classification","0.631422139830508","Proportion","UP","6.239438145291301","0.6428571428571429","0.4878048780487805","0.3125"
"Kinase Assay","Inhibition","Target (full name):Proto-oncogene tyrosine-protein kinase MER","364","Weka RF classification","0.6188426906779657","Proportion","UP","6.239438145291301","0.6565934065934066","0.5172413793103449","0.3515625"
"Kinase Assay","Inhibition","Target (full name):Proto-oncogene tyrosine-protein kinase MER","364","Smile Bernoulli NB classification","0.6176675052966097","Proportion","UP","6.239438145291301","0.5521978021978022","0.425531914893617","0.78125"
"Kinase Assay","Inhibition","Target (full name):Proto-oncogene tyrosine-protein kinase MER","364","Smile SVC RBF classification","0.6083818855932202","Proportion","UP","6.239438145291301","0.6840659340659341","0.6511627906976745","0.21875"
"Kinase Assay","Inhibition","Target (full name):Proto-oncogene tyrosine-protein kinase MER","364","Smile SVC Poly classification","0.6004700741525422","Proportion","UP","6.239438145291301","0.6510989010989011","0.5555555555555556","0.0390625"
"Kinase Assay","Inhibition","Target (full name):Proto-oncogene tyrosine-protein kinase MER","364","Smile SVC Tanimoto classification","0.5938162076271183","Proportion","UP","6.239438145291301","0.6098901098901099","0.4186046511627907","0.28125"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase Lyn","364","Smile SVC Tanimoto classification","0.8496411930755351","Proportion","UP","7.591475423722905","0.8021978021978022","0.7130434782608696","0.6776859504132231"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase Lyn","364","Weka RF classification","0.8397442437846478","Proportion","UP","7.591475423722905","0.7582417582417582","0.6941176470588235","0.48760330578512395"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase Lyn","364","Weka RF on folded fp classification","0.8382818079787774","Proportion","UP","7.591475423722905","0.7692307692307693","0.7032967032967034","0.5289256198347108"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase Lyn","364","Smile Bernoulli NB classification","0.8334693738734132","Proportion","UP","7.591475423722905","0.7527472527472527","0.5906432748538012","0.8347107438016529"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase Lyn","364","Smile SVC Poly classification","0.8177396864265529","Proportion","UP","7.591475423722905","0.695054945054945","0.7083333333333334","0.14049586776859505"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase Lyn","364","Smile SVC RBF classification","0.8013808114818205","Proportion","UP","7.591475423722905","0.739010989010989","0.7166666666666667","0.35537190082644626"
"Kinase Assay","Inhibition","Target (full name):Leukocyte tyrosine kinase receptor","364","Smile SVC Tanimoto classification","0.7536261491317651","Proportion","UP","5.400958243229564","0.8269230769230769","0.8611111111111112","0.34831460674157305"
"Kinase Assay","Inhibition","Target (full name):Leukocyte tyrosine kinase receptor","364","Smile SVC Poly classification","0.7424719101123589","Proportion","UP","5.400958243229564","0.7939560439560439","1.0","0.15730337078651685"
"Kinase Assay","Inhibition","Target (full name):Leukocyte tyrosine kinase receptor","364","Smile Bernoulli NB classification","0.7215526046986712","Proportion","UP","5.400958243229564","0.6208791208791209","0.3615819209039548","0.7191011235955056"
"Kinase Assay","Inhibition","Target (full name):Leukocyte tyrosine kinase receptor","364","Weka RF on folded fp classification","0.7051072522982631","Proportion","UP","5.400958243229564","0.8296703296703297","0.8461538461538461","0.3707865168539326"
"Kinase Assay","Inhibition","Target (full name):Leukocyte tyrosine kinase receptor","364","Smile SVC RBF classification","0.7019816138917258","Proportion","UP","5.400958243229564","0.7692307692307693","0.6666666666666666","0.11235955056179775"
"Kinase Assay","Inhibition","Target (full name):Leukocyte tyrosine kinase receptor","364","Weka RF classification","0.6939530132788561","Proportion","UP","5.400958243229564","0.782967032967033","0.6190476190476191","0.29213483146067415"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase LCK","364","Weka RF on folded fp classification","0.8374159946236558","Proportion","UP","6.490532906833467","0.7884615384615384","0.7473684210526316","0.5725806451612904"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase LCK","364","Smile SVC Tanimoto classification","0.837096774193549","Proportion","UP","6.490532906833467","0.8076923076923077","0.7596153846153846","0.6370967741935484"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase LCK","364","Smile Bernoulli NB classification","0.8329805107526863","Proportion","UP","6.490532906833467","0.7527472527472527","0.6049382716049383","0.7903225806451613"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase LCK","364","Smile SVC Poly classification","0.8202284946236571","Proportion","UP","6.490532906833467","0.6895604395604396","0.7894736842105263","0.12096774193548387"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase LCK","364","Weka RF classification","0.8101982526881717","Proportion","UP","6.490532906833467","0.75","0.7088607594936709","0.45161290322580644"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase LCK","364","Smile SVC RBF classification","0.8038306451612905","Proportion","UP","6.490532906833467","0.75","0.8","0.3548387096774194"
"Kinase Assay","Inhibition","Target (full name):Stem cell growth factor receptor","364","Smile Bernoulli NB classification","0.8962180729857483","Proportion","UP","5.99459283949789","0.8379120879120879","0.7123287671232876","0.859504132231405"
"Kinase Assay","Inhibition","Target (full name):Stem cell growth factor receptor","364","Weka RF on folded fp classification","0.8865081794374718","Proportion","UP","5.99459283949789","0.8186813186813187","0.7433628318584071","0.6942148760330579"
"Kinase Assay","Inhibition","Target (full name):Stem cell growth factor receptor","364","Smile SVC Poly classification","0.882392953100023","Proportion","UP","5.99459283949789","0.739010989010989","0.7321428571428571","0.33884297520661155"
"Kinase Assay","Inhibition","Target (full name):Stem cell growth factor receptor","364","Smile SVC Tanimoto classification","0.87633914906642","Proportion","UP","5.99459283949789","0.8516483516483516","0.8130841121495327","0.71900826446281"
"Kinase Assay","Inhibition","Target (full name):Stem cell growth factor receptor","364","Weka RF classification","0.869605142332415","Proportion","UP","5.99459283949789","0.8131868131868132","0.7731958762886598","0.6198347107438017"
"Kinase Assay","Inhibition","Target (full name):Stem cell growth factor receptor","364","Smile SVC RBF classification","0.8633472774886901","Proportion","UP","5.99459283949789","0.7802197802197802","0.8059701492537313","0.4462809917355372"
"Kinase Assay","Inhibition","Target (full name):Vascular endothelial growth factor receptor 2","364","Weka RF on folded fp classification","0.8523173346528121","Proportion","UP","13.818079391093885","0.782967032967033","0.7403846153846154","0.5968992248062015"
"Kinase Assay","Inhibition","Target (full name):Vascular endothelial growth factor receptor 2","364","Smile Bernoulli NB classification","0.8338281378855356","Proportion","UP","13.818079391093885","0.75","0.6079545454545454","0.8294573643410853"
"Kinase Assay","Inhibition","Target (full name):Vascular endothelial growth factor receptor 2","364","Smile SVC Tanimoto classification","0.8296882731321138","Proportion","UP","13.818079391093885","0.7747252747252747","0.6974789915966386","0.6434108527131783"
"Kinase Assay","Inhibition","Target (full name):Vascular endothelial growth factor receptor 2","364","Smile SVC Poly classification","0.8220352960580574","Proportion","UP","13.818079391093885","0.6456043956043956","0.5","0.06201550387596899"
"Kinase Assay","Inhibition","Target (full name):Vascular endothelial growth factor receptor 2","364","Weka RF classification","0.7976084446643577","Proportion","UP","13.818079391093885","0.7307692307692307","0.6631578947368421","0.4883720930232558"
"Kinase Assay","Inhibition","Target (full name):Vascular endothelial growth factor receptor 2","364","Smile SVC RBF classification","0.7858815767771725","Proportion","UP","13.818079391093885","0.7225274725274725","0.7058823529411765","0.37209302325581395"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase JAK3","364","Smile SVC RBF classification","0.7018857740444631","Proportion","UP","1.2137337592307933","0.7032967032967034","0.6470588235294118","0.2682926829268293"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase JAK3","364","Weka RF classification","0.6880713827885171","Proportion","UP","1.2137337592307933","0.6978021978021978","0.5866666666666667","0.35772357723577236"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase JAK3","364","Smile SVC Tanimoto classification","0.682252133724656","Proportion","UP","1.2137337592307933","0.7115384615384616","0.618421052631579","0.3821138211382114"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase JAK3","364","Weka RF on folded fp classification","0.6806665991971123","Proportion","UP","1.2137337592307933","0.7197802197802198","0.647887323943662","0.37398373983739835"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase JAK3","364","Smile Bernoulli NB classification","0.680109975373612","Proportion","UP","1.2137337592307933","0.6565934065934066","0.4935064935064935","0.6178861788617886"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase JAK3","364","Smile SVC Poly classification","0.6785413082346601","Proportion","UP","1.2137337592307933","0.6593406593406593","0.42857142857142855","0.024390243902439025"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase JAK2","364","Smile SVC Poly classification","0.6272189349112428","Proportion","UP","2.211195868234606","0.6785714285714286","NaN","0.0"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase JAK2","364","Smile Bernoulli NB classification","0.622149555347936","Proportion","UP","2.211195868234606","0.5961538461538461","0.40625","0.5555555555555556"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase JAK2","364","Smile SVC Tanimoto classification","0.6208519325928231","Proportion","UP","2.211195868234606","0.695054945054945","0.5535714285714286","0.26495726495726496"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase JAK2","364","Smile SVC RBF classification","0.5969410706252816","Proportion","UP","2.211195868234606","0.6703296703296703","0.42857142857142855","0.07692307692307693"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase JAK2","364","Weka RF on folded fp classification","0.5967680542579326","Proportion","UP","2.211195868234606","0.6923076923076923","0.5471698113207547","0.24786324786324787"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase JAK2","364","Weka RF classification","0.5756600574414339","Proportion","UP","2.211195868234606","0.6456043956043956","0.4117647058823529","0.23931623931623933"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase JAK1","364","Smile Bernoulli NB classification","0.5633629191321495","Proportion","UP","4.841666062554914","0.5686813186813187","0.41818181818181815","0.5307692307692308"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase JAK1","364","Smile SVC Poly classification","0.5383957922419466","Proportion","UP","4.841666062554914","0.6428571428571429","NaN","0.0"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase JAK1","364","Smile SVC Tanimoto classification","0.5360618014464168","Proportion","UP","4.841666062554914","0.6263736263736264","0.4444444444444444","0.18461538461538463"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase JAK1","364","Weka RF classification","0.5257560815253122","Proportion","UP","4.841666062554914","0.5961538461538461","0.3924050632911392","0.23846153846153847"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase JAK1","364","Smile SVC RBF classification","0.5242932281393823","Proportion","UP","4.841666062554914","0.6181318681318682","0.36363636363636365","0.09230769230769231"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase JAK1","364","Weka RF on folded fp classification","0.5242274819197899","Proportion","UP","4.841666062554914","0.6098901098901099","0.4090909090909091","0.2076923076923077"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase ITK/TSK","364","Smile Bernoulli NB classification","0.6612366535029982","Proportion","UP","2.022945955940733","0.6346153846153846","0.4140127388535032","0.6132075471698113"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase ITK/TSK","364","Smile SVC Tanimoto classification","0.6569401784408355","Proportion","UP","2.022945955940733","0.7225274725274725","0.5471698113207547","0.27358490566037735"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase ITK/TSK","364","Smile SVC Poly classification","0.6397908439373997","Proportion","UP","2.022945955940733","0.7087912087912088","NaN","0.0"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase ITK/TSK","364","Weka RF on folded fp classification","0.6311978938130742","Proportion","UP","2.022945955940733","0.7087912087912088","0.5","0.25471698113207547"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase ITK/TSK","364","Smile SVC RBF classification","0.6300643557115688","Proportion","UP","2.022945955940733","0.7225274725274725","0.6086956521739131","0.1320754716981132"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase ITK/TSK","364","Weka RF classification","0.6233179757203452","Proportion","UP","2.022945955940733","0.7060439560439561","0.4909090909090909","0.25471698113207547"
"Kinase Assay","Inhibition","Target (full name):Insulin receptor-related protein","364","Smile SVC Poly classification","0.6566207878500245","Proportion","UP","3.4923677747639106","0.8653846153846154","1.0","0.2222222222222222"
"Kinase Assay","Inhibition","Target (full name):Insulin receptor-related protein","364","Smile SVC Tanimoto classification","0.6510836892896694","Proportion","UP","3.4923677747639106","0.8791208791208791","1.0","0.30158730158730157"
"Kinase Assay","Inhibition","Target (full name):Insulin receptor-related protein","364","Weka RF on folded fp classification","0.648341507145493","Proportion","UP","3.4923677747639106","0.8736263736263736","0.8148148148148148","0.3492063492063492"
"Kinase Assay","Inhibition","Target (full name):Insulin receptor-related protein","364","Smile SVC RBF classification","0.6437008912091976","Proportion","UP","3.4923677747639106","0.8434065934065934","0.875","0.1111111111111111"
"Kinase Assay","Inhibition","Target (full name):Insulin receptor-related protein","364","Weka RF classification","0.6375837156568056","Proportion","UP","3.4923677747639106","0.8489010989010989","0.7","0.2222222222222222"
"Kinase Assay","Inhibition","Target (full name):Insulin receptor-related protein","364","Smile Bernoulli NB classification","0.6369509043927647","Proportion","UP","3.4923677747639106","0.5631868131868132","0.22727272727272727","0.6349206349206349"
"Kinase Assay","Inhibition","Target (full name):Insulin receptor","364","Smile SVC Tanimoto classification","0.737866326885207","Proportion","UP","5.8996365650161415","0.7994505494505495","0.8333333333333334","0.30927835051546393"
"Kinase Assay","Inhibition","Target (full name):Insulin receptor","364","Weka RF classification","0.721842542183096","Proportion","UP","5.8996365650161415","0.7692307692307693","0.6226415094339622","0.3402061855670103"
"Kinase Assay","Inhibition","Target (full name):Insulin receptor","364","Smile SVC Poly classification","0.6968994941889652","Proportion","UP","5.8996365650161415","0.771978021978022","1.0","0.14432989690721648"
"Kinase Assay","Inhibition","Target (full name):Insulin receptor","364","Smile SVC RBF classification","0.6952778099540524","Proportion","UP","5.8996365650161415","0.7527472527472527","0.6842105263157895","0.13402061855670103"
"Kinase Assay","Inhibition","Target (full name):Insulin receptor","364","Smile Bernoulli NB classification","0.6840032433684705","Proportion","UP","5.8996365650161415","0.6181318681318682","0.3670886075949367","0.5979381443298969"
"Kinase Assay","Inhibition","Target (full name):Insulin receptor","364","Weka RF on folded fp classification","0.6700644812541035","Proportion","UP","5.8996365650161415","0.7774725274725275","0.7222222222222222","0.26804123711340205"
"Kinase Assay","Inhibition","Target (full name):Insulin-like growth factor I receptor","364","Weka RF classification","0.7020856078003238","Proportion","UP","4.91518609049645","0.7115384615384616","0.4642857142857143","0.25742574257425743"
"Kinase Assay","Inhibition","Target (full name):Insulin-like growth factor I receptor","364","Smile Bernoulli NB classification","0.6909611113202577","Proportion","UP","4.91518609049645","0.6346153846153846","0.4036144578313253","0.6633663366336634"
"Kinase Assay","Inhibition","Target (full name):Insulin-like growth factor I receptor","364","Smile SVC Tanimoto classification","0.6748484734404999","Proportion","UP","4.91518609049645","0.7692307692307693","0.6808510638297872","0.31683168316831684"
"Kinase Assay","Inhibition","Target (full name):Insulin-like growth factor I receptor","364","Smile SVC Poly classification","0.6669427399013671","Proportion","UP","4.91518609049645","0.760989010989011","1.0","0.13861386138613863"
"Kinase Assay","Inhibition","Target (full name):Insulin-like growth factor I receptor","364","Smile SVC RBF classification","0.6658509957459622","Proportion","UP","4.91518609049645","0.7472527472527473","0.7647058823529411","0.12871287128712872"
"Kinase Assay","Inhibition","Target (full name):Insulin-like growth factor I receptor","364","Weka RF on folded fp classification","0.6519594925272002","Proportion","UP","4.91518609049645","0.7582417582417582","0.6756756756756757","0.24752475247524752"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase HCK","364","Weka RF on folded fp classification","0.8113724708462082","Proportion","UP","9.108808512764629","0.7362637362637363","0.6703296703296703","0.48031496062992124"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase HCK","364","Smile Bernoulli NB classification","0.7981826638758773","Proportion","UP","9.108808512764629","0.7252747252747253","0.576271186440678","0.8031496062992126"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase HCK","364","Smile SVC Poly classification","0.7932157214525398","Proportion","UP","9.108808512764629","0.6675824175824175","0.6875","0.08661417322834646"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase HCK","364","Smile SVC Tanimoto classification","0.7931160503671222","Proportion","UP","9.108808512764629","0.75","0.6698113207547169","0.5590551181102362"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase HCK","364","Weka RF classification","0.793116050367122","Proportion","UP","9.108808512764629","0.728021978021978","0.6521739130434783","0.47244094488188976"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase HCK","364","Smile SVC RBF classification","0.7850094687531134","Proportion","UP","9.108808512764629","0.7115384615384616","0.6896551724137931","0.31496062992125984"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FYN","364","Smile Bernoulli NB classification","0.814353206642456","Proportion","UP","5.5249612369462024","0.7307692307692307","0.5449101796407185","0.8053097345132744"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FYN","364","Smile SVC Tanimoto classification","0.8016429855798031","Proportion","UP","5.5249612369462024","0.7554945054945055","0.6333333333333333","0.504424778761062"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FYN","364","Weka RF on folded fp classification","0.7900081091562938","Proportion","UP","5.5249612369462024","0.7362637362637363","0.6231884057971014","0.3805309734513274"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FYN","364","Weka RF classification","0.7888622501145857","Proportion","UP","5.5249612369462024","0.7335164835164835","0.6176470588235294","0.37168141592920356"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FYN","364","Smile SVC Poly classification","0.7857243592003653","Proportion","UP","5.5249612369462024","0.7032967032967034","0.7777777777777778","0.061946902654867256"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase FYN","364","Smile SVC RBF classification","0.7574657123717495","Proportion","UP","5.5249612369462024","0.739010989010989","0.725","0.25663716814159293"
"Kinase Assay","Inhibition","Target (full name):Macrophage colony stimulating factor receptor","364","Smile Bernoulli NB classification","0.8875929626838781","Proportion","UP","8.47773599820828","0.7967032967032966","0.6647398843930635","0.8778625954198473"
"Kinase Assay","Inhibition","Target (full name):Macrophage colony stimulating factor receptor","364","Weka RF on folded fp classification","0.8875274383251992","Proportion","UP","8.47773599820828","0.7967032967032966","0.7394957983193278","0.6717557251908397"
"Kinase Assay","Inhibition","Target (full name):Macrophage colony stimulating factor receptor","364","Smile SVC Tanimoto classification","0.886642859483012","Proportion","UP","8.47773599820828","0.7967032967032966","0.7244094488188977","0.7022900763358778"
"Kinase Assay","Inhibition","Target (full name):Macrophage colony stimulating factor receptor","364","Smile SVC Poly classification","0.8736035121056246","Proportion","UP","8.47773599820828","0.6923076923076923","0.7567567567567568","0.21374045801526717"
"Kinase Assay","Inhibition","Target (full name):Macrophage colony stimulating factor receptor","364","Weka RF classification","0.849998361891033","Proportion","UP","8.47773599820828","0.7554945054945055","0.6981132075471698","0.5648854961832062"
"Kinase Assay","Inhibition","Target (full name):Macrophage colony stimulating factor receptor","364","Smile SVC RBF classification","0.8239688104052685","Proportion","UP","8.47773599820828","0.7692307692307693","0.7901234567901234","0.48854961832061067"
"Kinase Assay","Inhibition","Target (full name):Vascular endothelial growth factor receptor 3","364","Weka RF on folded fp classification","0.7528987674009114","Proportion","UP","7.438940546493985","0.7225274725274725","0.6511627906976745","0.4409448818897638"
"Kinase Assay","Inhibition","Target (full name):Vascular endothelial growth factor receptor 3","364","Weka RF classification","0.7455729426226785","Proportion","UP","7.438940546493985","0.7252747252747253","0.651685393258427","0.4566929133858268"
"Kinase Assay","Inhibition","Target (full name):Vascular endothelial growth factor receptor 3","364","Smile Bernoulli NB classification","0.7412206385594214","Proportion","UP","7.438940546493985","0.6703296703296703","0.52046783625731","0.7007874015748031"
"Kinase Assay","Inhibition","Target (full name):Vascular endothelial growth factor receptor 3","364","Smile SVC Tanimoto classification","0.7192929997674337","Proportion","UP","7.438940546493985","0.6978021978021978","0.580952380952381","0.48031496062992124"
"Kinase Assay","Inhibition","Target (full name):Vascular endothelial growth factor receptor 3","364","Smile SVC Poly classification","0.712814379215257","Proportion","UP","7.438940546493985","0.6593406593406593","0.7142857142857143","0.03937007874015748"
"Kinase Assay","Inhibition","Target (full name):Vascular endothelial growth factor receptor 3","364","Smile SVC RBF classification","0.708727864713114","Proportion","UP","7.438940546493985","0.7060439560439561","0.7083333333333334","0.2677165354330709"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase receptor FLT3","364","Smile SVC Poly classification","0.907667233560091","Proportion","UP","4.408084823585304","0.7362637362637363","0.7352941176470589","0.22321428571428573"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase receptor FLT3","364","Smile SVC Tanimoto classification","0.9050099206349214","Proportion","UP","4.408084823585304","0.8791208791208791","0.8541666666666666","0.7321428571428571"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase receptor FLT3","364","Smile Bernoulli NB classification","0.9045670351473929","Proportion","UP","4.408084823585304","0.8406593406593407","0.6956521739130435","0.8571428571428571"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase receptor FLT3","364","Weka RF on folded fp classification","0.9034332482993207","Proportion","UP","4.408084823585304","0.8571428571428571","0.8333333333333334","0.6696428571428571"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase receptor FLT3","364","Weka RF classification","0.8804386337868481","Proportion","UP","4.408084823585304","0.8296703296703297","0.7906976744186046","0.6071428571428571"
"Kinase Assay","Inhibition","Target (full name):Tyrosine-protein kinase receptor FLT3","364","Smile SVC RBF classification","0.8680201247165559","Proportion","UP","4.408084823585304","0.804945054945055","0.847457627118644","0.44642857142857145"
"Kinase Assay","Inhibition","Target (full name):Dual specificity protein kinase TTK","364","Smile SVC Tanimoto classification","0.6689923253264223","Proportion","UP","9.129808890802584","0.7252747252747253","0.7213114754098361","0.3464566929133858"
"Kinase Assay","Inhibition","Target (full name):Dual specificity protein kinase TTK","364","Smile SVC Poly classification","0.6576298215887567","Proportion","UP","9.129808890802584","0.6895604395604396","1.0","0.11023622047244094"
"Kinase Assay","Inhibition","Target (full name):Dual specificity protein kinase TTK","364","Smile SVC RBF classification","0.6379281703711085","Proportion","UP","9.129808890802584","0.6703296703296703","0.5853658536585366","0.1889763779527559"
"Kinase Assay","Inhibition","Target (full name):Dual specificity protein kinase TTK","364","Weka RF on folded fp classification","0.6329446161002028","Proportion","UP","9.129808890802584","0.7060439560439561","0.6470588235294118","0.3464566929133858"
"Kinase Assay","Inhibition","Target (full name):Dual specificity protein kinase TTK","364","Weka RF classification","0.6328117213196449","Proportion","UP","9.129808890802584","0.6840659340659341","0.575","0.36220472440944884"
"Kinase Assay","Inhibition","Target (full name):Dual specificity protein kinase TTK","364","Smile Bernoulli NB classification","0.6273298116216484","Proportion","UP","9.129808890802584","0.5906593406593407","0.4367816091954023","0.5984251968503937"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PLK1","364","Weka RF on folded fp classification","0.83095760233918","Proportion","UP","5.60492429581814","0.8653846153846154","0.8292682926829268","0.4473684210526316"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PLK1","364","Smile SVC Tanimoto classification","0.8180966739766068","Proportion","UP","5.60492429581814","0.8791208791208791","0.9210526315789473","0.4605263157894737"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PLK1","364","Weka RF classification","0.808068347953216","Proportion","UP","5.60492429581814","0.8489010989010989","0.7560975609756098","0.40789473684210525"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PLK1","364","Smile Bernoulli NB classification","0.8009868421052615","Proportion","UP","5.60492429581814","0.7115384615384616","0.40268456375838924","0.7894736842105263"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PLK1","364","Smile SVC RBF classification","0.7942936769005831","Proportion","UP","5.60492429581814","0.8324175824175825","0.8947368421052632","0.2236842105263158"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PLK1","364","Smile SVC Poly classification","0.7798565423976587","Proportion","UP","5.60492429581814","0.8708791208791209","0.9142857142857143","0.42105263157894735"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase NEK9","364","Smile SVC Poly classification","0.6047970853152512","Proportion","UP","6.964320862474562","0.6758241758241759","0.7272727272727273","0.06504065040650407"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase NEK9","364","Smile SVC RBF classification","0.6030428769017983","Proportion","UP","6.964320862474562","0.6593406593406593","0.4827586206896552","0.11382113821138211"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase NEK9","364","Smile SVC Tanimoto classification","0.5976790473298926","Proportion","UP","6.964320862474562","0.6758241758241759","0.5510204081632653","0.21951219512195122"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase NEK9","364","Smile Bernoulli NB classification","0.597054953952029","Proportion","UP","6.964320862474562","0.5467032967032966","0.3939393939393939","0.6341463414634146"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase NEK9","364","Weka RF on folded fp classification","0.5735586816449076","Proportion","UP","6.964320862474562","0.6675824175824175","0.5185185185185185","0.22764227642276422"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase NEK9","364","Weka RF classification","0.5645346287487774","Proportion","UP","6.964320862474562","0.6510989010989011","0.46296296296296297","0.2032520325203252"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase NEK7","364","Weka RF classification","0.6956317991631802","Proportion","UP","4.02532187292163","0.6703296703296703","0.5352112676056338","0.304"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase NEK7","364","Smile SVC RBF classification","0.6753472803347292","Proportion","UP","4.02532187292163","0.6895604395604396","0.6428571428571429","0.216"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase NEK7","364","Weka RF on folded fp classification","0.6691380753138072","Proportion","UP","4.02532187292163","0.6895604395604396","0.6111111111111112","0.264"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase NEK7","364","Smile SVC Poly classification","0.6593138075313797","Proportion","UP","4.02532187292163","0.6703296703296703","0.7272727272727273","0.064"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase NEK7","364","Smile SVC Tanimoto classification","0.6565020920502095","Proportion","UP","4.02532187292163","0.6923076923076923","0.5942028985507246","0.328"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase NEK7","364","Smile Bernoulli NB classification","0.6088702928870295","Proportion","UP","4.02532187292163","0.5769230769230769","0.4121212121212121","0.544"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase NEK6","364","Smile SVC Tanimoto classification","0.558621113432469","Inflection","DOWN","1.147676767676768","0.5686813186813187","0.5039370078740157","0.4050632911392405"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase NEK6","364","Smile Bernoulli NB classification","0.5522305518004179","Inflection","DOWN","1.147676767676768","0.5247252747252747","0.4619289340101523","0.5759493670886076"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase NEK6","364","Smile SVC Poly classification","0.546423743394371","Inflection","DOWN","1.147676767676768","0.5659340659340659","0.5","0.0379746835443038"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase NEK6","364","Weka RF on folded fp classification","0.5413235836303305","Inflection","DOWN","1.147676767676768","0.5576923076923077","0.48672566371681414","0.34810126582278483"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase NEK6","364","Weka RF classification","0.5265761337102131","Inflection","DOWN","1.147676767676768","0.5302197802197802","0.44881889763779526","0.36075949367088606"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase NEK6","364","Smile SVC RBF classification","0.5259923804842079","Inflection","DOWN","1.147676767676768","0.5384615384615384","0.44565217391304346","0.25949367088607594"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase NEK2","364","Smile SVC Poly classification","0.6083766840069371","Proportion","UP","4.396919717304852","0.6675824175824175","0.6923076923076923","0.07142857142857142"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase NEK2","364","Smile SVC Tanimoto classification","0.5958049886621314","Proportion","UP","4.396919717304852","0.6593406593406593","0.5227272727272727","0.18253968253968253"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase NEK2","364","Smile Bernoulli NB classification","0.5782813125250098","Proportion","UP","4.396919717304852","0.5302197802197802","0.37967914438502676","0.5634920634920635"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase NEK2","364","Smile SVC RBF classification","0.5756302521008405","Proportion","UP","4.396919717304852","0.6401098901098901","0.42424242424242425","0.1111111111111111"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase NEK2","364","Weka RF classification","0.5746298519407764","Proportion","UP","4.396919717304852","0.6181318681318682","0.4057971014492754","0.2222222222222222"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase NEK2","364","Weka RF on folded fp classification","0.5505535547552357","Proportion","UP","4.396919717304852","0.6428571428571429","0.45652173913043476","0.16666666666666666"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Nek1","364","Smile SVC Poly classification","0.6968616508198977","Proportion","UP","3.0145499976314776","0.6785714285714286","0.6","0.025423728813559324"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Nek1","364","Smile SVC RBF classification","0.6886282210279728","Proportion","UP","3.0145499976314776","0.7005494505494505","0.6285714285714286","0.1864406779661017"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Nek1","364","Smile SVC Tanimoto classification","0.6864234532175817","Proportion","UP","3.0145499976314776","0.7252747252747253","0.65","0.3305084745762712"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Nek1","364","Smile Bernoulli NB classification","0.6650647650544294","Proportion","UP","3.0145499976314776","0.6126373626373627","0.42857142857142855","0.5847457627118644"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Nek1","364","Weka RF on folded fp classification","0.6570035827476914","Proportion","UP","3.0145499976314776","0.7005494505494505","0.5818181818181818","0.2711864406779661"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Nek1","364","Weka RF classification","0.6542303982361857","Proportion","UP","3.0145499976314776","0.6758241758241759","0.5","0.2711864406779661"
"Kinase Assay","Inhibition","Target (full name):Inhibitor of nuclear factor kappa B kinase epsilon subunit","364","Smile Bernoulli NB classification","0.7572365405634089","Proportion","UP","5.091912631397763","0.7032967032967034","0.5159235668789809","0.7168141592920354"
"Kinase Assay","Inhibition","Target (full name):Inhibitor of nuclear factor kappa B kinase epsilon subunit","364","Weka RF on folded fp classification","0.7297888093643106","Proportion","UP","5.091912631397763","0.7362637362637363","0.6307692307692307","0.36283185840707965"
"Kinase Assay","Inhibition","Target (full name):Inhibitor of nuclear factor kappa B kinase epsilon subunit","364","Smile SVC Poly classification","0.7278849204950099","Proportion","UP","5.091912631397763","0.695054945054945","0.6666666666666666","0.035398230088495575"
"Kinase Assay","Inhibition","Target (full name):Inhibitor of nuclear factor kappa B kinase epsilon subunit","364","Smile SVC Tanimoto classification","0.7207982230370534","Proportion","UP","5.091912631397763","0.7252747252747253","0.5970149253731343","0.35398230088495575"
"Kinase Assay","Inhibition","Target (full name):Inhibitor of nuclear factor kappa B kinase epsilon subunit","364","Weka RF classification","0.6910058879526143","Proportion","UP","5.091912631397763","0.7032967032967034","0.5333333333333333","0.35398230088495575"
"Kinase Assay","Inhibition","Target (full name):Inhibitor of nuclear factor kappa B kinase epsilon subunit","364","Smile SVC RBF classification","0.6485562176074449","Proportion","UP","5.091912631397763","0.7060439560439561","0.5714285714285714","0.21238938053097345"
"Kinase Assay","Inhibition","Target (full name):Inhibitor of nuclear factor kappa B kinase beta subunit","364","Smile SVC Tanimoto classification","0.6248391885205351","Proportion","UP","1.9653103666832807","0.6483516483516484","0.5074626865671642","0.26356589147286824"
"Kinase Assay","Inhibition","Target (full name):Inhibitor of nuclear factor kappa B kinase beta subunit","364","Smile SVC Poly classification","0.6219033481774696","Proportion","UP","1.9653103666832807","0.6483516483516484","0.5555555555555556","0.03875968992248062"
"Kinase Assay","Inhibition","Target (full name):Inhibitor of nuclear factor kappa B kinase beta subunit","364","Smile Bernoulli NB classification","0.6164934850733963","Proportion","UP","1.9653103666832807","0.5906593406593407","0.4473684210526316","0.6589147286821705"
"Kinase Assay","Inhibition","Target (full name):Inhibitor of nuclear factor kappa B kinase beta subunit","364","Weka RF on folded fp classification","0.6052449282533402","Proportion","UP","1.9653103666832807","0.6428571428571429","0.4915254237288136","0.2248062015503876"
"Kinase Assay","Inhibition","Target (full name):Inhibitor of nuclear factor kappa B kinase beta subunit","364","Weka RF classification","0.5833085931057232","Proportion","UP","1.9653103666832807","0.6098901098901099","0.41333333333333333","0.24031007751937986"
"Kinase Assay","Inhibition","Target (full name):Inhibitor of nuclear factor kappa B kinase beta subunit","364","Smile SVC RBF classification","0.5736104238825662","Proportion","UP","1.9653103666832807","0.6346153846153846","0.45454545454545453","0.15503875968992248"
"Kinase Assay","Inhibition","Target (full name):Inhibitor of nuclear factor kappa B kinase alpha subunit","364","Smile SVC Tanimoto classification","0.6076980134158929","Proportion","UP","3.9443759464658026","0.6593406593406593","0.6","0.2647058823529412"
"Kinase Assay","Inhibition","Target (full name):Inhibitor of nuclear factor kappa B kinase alpha subunit","364","Weka RF classification","0.58765479876161","Proportion","UP","3.9443759464658026","0.6071428571428571","0.4639175257731959","0.33088235294117646"
"Kinase Assay","Inhibition","Target (full name):Inhibitor of nuclear factor kappa B kinase alpha subunit","364","Smile Bernoulli NB classification","0.5808662280701751","Proportion","UP","3.9443759464658026","0.5824175824175825","0.44805194805194803","0.5073529411764706"
"Kinase Assay","Inhibition","Target (full name):Inhibitor of nuclear factor kappa B kinase alpha subunit","364","Smile SVC Poly classification","0.5782217492260063","Proportion","UP","3.9443759464658026","0.6538461538461539","0.8125","0.09558823529411764"
"Kinase Assay","Inhibition","Target (full name):Inhibitor of nuclear factor kappa B kinase alpha subunit","364","Smile SVC RBF classification","0.572545794633643","Proportion","UP","3.9443759464658026","0.6181318681318682","0.47368421052631576","0.19852941176470587"
"Kinase Assay","Inhibition","Target (full name):Inhibitor of nuclear factor kappa B kinase alpha subunit","364","Weka RF on folded fp classification","0.571900799793602","Proportion","UP","3.9443759464658026","0.6263736263736264","0.5","0.2867647058823529"
"Kinase Assay","Inhibition","Target (full name):Casein kinase II alpha","364","Smile Bernoulli NB classification","0.7067269044020711","Proportion","UP","5.949167176650057","0.6318681318681318","0.50920245398773","0.6058394160583942"
"Kinase Assay","Inhibition","Target (full name):Casein kinase II alpha","364","Smile SVC Tanimoto classification","0.6888324383420688","Proportion","UP","5.949167176650057","0.6730769230769231","0.59","0.4306569343065693"
"Kinase Assay","Inhibition","Target (full name):Casein kinase II alpha","364","Smile SVC Poly classification","0.6881250200971099","Proportion","UP","5.949167176650057","0.6675824175824175","0.8076923076923077","0.15328467153284672"
"Kinase Assay","Inhibition","Target (full name):Casein kinase II alpha","364","Weka RF on folded fp classification","0.6826907617608278","Proportion","UP","5.949167176650057","0.6813186813186813","0.6060606060606061","0.43795620437956206"
"Kinase Assay","Inhibition","Target (full name):Casein kinase II alpha","364","Smile SVC RBF classification","0.661982700408373","Proportion","UP","5.949167176650057","0.6703296703296703","0.6491228070175439","0.27007299270072993"
"Kinase Assay","Inhibition","Target (full name):Casein kinase II alpha","364","Weka RF classification","0.6339110582333838","Proportion","UP","5.949167176650057","0.6648351648351648","0.5842696629213483","0.3795620437956204"
"Kinase Assay","Inhibition","Target (full name):Sphingosine kinase 2","364","Smile Bernoulli NB classification","0.5506020122051793","Proportion","UP","0.26112054915903204","0.5412087912087912","0.39325842696629215","0.5426356589147286"
"Kinase Assay","Inhibition","Target (full name):Sphingosine kinase 2","364","Smile SVC Poly classification","0.5297542470724067","Proportion","UP","0.26112054915903204","0.6456043956043956","NaN","0.0"
"Kinase Assay","Inhibition","Target (full name):Sphingosine kinase 2","364","Weka RF on folded fp classification","0.5163615371928086","Proportion","UP","0.26112054915903204","0.6016483516483516","0.35185185185185186","0.14728682170542637"
"Kinase Assay","Inhibition","Target (full name):Sphingosine kinase 2","364","Weka RF classification","0.5147616691406894","Proportion","UP","0.26112054915903204","0.5879120879120879","0.352112676056338","0.1937984496124031"
"Kinase Assay","Inhibition","Target (full name):Sphingosine kinase 2","364","Smile SVC Tanimoto classification","0.5031337621639456","Proportion","UP","0.26112054915903204","0.5934065934065934","0.32075471698113206","0.13178294573643412"
"Kinase Assay","Inhibition","Target (full name):Sphingosine kinase 2","364","Smile SVC RBF classification","0.4757545769421081","Proportion","UP","0.26112054915903204","0.6373626373626373","0.45714285714285713","0.12403100775193798"
"Kinase Assay","Inhibition","Target (full name):Sphingosine kinase 1","364","Smile Bernoulli NB classification","0.5631250207648094","Proportion","UP","0.5286234581096441","0.5054945054945055","0.38222222222222224","0.6771653543307087"
"Kinase Assay","Inhibition","Target (full name):Sphingosine kinase 1","364","Smile SVC Poly classification","0.5487391607694613","Proportion","UP","0.5286234581096441","0.6428571428571429","0.0","0.0"
"Kinase Assay","Inhibition","Target (full name):Sphingosine kinase 1","364","Smile SVC Tanimoto classification","0.5358483670553842","Proportion","UP","0.5286234581096441","0.6181318681318682","0.40625","0.2047244094488189"
"Kinase Assay","Inhibition","Target (full name):Sphingosine kinase 1","364","Weka RF classification","0.5310807668028839","Proportion","UP","0.5286234581096441","0.6043956043956044","0.4","0.2677165354330709"
"Kinase Assay","Inhibition","Target (full name):Sphingosine kinase 1","364","Weka RF on folded fp classification","0.5070434233695473","Proportion","UP","0.5286234581096441","0.6208791208791209","0.4153846153846154","0.2125984251968504"
"Kinase Assay","Inhibition","Target (full name):Sphingosine kinase 1","364","Smile SVC RBF classification","0.4924249975082228","Proportion","UP","0.5286234581096441","0.6043956043956044","0.3023255813953488","0.10236220472440945"
"Kinase Assay","Inhibition","Target (full name):PI4-kinase beta subunit","364","Weka RF on folded fp classification","0.6188185882671721","Proportion","UP","1.3539616344576988","0.6840659340659341","0.5555555555555556","0.28688524590163933"
"Kinase Assay","Inhibition","Target (full name):PI4-kinase beta subunit","364","Smile SVC Tanimoto classification","0.6187339113941198","Proportion","UP","1.3539616344576988","0.6758241758241759","0.5370370370370371","0.23770491803278687"
"Kinase Assay","Inhibition","Target (full name):PI4-kinase beta subunit","364","Smile SVC Poly classification","0.6077259178973031","Proportion","UP","1.3539616344576988","0.6648351648351648","NaN","0.0"
"Kinase Assay","Inhibition","Target (full name):PI4-kinase beta subunit","364","Smile Bernoulli NB classification","0.5958542202953526","Proportion","UP","1.3539616344576988","0.5576923076923077","0.3898305084745763","0.5655737704918032"
"Kinase Assay","Inhibition","Target (full name):PI4-kinase beta subunit","364","Weka RF classification","0.5840163934426228","Proportion","UP","1.3539616344576988","0.6538461538461539","0.46774193548387094","0.23770491803278687"
"Kinase Assay","Inhibition","Target (full name):PI4-kinase beta subunit","364","Smile SVC RBF classification","0.5537698143882944","Proportion","UP","1.3539616344576988","0.6510989010989011","0.41935483870967744","0.10655737704918032"
"Kinase Assay","Inhibition","Target (full name):PI3-kinase p110-delta subunit","364","Smile SVC RBF classification","0.6571628651460582","Proportion","UP","3.522483159143391","0.6785714285714286","0.5849056603773585","0.24603174603174602"
"Kinase Assay","Inhibition","Target (full name):PI3-kinase p110-delta subunit","364","Weka RF classification","0.6535947712418302","Proportion","UP","3.522483159143391","0.6456043956043956","0.4827586206896552","0.3333333333333333"
"Kinase Assay","Inhibition","Target (full name):PI3-kinase p110-delta subunit","364","Weka RF on folded fp classification","0.6210317460317457","Proportion","UP","3.522483159143391","0.6565934065934066","0.5064935064935064","0.30952380952380953"
"Kinase Assay","Inhibition","Target (full name):PI3-kinase p110-delta subunit","364","Smile SVC Tanimoto classification","0.6198479391756706","Proportion","UP","3.522483159143391","0.6730769230769231","0.5454545454545454","0.3333333333333333"
"Kinase Assay","Inhibition","Target (full name):PI3-kinase p110-delta subunit","364","Smile SVC Poly classification","0.6148125917033481","Proportion","UP","3.522483159143391","0.6923076923076923","0.8181818181818182","0.14285714285714285"
"Kinase Assay","Inhibition","Target (full name):PI3-kinase p110-delta subunit","364","Smile Bernoulli NB classification","0.595171401894091","Proportion","UP","3.522483159143391","0.5302197802197802","0.3783783783783784","0.5555555555555556"
"Kinase Assay","Inhibition","Target (full name):PI3-kinase p110-alpha subunit","364","Smile Bernoulli NB classification","0.6258653343782656","Proportion","UP","3.974057556829382","0.5824175824175825","0.4411764705882353","0.5681818181818182"
"Kinase Assay","Inhibition","Target (full name):PI3-kinase p110-alpha subunit","364","Weka RF classification","0.6111709770114943","Proportion","UP","3.974057556829382","0.6428571428571429","0.5125","0.3106060606060606"
"Kinase Assay","Inhibition","Target (full name):PI3-kinase p110-alpha subunit","364","Smile SVC Tanimoto classification","0.6089015151515144","Proportion","UP","3.974057556829382","0.6538461538461539","0.5428571428571428","0.2878787878787879"
"Kinase Assay","Inhibition","Target (full name):PI3-kinase p110-alpha subunit","364","Smile SVC RBF classification","0.6025339602925812","Proportion","UP","3.974057556829382","0.6401098901098901","0.5121951219512195","0.1590909090909091"
"Kinase Assay","Inhibition","Target (full name):PI3-kinase p110-alpha subunit","364","Smile SVC Poly classification","0.5978317659352141","Proportion","UP","3.974057556829382","0.6456043956043956","0.6153846153846154","0.06060606060606061"
"Kinase Assay","Inhibition","Target (full name):PI3-kinase p110-alpha subunit","364","Weka RF on folded fp classification","0.5847537878787876","Proportion","UP","3.974057556829382","0.6565934065934066","0.559322033898305","0.25"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase SRPK1","364","Smile SVC RBF classification","0.5857001972386586","Proportion","UP","-0.7483710130924823","0.6538461538461539","0.5476190476190477","0.17692307692307693"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase SRPK1","364","Weka RF classification","0.5654996712689021","Proportion","UP","-0.7483710130924823","0.6236263736263736","0.4578313253012048","0.2923076923076923"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase SRPK1","364","Smile SVC Poly classification","0.5649901380670613","Proportion","UP","-0.7483710130924823","0.6428571428571429","NaN","0.0"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase SRPK1","364","Smile SVC Tanimoto classification","0.5541091387245237","Proportion","UP","-0.7483710130924823","0.5934065934065934","0.37142857142857144","0.2"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase SRPK1","364","Smile Bernoulli NB classification","0.5514628533859305","Proportion","UP","-0.7483710130924823","0.521978021978022","0.3735632183908046","0.5"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase SRPK1","364","Weka RF on folded fp classification","0.5473044049967128","Proportion","UP","-0.7483710130924823","0.5989010989010989","0.3888888888888889","0.2153846153846154"
"Kinase Assay","Inhibition","Target (full name):MAP kinase p38 gamma","364","Smile SVC Tanimoto classification","0.5802320928371353","Proportion","UP","2.7567850607874","0.6758241758241759","0.5909090909090909","0.20634920634920634"
"Kinase Assay","Inhibition","Target (full name):MAP kinase p38 gamma","364","Weka RF classification","0.5769140989729222","Proportion","UP","2.7567850607874","0.6263736263736264","0.4342105263157895","0.2619047619047619"
"Kinase Assay","Inhibition","Target (full name):MAP kinase p38 gamma","364","Weka RF on folded fp classification","0.5723622782446312","Proportion","UP","2.7567850607874","0.6346153846153846","0.4492753623188406","0.24603174603174602"
"Kinase Assay","Inhibition","Target (full name):MAP kinase p38 gamma","364","Smile Bernoulli NB classification","0.5670768307322931","Proportion","UP","2.7567850607874","0.5137362637362637","0.36649214659685864","0.5555555555555556"
"Kinase Assay","Inhibition","Target (full name):MAP kinase p38 gamma","364","Smile SVC Poly classification","0.5661597972522341","Proportion","UP","2.7567850607874","0.6620879120879121","0.6666666666666666","0.047619047619047616"
"Kinase Assay","Inhibition","Target (full name):MAP kinase p38 gamma","364","Smile SVC RBF classification","0.5627584367080166","Proportion","UP","2.7567850607874","0.6620879120879121","0.5428571428571428","0.15079365079365079"
"Kinase Assay","Inhibition","Target (full name):MAP kinase p38 delta","364","Smile SVC Poly classification","0.6402441035790857","Proportion","UP","3.333016304924671","0.6565934065934066","0.625","0.07751937984496124"
"Kinase Assay","Inhibition","Target (full name):MAP kinase p38 delta","364","Weka RF on folded fp classification","0.6182417944911769","Proportion","UP","3.333016304924671","0.6675824175824175","0.5769230769230769","0.23255813953488372"
"Kinase Assay","Inhibition","Target (full name):MAP kinase p38 delta","364","Smile Bernoulli NB classification","0.609021936335148","Proportion","UP","3.333016304924671","0.5714285714285714","0.42105263157894735","0.5581395348837209"
"Kinase Assay","Inhibition","Target (full name):MAP kinase p38 delta","364","Smile SVC Tanimoto classification","0.6001319478805875","Proportion","UP","3.333016304924671","0.6318681318681318","0.4528301886792453","0.18604651162790697"
"Kinase Assay","Inhibition","Target (full name):MAP kinase p38 delta","364","Smile SVC RBF classification","0.5999010390895595","Proportion","UP","3.333016304924671","0.6428571428571429","0.4883720930232558","0.16279069767441862"
"Kinase Assay","Inhibition","Target (full name):MAP kinase p38 delta","364","Weka RF classification","0.5759030183077687","Proportion","UP","3.333016304924671","0.6291208791208791","0.4594594594594595","0.26356589147286824"
"Kinase Assay","Inhibition","Target (full name):MAP kinase p38 beta","364","Smile Bernoulli NB classification","0.8553693033001584","Proportion","UP","6.243936842681618","0.771978021978022","0.6159420289855072","0.7391304347826086"
"Kinase Assay","Inhibition","Target (full name):MAP kinase p38 beta","364","Weka RF on folded fp classification","0.8462895058494865","Proportion","UP","6.243936842681618","0.8131868131868132","0.8051948051948052","0.5391304347826087"
"Kinase Assay","Inhibition","Target (full name):MAP kinase p38 beta","364","Smile SVC Poly classification","0.8462720447005428","Proportion","UP","6.243936842681618","0.7637362637362637","0.967741935483871","0.2608695652173913"
"Kinase Assay","Inhibition","Target (full name):MAP kinase p38 beta","364","Smile SVC Tanimoto classification","0.8451894534660399","Proportion","UP","6.243936842681618","0.8131868131868132","0.7701149425287356","0.5826086956521739"
"Kinase Assay","Inhibition","Target (full name):MAP kinase p38 beta","364","Weka RF classification","0.8354461323555091","Proportion","UP","6.243936842681618","0.7967032967032966","0.7662337662337663","0.5130434782608696"
"Kinase Assay","Inhibition","Target (full name):MAP kinase p38 beta","364","Smile SVC RBF classification","0.7842151213549867","Proportion","UP","6.243936842681618","0.7692307692307693","0.8444444444444444","0.33043478260869563"
"Kinase Assay","Inhibition","Target (full name):MAP kinase p38 alpha","364","Smile SVC Tanimoto classification","0.8311157674174962","Proportion","UP","9.707221310271056","0.8296703296703297","0.7912087912087912","0.6260869565217392"
"Kinase Assay","Inhibition","Target (full name):MAP kinase p38 alpha","364","Smile Bernoulli NB classification","0.8227693382224545","Proportion","UP","9.707221310271056","0.7774725274725275","0.6268656716417911","0.7304347826086957"
"Kinase Assay","Inhibition","Target (full name):MAP kinase p38 alpha","364","Weka RF on folded fp classification","0.8115592806006636","Proportion","UP","9.707221310271056","0.8269230769230769","0.825","0.5739130434782609"
"Kinase Assay","Inhibition","Target (full name):MAP kinase p38 alpha","364","Smile SVC Poly classification","0.8074384494499749","Proportion","UP","9.707221310271056","0.771978021978022","0.9705882352941176","0.28695652173913044"
"Kinase Assay","Inhibition","Target (full name):MAP kinase p38 alpha","364","Weka RF classification","0.8034922297887199","Proportion","UP","9.707221310271056","0.804945054945055","0.7619047619047619","0.5565217391304348"
"Kinase Assay","Inhibition","Target (full name):MAP kinase p38 alpha","364","Smile SVC RBF classification","0.7823642395669631","Proportion","UP","9.707221310271056","0.7664835164835165","0.7777777777777778","0.3652173913043478"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase SRPK3","364","Smile SVC RBF classification","0.6078892371995825","Proportion","UP","0.4116369814860814","0.6428571428571429","0.525","0.1590909090909091"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase SRPK3","364","Smile Bernoulli NB classification","0.6059463166144201","Proportion","UP","0.4116369814860814","0.5961538461538461","0.45222929936305734","0.5378787878787878"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase SRPK3","364","Smile SVC Poly classification","0.5970154127481715","Proportion","UP","0.4116369814860814","0.6538461538461539","0.6875","0.08333333333333333"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase SRPK3","364","Weka RF classification","0.5864681295715778","Proportion","UP","0.4116369814860814","0.6346153846153846","0.4935064935064935","0.2878787878787879"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase SRPK3","364","Smile SVC Tanimoto classification","0.5766065830721003","Proportion","UP","0.4116369814860814","0.6648351648351648","0.5657894736842105","0.32575757575757575"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase SRPK3","364","Weka RF on folded fp classification","0.5595284743991643","Proportion","UP","0.4116369814860814","0.6236263736263736","0.463768115942029","0.24242424242424243"
"Kinase Assay","Inhibition","Target (full name):MAP kinase ERK1","364","Smile SVC RBF classification","0.5864698247890981","Proportion","UP","3.793272702674507","0.6428571428571429","0.5666666666666667","0.12686567164179105"
"Kinase Assay","Inhibition","Target (full name):MAP kinase ERK1","364","Smile SVC Poly classification","0.561810512654121","Proportion","UP","3.793272702674507","0.6318681318681318","0.5","0.03731343283582089"
"Kinase Assay","Inhibition","Target (full name):MAP kinase ERK1","364","Weka RF classification","0.5537313432835823","Proportion","UP","3.793272702674507","0.6208791208791209","0.47058823529411764","0.23880597014925373"
"Kinase Assay","Inhibition","Target (full name):MAP kinase ERK1","364","Smile SVC Tanimoto classification","0.5343608046722909","Proportion","UP","3.793272702674507","0.6181318681318682","0.41379310344827586","0.08955223880597014"
"Kinase Assay","Inhibition","Target (full name):MAP kinase ERK1","364","Smile Bernoulli NB classification","0.5092796885139518","Proportion","UP","3.793272702674507","0.5192307692307693","0.36774193548387096","0.4253731343283582"
"Kinase Assay","Inhibition","Target (full name):MAP kinase ERK1","364","Weka RF on folded fp classification","0.47800129785853324","Proportion","UP","3.793272702674507","0.6043956043956044","0.38095238095238093","0.11940298507462686"
"Kinase Assay","Inhibition","Target (full name):MAP kinase ERK2","364","Smile SVC RBF classification","0.663465386154462","Proportion","UP","4.76415674869741","0.6895604395604396","0.6511627906976745","0.2222222222222222"
"Kinase Assay","Inhibition","Target (full name):MAP kinase ERK2","364","Weka RF on folded fp classification","0.6458416700013336","Proportion","UP","4.76415674869741","0.6895604395604396","0.6140350877192983","0.2777777777777778"
"Kinase Assay","Inhibition","Target (full name):MAP kinase ERK2","364","Smile SVC Poly classification","0.6392890489529146","Proportion","UP","4.76415674869741","0.6620879120879121","0.6666666666666666","0.047619047619047616"
"Kinase Assay","Inhibition","Target (full name):MAP kinase ERK2","364","Smile SVC Tanimoto classification","0.6380552220888352","Proportion","UP","4.76415674869741","0.6730769230769231","0.5660377358490566","0.23809523809523808"
"Kinase Assay","Inhibition","Target (full name):MAP kinase ERK2","364","Weka RF classification","0.633086567960518","Proportion","UP","4.76415674869741","0.6565934065934066","0.5058823529411764","0.3412698412698413"
"Kinase Assay","Inhibition","Target (full name):MAP kinase ERK2","364","Smile Bernoulli NB classification","0.6327531012404961","Proportion","UP","4.76415674869741","0.5686813186813187","0.4221105527638191","0.6666666666666666"
"Kinase Assay","Inhibition","Target (full name):c-Jun N-terminal kinase 2","364","Smile Bernoulli NB classification","0.7078817233437199","Proportion","UP","5.413932121337996","0.6703296703296703","0.50625","0.6639344262295082"
"Kinase Assay","Inhibition","Target (full name):c-Jun N-terminal kinase 2","364","Smile SVC Tanimoto classification","0.6988890394255508","Proportion","UP","5.413932121337996","0.6978021978021978","0.5666666666666667","0.4180327868852459"
"Kinase Assay","Inhibition","Target (full name):c-Jun N-terminal kinase 2","364","Smile SVC Poly classification","0.6830036580409152","Proportion","UP","5.413932121337996","0.7197802197802198","0.7272727272727273","0.26229508196721313"
"Kinase Assay","Inhibition","Target (full name):c-Jun N-terminal kinase 2","364","Smile SVC RBF classification","0.6628166915052157","Proportion","UP","5.413932121337996","0.6785714285714286","0.5531914893617021","0.21311475409836064"
"Kinase Assay","Inhibition","Target (full name):c-Jun N-terminal kinase 2","364","Weka RF classification","0.6556530280449805","Proportion","UP","5.413932121337996","0.6785714285714286","0.5294117647058824","0.36885245901639346"
"Kinase Assay","Inhibition","Target (full name):c-Jun N-terminal kinase 2","364","Weka RF on folded fp classification","0.6506232217856663","Proportion","UP","5.413932121337996","0.717032967032967","0.6233766233766234","0.39344262295081966"
"Kinase Assay","Inhibition","Target (full name):Homeodomain-interacting protein kinase 4","364","Smile Bernoulli NB classification","0.7847595425106777","Proportion","UP","5.4877400840219","0.7060439560439561","0.5317919075144508","0.7796610169491526"
"Kinase Assay","Inhibition","Target (full name):Homeodomain-interacting protein kinase 4","364","Smile SVC Poly classification","0.7831404161499225","Proportion","UP","5.4877400840219","0.695054945054945","0.8181818181818182","0.07627118644067797"
"Kinase Assay","Inhibition","Target (full name):Homeodomain-interacting protein kinase 4","364","Weka RF on folded fp classification","0.7728744660327942","Proportion","UP","5.4877400840219","0.7527472527472527","0.6707317073170732","0.4661016949152542"
"Kinase Assay","Inhibition","Target (full name):Homeodomain-interacting protein kinase 4","364","Smile SVC RBF classification","0.7664668595838496","Proportion","UP","5.4877400840219","0.75","0.7454545454545455","0.3474576271186441"
"Kinase Assay","Inhibition","Target (full name):Homeodomain-interacting protein kinase 4","364","Smile SVC Tanimoto classification","0.7660879151164381","Proportion","UP","5.4877400840219","0.7554945054945055","0.6559139784946236","0.5169491525423728"
"Kinase Assay","Inhibition","Target (full name):Homeodomain-interacting protein kinase 4","364","Weka RF classification","0.760954940057875","Proportion","UP","5.4877400840219","0.7445054945054945","0.6470588235294118","0.4661016949152542"
"Kinase Assay","Inhibition","Target (full name):Homeodomain-interacting protein kinase 1","364","Weka RF on folded fp classification","0.7990216342841394","Proportion","UP","4.117262566467382","0.771978021978022","0.7108433734939759","0.5"
"Kinase Assay","Inhibition","Target (full name):Homeodomain-interacting protein kinase 1","364","Smile Bernoulli NB classification","0.7896858205870191","Proportion","UP","4.117262566467382","0.7142857142857143","0.54375","0.7372881355932204"
"Kinase Assay","Inhibition","Target (full name):Homeodomain-interacting protein kinase 1","364","Smile SVC Poly classification","0.7742179964172514","Proportion","UP","4.117262566467382","0.6978021978021978","0.8333333333333334","0.0847457627118644"
"Kinase Assay","Inhibition","Target (full name):Homeodomain-interacting protein kinase 1","364","Smile SVC Tanimoto classification","0.7688783243764631","Proportion","UP","4.117262566467382","0.7554945054945055","0.6593406593406593","0.5084745762711864"
"Kinase Assay","Inhibition","Target (full name):Homeodomain-interacting protein kinase 1","364","Weka RF classification","0.7447809011988424","Proportion","UP","4.117262566467382","0.7417582417582418","0.6818181818181818","0.3813559322033898"
"Kinase Assay","Inhibition","Target (full name):Homeodomain-interacting protein kinase 1","364","Smile SVC RBF classification","0.7415598732258502","Proportion","UP","4.117262566467382","0.7362637362637363","0.7391304347826086","0.288135593220339"
"Kinase Assay","Inhibition","Target (full name):Glycogen synthase kinase-3 beta","364","Smile Bernoulli NB classification","0.8754680700333992","Proportion","UP","8.496613514249868","0.8021978021978022","0.673469387755102","0.8048780487804879"
"Kinase Assay","Inhibition","Target (full name):Glycogen synthase kinase-3 beta","364","Weka RF on folded fp classification","0.8747765071011709","Proportion","UP","8.496613514249868","0.8296703296703297","0.8210526315789474","0.6341463414634146"
"Kinase Assay","Inhibition","Target (full name):Glycogen synthase kinase-3 beta","364","Smile SVC Poly classification","0.856694666531728","Proportion","UP","8.496613514249868","0.739010989010989","0.85","0.2764227642276423"
"Kinase Assay","Inhibition","Target (full name):Glycogen synthase kinase-3 beta","364","Smile SVC Tanimoto classification","0.8485308504537331","Proportion","UP","8.496613514249868","0.8159340659340659","0.7692307692307693","0.6504065040650406"
"Kinase Assay","Inhibition","Target (full name):Glycogen synthase kinase-3 beta","364","Weka RF classification","0.8376345174240124","Proportion","UP","8.496613514249868","0.8186813186813187","0.7821782178217822","0.6422764227642277"
"Kinase Assay","Inhibition","Target (full name):Glycogen synthase kinase-3 beta","364","Smile SVC RBF classification","0.8229936241271134","Proportion","UP","8.496613514249868","0.7967032967032966","0.8356164383561644","0.4959349593495935"
"Kinase Assay","Inhibition","Target (full name):Glycogen synthase kinase-3 alpha","364","Smile Bernoulli NB classification","0.869706284153005","Proportion","UP","8.966682185759753","0.782967032967033","0.6357615894039735","0.8"
"Kinase Assay","Inhibition","Target (full name):Glycogen synthase kinase-3 alpha","364","Weka RF on folded fp classification","0.8695696721311473","Proportion","UP","8.966682185759753","0.8186813186813187","0.78125","0.625"
"Kinase Assay","Inhibition","Target (full name):Glycogen synthase kinase-3 alpha","364","Smile SVC Poly classification","0.8666666666666654","Proportion","UP","8.966682185759753","0.7307692307692307","0.9230769230769231","0.2"
"Kinase Assay","Inhibition","Target (full name):Glycogen synthase kinase-3 alpha","364","Smile SVC Tanimoto classification","0.8565232240437156","Proportion","UP","8.966682185759753","0.8241758241758241","0.7916666666666666","0.6333333333333333"
"Kinase Assay","Inhibition","Target (full name):Glycogen synthase kinase-3 alpha","364","Weka RF classification","0.8434426229508197","Proportion","UP","8.966682185759753","0.8021978021978022","0.75","0.6"
"Kinase Assay","Inhibition","Target (full name):Glycogen synthase kinase-3 alpha","364","Smile SVC RBF classification","0.8261612021857921","Proportion","UP","8.966682185759753","0.7912087912087912","0.8333333333333334","0.4583333333333333"
"Kinase Assay","Inhibition","Target (full name):Dual-specificity tyrosine-phosphorylation regulated kinase 2","364","Smile Bernoulli NB classification","0.7402621595989693","Proportion","UP","3.780206725122352","0.695054945054945","0.5359477124183006","0.6721311475409836"
"Kinase Assay","Inhibition","Target (full name):Dual-specificity tyrosine-phosphorylation regulated kinase 2","364","Smile SVC Tanimoto classification","0.7395339384907186","Proportion","UP","3.780206725122352","0.7307692307692307","0.6428571428571429","0.4426229508196721"
"Kinase Assay","Inhibition","Target (full name):Dual-specificity tyrosine-phosphorylation regulated kinase 2","364","Weka RF on folded fp classification","0.7248509687034271","Proportion","UP","3.780206725122352","0.7060439560439561","0.631578947368421","0.29508196721311475"
"Kinase Assay","Inhibition","Target (full name):Dual-specificity tyrosine-phosphorylation regulated kinase 2","364","Smile SVC Poly classification","0.7193131012057974","Proportion","UP","3.780206725122352","0.6868131868131868","1.0","0.06557377049180328"
"Kinase Assay","Inhibition","Target (full name):Dual-specificity tyrosine-phosphorylation regulated kinase 2","364","Smile SVC RBF classification","0.7023099850968703","Proportion","UP","3.780206725122352","0.6923076923076923","0.625","0.20491803278688525"
"Kinase Assay","Inhibition","Target (full name):Dual-specificity tyrosine-phosphorylation regulated kinase 2","364","Weka RF classification","0.6857302533532036","Proportion","UP","3.780206725122352","0.695054945054945","0.5846153846153846","0.3114754098360656"
"Kinase Assay","Inhibition","Target (full name):Dual specificity tyrosine-phosphorylation-regulated kinase 1B","364","Smile Bernoulli NB classification","0.8663097886540575","Proportion","UP","3.8926875817069124","0.7692307692307693","0.6025641025641025","0.8103448275862069"
"Kinase Assay","Inhibition","Target (full name):Dual specificity tyrosine-phosphorylation-regulated kinase 1B","364","Weka RF on folded fp classification","0.8437499999999996","Proportion","UP","3.8926875817069124","0.782967032967033","0.7228915662650602","0.5172413793103449"
"Kinase Assay","Inhibition","Target (full name):Dual specificity tyrosine-phosphorylation-regulated kinase 1B","364","Smile SVC Tanimoto classification","0.8426376529477191","Proportion","UP","3.8926875817069124","0.8021978021978022","0.7340425531914894","0.5948275862068966"
"Kinase Assay","Inhibition","Target (full name):Dual specificity tyrosine-phosphorylation-regulated kinase 1B","364","Smile SVC Poly classification","0.8383446885428251","Proportion","UP","3.8926875817069124","0.760989010989011","0.9393939393939394","0.2672413793103448"
"Kinase Assay","Inhibition","Target (full name):Dual specificity tyrosine-phosphorylation-regulated kinase 1B","364","Weka RF classification","0.7864988876529476","Proportion","UP","3.8926875817069124","0.7472527472527473","0.6463414634146342","0.45689655172413796"
"Kinase Assay","Inhibition","Target (full name):Dual specificity tyrosine-phosphorylation-regulated kinase 1B","364","Smile SVC RBF classification","0.7641824249165736","Proportion","UP","3.8926875817069124","0.75","0.6984126984126984","0.3793103448275862"
"Kinase Assay","Inhibition","Target (full name):Dual-specificity tyrosine-phosphorylation regulated kinase 1A","364","Smile SVC Tanimoto classification","0.8713151927437653","Proportion","UP","5.821394293620148","0.8324175824175825","0.7628865979381443","0.6607142857142857"
"Kinase Assay","Inhibition","Target (full name):Dual-specificity tyrosine-phosphorylation regulated kinase 1A","364","Smile Bernoulli NB classification","0.8690476190476193","Proportion","UP","5.821394293620148","0.7939560439560439","0.6312056737588653","0.7946428571428571"
"Kinase Assay","Inhibition","Target (full name):Dual-specificity tyrosine-phosphorylation regulated kinase 1A","364","Weka RF on folded fp classification","0.8603316326530623","Proportion","UP","5.821394293620148","0.7994505494505495","0.7349397590361446","0.5446428571428571"
"Kinase Assay","Inhibition","Target (full name):Dual-specificity tyrosine-phosphorylation regulated kinase 1A","364","Smile SVC Poly classification","0.8508361678004558","Proportion","UP","5.821394293620148","0.728021978021978","0.8095238095238095","0.15178571428571427"
"Kinase Assay","Inhibition","Target (full name):Dual-specificity tyrosine-phosphorylation regulated kinase 1A","364","Weka RF classification","0.8422441893424036","Proportion","UP","5.821394293620148","0.782967032967033","0.6896551724137931","0.5357142857142857"
"Kinase Assay","Inhibition","Target (full name):Dual-specificity tyrosine-phosphorylation regulated kinase 1A","364","Smile SVC RBF classification","0.8218183106575976","Proportion","UP","5.821394293620148","0.760989010989011","0.7272727272727273","0.35714285714285715"
"Kinase Assay","Inhibition","Target (full name):Dual specificity protein kinase CLK3","364","Smile Bernoulli NB classification","0.7254059717129386","Proportion","UP","2.252511235033614","0.6978021978021978","0.515527950310559","0.7217391304347827"
"Kinase Assay","Inhibition","Target (full name):Dual specificity protein kinase CLK3","364","Smile SVC Tanimoto classification","0.7221581980094284","Proportion","UP","2.252511235033614","0.717032967032967","0.575","0.4"
"Kinase Assay","Inhibition","Target (full name):Dual specificity protein kinase CLK3","364","Smile SVC Poly classification","0.7008905185961232","Proportion","UP","2.252511235033614","0.6785714285714286","0.3333333333333333","0.017391304347826087"
"Kinase Assay","Inhibition","Target (full name):Dual specificity protein kinase CLK3","364","Weka RF on folded fp classification","0.6949188056574128","Proportion","UP","2.252511235033614","0.6813186813186813","0.49056603773584906","0.22608695652173913"
"Kinase Assay","Inhibition","Target (full name):Dual specificity protein kinase CLK3","364","Weka RF classification","0.6898725336127116","Proportion","UP","2.252511235033614","0.6895604395604396","0.515625","0.28695652173913044"
"Kinase Assay","Inhibition","Target (full name):Dual specificity protein kinase CLK3","364","Smile SVC RBF classification","0.6525580583202372","Proportion","UP","2.252511235033614","0.7032967032967034","0.5945945945945946","0.19130434782608696"
"Kinase Assay","Inhibition","Target (full name):Dual specificity protein kinase CLK2","364","Weka RF on folded fp classification","0.8849547337732114","Proportion","UP","4.571720705709909","0.8296703296703297","0.8","0.4897959183673469"
"Kinase Assay","Inhibition","Target (full name):Dual specificity protein kinase CLK2","364","Smile SVC Tanimoto classification","0.8662344637102961","Proportion","UP","4.571720705709909","0.8214285714285714","0.7142857142857143","0.5612244897959183"
"Kinase Assay","Inhibition","Target (full name):Dual specificity protein kinase CLK2","364","Smile Bernoulli NB classification","0.8657933098051261","Proportion","UP","4.571720705709909","0.771978021978022","0.5503355704697986","0.8367346938775511"
"Kinase Assay","Inhibition","Target (full name):Dual specificity protein kinase CLK2","364","Smile SVC Poly classification","0.8543808500843938","Proportion","UP","4.571720705709909","0.7774725274725275","1.0","0.17346938775510204"
"Kinase Assay","Inhibition","Target (full name):Dual specificity protein kinase CLK2","364","Weka RF classification","0.8455194107718275","Proportion","UP","4.571720705709909","0.7967032967032966","0.7307692307692307","0.3877551020408163"
"Kinase Assay","Inhibition","Target (full name):Dual specificity protein kinase CLK2","364","Smile SVC RBF classification","0.8413380389749868","Proportion","UP","4.571720705709909","0.7747252747252747","0.7105263157894737","0.2755102040816326"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 6","364","Smile Bernoulli NB classification","0.820732578308334","Proportion","UP","3.3306120674132593","0.7252747252747253","0.562874251497006","0.7768595041322314"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 6","364","Weka RF on folded fp classification","0.810699588477365","Proportion","UP","3.3306120674132593","0.75","0.6595744680851063","0.512396694214876"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 6","364","Smile SVC Poly classification","0.8055980682243303","Proportion","UP","3.3306120674132593","0.7032967032967034","0.8823529411764706","0.12396694214876033"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 6","364","Smile SVC Tanimoto classification","0.7950889365030777","Proportion","UP","3.3306120674132593","0.7939560439560439","0.7254901960784313","0.6115702479338843"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 6","364","Weka RF classification","0.7813658470224126","Proportion","UP","3.3306120674132593","0.7527472527472527","0.6741573033707865","0.49586776859504134"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 6","364","Smile SVC RBF classification","0.7481549501751524","Proportion","UP","3.3306120674132593","0.7417582417582418","0.7213114754098361","0.36363636363636365"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 5","364","Smile SVC Tanimoto classification","0.8235618597320724","Proportion","UP","3.610773746397065","0.8598901098901099","0.8307692307692308","0.574468085106383"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 5","364","Weka RF on folded fp classification","0.8220055161544525","Proportion","UP","3.610773746397065","0.8434065934065934","0.8363636363636363","0.48936170212765956"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 5","364","Smile SVC Poly classification","0.8142237982663518","Proportion","UP","3.610773746397065","0.7664835164835165","0.9090909090909091","0.10638297872340426"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 5","364","Smile Bernoulli NB classification","0.8001182033096936","Proportion","UP","3.610773746397065","0.7445054945054945","0.5039370078740157","0.6808510638297872"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 5","364","Weka RF classification","0.7971631205673758","Proportion","UP","3.610773746397065","0.8131868131868132","0.7241379310344828","0.44680851063829785"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 5","364","Smile SVC RBF classification","0.7727738376674562","Proportion","UP","3.610773746397065","0.7912087912087912","0.7647058823529411","0.2765957446808511"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 4","364","Weka RF on folded fp classification","0.8202245136755888","Proportion","UP","4.536549109495855","0.8324175824175825","0.7922077922077922","0.5754716981132075"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 4","364","Smile Bernoulli NB classification","0.8170250109697225","Proportion","UP","4.536549109495855","0.7582417582417582","0.5633802816901409","0.7547169811320755"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 4","364","Smile SVC Tanimoto classification","0.8132953049583143","Proportion","UP","4.536549109495855","0.8269230769230769","0.7590361445783133","0.5943396226415094"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 4","364","Smile SVC Poly classification","0.8117961094047093","Proportion","UP","4.536549109495855","0.7225274725274725","0.7777777777777778","0.0660377358490566"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 4","364","Weka RF classification","0.8040990200380284","Proportion","UP","4.536549109495855","0.804945054945055","0.7215189873417721","0.5377358490566038"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 4","364","Smile SVC RBF classification","0.76638145385403","Proportion","UP","4.536549109495855","0.7747252747252747","0.7307692307692307","0.3584905660377358"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 3","364","Smile SVC Tanimoto classification","0.8847756219497646","Proportion","UP","2.8054374329705354","0.8543956043956044","0.7702702702702703","0.6129032258064516"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 3","364","Weka RF on folded fp classification","0.8716819426258776","Proportion","UP","2.8054374329705354","0.8379120879120879","0.7741935483870968","0.5161290322580645"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 3","364","Smile SVC Poly classification","0.8689044954965632","Proportion","UP","2.8054374329705354","0.7554945054945055","0.7","0.07526881720430108"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 3","364","Smile Bernoulli NB classification","0.8546006427806193","Proportion","UP","2.8054374329705354","0.7939560439560439","0.5703125","0.7849462365591398"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 3","364","Weka RF classification","0.8456532952426299","Proportion","UP","2.8054374329705354","0.8214285714285714","0.7258064516129032","0.4838709677419355"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 3","364","Smile SVC RBF classification","0.8001428401380771","Proportion","UP","2.8054374329705354","0.782967032967033","0.6842105263157895","0.27956989247311825"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 2","364","Weka RF on folded fp classification","0.8750999040920705","Proportion","UP","5.678666332231444","0.8461538461538461","0.78125","0.5434782608695652"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 2","364","Smile SVC Tanimoto classification","0.8732816496163689","Proportion","UP","5.678666332231444","0.8543956043956044","0.7671232876712328","0.6086956521739131"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 2","364","Smile Bernoulli NB classification","0.8565577046035802","Proportion","UP","5.678666332231444","0.782967032967033","0.5503875968992248","0.7717391304347826"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 2","364","Smile SVC Poly classification","0.8494645140664954","Proportion","UP","5.678666332231444","0.771978021978022","0.9090909090909091","0.10869565217391304"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 2","364","Weka RF classification","0.8389146419437342","Proportion","UP","5.678666332231444","0.8598901098901099","0.8059701492537313","0.5869565217391305"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 2","364","Smile SVC RBF classification","0.7804907289002566","Proportion","UP","5.678666332231444","0.8076923076923077","0.7619047619047619","0.34782608695652173"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 1","364","Weka RF on folded fp classification","0.8117231855148083","Proportion","UP","3.666269410159595","0.8489010989010989","0.8909090909090909","0.5"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 1","364","Smile SVC Poly classification","0.7943455577719821","Proportion","UP","3.666269410159595","0.7527472527472527","0.9","0.09183673469387756"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 1","364","Smile Bernoulli NB classification","0.7921014270369803","Proportion","UP","3.666269410159595","0.7225274725274725","0.48872180451127817","0.6632653061224489"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 1","364","Smile SVC Tanimoto classification","0.7880926806812965","Proportion","UP","3.666269410159595","0.8489010989010989","0.8412698412698413","0.5408163265306123"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 1","364","Weka RF classification","0.7837003222341569","Proportion","UP","3.666269410159595","0.8076923076923077","0.7333333333333333","0.4489795918367347"
"Kinase Assay","Inhibition","Target (full name):Cyclin-dependent kinase 1","364","Smile SVC RBF classification","0.7560227098358141","Proportion","UP","3.666269410159595","0.7802197802197802","0.75","0.2755102040816326"
"Kinase Assay","Inhibition","Target (full name):Casein kinase I isoform gamma-3","364","Smile Bernoulli NB classification","0.7713752167533684","Proportion","UP","3.476748980827642","0.6978021978021978","0.55","0.6984126984126984"
"Kinase Assay","Inhibition","Target (full name):Casein kinase I isoform gamma-3","364","Smile SVC Poly classification","0.7540349473122574","Proportion","UP","3.476748980827642","0.7252747252747253","0.8421052631578947","0.25396825396825395"
"Kinase Assay","Inhibition","Target (full name):Casein kinase I isoform gamma-3","364","Smile SVC Tanimoto classification","0.7500666933440053","Proportion","UP","3.476748980827642","0.739010989010989","0.6867469879518072","0.4523809523809524"
"Kinase Assay","Inhibition","Target (full name):Casein kinase I isoform gamma-3","364","Weka RF on folded fp classification","0.7312925170068018","Proportion","UP","3.476748980827642","0.7197802197802198","0.6463414634146342","0.42063492063492064"
"Kinase Assay","Inhibition","Target (full name):Casein kinase I isoform gamma-3","364","Weka RF classification","0.7176370548219286","Proportion","UP","3.476748980827642","0.6813186813186813","0.5641025641025641","0.3492063492063492"
"Kinase Assay","Inhibition","Target (full name):Casein kinase I isoform gamma-3","364","Smile SVC RBF classification","0.6973789515806329","Proportion","UP","3.476748980827642","0.7060439560439561","0.7021276595744681","0.2619047619047619"
"Kinase Assay","Inhibition","Target (full name):Casein kinase I gamma 2","364","Smile Bernoulli NB classification","0.670617816091954","Proportion","UP","3.4771319740072677","0.6043956043956044","0.46774193548387094","0.6590909090909091"
"Kinase Assay","Inhibition","Target (full name):Casein kinase I gamma 2","364","Weka RF on folded fp classification","0.6651809038662497","Proportion","UP","3.4771319740072677","0.6730769230769231","0.5942028985507246","0.3106060606060606"
"Kinase Assay","Inhibition","Target (full name):Casein kinase I gamma 2","364","Smile SVC Tanimoto classification","0.662911442006269","Proportion","UP","3.4771319740072677","0.6703296703296703","0.59375","0.2878787878787879"
"Kinase Assay","Inhibition","Target (full name):Casein kinase I gamma 2","364","Smile SVC Poly classification","0.6498497910135841","Proportion","UP","3.4771319740072677","0.6456043956043956","0.5882352941176471","0.07575757575757576"
"Kinase Assay","Inhibition","Target (full name):Casein kinase I gamma 2","364","Weka RF classification","0.6365432340647859","Proportion","UP","3.4771319740072677","0.6373626373626373","0.5","0.3333333333333333"
"Kinase Assay","Inhibition","Target (full name):Casein kinase I gamma 2","364","Smile SVC RBF classification","0.5957092476489034","Proportion","UP","3.4771319740072677","0.6181318681318682","0.4186046511627907","0.13636363636363635"
"Kinase Assay","Inhibition","Target (full name):Casein kinase I gamma 1","364","Smile Bernoulli NB classification","0.6676136363636369","Proportion","UP","3.8421518321385566","0.6098901098901099","0.47126436781609193","0.6212121212121212"
"Kinase Assay","Inhibition","Target (full name):Casein kinase I gamma 1","364","Weka RF on folded fp classification","0.6627644984326021","Proportion","UP","3.8421518321385566","0.6703296703296703","0.581081081081081","0.32575757575757575"
"Kinase Assay","Inhibition","Target (full name):Casein kinase I gamma 1","364","Smile SVC Tanimoto classification","0.6592215256008357","Proportion","UP","3.8421518321385566","0.6868131868131868","0.6285714285714286","0.3333333333333333"
"Kinase Assay","Inhibition","Target (full name):Casein kinase I gamma 1","364","Smile SVC Poly classification","0.6497844827586206","Proportion","UP","3.8421518321385566","0.6510989010989011","0.6470588235294118","0.08333333333333333"
"Kinase Assay","Inhibition","Target (full name):Casein kinase I gamma 1","364","Weka RF classification","0.6444128787878786","Proportion","UP","3.8421518321385566","0.6346153846153846","0.4943820224719101","0.3333333333333333"
"Kinase Assay","Inhibition","Target (full name):Casein kinase I gamma 1","364","Smile SVC RBF classification","0.6412291013584115","Proportion","UP","3.8421518321385566","0.6373626373626373","0.5","0.18181818181818182"
"Kinase Assay","Inhibition","Target (full name):Casein kinase I alpha","364","Smile Bernoulli NB classification","0.7793762541237287","Proportion","UP","5.246340469289376","0.7335164835164835","0.5895522388059702","0.6528925619834711"
"Kinase Assay","Inhibition","Target (full name):Casein kinase I alpha","364","Smile SVC Poly classification","0.7465564738292005","Proportion","UP","5.246340469289376","0.739010989010989","0.825","0.2727272727272727"
"Kinase Assay","Inhibition","Target (full name):Casein kinase I alpha","364","Smile SVC Tanimoto classification","0.7442437846478245","Proportion","UP","5.246340469289376","0.760989010989011","0.6931818181818182","0.5041322314049587"
"Kinase Assay","Inhibition","Target (full name):Casein kinase I alpha","364","Weka RF on folded fp classification","0.7230724755977276","Proportion","UP","5.246340469289376","0.7664835164835165","0.7571428571428571","0.4380165289256198"
"Kinase Assay","Inhibition","Target (full name):Casein kinase I alpha","364","Weka RF classification","0.7126823793490461","Proportion","UP","5.246340469289376","0.7362637362637363","0.6506024096385542","0.4462809917355372"
"Kinase Assay","Inhibition","Target (full name):Casein kinase I alpha","364","Smile SVC RBF classification","0.6852702105227351","Proportion","UP","5.246340469289376","0.6923076923076923","0.6046511627906976","0.21487603305785125"
"Kinase Assay","Inhibition","Target (full name):Testis-specific serine/threonine-protein kinase 2","364","Smile SVC Tanimoto classification","0.558218183327108","Proportion","UP","2.678010986237145","0.7939560439560439","0.8333333333333334","0.1724137931034483"
"Kinase Assay","Inhibition","Target (full name):Testis-specific serine/threonine-protein kinase 2","364","Weka RF classification","0.5550022822523756","Proportion","UP","2.678010986237145","0.7664835164835165","0.53125","0.19540229885057472"
"Kinase Assay","Inhibition","Target (full name):Testis-specific serine/threonine-protein kinase 2","364","Smile SVC RBF classification","0.5540271380555207","Proportion","UP","2.678010986237145","0.7692307692307693","0.6363636363636364","0.08045977011494253"
"Kinase Assay","Inhibition","Target (full name):Testis-specific serine/threonine-protein kinase 2","364","Smile SVC Poly classification","0.5480932818789161","Proportion","UP","2.678010986237145","0.7994505494505495","1.0","0.16091954022988506"
"Kinase Assay","Inhibition","Target (full name):Testis-specific serine/threonine-protein kinase 2","364","Smile Bernoulli NB classification","0.5422631644466572","Proportion","UP","2.678010986237145","0.5247252747252747","0.26881720430107525","0.5747126436781609"
"Kinase Assay","Inhibition","Target (full name):Testis-specific serine/threonine-protein kinase 2","364","Weka RF on folded fp classification","0.5342752811319973","Proportion","UP","2.678010986237145","0.782967032967033","0.6666666666666666","0.1839080459770115"
"Kinase Assay","Inhibition","Target (full name):Testis-specific serine/threonine-protein kinase 1","364","Weka RF classification","0.764102861114329","Proportion","UP","4.920164371506299","0.804945054945055","0.782608695652174","0.3711340206185567"
"Kinase Assay","Inhibition","Target (full name):Testis-specific serine/threonine-protein kinase 1","364","Smile SVC RBF classification","0.7472103170006578","Proportion","UP","4.920164371506299","0.7857142857142857","0.88","0.2268041237113402"
"Kinase Assay","Inhibition","Target (full name):Testis-specific serine/threonine-protein kinase 1","364","Weka RF on folded fp classification","0.7399513494729529","Proportion","UP","4.920164371506299","0.8159340659340659","0.8125","0.4020618556701031"
"Kinase Assay","Inhibition","Target (full name):Testis-specific serine/threonine-protein kinase 1","364","Smile SVC Poly classification","0.7338893393567326","Proportion","UP","4.920164371506299","0.7967032967032966","1.0","0.23711340206185566"
"Kinase Assay","Inhibition","Target (full name):Testis-specific serine/threonine-protein kinase 1","364","Smile Bernoulli NB classification","0.7290628981813969","Proportion","UP","4.920164371506299","0.6785714285714286","0.43506493506493504","0.6907216494845361"
"Kinase Assay","Inhibition","Target (full name):Testis-specific serine/threonine-protein kinase 1","364","Smile SVC Tanimoto classification","0.7216494845360827","Proportion","UP","4.920164371506299","0.7939560439560439","0.75","0.3402061855670103"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase TBK1","364","Smile Bernoulli NB classification","0.8337718854366967","Proportion","UP","4.662139620200089","0.7637362637362637","0.6045197740112994","0.8699186991869918"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase TBK1","364","Weka RF on folded fp classification","0.8336706811051501","Proportion","UP","4.662139620200089","0.739010989010989","0.6521739130434783","0.4878048780487805"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase TBK1","364","Smile SVC Tanimoto classification","0.8267719191714735","Proportion","UP","4.662139620200089","0.7664835164835165","0.6610169491525424","0.6341463414634146"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase TBK1","364","Smile SVC Poly classification","0.8156394427014799","Proportion","UP","4.662139620200089","0.6620879120879121","0.5","0.04878048780487805"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase TBK1","364","Weka RF classification","0.8004756603582635","Proportion","UP","4.662139620200089","0.7472527472527473","0.6448598130841121","0.5609756097560976"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase TBK1","364","Smile SVC RBF classification","0.7860203083358628","Proportion","UP","4.662139620200089","0.7362637362637363","0.7014925373134329","0.3821138211382114"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase SIK2","364","Weka RF classification","0.7435447563559321","Proportion","UP","7.713482038154943","0.7005494505494505","0.6043956043956044","0.4296875"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase SIK2","364","Smile SVC Tanimoto classification","0.7312963453389836","Proportion","UP","7.713482038154943","0.7060439560439561","0.6329113924050633","0.390625"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase SIK2","364","Smile SVC RBF classification","0.6983911546610169","Proportion","UP","7.713482038154943","0.6895604395604396","0.6470588235294118","0.2578125"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase SIK2","364","Smile Bernoulli NB classification","0.6934917902542371","Proportion","UP","7.713482038154943","0.6483516483516484","0.5","0.640625"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase SIK2","364","Weka RF on folded fp classification","0.6871689618644078","Proportion","UP","7.713482038154943","0.6895604395604396","0.6153846153846154","0.3125"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase SIK2","364","Smile SVC Poly classification","0.6826999470338986","Proportion","UP","7.713482038154943","0.6593406593406593","0.6666666666666666","0.0625"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase SIK1","364","Weka RF classification","0.7856642657062827","Proportion","UP","7.654132099122242","0.7664835164835165","0.7252747252747253","0.5238095238095238"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase SIK1","364","Smile Bernoulli NB classification","0.7555522208883562","Proportion","UP","7.654132099122242","0.7142857142857143","0.5733333333333334","0.6825396825396826"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase SIK1","364","Smile SVC Tanimoto classification","0.7544684540482856","Proportion","UP","7.654132099122242","0.7417582417582418","0.6739130434782609","0.49206349206349204"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase SIK1","364","Smile SVC Poly classification","0.750833666800054","Proportion","UP","7.654132099122242","0.6648351648351648","0.6428571428571429","0.07142857142857142"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase SIK1","364","Weka RF on folded fp classification","0.7495664932639714","Proportion","UP","7.654132099122242","0.75","0.7058823529411765","0.47619047619047616"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase SIK1","364","Smile SVC RBF classification","0.7368614112311587","Proportion","UP","7.654132099122242","0.7115384615384616","0.6615384615384615","0.3412698412698413"
"Kinase Assay","Inhibition","Target (full name):MAP kinase-activated protein kinase 5","364","Smile SVC RBF classification","0.546890978063665","Proportion","UP","1.388977593762768","0.6373626373626373","0.46153846153846156","0.13953488372093023"
"Kinase Assay","Inhibition","Target (full name):MAP kinase-activated protein kinase 5","364","Weka RF classification","0.5419759195117927","Proportion","UP","1.388977593762768","0.6236263736263736","0.4411764705882353","0.23255813953488372"
"Kinase Assay","Inhibition","Target (full name):MAP kinase-activated protein kinase 5","364","Smile SVC Poly classification","0.5409203364670957","Proportion","UP","1.388977593762768","0.6401098901098901","0.25","0.007751937984496124"
"Kinase Assay","Inhibition","Target (full name):MAP kinase-activated protein kinase 5","364","Smile SVC Tanimoto classification","0.5335642421243607","Proportion","UP","1.388977593762768","0.6456043956043956","0.5","0.16279069767441862"
"Kinase Assay","Inhibition","Target (full name):MAP kinase-activated protein kinase 5","364","Smile Bernoulli NB classification","0.5298367144977735","Proportion","UP","1.388977593762768","0.521978021978022","0.3728813559322034","0.5116279069767442"
"Kinase Assay","Inhibition","Target (full name):MAP kinase-activated protein kinase 5","364","Weka RF on folded fp classification","0.5192478970806529","Proportion","UP","1.388977593762768","0.6098901098901099","0.40298507462686567","0.20930232558139536"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PIM3","364","Smile SVC Tanimoto classification","0.7431972789115653","Proportion","UP","2.2273974308469455","0.7527472527472527","0.6410256410256411","0.44642857142857145"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PIM3","364","Smile SVC Poly classification","0.7354733560090708","Proportion","UP","2.2273974308469455","0.7032967032967034","0.7","0.0625"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PIM3","364","Weka RF on folded fp classification","0.7165178571428583","Proportion","UP","2.2273974308469455","0.7307692307692307","0.6","0.375"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PIM3","364","Smile Bernoulli NB classification","0.7062251984126984","Proportion","UP","2.2273974308469455","0.6868131868131868","0.4934210526315789","0.6696428571428571"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PIM3","364","Smile SVC RBF classification","0.6713789682539675","Proportion","UP","2.2273974308469455","0.6923076923076923","0.5","0.16071428571428573"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PIM3","364","Weka RF classification","0.6712195294784583","Proportion","UP","2.2273974308469455","0.7307692307692307","0.6166666666666667","0.33035714285714285"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PIM2","364","Smile SVC Tanimoto classification","0.7261649580615098","Proportion","UP","1.0987559669920248","0.7994505494505495","0.5135135135135135","0.25675675675675674"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PIM2","364","Weka RF classification","0.7165191053122089","Proportion","UP","1.0987559669920248","0.8076923076923077","0.5666666666666667","0.22972972972972974"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PIM2","364","Smile Bernoulli NB classification","0.7101351351351369","Proportion","UP","1.0987559669920248","0.5961538461538461","0.28402366863905326","0.6486486486486487"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PIM2","364","Smile SVC Poly classification","0.7082712022367186","Proportion","UP","1.0987559669920248","0.7967032967032966","NaN","0.0"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PIM2","364","Weka RF on folded fp classification","0.7082479030754886","Proportion","UP","1.0987559669920248","0.7939560439560439","0.4838709677419355","0.20270270270270271"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PIM2","364","Smile SVC RBF classification","0.6958760484622535","Proportion","UP","1.0987559669920248","0.804945054945055","0.6363636363636364","0.0945945945945946"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PIM1","364","Smile SVC Tanimoto classification","0.8582572298325738","Proportion","UP","2.402598553607838","0.8626373626373627","0.7391304347826086","0.4722222222222222"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PIM1","364","Smile SVC Poly classification","0.8425608828006118","Proportion","UP","2.402598553607838","0.8021978021978022","NaN","0.0"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PIM1","364","Weka RF on folded fp classification","0.8360920852359212","Proportion","UP","2.402598553607838","0.8543956043956044","0.7317073170731707","0.4166666666666667"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PIM1","364","Smile Bernoulli NB classification","0.818017503805174","Proportion","UP","2.402598553607838","0.7197802197802198","0.3972602739726027","0.8055555555555556"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PIM1","364","Weka RF classification","0.7931887366818874","Proportion","UP","2.402598553607838","0.8379120879120879","0.7096774193548387","0.3055555555555556"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PIM1","364","Smile SVC RBF classification","0.7680270167427694","Proportion","UP","2.402598553607838","0.8159340659340659","0.6923076923076923","0.125"
"Kinase Assay","Inhibition","Target (full name):Phosphorylase kinase gamma subunit 2","364","Smile Bernoulli NB classification","0.6157955292570679","Proportion","UP","4.615722685543966","0.5989010989010989","0.45604395604395603","0.6384615384615384"
"Kinase Assay","Inhibition","Target (full name):Phosphorylase kinase gamma subunit 2","364","Smile SVC RBF classification","0.6134451019066399","Proportion","UP","4.615722685543966","0.6620879120879121","0.5686274509803921","0.2230769230769231"
"Kinase Assay","Inhibition","Target (full name):Phosphorylase kinase gamma subunit 2","364","Smile SVC Poly classification","0.6052268244575941","Proportion","UP","4.615722685543966","0.6401098901098901","0.3333333333333333","0.007692307692307693"
"Kinase Assay","Inhibition","Target (full name):Phosphorylase kinase gamma subunit 2","364","Weka RF on folded fp classification","0.5970414201183427","Proportion","UP","4.615722685543966","0.6153846153846154","0.42857142857142855","0.23076923076923078"
"Kinase Assay","Inhibition","Target (full name):Phosphorylase kinase gamma subunit 2","364","Weka RF classification","0.5858481262327416","Proportion","UP","4.615722685543966","0.6318681318681318","0.47619047619047616","0.3076923076923077"
"Kinase Assay","Inhibition","Target (full name):Phosphorylase kinase gamma subunit 2","364","Smile SVC Tanimoto classification","0.5756081525312294","Proportion","UP","4.615722685543966","0.6208791208791209","0.44871794871794873","0.2692307692307692"
"Kinase Assay","Inhibition","Target (full name):Phosphorylase kinase gamma subunit 1","364","Smile SVC Tanimoto classification","0.7281651654690816","Proportion","UP","5.711691742358716","0.771978021978022","0.7272727272727273","0.5203252032520326"
"Kinase Assay","Inhibition","Target (full name):Phosphorylase kinase gamma subunit 1","364","Smile SVC Poly classification","0.7049893735451884","Proportion","UP","5.711691742358716","0.6813186813186813","0.7692307692307693","0.08130081300813008"
"Kinase Assay","Inhibition","Target (full name):Phosphorylase kinase gamma subunit 1","364","Smile Bernoulli NB classification","0.7003845764598723","Proportion","UP","5.711691742358716","0.7032967032967034","0.5517241379310345","0.6504065040650406"
"Kinase Assay","Inhibition","Target (full name):Phosphorylase kinase gamma subunit 1","364","Weka RF on folded fp classification","0.6970279661302842","Proportion","UP","5.711691742358716","0.7417582417582418","0.6933333333333334","0.42276422764227645"
"Kinase Assay","Inhibition","Target (full name):Phosphorylase kinase gamma subunit 1","364","Smile SVC RBF classification","0.6867388590898355","Proportion","UP","5.711691742358716","0.7032967032967034","0.6470588235294118","0.2682926829268293"
"Kinase Assay","Inhibition","Target (full name):Phosphorylase kinase gamma subunit 1","364","Weka RF classification","0.6840906790810646","Proportion","UP","5.711691742358716","0.7032967032967034","0.6","0.36585365853658536"
"Kinase Assay","Inhibition","Target (full name):PAS domain-containing serine/threonine-protein kinase","364","Smile SVC Poly classification","0.6152729671779655","Proportion","UP","0.6158820331875399","0.6510989010989011","0.6666666666666666","0.031007751937984496"
"Kinase Assay","Inhibition","Target (full name):PAS domain-containing serine/threonine-protein kinase","364","Weka RF classification","0.5996536368134588","Proportion","UP","0.6158820331875399","0.6346153846153846","0.47297297297297297","0.2713178294573643"
"Kinase Assay","Inhibition","Target (full name):PAS domain-containing serine/threonine-protein kinase","364","Smile SVC RBF classification","0.5968332508659083","Proportion","UP","0.6158820331875399","0.6620879120879121","0.5714285714285714","0.18604651162790697"
"Kinase Assay","Inhibition","Target (full name):PAS domain-containing serine/threonine-protein kinase","364","Weka RF on folded fp classification","0.5842652152399808","Proportion","UP","0.6158820331875399","0.6208791208791209","0.44155844155844154","0.26356589147286824"
"Kinase Assay","Inhibition","Target (full name):PAS domain-containing serine/threonine-protein kinase","364","Smile SVC Tanimoto classification","0.5752927593600532","Proportion","UP","0.6158820331875399","0.6318681318681318","0.45454545454545453","0.1937984496124031"
"Kinase Assay","Inhibition","Target (full name):PAS domain-containing serine/threonine-protein kinase","364","Smile Bernoulli NB classification","0.569816922315685","Proportion","UP","0.6158820331875399","0.5274725274725275","0.37714285714285717","0.5116279069767442"
"Kinase Assay","Inhibition","Target (full name):MAP/microtubule affinity-regulating kinase 2","364","Smile Bernoulli NB classification","0.7316984149054506","Proportion","UP","2.3855057080804114","0.6978021978021978","0.5197368421052632","0.6810344827586207"
"Kinase Assay","Inhibition","Target (full name):MAP/microtubule affinity-regulating kinase 2","364","Weka RF classification","0.7297865684093436","Proportion","UP","2.3855057080804114","0.7335164835164835","0.6144578313253012","0.4396551724137931"
"Kinase Assay","Inhibition","Target (full name):MAP/microtubule affinity-regulating kinase 2","364","Smile SVC Tanimoto classification","0.7289696885428236","Proportion","UP","2.3855057080804114","0.717032967032967","0.5970149253731343","0.3448275862068966"
"Kinase Assay","Inhibition","Target (full name):MAP/microtubule affinity-regulating kinase 2","364","Smile SVC Poly classification","0.7256326473859838","Proportion","UP","2.3855057080804114","0.7060439560439561","1.0","0.07758620689655173"
"Kinase Assay","Inhibition","Target (full name):MAP/microtubule affinity-regulating kinase 2","364","Weka RF on folded fp classification","0.724276974416018","Proportion","UP","2.3855057080804114","0.7307692307692307","0.625","0.3879310344827586"
"Kinase Assay","Inhibition","Target (full name):MAP/microtubule affinity-regulating kinase 2","364","Smile SVC RBF classification","0.7207661290322577","Proportion","UP","2.3855057080804114","0.7472527472527473","0.8157894736842105","0.2672413793103448"
"Kinase Assay","Inhibition","Target (full name):MAP kinase signal-integrating kinase 2","364","Smile SVC Poly classification","0.7034143801061099","Proportion","UP","4.9160922419269415","0.6208791208791209","0.2727272727272727","0.022556390977443608"
"Kinase Assay","Inhibition","Target (full name):MAP kinase signal-integrating kinase 2","364","Smile SVC Tanimoto classification","0.7026332063926048","Proportion","UP","4.9160922419269415","0.6703296703296703","0.5656565656565656","0.42105263157894735"
"Kinase Assay","Inhibition","Target (full name):MAP kinase signal-integrating kinase 2","364","Smile Bernoulli NB classification","0.698401848777788","Proportion","UP","4.9160922419269415","0.6428571428571429","0.5087719298245614","0.6541353383458647"
"Kinase Assay","Inhibition","Target (full name):MAP kinase signal-integrating kinase 2","364","Weka RF on folded fp classification","0.683722292744849","Proportion","UP","4.9160922419269415","0.6483516483516484","0.5301204819277109","0.3308270676691729"
"Kinase Assay","Inhibition","Target (full name):MAP kinase signal-integrating kinase 2","364","Smile SVC RBF classification","0.6540376916316767","Proportion","UP","4.9160922419269415","0.6373626373626373","0.5102040816326531","0.18796992481203006"
"Kinase Assay","Inhibition","Target (full name):MAP kinase signal-integrating kinase 2","364","Weka RF classification","0.6506688799921884","Proportion","UP","4.9160922419269415","0.6373626373626373","0.5061728395061729","0.3082706766917293"
"Kinase Assay","Inhibition","Target (full name):MAP kinase-interacting serine/threonine-protein kinase MNK1","364","Smile SVC Tanimoto classification","0.7297428432799621","Proportion","UP","6.014947783208644","0.7005494505494505","0.6382978723404256","0.4444444444444444"
"Kinase Assay","Inhibition","Target (full name):MAP kinase-interacting serine/threonine-protein kinase MNK1","364","Smile SVC Poly classification","0.7043829856056936","Proportion","UP","6.014947783208644","0.6483516483516484","0.8888888888888888","0.05925925925925926"
"Kinase Assay","Inhibition","Target (full name):MAP kinase-interacting serine/threonine-protein kinase MNK1","364","Weka RF on folded fp classification","0.7016011644832609","Proportion","UP","6.014947783208644","0.695054945054945","0.6333333333333333","0.4222222222222222"
"Kinase Assay","Inhibition","Target (full name):MAP kinase-interacting serine/threonine-protein kinase MNK1","364","Smile Bernoulli NB classification","0.6941290635613774","Proportion","UP","6.014947783208644","0.6236263736263736","0.4943181818181818","0.6444444444444445"
"Kinase Assay","Inhibition","Target (full name):MAP kinase-interacting serine/threonine-protein kinase MNK1","364","Smile SVC RBF classification","0.6731360181141847","Proportion","UP","6.014947783208644","0.6675824175824175","0.6129032258064516","0.2814814814814815"
"Kinase Assay","Inhibition","Target (full name):MAP kinase-interacting serine/threonine-protein kinase MNK1","364","Weka RF classification","0.655054180818373","Proportion","UP","6.014947783208644","0.6565934065934066","0.5520833333333334","0.3925925925925926"
"Kinase Assay","Inhibition","Target (full name):Maternal embryonic leucine zipper kinase","364","Smile Bernoulli NB classification","0.7715983263598333","Proportion","UP","6.404142158670698","0.6978021978021978","0.546583850931677","0.704"
"Kinase Assay","Inhibition","Target (full name):Maternal embryonic leucine zipper kinase","364","Smile SVC Tanimoto classification","0.7638158995815904","Proportion","UP","6.404142158670698","0.7912087912087912","0.7752808988764045","0.552"
"Kinase Assay","Inhibition","Target (full name):Maternal embryonic leucine zipper kinase","364","Weka RF on folded fp classification","0.7567029288702926","Proportion","UP","6.404142158670698","0.7747252747252747","0.7471264367816092","0.52"
"Kinase Assay","Inhibition","Target (full name):Maternal embryonic leucine zipper kinase","364","Smile SVC Poly classification","0.7555481171548111","Proportion","UP","6.404142158670698","0.6840659340659341","0.8125","0.104"
"Kinase Assay","Inhibition","Target (full name):Maternal embryonic leucine zipper kinase","364","Weka RF classification","0.737991631799163","Proportion","UP","6.404142158670698","0.728021978021978","0.6547619047619048","0.44"
"Kinase Assay","Inhibition","Target (full name):Maternal embryonic leucine zipper kinase","364","Smile SVC RBF classification","0.722543933054393","Proportion","UP","6.404142158670698","0.7005494505494505","0.6904761904761905","0.232"
"Kinase Assay","Inhibition","Target (full name):MAP/microtubule affinity-regulating kinase 4","364","Smile Bernoulli NB classification","0.7736146541950112","Proportion","UP","3.2074180550946583","0.7142857142857143","0.5266666666666666","0.7053571428571429"
"Kinase Assay","Inhibition","Target (full name):MAP/microtubule affinity-regulating kinase 4","364","Weka RF on folded fp classification","0.766156462585036","Proportion","UP","3.2074180550946583","0.75","0.647887323943662","0.4107142857142857"
"Kinase Assay","Inhibition","Target (full name):MAP/microtubule affinity-regulating kinase 4","364","Weka RF classification","0.764296343537415","Proportion","UP","3.2074180550946583","0.7445054945054945","0.6233766233766234","0.42857142857142855"
"Kinase Assay","Inhibition","Target (full name):MAP/microtubule affinity-regulating kinase 4","364","Smile SVC Tanimoto classification","0.763818027210884","Proportion","UP","3.2074180550946583","0.7747252747252747","0.7083333333333334","0.45535714285714285"
"Kinase Assay","Inhibition","Target (full name):MAP/microtubule affinity-regulating kinase 4","364","Smile SVC Poly classification","0.7463151927437653","Proportion","UP","3.2074180550946583","0.7060439560439561","0.8571428571428571","0.05357142857142857"
"Kinase Assay","Inhibition","Target (full name):MAP/microtubule affinity-regulating kinase 4","364","Smile SVC RBF classification","0.7120181405895695","Proportion","UP","3.2074180550946583","0.7472527472527473","0.6851851851851852","0.33035714285714285"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase c-TAK1","364","Weka RF classification","0.7040598290598293","Proportion","UP","4.850271967633936","0.6895604395604396","0.5913978494623656","0.4230769230769231"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase c-TAK1","364","Smile SVC Tanimoto classification","0.6756410256410252","Proportion","UP","4.850271967633936","0.6785714285714286","0.589041095890411","0.33076923076923076"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase c-TAK1","364","Smile Bernoulli NB classification","0.6739809335963175","Proportion","UP","4.850271967633936","0.6483516483516484","0.5064935064935064","0.6"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase c-TAK1","364","Smile SVC Poly classification","0.6679158448389214","Proportion","UP","4.850271967633936","0.6620879120879121","1.0","0.05384615384615385"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase c-TAK1","364","Weka RF on folded fp classification","0.6584648257725184","Proportion","UP","4.850271967633936","0.6675824175824175","0.5692307692307692","0.2846153846153846"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase c-TAK1","364","Smile SVC RBF classification","0.6523339907955287","Proportion","UP","4.850271967633936","0.6510989010989011","0.5306122448979592","0.2"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MARK1","364","Weka RF classification","0.7578426521523997","Proportion","UP","4.70872542370379","0.7087912087912088","0.6352941176470588","0.4186046511627907"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MARK1","364","Smile SVC Tanimoto classification","0.7311891802737929","Proportion","UP","4.70872542370379","0.7060439560439561","0.6145833333333334","0.4573643410852713"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MARK1","364","Smile Bernoulli NB classification","0.7286326900874163","Proportion","UP","4.70872542370379","0.6648351648351648","0.5220125786163522","0.6434108527131783"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MARK1","364","Smile SVC Poly classification","0.7202704931552045","Proportion","UP","4.70872542370379","0.6703296703296703","0.8","0.09302325581395349"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MARK1","364","Weka RF on folded fp classification","0.7150915388421571","Proportion","UP","4.70872542370379","0.6895604395604396","0.6025641025641025","0.3643410852713178"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MARK1","364","Smile SVC RBF classification","0.7028203859475519","Proportion","UP","4.70872542370379","0.6648351648351648","0.5636363636363636","0.24031007751937986"
"Kinase Assay","Inhibition","Target (full name):MAP kinase-activated protein kinase 3","364","Smile SVC Tanimoto classification","0.8104780217926653","Proportion","UP","5.274635335515647","0.7967032967032966","0.810126582278481","0.5203252032520326"
"Kinase Assay","Inhibition","Target (full name):MAP kinase-activated protein kinase 3","364","Smile Bernoulli NB classification","0.8033599838073069","Proportion","UP","5.274635335515647","0.728021978021978","0.573170731707317","0.7642276422764228"
"Kinase Assay","Inhibition","Target (full name):MAP kinase-activated protein kinase 3","364","Smile SVC Poly classification","0.7983503693958108","Proportion","UP","5.274635335515647","0.7445054945054945","0.96875","0.25203252032520324"
"Kinase Assay","Inhibition","Target (full name):MAP kinase-activated protein kinase 3","364","Weka RF on folded fp classification","0.7944708700199036","Proportion","UP","5.274635335515647","0.782967032967033","0.7619047619047619","0.5203252032520326"
"Kinase Assay","Inhibition","Target (full name):MAP kinase-activated protein kinase 3","364","Weka RF classification","0.758054178052154","Proportion","UP","5.274635335515647","0.7554945054945055","0.67","0.5447154471544715"
"Kinase Assay","Inhibition","Target (full name):MAP kinase-activated protein kinase 3","364","Smile SVC RBF classification","0.7402084809229834","Proportion","UP","5.274635335515647","0.739010989010989","0.7916666666666666","0.3089430894308943"
"Kinase Assay","Inhibition","Target (full name):MAP kinase-activated protein kinase 2","364","Smile SVC RBF classification","0.5751021628625536","Proportion","UP","1.6997157807807861","0.6620879120879121","0.5714285714285714","0.12598425196850394"
"Kinase Assay","Inhibition","Target (full name):MAP kinase-activated protein kinase 2","364","Weka RF classification","0.5337386624140334","Proportion","UP","1.6997157807807861","0.5906593406593407","0.34285714285714286","0.1889763779527559"
"Kinase Assay","Inhibition","Target (full name):MAP kinase-activated protein kinase 2","364","Smile Bernoulli NB classification","0.5062792783813417","Proportion","UP","1.6997157807807861","0.5192307692307693","0.35542168674698793","0.4645669291338583"
"Kinase Assay","Inhibition","Target (full name):MAP kinase-activated protein kinase 2","364","Smile SVC Poly classification","0.49446825475929446","Proportion","UP","1.6997157807807861","0.6510989010989011","NaN","0.0"
"Kinase Assay","Inhibition","Target (full name):MAP kinase-activated protein kinase 2","364","Smile SVC Tanimoto classification","0.4838034486195556","Proportion","UP","1.6997157807807861","0.6263736263736264","0.37142857142857144","0.10236220472440945"
"Kinase Assay","Inhibition","Target (full name):MAP kinase-activated protein kinase 2","364","Weka RF on folded fp classification","0.4583873218379349","Proportion","UP","1.6997157807807861","0.6181318681318682","0.35714285714285715","0.11811023622047244"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase DCLK2","364","Smile SVC RBF classification","0.557534662483555","Proportion","UP","1.2841508837471611","0.6401098901098901","0.375","0.0975609756097561"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase DCLK2","364","Smile Bernoulli NB classification","0.5355901899267959","Proportion","UP","1.2841508837471611","0.5384615384615384","0.3770491803278688","0.5609756097560976"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase DCLK2","364","Smile SVC Tanimoto classification","0.5293323887595727","Proportion","UP","1.2841508837471611","0.6263736263736264","0.3488372093023256","0.12195121951219512"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase DCLK2","364","Smile SVC Poly classification","0.527443241237392","Proportion","UP","1.2841508837471611","0.6620879120879121","NaN","0.0"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase DCLK2","364","Weka RF on folded fp classification","0.5136963195358092","Proportion","UP","1.2841508837471611","0.6153846153846154","0.33962264150943394","0.14634146341463414"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase DCLK2","364","Weka RF classification","0.5095806767196304","Proportion","UP","1.2841508837471611","0.5906593406593407","0.32432432432432434","0.1951219512195122"
"Kinase Assay","Inhibition","Target (full name):Death-associated protein kinase 1","364","Smile SVC RBF classification","0.5658914728682171","Proportion","UP","3.8059320764880464","0.6401098901098901","0.4722222222222222","0.13178294573643412"
"Kinase Assay","Inhibition","Target (full name):Death-associated protein kinase 1","364","Smile Bernoulli NB classification","0.5249381494309747","Proportion","UP","3.8059320764880464","0.5192307692307693","0.367816091954023","0.49612403100775193"
"Kinase Assay","Inhibition","Target (full name):Death-associated protein kinase 1","364","Weka RF classification","0.5145472538347353","Proportion","UP","3.8059320764880464","0.5906593406593407","0.3717948717948718","0.2248062015503876"
"Kinase Assay","Inhibition","Target (full name):Death-associated protein kinase 1","364","Smile SVC Poly classification","0.5139369948870195","Proportion","UP","3.8059320764880464","0.6456043956043956","NaN","0.0"
"Kinase Assay","Inhibition","Target (full name):Death-associated protein kinase 1","364","Smile SVC Tanimoto classification","0.5093188190664688","Proportion","UP","3.8059320764880464","0.6428571428571429","0.4878048780487805","0.15503875968992248"
"Kinase Assay","Inhibition","Target (full name):Death-associated protein kinase 1","364","Weka RF on folded fp classification","0.4910770245752929","Proportion","UP","3.8059320764880464","0.6181318681318682","0.391304347826087","0.13953488372093023"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Chk2","364","Smile SVC Poly classification","0.7066679956144729","Proportion","UP","4.378544005134113","0.6785714285714286","0.7272727272727273","0.12598425196850394"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Chk2","364","Smile Bernoulli NB classification","0.6993753945313804","Proportion","UP","4.378544005134113","0.6346153846153846","0.48125","0.6062992125984252"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Chk2","364","Weka RF on folded fp classification","0.6993255589886709","Proportion","UP","4.378544005134113","0.6978021978021978","0.6231884057971014","0.33858267716535434"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Chk2","364","Smile SVC Tanimoto classification","0.6728462739625899","Proportion","UP","4.378544005134113","0.7225274725274725","0.696969696969697","0.36220472440944884"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Chk2","364","Smile SVC RBF classification","0.6475630419615269","Proportion","UP","4.378544005134113","0.6758241758241759","0.6216216216216216","0.18110236220472442"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Chk2","364","Weka RF classification","0.6470480746868665","Proportion","UP","4.378544005134113","0.6813186813186813","0.5662650602409639","0.3700787401574803"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Chk1","364","Smile SVC RBF classification","0.5813514151739031","Proportion","UP","3.665163220602448","0.6510989010989011","0.4411764705882353","0.12195121951219512"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Chk1","364","Weka RF classification","0.556590088722464","Proportion","UP","3.665163220602448","0.6098901098901099","0.36619718309859156","0.21138211382113822"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Chk1","364","Smile Bernoulli NB classification","0.5357588638127044","Proportion","UP","3.665163220602448","0.5054945054945055","0.3352601156069364","0.4715447154471545"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Chk1","364","Smile SVC Tanimoto classification","0.5283203454441181","Proportion","UP","3.665163220602448","0.6675824175824175","0.525","0.17073170731707318"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Chk1","364","Smile SVC Poly classification","0.5244071112910298","Proportion","UP","3.665163220602448","0.6620879120879121","NaN","0.0"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Chk1","364","Weka RF on folded fp classification","0.5102385048746754","Proportion","UP","3.665163220602448","0.6291208791208791","0.35","0.11382113821138211"
"Kinase Assay","Inhibition","Target (full name):CaM kinase IV","364","Weka RF on folded fp classification","0.5871807795698927","Proportion","UP","1.0030800484936142","0.6730769230769231","0.5531914893617021","0.20967741935483872"
"Kinase Assay","Inhibition","Target (full name):CaM kinase IV","364","Smile SVC Poly classification","0.5807627688172039","Proportion","UP","1.0030800484936142","0.6813186813186813","0.8333333333333334","0.08064516129032258"
"Kinase Assay","Inhibition","Target (full name):CaM kinase IV","364","Smile Bernoulli NB classification","0.5750840053763444","Proportion","UP","1.0030800484936142","0.5467032967032966","0.384180790960452","0.5483870967741935"
"Kinase Assay","Inhibition","Target (full name):CaM kinase IV","364","Smile SVC RBF classification","0.5638944892473118","Proportion","UP","1.0030800484936142","0.6620879120879121","0.5161290322580645","0.12903225806451613"
"Kinase Assay","Inhibition","Target (full name):CaM kinase IV","364","Smile SVC Tanimoto classification","0.5488407258064513","Proportion","UP","1.0030800484936142","0.6648351648351648","0.525","0.1693548387096774"
"Kinase Assay","Inhibition","Target (full name):CaM kinase IV","364","Weka RF classification","0.5239415322580648","Proportion","UP","1.0030800484936142","0.6346153846153846","0.4262295081967213","0.20967741935483872"
"Kinase Assay","Inhibition","Target (full name):CaM kinase II delta","364","Smile SVC Poly classification","0.7039360434322036","Proportion","UP","4.269720383454736","0.6813186813186813","0.9285714285714286","0.1015625"
"Kinase Assay","Inhibition","Target (full name):CaM kinase II delta","364","Weka RF on folded fp classification","0.7028270656779657","Proportion","UP","4.269720383454736","0.6978021978021978","0.6216216216216216","0.359375"
"Kinase Assay","Inhibition","Target (full name):CaM kinase II delta","364","Smile Bernoulli NB classification","0.7014367055084737","Proportion","UP","4.269720383454736","0.6813186813186813","0.5370370370370371","0.6796875"
"Kinase Assay","Inhibition","Target (full name):CaM kinase II delta","364","Weka RF classification","0.6914228019067795","Proportion","UP","4.269720383454736","0.6758241758241759","0.5625","0.3515625"
"Kinase Assay","Inhibition","Target (full name):CaM kinase II delta","364","Smile SVC Tanimoto classification","0.6801509533898303","Proportion","UP","4.269720383454736","0.7005494505494505","0.6144578313253012","0.3984375"
"Kinase Assay","Inhibition","Target (full name):CaM kinase II delta","364","Smile SVC RBF classification","0.6705177436440677","Proportion","UP","4.269720383454736","0.6730769230769231","0.6","0.2109375"
"Kinase Assay","Inhibition","Target (full name):CaM kinase II alpha","364","Weka RF classification","0.5964190937981192","Proportion","UP","3.490010261667777","0.6291208791208791","0.47297297297297297","0.26717557251908397"
"Kinase Assay","Inhibition","Target (full name):CaM kinase II alpha","364","Smile SVC Poly classification","0.5822822134128366","Proportion","UP","3.490010261667777","0.6538461538461539","0.7777777777777778","0.05343511450381679"
"Kinase Assay","Inhibition","Target (full name):CaM kinase II alpha","364","Smile SVC RBF classification","0.5813484913016419","Proportion","UP","3.490010261667777","0.6456043956043956","0.5357142857142857","0.11450381679389313"
"Kinase Assay","Inhibition","Target (full name):CaM kinase II alpha","364","Smile SVC Tanimoto classification","0.571716410575632","Proportion","UP","3.490010261667777","0.6565934065934066","0.56","0.21374045801526717"
"Kinase Assay","Inhibition","Target (full name):CaM kinase II alpha","364","Smile Bernoulli NB classification","0.5366608786816501","Proportion","UP","3.490010261667777","0.49175824175824173","0.35638297872340424","0.5114503816793893"
"Kinase Assay","Inhibition","Target (full name):CaM kinase II alpha","364","Weka RF on folded fp classification","0.5315991219735936","Proportion","UP","3.490010261667777","0.6263736263736264","0.45454545454545453","0.19083969465648856"
"Kinase Assay","Inhibition","Target (full name):CaM kinase I delta","364","Smile SVC Tanimoto classification","0.6492878401360538","Proportion","UP","1.513462221523799","0.7417582417582418","0.725","0.25892857142857145"
"Kinase Assay","Inhibition","Target (full name):CaM kinase I delta","364","Smile SVC Poly classification","0.6466836734693885","Proportion","UP","1.513462221523799","0.7225274725274725","0.9230769230769231","0.10714285714285714"
"Kinase Assay","Inhibition","Target (full name):CaM kinase I delta","364","Weka RF classification","0.6188350340136058","Proportion","UP","1.513462221523799","0.7032967032967034","0.5357142857142857","0.26785714285714285"
"Kinase Assay","Inhibition","Target (full name):CaM kinase I delta","364","Weka RF on folded fp classification","0.617187500000001","Proportion","UP","1.513462221523799","0.7252747252747253","0.6428571428571429","0.24107142857142858"
"Kinase Assay","Inhibition","Target (full name):CaM kinase I delta","364","Smile Bernoulli NB classification","0.6119968820861674","Proportion","UP","1.513462221523799","0.5879120879120879","0.38271604938271603","0.5535714285714286"
"Kinase Assay","Inhibition","Target (full name):CaM kinase I delta","364","Smile SVC RBF classification","0.5970982142857143","Proportion","UP","1.513462221523799","0.6978021978021978","0.53125","0.15178571428571427"
"Kinase Assay","Inhibition","Target (full name):BR serine/threonine-protein kinase 2","364","Weka RF classification","0.8006984459577442","Proportion","UP","5.055296078362767","0.7637362637362637","0.6835443037974683","0.46956521739130436"
"Kinase Assay","Inhibition","Target (full name):BR serine/threonine-protein kinase 2","364","Smile Bernoulli NB classification","0.7981316570630351","Proportion","UP","5.055296078362767","0.739010989010989","0.5757575757575758","0.6608695652173913"
"Kinase Assay","Inhibition","Target (full name):BR serine/threonine-protein kinase 2","364","Smile SVC Tanimoto classification","0.7883010302077885","Proportion","UP","5.055296078362767","0.8104395604395604","0.7804878048780488","0.5565217391304348"
"Kinase Assay","Inhibition","Target (full name):BR serine/threonine-protein kinase 2","364","Smile SVC RBF classification","0.7860310808451204","Proportion","UP","5.055296078362767","0.7472527472527473","0.7090909090909091","0.3391304347826087"
"Kinase Assay","Inhibition","Target (full name):BR serine/threonine-protein kinase 2","364","Weka RF on folded fp classification","0.7744368779465677","Proportion","UP","5.055296078362767","0.7692307692307693","0.7066666666666667","0.4608695652173913"
"Kinase Assay","Inhibition","Target (full name):BR serine/threonine-protein kinase 2","364","Smile SVC Poly classification","0.7738431988824864","Proportion","UP","5.055296078362767","0.7197802197802198","0.8095238095238095","0.14782608695652175"
"Kinase Assay","Inhibition","Target (full name):BR serine/threonine-protein kinase 1","364","Smile Bernoulli NB classification","0.7665374281535896","Proportion","UP","3.705032100441467","0.7252747252747253","0.5777777777777777","0.6446280991735537"
"Kinase Assay","Inhibition","Target (full name):BR serine/threonine-protein kinase 1","364","Smile SVC Tanimoto classification","0.7549909873142197","Proportion","UP","3.705032100441467","0.75","0.6704545454545454","0.48760330578512395"
"Kinase Assay","Inhibition","Target (full name):BR serine/threonine-protein kinase 1","364","Weka RF classification","0.7546848960990377","Proportion","UP","3.705032100441467","0.7362637362637363","0.6470588235294118","0.45454545454545453"
"Kinase Assay","Inhibition","Target (full name):BR serine/threonine-protein kinase 1","364","Smile SVC Poly classification","0.7456722103186748","Proportion","UP","3.705032100441467","0.7032967032967034","0.8095238095238095","0.14049586776859505"
"Kinase Assay","Inhibition","Target (full name):BR serine/threonine-protein kinase 1","364","Smile SVC RBF classification","0.7343808454919559","Proportion","UP","3.705032100441467","0.717032967032967","0.6607142857142857","0.30578512396694213"
"Kinase Assay","Inhibition","Target (full name):BR serine/threonine-protein kinase 1","364","Weka RF on folded fp classification","0.7331394755637177","Proportion","UP","3.705032100441467","0.7362637362637363","0.654320987654321","0.4380165289256198"
"Kinase Assay","Inhibition","Target (full name):NUAK family SNF1-like kinase 1","364","Smile Bernoulli NB classification","0.888633812876236","Proportion","UP","6.422618196434545","0.8241758241758241","0.6838709677419355","0.8760330578512396"
"Kinase Assay","Inhibition","Target (full name):NUAK family SNF1-like kinase 1","364","Smile SVC Tanimoto classification","0.8848076726864579","Proportion","UP","6.422618196434545","0.8434065934065934","0.7461538461538462","0.8016528925619835"
"Kinase Assay","Inhibition","Target (full name):NUAK family SNF1-like kinase 1","364","Weka RF on folded fp classification","0.8789239193279591","Proportion","UP","6.422618196434545","0.7967032967032966","0.7526881720430108","0.5785123966942148"
"Kinase Assay","Inhibition","Target (full name):NUAK family SNF1-like kinase 1","364","Smile SVC Poly classification","0.8781076760874724","Proportion","UP","6.422618196434545","0.7087912087912088","0.7586206896551724","0.18181818181818182"
"Kinase Assay","Inhibition","Target (full name):NUAK family SNF1-like kinase 1","364","Weka RF classification","0.8697581879400061","Proportion","UP","6.422618196434545","0.7857142857142857","0.7128712871287128","0.5950413223140496"
"Kinase Assay","Inhibition","Target (full name):NUAK family SNF1-like kinase 1","364","Smile SVC RBF classification","0.829983335033838","Proportion","UP","6.422618196434545","0.7472527472527473","0.7230769230769231","0.3884297520661157"
"Kinase Assay","Inhibition","Target (full name):AMP-activated protein kinase, alpha-2 subunit","364","Weka RF classification","0.6670460251046029","Proportion","UP","4.171332408829601","0.6840659340659341","0.5625","0.36"
"Kinase Assay","Inhibition","Target (full name):AMP-activated protein kinase, alpha-2 subunit","364","Smile Bernoulli NB classification","0.6635313807531382","Proportion","UP","4.171332408829601","0.6153846153846154","0.45614035087719296","0.624"
"Kinase Assay","Inhibition","Target (full name):AMP-activated protein kinase, alpha-2 subunit","364","Weka RF on folded fp classification","0.6576736401673633","Proportion","UP","4.171332408829601","0.6785714285714286","0.5555555555555556","0.32"
"Kinase Assay","Inhibition","Target (full name):AMP-activated protein kinase, alpha-2 subunit","364","Smile SVC RBF classification","0.6573389121338914","Proportion","UP","4.171332408829601","0.6840659340659341","0.6190476190476191","0.208"
"Kinase Assay","Inhibition","Target (full name):AMP-activated protein kinase, alpha-2 subunit","364","Smile SVC Tanimoto classification","0.6348786610878664","Proportion","UP","4.171332408829601","0.6648351648351648","0.5189873417721519","0.328"
"Kinase Assay","Inhibition","Target (full name):AMP-activated protein kinase, alpha-2 subunit","364","Smile SVC Poly classification","0.6194476987447699","Proportion","UP","4.171332408829601","0.6538461538461539","0.0","0.0"
"Kinase Assay","Inhibition","Target (full name):AMP-activated protein kinase, alpha-1 subunit","364","Smile SVC Poly classification","0.7429049602962646","Proportion","UP","4.528804062193095","0.6978021978021978","1.0","0.009009009009009009"
"Kinase Assay","Inhibition","Target (full name):AMP-activated protein kinase, alpha-1 subunit","364","Smile SVC Tanimoto classification","0.7406616102268282","Proportion","UP","4.528804062193095","0.7664835164835165","0.6756756756756757","0.45045045045045046"
"Kinase Assay","Inhibition","Target (full name):AMP-activated protein kinase, alpha-1 subunit","364","Smile Bernoulli NB classification","0.7378129117259558","Proportion","UP","4.528804062193095","0.7197802197802198","0.5323741007194245","0.6666666666666666"
"Kinase Assay","Inhibition","Target (full name):AMP-activated protein kinase, alpha-1 subunit","364","Weka RF classification","0.7320621016273188","Proportion","UP","4.528804062193095","0.7664835164835165","0.703125","0.40540540540540543"
"Kinase Assay","Inhibition","Target (full name):AMP-activated protein kinase, alpha-1 subunit","364","Weka RF on folded fp classification","0.7229996795214192","Proportion","UP","4.528804062193095","0.760989010989011","0.7","0.3783783783783784"
"Kinase Assay","Inhibition","Target (full name):AMP-activated protein kinase, alpha-1 subunit","364","Smile SVC RBF classification","0.7061211409037501","Proportion","UP","4.528804062193095","0.7472527472527473","0.7317073170731707","0.2702702702702703"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Sgk3","364","Smile SVC Poly classification","0.644549334490741","Proportion","UP","3.7155721187935282","0.728021978021978","0.8461538461538461","0.10185185185185185"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Sgk3","364","Smile SVC RBF classification","0.6374421296296295","Proportion","UP","3.7155721187935282","0.7032967032967034","0.5","0.12037037037037036"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Sgk3","364","Smile SVC Tanimoto classification","0.6359230324074077","Proportion","UP","3.7155721187935282","0.7087912087912088","0.5263157894736842","0.18518518518518517"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Sgk3","364","Weka RF on folded fp classification","0.6171874999999994","Proportion","UP","3.7155721187935282","0.739010989010989","0.6326530612244898","0.28703703703703703"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Sgk3","364","Weka RF classification","0.6166630497685185","Proportion","UP","3.7155721187935282","0.7032967032967034","0.5","0.24074074074074073"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Sgk3","364","Smile Bernoulli NB classification","0.610803674768518","Proportion","UP","3.7155721187935282","0.6236263736263736","0.3986013986013986","0.5277777777777778"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Sgk2","364","Smile SVC RBF classification","0.5787520749926761","Proportion","UP","3.170221882705887","0.6263736263736264","0.45454545454545453","0.11278195488721804"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Sgk2","364","Weka RF on folded fp classification","0.5769944341372911","Proportion","UP","3.170221882705887","0.6373626373626373","0.5076923076923077","0.24812030075187969"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Sgk2","364","Smile SVC Poly classification","0.5751391465677181","Proportion","UP","3.170221882705887","0.6456043956043956","0.7","0.05263157894736842"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Sgk2","364","Smile Bernoulli NB classification","0.5663183933860626","Proportion","UP","3.170221882705887","0.5686813186813187","0.4189189189189189","0.46616541353383456"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Sgk2","364","Smile SVC Tanimoto classification","0.5538521628747188","Proportion","UP","3.170221882705887","0.6483516483516484","0.5454545454545454","0.22556390977443608"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Sgk2","364","Weka RF classification","0.5399049571981905","Proportion","UP","3.170221882705887","0.6098901098901099","0.4457831325301205","0.2781954887218045"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Sgk1","364","Smile SVC Poly classification","0.6261669953977648","Proportion","UP","3.464321603497166","0.6428571428571429","NaN","0.0"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Sgk1","364","Weka RF on folded fp classification","0.6239644970414204","Proportion","UP","3.464321603497166","0.6703296703296703","0.5833333333333334","0.2692307692307692"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Sgk1","364","Smile Bernoulli NB classification","0.6224358974358971","Proportion","UP","3.464321603497166","0.6016483516483516","0.45098039215686275","0.5307692307692308"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Sgk1","364","Weka RF classification","0.5982741617357004","Proportion","UP","3.464321603497166","0.6428571428571429","0.5","0.3076923076923077"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Sgk1","364","Smile SVC Tanimoto classification","0.5976988823142668","Proportion","UP","3.464321603497166","0.6401098901098901","0.4925373134328358","0.25384615384615383"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase Sgk1","364","Smile SVC RBF classification","0.5844510190664035","Proportion","UP","3.464321603497166","0.6456043956043956","0.5151515151515151","0.13076923076923078"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 6","364","Weka RF on folded fp classification","0.851649122807017","Proportion","UP","2.9314730507825004","0.7967032967032966","0.7325581395348837","0.5526315789473685"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 6","364","Smile Bernoulli NB classification","0.8418947368421053","Proportion","UP","2.9314730507825004","0.7664835164835165","0.5935483870967742","0.8070175438596491"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 6","364","Weka RF classification","0.8311403508771932","Proportion","UP","2.9314730507825004","0.7664835164835165","0.6790123456790124","0.4824561403508772"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 6","364","Smile SVC Poly classification","0.8189473684210516","Proportion","UP","2.9314730507825004","0.7197802197802198","0.7727272727272727","0.14912280701754385"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 6","364","Smile SVC Tanimoto classification","0.8092631578947368","Proportion","UP","2.9314730507825004","0.7802197802197802","0.6931818181818182","0.5350877192982456"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 6","364","Smile SVC RBF classification","0.7937894736842112","Proportion","UP","2.9314730507825004","0.7472527472527473","0.7115384615384616","0.32456140350877194"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 2","364","Weka RF on folded fp classification","0.8653713365045281","Proportion","UP","3.9743783583247585","0.8214285714285714","0.7323943661971831","0.5306122448979592"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 2","364","Smile Bernoulli NB classification","0.8635299984655513","Proportion","UP","3.9743783583247585","0.7857142857142857","0.564935064935065","0.8877551020408163"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 2","364","Smile SVC Poly classification","0.8571812183520027","Proportion","UP","3.9743783583247585","0.75","0.7333333333333333","0.11224489795918367"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 2","364","Weka RF classification","0.8381348780113549","Proportion","UP","3.9743783583247585","0.8131868131868132","0.7272727272727273","0.4897959183673469"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 2","364","Smile SVC Tanimoto classification","0.8261470001534457","Proportion","UP","3.9743783583247585","0.8104395604395604","0.6883116883116883","0.5408163265306123"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 2","364","Smile SVC RBF classification","0.8049332514960896","Proportion","UP","3.9743783583247585","0.7994505494505495","0.7906976744186046","0.3469387755102041"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 3","364","Smile Bernoulli NB classification","0.8124659078511958","Proportion","UP","3.2158276574185","0.7637362637362637","0.5734265734265734","0.7663551401869159"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 3","364","Smile SVC Tanimoto classification","0.8053747408996698","Proportion","UP","3.2158276574185","0.804945054945055","0.7432432432432432","0.514018691588785"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 3","364","Weka RF on folded fp classification","0.8050110913124112","Proportion","UP","3.2158276574185","0.7967032967032966","0.7323943661971831","0.48598130841121495"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 3","364","Smile SVC Poly classification","0.8037019527982846","Proportion","UP","3.2158276574185","0.7335164835164835","0.7272727272727273","0.14953271028037382"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 3","364","Weka RF classification","0.7909378522855378","Proportion","UP","3.2158276574185","0.7774725274725275","0.696969696969697","0.42990654205607476"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 3","364","Smile SVC RBF classification","0.7716280592021527","Proportion","UP","3.2158276574185","0.7527472527472527","0.6976744186046512","0.2803738317757009"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 1","364","Smile Bernoulli NB classification","0.7876479289940841","Proportion","UP","3.9560870608717735","0.7362637362637363","0.5273972602739726","0.7403846153846154"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 1","364","Weka RF classification","0.771930473372781","Proportion","UP","3.9560870608717735","0.7857142857142857","0.7096774193548387","0.4230769230769231"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 1","364","Smile SVC Poly classification","0.7652736686390534","Proportion","UP","3.9560870608717735","0.7417582417582418","0.75","0.14423076923076922"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 1","364","Weka RF on folded fp classification","0.7617973372781053","Proportion","UP","3.9560870608717735","0.8021978021978022","0.7424242424242424","0.47115384615384615"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 1","364","Smile SVC Tanimoto classification","0.7509615384615385","Proportion","UP","3.9560870608717735","0.8131868131868132","0.8103448275862069","0.4519230769230769"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 1","364","Smile SVC RBF classification","0.746116863905326","Proportion","UP","3.9560870608717735","0.7692307692307693","0.7631578947368421","0.27884615384615385"
"Kinase Assay","Inhibition","Target (full name):Rho-associated protein kinase 2","364","Weka RF on folded fp classification","0.7983912721893507","Proportion","UP","5.459779427960369","0.7912087912087912","0.7058823529411765","0.46153846153846156"
"Kinase Assay","Inhibition","Target (full name):Rho-associated protein kinase 2","364","Smile SVC Poly classification","0.7961538461538468","Proportion","UP","5.459779427960369","0.717032967032967","0.6","0.028846153846153848"
"Kinase Assay","Inhibition","Target (full name):Rho-associated protein kinase 2","364","Smile Bernoulli NB classification","0.7877773668639058","Proportion","UP","5.459779427960369","0.6978021978021978","0.4817073170731707","0.7596153846153846"
"Kinase Assay","Inhibition","Target (full name):Rho-associated protein kinase 2","364","Smile SVC Tanimoto classification","0.7857248520710063","Proportion","UP","5.459779427960369","0.7884615384615384","0.7076923076923077","0.4423076923076923"
"Kinase Assay","Inhibition","Target (full name):Rho-associated protein kinase 2","364","Weka RF classification","0.7612980769230768","Proportion","UP","5.459779427960369","0.7747252747252747","0.6527777777777778","0.4519230769230769"
"Kinase Assay","Inhibition","Target (full name):Rho-associated protein kinase 2","364","Smile SVC RBF classification","0.7455251479289935","Proportion","UP","5.459779427960369","0.75","0.76","0.18269230769230768"
"Kinase Assay","Inhibition","Target (full name):Rho-associated protein kinase 1","364","Smile SVC Tanimoto classification","0.796935648621041","Proportion","UP","3.86359728460774","0.8159340659340659","0.7391304347826086","0.38202247191011235"
"Kinase Assay","Inhibition","Target (full name):Rho-associated protein kinase 1","364","Weka RF on folded fp classification","0.790888661899897","Proportion","UP","3.86359728460774","0.8186813186813187","0.7674418604651163","0.3707865168539326"
"Kinase Assay","Inhibition","Target (full name):Rho-associated protein kinase 1","364","Smile SVC Poly classification","0.7864351378958118","Proportion","UP","3.86359728460774","0.7774725274725275","0.7857142857142857","0.12359550561797752"
"Kinase Assay","Inhibition","Target (full name):Rho-associated protein kinase 1","364","Weka RF classification","0.7841266598569969","Proportion","UP","3.86359728460774","0.7994505494505495","0.6739130434782609","0.34831460674157305"
"Kinase Assay","Inhibition","Target (full name):Rho-associated protein kinase 1","364","Smile Bernoulli NB classification","0.779223697650663","Proportion","UP","3.86359728460774","0.7115384615384616","0.44366197183098594","0.7078651685393258"
"Kinase Assay","Inhibition","Target (full name):Rho-associated protein kinase 1","364","Smile SVC RBF classification","0.7756894790602644","Proportion","UP","3.86359728460774","0.7912087912087912","0.7407407407407407","0.2247191011235955"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PRKX","364","Smile SVC Poly classification","0.6723272544754879","Proportion","UP","3.3736196294786396","0.7857142857142857","0.9","0.10465116279069768"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PRKX","364","Smile SVC Tanimoto classification","0.6598628074284764","Proportion","UP","3.3736196294786396","0.8021978021978022","0.8181818181818182","0.20930232558139536"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PRKX","364","Smile SVC RBF classification","0.6326334281412063","Proportion","UP","3.3736196294786396","0.7857142857142857","0.7857142857142857","0.12790697674418605"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PRKX","364","Weka RF on folded fp classification","0.6272586581897275","Proportion","UP","3.3736196294786396","0.804945054945055","0.7272727272727273","0.27906976744186046"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PRKX","364","Weka RF classification","0.6244144219508112","Proportion","UP","3.3736196294786396","0.7884615384615384","0.6666666666666666","0.20930232558139536"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase PRKX","364","Smile Bernoulli NB classification","0.6159026267358205","Proportion","UP","3.3736196294786396","0.6620879120879121","0.3543307086614173","0.5232558139534884"
"Kinase Assay","Inhibition","Target (full name):cGMP-dependent protein kinase 2","364","Smile Bernoulli NB classification","0.8023165422885581","Proportion","UP","4.466344921011412","0.7417582417582418","0.5075757575757576","0.6979166666666666"
"Kinase Assay","Inhibition","Target (full name):cGMP-dependent protein kinase 2","364","Smile SVC Poly classification","0.7959421641791047","Proportion","UP","4.466344921011412","0.771978021978022","0.9333333333333333","0.14583333333333334"
"Kinase Assay","Inhibition","Target (full name):cGMP-dependent protein kinase 2","364","Weka RF classification","0.7878575870646765","Proportion","UP","4.466344921011412","0.8241758241758241","0.82","0.4270833333333333"
"Kinase Assay","Inhibition","Target (full name):cGMP-dependent protein kinase 2","364","Weka RF on folded fp classification","0.7827658582089542","Proportion","UP","4.466344921011412","0.8269230769230769","0.8","0.4583333333333333"
"Kinase Assay","Inhibition","Target (full name):cGMP-dependent protein kinase 2","364","Smile SVC Tanimoto classification","0.7718827736318397","Proportion","UP","4.466344921011412","0.8021978021978022","0.7307692307692307","0.3958333333333333"
"Kinase Assay","Inhibition","Target (full name):cGMP-dependent protein kinase 2","364","Smile SVC RBF classification","0.7274953358208951","Proportion","UP","4.466344921011412","0.782967032967033","0.7741935483870968","0.25"
"Kinase Assay","Inhibition","Target (full name):cGMP-dependent protein kinase 1 beta","364","Weka RF classification","0.6996894177518335","Proportion","UP","4.383805911678872","0.7417582417582418","0.5833333333333334","0.27450980392156865"
"Kinase Assay","Inhibition","Target (full name):cGMP-dependent protein kinase 1 beta","364","Smile Bernoulli NB classification","0.6870790300853159","Proportion","UP","4.383805911678872","0.6346153846153846","0.4012738853503185","0.6176470588235294"
"Kinase Assay","Inhibition","Target (full name):cGMP-dependent protein kinase 1 beta","364","Weka RF on folded fp classification","0.6662176320910039","Proportion","UP","4.383805911678872","0.771978021978022","0.6792452830188679","0.35294117647058826"
"Kinase Assay","Inhibition","Target (full name):cGMP-dependent protein kinase 1 beta","364","Smile SVC Poly classification","0.6632614878012262","Proportion","UP","4.383805911678872","0.7445054945054945","0.9090909090909091","0.09803921568627451"
"Kinase Assay","Inhibition","Target (full name):cGMP-dependent protein kinase 1 beta","364","Smile SVC RBF classification","0.6627001945816502","Proportion","UP","4.383805911678872","0.7445054945054945","0.7368421052631579","0.13725490196078433"
"Kinase Assay","Inhibition","Target (full name):cGMP-dependent protein kinase 1 beta","364","Smile SVC Tanimoto classification","0.6479194731327637","Proportion","UP","4.383805911678872","0.7582417582417582","0.675","0.2647058823529412"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C nu","364","Smile SVC Tanimoto classification","0.7150887573964497","Proportion","UP","4.983441889670868","0.6978021978021978","0.6063829787234043","0.43846153846153846"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C nu","364","Smile Bernoulli NB classification","0.7091058514135443","Proportion","UP","4.983441889670868","0.6840659340659341","0.5460122699386503","0.6846153846153846"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C nu","364","Smile SVC Poly classification","0.7068047337278112","Proportion","UP","4.983441889670868","0.6565934065934066","0.6666666666666666","0.07692307692307693"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C nu","364","Weka RF on folded fp classification","0.6953977646285344","Proportion","UP","4.983441889670868","0.7060439560439561","0.6666666666666666","0.35384615384615387"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C nu","364","Weka RF classification","0.6867685733070348","Proportion","UP","4.983441889670868","0.6620879120879121","0.5384615384615384","0.3769230769230769"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C nu","364","Smile SVC RBF classification","0.6601906640368194","Proportion","UP","4.983441889670868","0.6456043956043956","0.5121951219512195","0.16153846153846155"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase D2","364","Smile SVC Tanimoto classification","0.700447093889716","Proportion","UP","4.8602086104286055","0.7060439560439561","0.6056338028169014","0.3524590163934426"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase D2","364","Weka RF classification","0.6967043761007994","Proportion","UP","4.8602086104286055","0.6758241758241759","0.527027027027027","0.319672131147541"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase D2","364","Smile SVC Poly classification","0.6836810730253359","Proportion","UP","4.8602086104286055","0.6703296703296703","0.75","0.02459016393442623"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase D2","364","Weka RF on folded fp classification","0.6832068825362415","Proportion","UP","4.8602086104286055","0.6730769230769231","0.5238095238095238","0.27049180327868855"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase D2","364","Smile Bernoulli NB classification","0.6706069638260392","Proportion","UP","4.8602086104286055","0.6538461538461539","0.4880952380952381","0.6721311475409836"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase D2","364","Smile SVC RBF classification","0.6644424874678222","Proportion","UP","4.8602086104286055","0.6703296703296703","0.5357142857142857","0.12295081967213115"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C mu","364","Smile Bernoulli NB classification","0.7052393767234789","Proportion","UP","5.1636002386308295","0.6510989010989011","0.5","0.6771653543307087"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C mu","364","Smile SVC Poly classification","0.6999900328914576","Proportion","UP","5.1636002386308295","0.6565934065934066","0.5833333333333334","0.05511811023622047"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C mu","364","Weka RF on folded fp classification","0.6928469384364936","Proportion","UP","5.1636002386308295","0.6868131868131868","0.5844155844155844","0.3543307086614173"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C mu","364","Smile SVC Tanimoto classification","0.6916841091066147","Proportion","UP","5.1636002386308295","0.7087912087912088","0.6153846153846154","0.4409448818897638"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C mu","364","Weka RF classification","0.6804212764543673","Proportion","UP","5.1636002386308295","0.6675824175824175","0.5333333333333333","0.3779527559055118"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C mu","364","Smile SVC RBF classification","0.6282600750855519","Proportion","UP","5.1636002386308295","0.6401098901098901","0.4411764705882353","0.11811023622047244"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C theta","364","Smile Bernoulli NB classification","0.6421768707482992","Proportion","UP","3.079892975145361","0.6043956043956044","0.37579617834394907","0.5619047619047619"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C theta","364","Smile SVC Tanimoto classification","0.6170987313844467","Proportion","UP","3.079892975145361","0.7307692307692307","0.5897435897435898","0.21904761904761905"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C theta","364","Smile SVC Poly classification","0.6169516455230746","Proportion","UP","3.079892975145361","0.7335164835164835","0.9","0.08571428571428572"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C theta","364","Weka RF classification","0.6139915425629714","Proportion","UP","3.079892975145361","0.7142857142857143","0.5102040816326531","0.23809523809523808"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C theta","364","Weka RF on folded fp classification","0.6107740393454689","Proportion","UP","3.079892975145361","0.7197802197802198","0.5294117647058824","0.2571428571428571"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C theta","364","Smile SVC RBF classification","0.6041184041184042","Proportion","UP","3.079892975145361","0.7445054945054945","0.8","0.1523809523809524"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C iota","364","Weka RF on folded fp classification","0.5709790794979079","Proportion","UP","1.9118415369675352","0.6208791208791209","0.3617021276595745","0.136"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C iota","364","Smile SVC Tanimoto classification","0.5685355648535563","Proportion","UP","1.9118415369675352","0.6236263736263736","0.3888888888888889","0.168"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C iota","364","Smile SVC Poly classification","0.5667447698744765","Proportion","UP","1.9118415369675352","0.6565934065934066","NaN","0.0"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C iota","364","Smile Bernoulli NB classification","0.5615732217573222","Proportion","UP","1.9118415369675352","0.5302197802197802","0.36470588235294116","0.496"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C iota","364","Weka RF classification","0.4980585774058577","Proportion","UP","1.9118415369675352","0.5989010989010989","0.3384615384615385","0.176"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C iota","364","Smile SVC RBF classification","0.49523012552301254","Proportion","UP","1.9118415369675352","0.6071428571428571","0.2","0.048"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C gamma","364","Smile SVC Poly classification","0.6469087635054025","Proportion","UP","3.391496717460683","0.6620879120879121","0.7142857142857143","0.03968253968253968"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C gamma","364","Smile SVC Tanimoto classification","0.6435074029611838","Proportion","UP","3.391496717460683","0.6923076923076923","0.5972222222222222","0.3412698412698413"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C gamma","364","Smile Bernoulli NB classification","0.5958049886621317","Proportion","UP","3.391496717460683","0.5906593406593407","0.4311377245508982","0.5714285714285714"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C gamma","364","Weka RF on folded fp classification","0.5933540082699749","Proportion","UP","3.391496717460683","0.6675824175824175","0.5396825396825397","0.2698412698412698"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C gamma","364","Smile SVC RBF classification","0.5889189008936916","Proportion","UP","3.391496717460683","0.6593406593406593","0.525","0.16666666666666666"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C gamma","364","Weka RF classification","0.5872515672935842","Proportion","UP","3.391496717460683","0.6373626373626373","0.4605263157894737","0.2777777777777778"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C eta","364","Weka RF on folded fp classification","0.6735331632653067","Proportion","UP","4.909896219715718","0.8269230769230769","0.7837837837837838","0.34523809523809523"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C eta","364","Smile Bernoulli NB classification","0.6639668367346943","Proportion","UP","4.909896219715718","0.6648351648351648","0.3492063492063492","0.5238095238095238"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C eta","364","Smile SVC Poly classification","0.6511692176870754","Proportion","UP","4.909896219715718","0.8104395604395604","0.9411764705882353","0.19047619047619047"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C eta","364","Smile SVC RBF classification","0.6289753401360555","Proportion","UP","4.909896219715718","0.7994505494505495","0.7619047619047619","0.19047619047619047"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C eta","364","Weka RF classification","0.6211522108843537","Proportion","UP","4.909896219715718","0.7857142857142857","0.575","0.27380952380952384"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C eta","364","Smile SVC Tanimoto classification","0.603762755102041","Proportion","UP","4.909896219715718","0.8324175824175825","0.9259259259259259","0.2976190476190476"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C beta","364","Smile Bernoulli NB classification","0.8035969935576238","Proportion","UP","2.675474679220099","0.7362637362637363","0.547945205479452","0.7272727272727273"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C beta","364","Weka RF on folded fp classification","0.7958840372226195","Proportion","UP","2.675474679220099","0.7802197802197802","0.6923076923076923","0.4909090909090909"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C beta","364","Smile SVC Tanimoto classification","0.7844130279169648","Proportion","UP","2.675474679220099","0.782967032967033","0.7246376811594203","0.45454545454545453"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C beta","364","Weka RF classification","0.7802970651395849","Proportion","UP","2.675474679220099","0.7857142857142857","0.7424242424242424","0.44545454545454544"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C beta","364","Smile SVC RBF classification","0.7568897637795264","Proportion","UP","2.675474679220099","0.7774725274725275","0.8222222222222222","0.33636363636363636"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C beta","364","Smile SVC Poly classification","0.7531675017895497","Proportion","UP","2.675474679220099","0.760989010989011","0.8108108108108109","0.2727272727272727"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C alpha","364","Smile SVC Poly classification","0.7714772727272721","Proportion","UP","2.029788117140331","0.7225274725274725","0.4444444444444444","0.04"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C alpha","364","Smile SVC Tanimoto classification","0.7657196969696972","Proportion","UP","2.029788117140331","0.7857142857142857","0.7291666666666666","0.35"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C alpha","364","Smile Bernoulli NB classification","0.7643181818181807","Proportion","UP","2.029788117140331","0.6593406593406593","0.4294117647058823","0.73"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C alpha","364","Weka RF on folded fp classification","0.7543181818181833","Proportion","UP","2.029788117140331","0.782967032967033","0.7058823529411765","0.36"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C alpha","364","Smile SVC RBF classification","0.7258333333333329","Proportion","UP","2.029788117140331","0.7582417582417582","0.7","0.21"
"Kinase Assay","Inhibition","Target (full name):Protein kinase C alpha","364","Weka RF classification","0.7236363636363635","Proportion","UP","2.029788117140331","0.75","0.5849056603773585","0.31"
"Kinase Assay","Inhibition","Target (full name):cAMP-dependent protein kinase alpha-catalytic subunit","364","Weka RF classification","0.7964781843083547","Proportion","UP","3.731267857315441","0.8104395604395604","0.7321428571428571","0.43157894736842106"
"Kinase Assay","Inhibition","Target (full name):cAMP-dependent protein kinase alpha-catalytic subunit","364","Weka RF on folded fp classification","0.7823322246135787","Proportion","UP","3.731267857315441","0.8351648351648352","0.7966101694915254","0.49473684210526314"
"Kinase Assay","Inhibition","Target (full name):cAMP-dependent protein kinase alpha-catalytic subunit","364","Smile Bernoulli NB classification","0.7814909019761305","Proportion","UP","3.731267857315441","0.7252747252747253","0.48226950354609927","0.7157894736842105"
"Kinase Assay","Inhibition","Target (full name):cAMP-dependent protein kinase alpha-catalytic subunit","364","Smile SVC Poly classification","0.779808256701233","Proportion","UP","3.731267857315441","0.8021978021978022","0.8484848484848485","0.29473684210526313"
"Kinase Assay","Inhibition","Target (full name):cAMP-dependent protein kinase alpha-catalytic subunit","364","Smile SVC Tanimoto classification","0.7707297984738809","Proportion","UP","3.731267857315441","0.8214285714285714","0.7777777777777778","0.4421052631578947"
"Kinase Assay","Inhibition","Target (full name):cAMP-dependent protein kinase alpha-catalytic subunit","364","Smile SVC RBF classification","0.7690080219135179","Proportion","UP","3.731267857315441","0.7967032967032966","0.8181818181818182","0.28421052631578947"
"Kinase Assay","Inhibition","Target (full name):Pyruvate dehydrogenase kinase isoform 1","364","Weka RF classification","0.6622456140350879","Proportion","UP","2.958325439653302","0.7060439560439561","0.5636363636363636","0.2719298245614035"
"Kinase Assay","Inhibition","Target (full name):Pyruvate dehydrogenase kinase isoform 1","364","Smile SVC Poly classification","0.6584561403508769","Proportion","UP","2.958325439653302","0.6895604395604396","0.6","0.02631578947368421"
"Kinase Assay","Inhibition","Target (full name):Pyruvate dehydrogenase kinase isoform 1","364","Smile SVC RBF classification","0.6549473684210517","Proportion","UP","2.958325439653302","0.6895604395604396","0.5161290322580645","0.14035087719298245"
"Kinase Assay","Inhibition","Target (full name):Pyruvate dehydrogenase kinase isoform 1","364","Smile SVC Tanimoto classification","0.6469473684210526","Proportion","UP","2.958325439653302","0.7005494505494505","0.5471698113207547","0.2543859649122807"
"Kinase Assay","Inhibition","Target (full name):Pyruvate dehydrogenase kinase isoform 1","364","Weka RF on folded fp classification","0.6460175438596497","Proportion","UP","2.958325439653302","0.6813186813186813","0.4838709677419355","0.2631578947368421"
"Kinase Assay","Inhibition","Target (full name):Pyruvate dehydrogenase kinase isoform 1","364","Smile Bernoulli NB classification","0.6315087719298249","Proportion","UP","2.958325439653302","0.6043956043956044","0.39864864864864863","0.5175438596491229"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase 1","364","Weka RF on folded fp classification","0.8027229379287253","Proportion","UP","3.3548750534928686","0.8159340659340659","0.7111111111111111","0.37209302325581395"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase 1","364","Smile Bernoulli NB classification","0.7938556131838698","Proportion","UP","3.3548750534928686","0.7417582417582418","0.4701492537313433","0.7325581395348837"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase 1","364","Weka RF classification","0.792558976074954","Proportion","UP","3.3548750534928686","0.804945054945055","0.6666666666666666","0.3488372093023256"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase 1","364","Smile SVC Poly classification","0.7766019742345652","Proportion","UP","3.3548750534928686","0.7967032967032966","0.875","0.16279069767441862"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase 1","364","Smile SVC Tanimoto classification","0.7701606156934921","Proportion","UP","3.3548750534928686","0.8269230769230769","0.7555555555555555","0.3953488372093023"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase 1","364","Smile SVC RBF classification","0.7328091015559647","Proportion","UP","3.3548750534928686","0.804945054945055","0.8","0.23255813953488372"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 4","364","Smile SVC Poly classification","0.7595968934911235","Proportion","UP","4.021581452371949","0.7445054945054945","0.8666666666666667","0.125"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 4","364","Smile Bernoulli NB classification","0.7569526627218934","Proportion","UP","4.021581452371949","0.6868131868131868","0.4642857142857143","0.625"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 4","364","Weka RF on folded fp classification","0.7436760355029585","Proportion","UP","4.021581452371949","0.7774725274725275","0.7169811320754716","0.36538461538461536"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 4","364","Weka RF classification","0.7240199704142013","Proportion","UP","4.021581452371949","0.7554945054945055","0.6530612244897959","0.3076923076923077"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 4","364","Smile SVC Tanimoto classification","0.722078402366864","Proportion","UP","4.021581452371949","0.782967032967033","0.7659574468085106","0.34615384615384615"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 4","364","Smile SVC RBF classification","0.6899408284023669","Proportion","UP","4.021581452371949","0.7445054945054945","0.6666666666666666","0.21153846153846154"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 5","364","Weka RF on folded fp classification","0.6909202025493273","Proportion","UP","4.4278754674151255","0.7142857142857143","0.627906976744186","0.23478260869565218"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 5","364","Smile Bernoulli NB classification","0.6874105116116637","Proportion","UP","4.4278754674151255","0.6483516483516484","0.45112781954887216","0.5217391304347826"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 5","364","Smile SVC Poly classification","0.6807054304173223","Proportion","UP","4.4278754674151255","0.6923076923076923","0.6666666666666666","0.05217391304347826"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 5","364","Smile SVC Tanimoto classification","0.664676095687096","Proportion","UP","4.4278754674151255","0.7060439560439561","0.5952380952380952","0.21739130434782608"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 5","364","Weka RF classification","0.6439147895931551","Proportion","UP","4.4278754674151255","0.6785714285714286","0.48214285714285715","0.23478260869565218"
"Kinase Assay","Inhibition","Target (full name):Ribosomal protein S6 kinase alpha 5","364","Smile SVC RBF classification","0.6219312030731613","Proportion","UP","4.4278754674151255","0.6868131868131868","0.5151515151515151","0.14782608695652175"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MRCK beta","364","Weka RF on folded fp classification","0.7329751317523047","Proportion","UP","1.7413087716637383","0.8104395604395604","0.7567567567567568","0.3181818181818182"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MRCK beta","364","Smile SVC Tanimoto classification","0.7296607378129122","Proportion","UP","1.7413087716637383","0.8104395604395604","0.7714285714285715","0.3068181818181818"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MRCK beta","364","Smile SVC Poly classification","0.718811758893281","Proportion","UP","1.7413087716637383","0.7774725274725275","0.8181818181818182","0.10227272727272728"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MRCK beta","364","Weka RF classification","0.7131093544137024","Proportion","UP","1.7413087716637383","0.771978021978022","0.5675675675675675","0.23863636363636365"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MRCK beta","364","Smile Bernoulli NB classification","0.6987607048748357","Proportion","UP","1.7413087716637383","0.6648351648351648","0.3835616438356164","0.6363636363636364"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MRCK beta","364","Smile SVC RBF classification","0.6936758893280632","Proportion","UP","1.7413087716637383","0.7802197802197802","0.7","0.1590909090909091"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MRCK-A","364","Weka RF on folded fp classification","0.6470403352540604","Proportion","UP","1.8382939958118154","0.7225274725274725","0.6129032258064516","0.33043478260869563"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MRCK-A","364","Weka RF classification","0.6449275362318845","Proportion","UP","1.8382939958118154","0.695054945054945","0.5357142857142857","0.2608695652173913"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MRCK-A","364","Smile Bernoulli NB classification","0.635603282696002","Proportion","UP","1.8382939958118154","0.5879120879120879","0.39520958083832336","0.5739130434782609"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MRCK-A","364","Smile SVC Poly classification","0.6339444735463592","Proportion","UP","1.8382939958118154","0.717032967032967","0.9285714285714286","0.11304347826086956"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MRCK-A","364","Smile SVC RBF classification","0.6185088178802169","Proportion","UP","1.8382939958118154","0.6978021978021978","0.5862068965517241","0.14782608695652175"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase MRCK-A","364","Smile SVC Tanimoto classification","0.6178103719224725","Proportion","UP","1.8382939958118154","0.7060439560439561","0.58","0.25217391304347825"
"Kinase Assay","Inhibition","Target (full name):G protein-coupled receptor kinase 7","364","Weka RF classification","0.6116124858482934","Proportion","UP","5.66651145446845","0.6263736263736264","0.4946236559139785","0.34074074074074073"
"Kinase Assay","Inhibition","Target (full name):G protein-coupled receptor kinase 7","364","Smile SVC RBF classification","0.6110302442180165","Proportion","UP","5.66651145446845","0.6510989010989011","0.5909090909090909","0.1925925925925926"
"Kinase Assay","Inhibition","Target (full name):G protein-coupled receptor kinase 7","364","Smile SVC Tanimoto classification","0.5947274785702733","Proportion","UP","5.66651145446845","0.6593406593406593","0.5932203389830508","0.25925925925925924"
"Kinase Assay","Inhibition","Target (full name):G protein-coupled receptor kinase 7","364","Smile SVC Poly classification","0.5849587578845219","Proportion","UP","5.66651145446845","0.6373626373626373","0.8","0.02962962962962963"
"Kinase Assay","Inhibition","Target (full name):G protein-coupled receptor kinase 7","364","Smile Bernoulli NB classification","0.5803978651140221","Proportion","UP","5.66651145446845","0.5494505494505495","0.41420118343195267","0.5185185185185185"
"Kinase Assay","Inhibition","Target (full name):G protein-coupled receptor kinase 7","364","Weka RF on folded fp classification","0.5658741711143457","Proportion","UP","5.66651145446845","0.6346153846153846","0.5138888888888888","0.2740740740740741"
"Kinase Assay","Inhibition","Target (full name):G protein-coupled receptor kinase 6","364","Smile SVC RBF classification","0.6518821223296456","Proportion","UP","4.113632615115627","0.6648351648351648","0.5641025641025641","0.1732283464566929"
"Kinase Assay","Inhibition","Target (full name):G protein-coupled receptor kinase 6","364","Smile Bernoulli NB classification","0.6341406691252198","Proportion","UP","4.113632615115627","0.6318681318681318","0.4748201438848921","0.5196850393700787"
"Kinase Assay","Inhibition","Target (full name):G protein-coupled receptor kinase 6","364","Weka RF classification","0.6324794843682512","Proportion","UP","4.113632615115627","0.6840659340659341","0.5652173913043478","0.4094488188976378"
"Kinase Assay","Inhibition","Target (full name):G protein-coupled receptor kinase 6","364","Smile SVC Tanimoto classification","0.6306854048307254","Proportion","UP","4.113632615115627","0.717032967032967","0.6875","0.3464566929133858"
"Kinase Assay","Inhibition","Target (full name):G protein-coupled receptor kinase 6","364","Smile SVC Poly classification","0.6166650054819096","Proportion","UP","4.113632615115627","0.6758241758241759","0.8461538461538461","0.08661417322834646"
"Kinase Assay","Inhibition","Target (full name):G protein-coupled receptor kinase 6","364","Weka RF on folded fp classification","0.604554968603608","Proportion","UP","4.113632615115627","0.6813186813186813","0.5901639344262295","0.28346456692913385"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase AKT3","364","Smile Bernoulli NB classification","0.6931654450917741","Proportion","UP","2.505742170324762","0.6428571428571429","0.23841059602649006","0.7058823529411765"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase AKT3","364","Weka RF classification","0.6458372486374739","Proportion","UP","2.505742170324762","0.8818681318681318","0.7857142857142857","0.21568627450980393"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase AKT3","364","Smile SVC Tanimoto classification","0.6355321681388204","Proportion","UP","2.505742170324762","0.8928571428571429","1.0","0.23529411764705882"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase AKT3","364","Smile SVC Poly classification","0.6335901772849702","Proportion","UP","2.505742170324762","0.8736263736263736","1.0","0.09803921568627451"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase AKT3","364","Weka RF on folded fp classification","0.6129173714214123","Proportion","UP","2.505742170324762","0.8653846153846154","0.55","0.21568627450980393"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase AKT3","364","Smile SVC RBF classification","0.6032700620184163","Proportion","UP","2.505742170324762","0.8791208791208791","1.0","0.13725490196078433"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase AKT2","364","Weka RF classification","0.6772266595073495","Proportion","UP","2.4581047186387393","0.8956043956043956","0.8","0.2553191489361702"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase AKT2","364","Smile Bernoulli NB classification","0.6716893751258471","Proportion","UP","2.4581047186387393","0.6016483516483516","0.19375","0.6595744680851063"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase AKT2","364","Smile SVC RBF classification","0.6599771796764887","Proportion","UP","2.4581047186387393","0.8901098901098901","0.8888888888888888","0.1702127659574468"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase AKT2","364","Weka RF on folded fp classification","0.6499765084905028","Proportion","UP","2.4581047186387393","0.8956043956043956","0.8","0.2553191489361702"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase AKT2","364","Smile SVC Poly classification","0.6421236324585544","Proportion","UP","2.4581047186387393","0.8901098901098901","1.0","0.14893617021276595"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase AKT2","364","Smile SVC Tanimoto classification","0.6178266997785089","Proportion","UP","2.4581047186387393","0.9038461538461539","0.9285714285714286","0.2765957446808511"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase AKT","364","Weka RF classification","0.7752496743378202","Proportion","UP","1.6850440661987323","0.9313186813186813","0.8571428571428571","0.34285714285714286"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase AKT","364","Smile SVC RBF classification","0.7524967433782044","Proportion","UP","1.6850440661987323","0.9230769230769231","1.0","0.2"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase AKT","364","Smile Bernoulli NB classification","0.7462006079027347","Proportion","UP","1.6850440661987323","0.6236263736263736","0.1554054054054054","0.6571428571428571"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase AKT","364","Weka RF on folded fp classification","0.7234910985670867","Proportion","UP","1.6850440661987323","0.9313186813186813","0.8571428571428571","0.34285714285714286"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase AKT","364","Smile SVC Poly classification","0.7114198871037771","Proportion","UP","1.6850440661987323","0.9285714285714286","1.0","0.2571428571428571"
"Kinase Assay","Inhibition","Target (full name):Serine/threonine-protein kinase AKT","364","Smile SVC Tanimoto classification","0.6746851932262274","Proportion","UP","1.6850440661987323","0.9368131868131868","1.0","0.34285714285714286"
"Kinase Assay","Inhibition","Target (short name):LRRK2 (G2019S mutant)","364","Weka RF on folded fp classification","0.8857437124156965","Proportion","UP","10.067788180850474","0.7857142857142857","0.7578947368421053","0.5669291338582677"
"Kinase Assay","Inhibition","Target (short name):LRRK2 (G2019S mutant)","364","Smile Bernoulli NB classification","0.8726701883783523","Proportion","UP","10.067788180850474","0.7857142857142857","0.6580645161290323","0.8031496062992126"
"Kinase Assay","Inhibition","Target (short name):LRRK2 (G2019S mutant)","364","Smile SVC Poly classification","0.8713246287252073","Proportion","UP","10.067788180850474","0.7142857142857143","0.896551724137931","0.2047244094488189"
"Kinase Assay","Inhibition","Target (short name):LRRK2 (G2019S mutant)","364","Smile SVC Tanimoto classification","0.8707930496029772","Proportion","UP","10.067788180850474","0.7967032967032966","0.7226890756302521","0.6771653543307087"
"Kinase Assay","Inhibition","Target (short name):LRRK2 (G2019S mutant)","364","Weka RF classification","0.865012126648726","Proportion","UP","10.067788180850474","0.7857142857142857","0.7289719626168224","0.6141732283464567"
"Kinase Assay","Inhibition","Target (short name):LRRK2 (G2019S mutant)","364","Smile SVC RBF classification","0.8004584869929243","Proportion","UP","10.067788180850474","0.7362637362637363","0.7183098591549296","0.4015748031496063"
"Kinase Assay","Inhibition","Target (short name):LRRK2","364","Weka RF classification","0.8374658435381035","Proportion","UP","7.357038535452799","0.7774725274725275","0.71","0.5772357723577236"
"Kinase Assay","Inhibition","Target (short name):LRRK2","364","Weka RF on folded fp classification","0.8370947609891036","Proportion","UP","7.357038535452799","0.7802197802197802","0.7362637362637363","0.5447154471544715"
"Kinase Assay","Inhibition","Target (short name):LRRK2","364","Smile Bernoulli NB classification","0.8357285025132408","Proportion","UP","7.357038535452799","0.7692307692307693","0.6211180124223602","0.8130081300813008"
"Kinase Assay","Inhibition","Target (short name):LRRK2","364","Smile SVC Tanimoto classification","0.8172587120062075","Proportion","UP","7.357038535452799","0.782967032967033","0.7037037037037037","0.6178861788617886"
"Kinase Assay","Inhibition","Target (short name):LRRK2","364","Smile SVC Poly classification","0.8149310123806638","Proportion","UP","7.357038535452799","0.717032967032967","0.9545454545454546","0.17073170731707318"
"Kinase Assay","Inhibition","Target (short name):LRRK2","364","Smile SVC RBF classification","0.789360051276861","Proportion","UP","7.357038535452799","0.7335164835164835","0.703125","0.36585365853658536"
"Kinase Assay","Inhibition","Target (short name):BRAF (V599E mutant)","364","Weka RF classification","0.6989704713983048","Proportion","UP","5.79891235983526","0.6923076923076923","0.5975609756097561","0.3828125"
"Kinase Assay","Inhibition","Target (short name):BRAF (V599E mutant)","364","Smile SVC RBF classification","0.6915717690677959","Proportion","UP","5.79891235983526","0.6675824175824175","0.6","0.1640625"
"Kinase Assay","Inhibition","Target (short name):BRAF (V599E mutant)","364","Smile Bernoulli NB classification","0.6825178760593231","Proportion","UP","5.79891235983526","0.6291208791208791","0.47953216374269003","0.640625"
"Kinase Assay","Inhibition","Target (short name):BRAF (V599E mutant)","364","Weka RF on folded fp classification","0.677039194915254","Proportion","UP","5.79891235983526","0.6895604395604396","0.6229508196721312","0.296875"
"Kinase Assay","Inhibition","Target (short name):BRAF (V599E mutant)","364","Smile SVC Poly classification","0.6676377118644072","Proportion","UP","5.79891235983526","0.6428571428571429","0.25","0.0078125"
"Kinase Assay","Inhibition","Target (short name):BRAF (V599E mutant)","364","Smile SVC Tanimoto classification","0.6446305614406775","Proportion","UP","5.79891235983526","0.6538461538461539","0.5178571428571429","0.2265625"
"Kinase Assay","Inhibition","Target (short name):BRAF","364","Smile SVC RBF classification","0.6743098555211557","Proportion","UP","6.690651371917534","0.6620879120879121","0.6181818181818182","0.25"
"Kinase Assay","Inhibition","Target (short name):BRAF","364","Weka RF classification","0.6638770639834881","Proportion","UP","6.690651371917534","0.6428571428571429","0.5348837209302325","0.3382352941176471"
"Kinase Assay","Inhibition","Target (short name):BRAF","364","Smile Bernoulli NB classification","0.6560565015479874","Proportion","UP","6.690651371917534","0.6373626373626373","0.5111111111111111","0.6764705882352942"
"Kinase Assay","Inhibition","Target (short name):BRAF","364","Smile SVC Poly classification","0.6511222910216722","Proportion","UP","6.690651371917534","0.6236263736263736","0.3333333333333333","0.007352941176470588"
"Kinase Assay","Inhibition","Target (short name):BRAF","364","Weka RF on folded fp classification","0.6507836687306507","Proportion","UP","6.690651371917534","0.6428571428571429","0.55","0.2426470588235294"
"Kinase Assay","Inhibition","Target (short name):BRAF","364","Smile SVC Tanimoto classification","0.6047471620227037","Proportion","UP","6.690651371917534","0.6208791208791209","0.48214285714285715","0.19852941176470587"
"Kinase Assay","Inhibition","Target (short name):FLT3","364","Weka RF on folded fp classification","0.913777972795085","Proportion","UP","5.716961141810766","0.8626373626373627","0.8181818181818182","0.6792452830188679"
"Kinase Assay","Inhibition","Target (short name):FLT3","364","Smile Bernoulli NB classification","0.8915094339622622","Proportion","UP","5.716961141810766","0.8076923076923077","0.6216216216216216","0.8679245283018868"
"Kinase Assay","Inhibition","Target (short name):FLT3","364","Smile SVC Poly classification","0.8902661986251239","Proportion","UP","5.716961141810766","0.7252747252747253","0.65","0.12264150943396226"
"Kinase Assay","Inhibition","Target (short name):FLT3","364","Smile SVC Tanimoto classification","0.8873775047535428","Proportion","UP","5.716961141810766","0.8681318681318682","0.8222222222222222","0.6981132075471698"
"Kinase Assay","Inhibition","Target (short name):FLT3","364","Weka RF classification","0.8768100043878896","Proportion","UP","5.716961141810766","0.8241758241758241","0.7386363636363636","0.6132075471698113"
"Kinase Assay","Inhibition","Target (short name):FLT3","364","Smile SVC RBF classification","0.8556750036565727","Proportion","UP","5.716961141810766","0.8021978021978022","0.84","0.39622641509433965"
"Kinase Assay","Inhibition","Target (short name):EGFR (T790M-L858R mutant)","364","Weka RF classification","0.6713867187499997","Proportion","UP","3.202660178136579","0.7115384615384616","0.5319148936170213","0.23148148148148148"
"Kinase Assay","Inhibition","Target (short name):EGFR (T790M-L858R mutant)","364","Smile SVC Tanimoto classification","0.6587818287037036","Proportion","UP","3.202660178136579","0.7225274725274725","0.5897435897435898","0.21296296296296297"
"Kinase Assay","Inhibition","Target (short name):EGFR (T790M-L858R mutant)","364","Smile SVC RBF classification","0.6342592592592592","Proportion","UP","3.202660178136579","0.6923076923076923","0.4","0.07407407407407407"
"Kinase Assay","Inhibition","Target (short name):EGFR (T790M-L858R mutant)","364","Smile SVC Poly classification","0.6253255208333329","Proportion","UP","3.202660178136579","0.7252747252747253","0.75","0.1111111111111111"
"Kinase Assay","Inhibition","Target (short name):EGFR (T790M-L858R mutant)","364","Smile Bernoulli NB classification","0.6242585358796299","Proportion","UP","3.202660178136579","0.5824175824175825","0.375","0.6111111111111112"
"Kinase Assay","Inhibition","Target (short name):EGFR (T790M-L858R mutant)","364","Weka RF on folded fp classification","0.6124855324074078","Proportion","UP","3.202660178136579","0.7142857142857143","0.5416666666666666","0.24074074074074073"
"Kinase Assay","Inhibition","Target (short name):EGFR (T790M mutant)","364","Smile SVC Poly classification","0.6842213114754109","Proportion","UP","2.6453728914744277","0.7252747252747253","0.7777777777777778","0.23333333333333334"
"Kinase Assay","Inhibition","Target (short name):EGFR (T790M mutant)","364","Smile SVC Tanimoto classification","0.6825478142076502","Proportion","UP","2.6453728914744277","0.7417582417582418","0.6911764705882353","0.39166666666666666"
"Kinase Assay","Inhibition","Target (short name):EGFR (T790M mutant)","364","Smile Bernoulli NB classification","0.6615949453551918","Proportion","UP","2.6453728914744277","0.5879120879120879","0.41847826086956524","0.6416666666666667"
"Kinase Assay","Inhibition","Target (short name):EGFR (T790M mutant)","364","Smile SVC RBF classification","0.6580259562841528","Proportion","UP","2.6453728914744277","0.6978021978021978","0.6785714285714286","0.15833333333333333"
"Kinase Assay","Inhibition","Target (short name):EGFR (T790M mutant)","364","Weka RF on folded fp classification","0.6462090163934427","Proportion","UP","2.6453728914744277","0.7307692307692307","0.6617647058823529","0.375"
"Kinase Assay","Inhibition","Target (short name):EGFR (T790M mutant)","364","Weka RF classification","0.6282616120218576","Proportion","UP","2.6453728914744277","0.695054945054945","0.5652173913043478","0.325"
"Kinase Assay","Inhibition","Target (short name):EGFR (L861Q mutant)","364","Smile SVC Tanimoto classification","0.8733225400251838","Proportion","UP","5.558916690769115","0.8159340659340659","0.75","0.5779816513761468"
"Kinase Assay","Inhibition","Target (short name):EGFR (L861Q mutant)","364","Smile SVC Poly classification","0.8661270012592194","Proportion","UP","5.558916690769115","0.7994505494505495","0.95","0.3486238532110092"
"Kinase Assay","Inhibition","Target (short name):EGFR (L861Q mutant)","364","Weka RF on folded fp classification","0.8655873358517723","Proportion","UP","5.558916690769115","0.8186813186813187","0.7721518987341772","0.5596330275229358"
"Kinase Assay","Inhibition","Target (short name):EGFR (L861Q mutant)","364","Smile Bernoulli NB classification","0.8548659830904846","Proportion","UP","5.558916690769115","0.75","0.5548780487804879","0.8348623853211009"
"Kinase Assay","Inhibition","Target (short name):EGFR (L861Q mutant)","364","Weka RF classification","0.8347364633926965","Proportion","UP","5.558916690769115","0.7664835164835165","0.6363636363636364","0.5137614678899083"
"Kinase Assay","Inhibition","Target (short name):EGFR (L861Q mutant)","364","Smile SVC RBF classification","0.828242489656413","Proportion","UP","5.558916690769115","0.7912087912087912","0.8","0.4036697247706422"
"Kinase Assay","Inhibition","Target (short name):EGFR (L858R mutant)","364","Weka RF on folded fp classification","0.863075196408529","Proportion","UP","8.05964191875933","0.7857142857142857","0.7171717171717171","0.5867768595041323"
"Kinase Assay","Inhibition","Target (short name):EGFR (L858R mutant)","364","Smile SVC Tanimoto classification","0.853824439683024","Proportion","UP","8.05964191875933","0.782967032967033","0.6944444444444444","0.6198347107438017"
"Kinase Assay","Inhibition","Target (short name):EGFR (L858R mutant)","364","Weka RF classification","0.8459000782233106","Proportion","UP","8.05964191875933","0.7802197802197802","0.7157894736842105","0.5619834710743802"
"Kinase Assay","Inhibition","Target (short name):EGFR (L858R mutant)","364","Smile SVC Poly classification","0.8441655613372763","Proportion","UP","8.05964191875933","0.760989010989011","0.9473684210526315","0.2975206611570248"
"Kinase Assay","Inhibition","Target (short name):EGFR (L858R mutant)","364","Smile SVC RBF classification","0.8439274903921361","Proportion","UP","8.05964191875933","0.7747252747252747","0.76","0.47107438016528924"
"Kinase Assay","Inhibition","Target (short name):EGFR (L858R mutant)","364","Smile Bernoulli NB classification","0.8335884093459855","Proportion","UP","8.05964191875933","0.7115384615384616","0.5412371134020618","0.8677685950413223"
"Kinase Assay","Inhibition","Target (short name):EGFR","364","Weka RF on folded fp classification","0.8065306420944863","Proportion","UP","7.594989688047807","0.8489010989010989","0.9180327868852459","0.5283018867924528"
"Kinase Assay","Inhibition","Target (short name):EGFR","364","Smile SVC Tanimoto classification","0.7888328214129002","Proportion","UP","7.594989688047807","0.8076923076923077","0.7727272727272727","0.4811320754716981"
"Kinase Assay","Inhibition","Target (short name):EGFR","364","Smile SVC Poly classification","0.783201696650578","Proportion","UP","7.594989688047807","0.8131868131868132","1.0","0.3584905660377358"
"Kinase Assay","Inhibition","Target (short name):EGFR","364","Smile Bernoulli NB classification","0.7802398712885763","Proportion","UP","7.594989688047807","0.6730769230769231","0.4601226993865031","0.7075471698113207"
"Kinase Assay","Inhibition","Target (short name):EGFR","364","Weka RF classification","0.7436009945882698","Proportion","UP","7.594989688047807","0.8021978021978022","0.765625","0.46226415094339623"
"Kinase Assay","Inhibition","Target (short name):EGFR","364","Smile SVC RBF classification","0.7235995319584622","Proportion","UP","7.594989688047807","0.7802197802197802","0.8095238095238095","0.32075471698113206"
"Kinase Assay","Inhibition","Target (short name):ABL1","364","Smile Bernoulli NB classification","0.880693855932202","Proportion","UP","10.058077912567919","0.771978021978022","0.6380368098159509","0.8125"
"Kinase Assay","Inhibition","Target (short name):ABL1","364","Weka RF on folded fp classification","0.8783103813559303","Proportion","UP","10.058077912567919","0.8324175824175825","0.819047619047619","0.671875"
"Kinase Assay","Inhibition","Target (short name):ABL1","364","Smile SVC Poly classification","0.8709282309322022","Proportion","UP","10.058077912567919","0.6978021978021978","0.875","0.1640625"
"Kinase Assay","Inhibition","Target (short name):ABL1","364","Smile SVC Tanimoto classification","0.8590108580508483","Proportion","UP","10.058077912567919","0.7939560439560439","0.7226890756302521","0.671875"
"Kinase Assay","Inhibition","Target (short name):ABL1","364","Weka RF classification","0.8429720603813559","Proportion","UP","10.058077912567919","0.7307692307692307","0.6415094339622641","0.53125"
"Kinase Assay","Inhibition","Target (short name):ABL1","364","Smile SVC RBF classification","0.8335209216101679","Proportion","UP","10.058077912567919","0.7417582417582418","0.7428571428571429","0.40625"
"Kinase Assay","Inhibition","Target (short name):ABL1 (Y253F mutant)","364","Smile Bernoulli NB classification","0.8913050624589086","Proportion","UP","9.23961620282164","0.7994505494505495","0.6727272727272727","0.8538461538461538"
"Kinase Assay","Inhibition","Target (short name):ABL1 (Y253F mutant)","364","Weka RF on folded fp classification","0.890072320841555","Proportion","UP","9.23961620282164","0.8104395604395604","0.7747747747747747","0.6615384615384615"
"Kinase Assay","Inhibition","Target (short name):ABL1 (Y253F mutant)","364","Smile SVC Poly classification","0.8803747534516769","Proportion","UP","9.23961620282164","0.7142857142857143","0.90625","0.2230769230769231"
"Kinase Assay","Inhibition","Target (short name):ABL1 (Y253F mutant)","364","Smile SVC Tanimoto classification","0.8741288625904033","Proportion","UP","9.23961620282164","0.8186813186813187","0.753968253968254","0.7307692307692307"
"Kinase Assay","Inhibition","Target (short name):ABL1 (Y253F mutant)","364","Weka RF classification","0.8528435239973703","Proportion","UP","9.23961620282164","0.7582417582417582","0.7058823529411765","0.5538461538461539"
"Kinase Assay","Inhibition","Target (short name):ABL1 (Y253F mutant)","364","Smile SVC RBF classification","0.8234056541748872","Proportion","UP","9.23961620282164","0.7582417582417582","0.7763157894736842","0.45384615384615384"
"Kinase Assay","Inhibition","Target (short name):ABL1 (T315I mutant)","364","Weka RF on folded fp classification","0.908275140842698","Proportion","UP","6.236638055279814","0.8461538461538461","0.819047619047619","0.6991869918699187"
"Kinase Assay","Inhibition","Target (short name):ABL1 (T315I mutant)","364","Smile Bernoulli NB classification","0.9037884154775179","Proportion","UP","6.236638055279814","0.8021978021978022","0.650887573964497","0.8943089430894309"
"Kinase Assay","Inhibition","Target (short name):ABL1 (T315I mutant)","364","Smile SVC Tanimoto classification","0.9008534898627","Proportion","UP","6.236638055279814","0.8406593406593407","0.7876106194690266","0.7235772357723578"
"Kinase Assay","Inhibition","Target (short name):ABL1 (T315I mutant)","364","Smile SVC Poly classification","0.8969739904867913","Proportion","UP","6.236638055279814","0.7335164835164835","0.90625","0.23577235772357724"
"Kinase Assay","Inhibition","Target (short name):ABL1 (T315I mutant)","364","Weka RF classification","0.8743548223863981","Proportion","UP","6.236638055279814","0.8131868131868132","0.7835051546391752","0.6178861788617886"
"Kinase Assay","Inhibition","Target (short name):ABL1 (T315I mutant)","364","Smile SVC RBF classification","0.8728873595789918","Proportion","UP","6.236638055279814","0.7912087912087912","0.8051948051948052","0.5040650406504065"
"Kinase Assay","Inhibition","Target (short name):ABL1 (Q252H mutant)","364","Smile SVC Tanimoto classification","0.8783110671284866","Proportion","UP","9.629710698139569","0.8296703296703297","0.7913043478260869","0.7054263565891473"
"Kinase Assay","Inhibition","Target (short name):ABL1 (Q252H mutant)","364","Weka RF on folded fp classification","0.8719445818901526","Proportion","UP","9.629710698139569","0.8076923076923077","0.7657657657657657","0.6589147286821705"
"Kinase Assay","Inhibition","Target (short name):ABL1 (Q252H mutant)","364","Smile Bernoulli NB classification","0.8684479630545938","Proportion","UP","9.629710698139569","0.7692307692307693","0.6380368098159509","0.8062015503875969"
"Kinase Assay","Inhibition","Target (short name):ABL1 (Q252H mutant)","364","Smile SVC Poly classification","0.8564077189510154","Proportion","UP","9.629710698139569","0.7252747252747253","0.8717948717948718","0.26356589147286824"
"Kinase Assay","Inhibition","Target (short name):ABL1 (Q252H mutant)","364","Weka RF classification","0.8372257958106549","Proportion","UP","9.629710698139569","0.75","0.6938775510204082","0.5271317829457365"
"Kinase Assay","Inhibition","Target (short name):ABL1 (Q252H mutant)","364","Smile SVC RBF classification","0.8107537522678546","Proportion","UP","9.629710698139569","0.7472527472527473","0.7681159420289855","0.4108527131782946"
"Kinase Assay","Inhibition","Target (short name):ABL1 (M351T mutant)","364","Weka RF on folded fp classification","0.9028637770897828","Proportion","UP","9.413042230349735","0.8434065934065934","0.8015267175572519","0.7720588235294118"
"Kinase Assay","Inhibition","Target (short name):ABL1 (M351T mutant)","364","Smile SVC Tanimoto classification","0.8999935500515985","Proportion","UP","9.413042230349735","0.8351648351648352","0.7753623188405797","0.7867647058823529"
"Kinase Assay","Inhibition","Target (short name):ABL1 (M351T mutant)","364","Smile Bernoulli NB classification","0.8999290505675949","Proportion","UP","9.413042230349735","0.8104395604395604","0.7055214723926381","0.8455882352941176"
"Kinase Assay","Inhibition","Target (short name):ABL1 (M351T mutant)","364","Smile SVC Poly classification","0.8917376160990701","Proportion","UP","9.413042230349735","0.7472527472527473","0.84375","0.39705882352941174"
"Kinase Assay","Inhibition","Target (short name):ABL1 (M351T mutant)","364","Weka RF classification","0.859455624355005","Proportion","UP","9.413042230349735","0.771978021978022","0.7304347826086957","0.6176470588235294"
"Kinase Assay","Inhibition","Target (short name):ABL1 (M351T mutant)","364","Smile SVC RBF classification","0.8247871517027866","Proportion","UP","9.413042230349735","0.7664835164835165","0.8072289156626506","0.49264705882352944"
"Kinase Assay","Inhibition","Target (short name):ABL1 (H396P mutant)","364","Weka RF on folded fp classification","0.886689757545769","Proportion","UP","9.671530376693266","0.8104395604395604","0.7941176470588235","0.627906976744186"
"Kinase Assay","Inhibition","Target (short name):ABL1 (H396P mutant)","364","Smile Bernoulli NB classification","0.8857331354115128","Proportion","UP","9.671530376693266","0.804945054945055","0.6790123456790124","0.8527131782945736"
"Kinase Assay","Inhibition","Target (short name):ABL1 (H396P mutant)","364","Smile SVC Poly classification","0.8846115784265232","Proportion","UP","9.671530376693266","0.7142857142857143","0.8787878787878788","0.2248062015503876"
"Kinase Assay","Inhibition","Target (short name):ABL1 (H396P mutant)","364","Smile SVC Tanimoto classification","0.874880422233217","Proportion","UP","9.671530376693266","0.8186813186813187","0.7603305785123967","0.7131782945736435"
"Kinase Assay","Inhibition","Target (short name):ABL1 (H396P mutant)","364","Weka RF classification","0.8399472208477654","Proportion","UP","9.671530376693266","0.7692307692307693","0.7272727272727273","0.5581395348837209"
"Kinase Assay","Inhibition","Target (short name):ABL1 (H396P mutant)","364","Smile SVC RBF classification","0.8341415141019315","Proportion","UP","9.671530376693266","0.7582417582417582","0.7733333333333333","0.4496124031007752"
"Kinase Assay","Inhibition","Target (short name):ABL1 (E255K mutant)","364","Weka RF on folded fp classification","0.8873401001112337","Proportion","UP","6.3775450359826","0.8076923076923077","0.7804878048780488","0.5517241379310345"
"Kinase Assay","Inhibition","Target (short name):ABL1 (E255K mutant)","364","Smile Bernoulli NB classification","0.8824909621801976","Proportion","UP","6.3775450359826","0.7664835164835165","0.5974842767295597","0.8189655172413793"
"Kinase Assay","Inhibition","Target (short name):ABL1 (E255K mutant)","364","Smile SVC Poly classification","0.8783718020022239","Proportion","UP","6.3775450359826","0.717032967032967","1.0","0.11206896551724138"
"Kinase Assay","Inhibition","Target (short name):ABL1 (E255K mutant)","364","Smile SVC Tanimoto classification","0.8725667408231331","Proportion","UP","6.3775450359826","0.8076923076923077","0.7613636363636364","0.5775862068965517"
"Kinase Assay","Inhibition","Target (short name):ABL1 (E255K mutant)","364","Weka RF classification","0.8253093715239156","Proportion","UP","6.3775450359826","0.771978021978022","0.6853932584269663","0.5258620689655172"
"Kinase Assay","Inhibition","Target (short name):ABL1 (E255K mutant)","364","Smile SVC RBF classification","0.8067644605116788","Proportion","UP","6.3775450359826","0.7472527472527473","0.7222222222222222","0.33620689655172414"
"Kinase Assay","Inhibition","Target (short name):RET (Y791F mutant)","364","Weka RF on folded fp classification","0.8339211076280032","Proportion","UP","13.75710030626529","0.7527472527472527","0.7441860465116279","0.48484848484848486"
"Kinase Assay","Inhibition","Target (short name):RET (Y791F mutant)","364","Smile SVC Tanimoto classification","0.8301005747126416","Proportion","UP","13.75710030626529","0.7637362637362637","0.6916666666666667","0.6287878787878788"
"Kinase Assay","Inhibition","Target (short name):RET (Y791F mutant)","364","Smile Bernoulli NB classification","0.8260841170323913","Proportion","UP","13.75710030626529","0.7417582417582418","0.6091954022988506","0.803030303030303"
"Kinase Assay","Inhibition","Target (short name):RET (Y791F mutant)","364","Weka RF classification","0.8154388714733543","Proportion","UP","13.75710030626529","0.7445054945054945","0.693069306930693","0.5303030303030303"
"Kinase Assay","Inhibition","Target (short name):RET (Y791F mutant)","364","Smile SVC Poly classification","0.8101815569487973","Proportion","UP","13.75710030626529","0.6813186813186813","0.9444444444444444","0.12878787878787878"
"Kinase Assay","Inhibition","Target (short name):RET (Y791F mutant)","364","Smile SVC RBF classification","0.8068508359456626","Proportion","UP","13.75710030626529","0.7225274725274725","0.7246376811594203","0.3787878787878788"
"Kinase Assay","Inhibition","Target (short name):RET (V804L mutant)","364","Smile SVC Tanimoto classification","0.8210032722733863","Proportion","UP","8.975800132516989","0.8159340659340659","0.7641509433962265","0.6585365853658537"
"Kinase Assay","Inhibition","Target (short name):RET (V804L mutant)","364","Smile Bernoulli NB classification","0.818118948824344","Proportion","UP","8.975800132516989","0.7582417582417582","0.6158940397350994","0.7560975609756098"
"Kinase Assay","Inhibition","Target (short name):RET (V804L mutant)","364","Weka RF on folded fp classification","0.8066322571939409","Proportion","UP","8.975800132516989","0.7664835164835165","0.7159090909090909","0.5121951219512195"
"Kinase Assay","Inhibition","Target (short name):RET (V804L mutant)","364","Smile SVC Poly classification","0.8049455183348531","Proportion","UP","8.975800132516989","0.6840659340659341","0.75","0.0975609756097561"
"Kinase Assay","Inhibition","Target (short name):RET (V804L mutant)","364","Weka RF classification","0.8042370880140336","Proportion","UP","8.975800132516989","0.7692307692307693","0.7191011235955056","0.5203252032520326"
"Kinase Assay","Inhibition","Target (short name):RET (V804L mutant)","364","Smile SVC RBF classification","0.7812637047532303","Proportion","UP","8.975800132516989","0.739010989010989","0.7333333333333333","0.35772357723577236"
"Kinase Assay","Inhibition","Target (short name):RET","364","Weka RF on folded fp classification","0.8277939618644076","Proportion","UP","11.080658782977466","0.782967032967033","0.7692307692307693","0.546875"
"Kinase Assay","Inhibition","Target (short name):RET","364","Smile Bernoulli NB classification","0.8217856197033896","Proportion","UP","11.080658782977466","0.75","0.6094674556213018","0.8046875"
"Kinase Assay","Inhibition","Target (short name):RET","364","Smile SVC Tanimoto classification","0.8169028072033906","Proportion","UP","11.080658782977466","0.75","0.6581196581196581","0.6015625"
"Kinase Assay","Inhibition","Target (short name):RET","364","Smile SVC Poly classification","0.8073358050847438","Proportion","UP","11.080658782977466","0.6813186813186813","0.875","0.109375"
"Kinase Assay","Inhibition","Target (short name):RET","364","Weka RF classification","0.8065909692796613","Proportion","UP","11.080658782977466","0.7637362637362637","0.7142857142857143","0.546875"
"Kinase Assay","Inhibition","Target (short name):RET","364","Smile SVC RBF classification","0.7677767478813566","Proportion","UP","11.080658782977466","0.75","0.7605633802816901","0.421875"
"Kinase Assay","Inhibition","Target (short name):PDGFRA (V561D mutant)","364","Weka RF on folded fp classification","0.9169677440354135","Proportion","UP","17.501373743043725","0.8434065934065934","0.796875","0.7669172932330827"
"Kinase Assay","Inhibition","Target (short name):PDGFRA (V561D mutant)","364","Smile Bernoulli NB classification","0.9109624711128468","Proportion","UP","17.501373743043725","0.8379120879120879","0.7283950617283951","0.8872180451127819"
"Kinase Assay","Inhibition","Target (short name):PDGFRA (V561D mutant)","364","Smile SVC Tanimoto classification","0.905836018617973","Proportion","UP","17.501373743043725","0.8406593406593407","0.7906976744186046","0.7669172932330827"
"Kinase Assay","Inhibition","Target (short name):PDGFRA (V561D mutant)","364","Smile SVC Poly classification","0.8989031019106201","Proportion","UP","17.501373743043725","0.7472527472527473","0.8360655737704918","0.38345864661654133"
"Kinase Assay","Inhibition","Target (short name):PDGFRA (V561D mutant)","364","Weka RF classification","0.8873645151840641","Proportion","UP","17.501373743043725","0.804945054945055","0.7672413793103449","0.6691729323308271"
"Kinase Assay","Inhibition","Target (short name):PDGFRA (V561D mutant)","364","Smile SVC RBF classification","0.8715945708426892","Proportion","UP","17.501373743043725","0.7857142857142857","0.8235294117647058","0.5263157894736842"
"Kinase Assay","Inhibition","Target (short name):PDGFRA (T674I mutant)","364","Smile SVC Tanimoto classification","0.8339564397187447","Proportion","UP","9.227981452959114","0.8131868131868132","0.7217391304347827","0.6974789915966386"
"Kinase Assay","Inhibition","Target (short name):PDGFRA (T674I mutant)","364","Weka RF on folded fp classification","0.8314697307494412","Proportion","UP","9.227981452959114","0.7939560439560439","0.7156862745098039","0.6134453781512605"
"Kinase Assay","Inhibition","Target (short name):PDGFRA (T674I mutant)","364","Smile Bernoulli NB classification","0.8209912536443147","Proportion","UP","9.227981452959114","0.75","0.5909090909090909","0.7647058823529411"
"Kinase Assay","Inhibition","Target (short name):PDGFRA (T674I mutant)","364","Smile SVC RBF classification","0.8201337677928315","Proportion","UP","9.227981452959114","0.7747252747252747","0.7936507936507936","0.42016806722689076"
"Kinase Assay","Inhibition","Target (short name):PDGFRA (T674I mutant)","364","Weka RF classification","0.808592008231864","Proportion","UP","9.227981452959114","0.7802197802197802","0.7191011235955056","0.5378151260504201"
"Kinase Assay","Inhibition","Target (short name):PDGFRA (T674I mutant)","364","Smile SVC Poly classification","0.8045618247298917","Proportion","UP","9.227981452959114","0.7252747252747253","0.9130434782608695","0.17647058823529413"
"Kinase Assay","Inhibition","Target (short name):PDGFRA (D842V mutant)","364","Weka RF on folded fp classification","0.8853057199211045","Proportion","UP","8.943278009041054","0.8379120879120879","0.8446601941747572","0.6692307692307692"
"Kinase Assay","Inhibition","Target (short name):PDGFRA (D842V mutant)","364","Smile Bernoulli NB classification","0.8739151873767265","Proportion","UP","8.943278009041054","0.7774725274725275","0.6432748538011696","0.8461538461538461"
"Kinase Assay","Inhibition","Target (short name):PDGFRA (D842V mutant)","364","Smile SVC Tanimoto classification","0.8721236028928351","Proportion","UP","8.943278009041054","0.8241758241758241","0.8","0.676923076923077"
"Kinase Assay","Inhibition","Target (short name):PDGFRA (D842V mutant)","364","Smile SVC Poly classification","0.8637738330046024","Proportion","UP","8.943278009041054","0.6895604395604396","0.7741935483870968","0.18461538461538463"
"Kinase Assay","Inhibition","Target (short name):PDGFRA (D842V mutant)","364","Smile SVC RBF classification","0.8382971729125586","Proportion","UP","8.943278009041054","0.7445054945054945","0.7681159420289855","0.4076923076923077"
"Kinase Assay","Inhibition","Target (short name):PDGFRA (D842V mutant)","364","Weka RF classification","0.8192800788954636","Proportion","UP","8.943278009041054","0.7692307692307693","0.7254901960784313","0.5692307692307692"
"Kinase Assay","Inhibition","Target (short name):PDGFRA","364","Smile Bernoulli NB classification","0.89180290272909","Proportion","UP","19.640517595740597","0.8159340659340659","0.7025316455696202","0.8473282442748091"
"Kinase Assay","Inhibition","Target (short name):PDGFRA","364","Smile SVC Tanimoto classification","0.8906398453625147","Proportion","UP","19.640517595740597","0.8324175824175825","0.7777777777777778","0.7480916030534351"
"Kinase Assay","Inhibition","Target (short name):PDGFRA","364","Weka RF on folded fp classification","0.8894604069062684","Proportion","UP","19.640517595740597","0.8186813186813187","0.751937984496124","0.7404580152671756"
"Kinase Assay","Inhibition","Target (short name):PDGFRA","364","Smile SVC Poly classification","0.8824493005274726","Proportion","UP","19.640517595740597","0.7527472527472527","0.847457627118644","0.3816793893129771"
"Kinase Assay","Inhibition","Target (short name):PDGFRA","364","Weka RF classification","0.8698194803918355","Proportion","UP","19.640517595740597","0.7802197802197802","0.7256637168141593","0.6259541984732825"
"Kinase Assay","Inhibition","Target (short name):PDGFRA","364","Smile SVC RBF classification","0.8489991154211589","Proportion","UP","19.640517595740597","0.7912087912087912","0.8021978021978022","0.5572519083969466"
"Kinase Assay","Inhibition","Target (short name):LYN B (splice variant)","364","Smile SVC Tanimoto classification","0.8496138734588808","Proportion","UP","6.557213335335278","0.8104395604395604","0.7264957264957265","0.6967213114754098"
"Kinase Assay","Inhibition","Target (short name):LYN B (splice variant)","364","Weka RF on folded fp classification","0.8484114618615348","Proportion","UP","6.557213335335278","0.7637362637362637","0.6764705882352942","0.5655737704918032"
"Kinase Assay","Inhibition","Target (short name):LYN B (splice variant)","364","Weka RF classification","0.8411123154044167","Proportion","UP","6.557213335335278","0.7692307692307693","0.7065217391304348","0.5327868852459017"
"Kinase Assay","Inhibition","Target (short name):LYN B (splice variant)","364","Smile Bernoulli NB classification","0.840536512667662","Proportion","UP","6.557213335335278","0.760989010989011","0.6023391812865497","0.8442622950819673"
"Kinase Assay","Inhibition","Target (short name):LYN B (splice variant)","364","Smile SVC Poly classification","0.8219753420945664","Proportion","UP","6.557213335335278","0.6923076923076923","0.7083333333333334","0.13934426229508196"
"Kinase Assay","Inhibition","Target (short name):LYN B (splice variant)","364","Smile SVC RBF classification","0.7996545183579448","Proportion","UP","6.557213335335278","0.75","0.7540983606557377","0.3770491803278688"
"Kinase Assay","Inhibition","Target (short name):LYN A (splice variant)","364","Smile SVC Tanimoto classification","0.8388827041797374","Proportion","UP","8.694883897214963","0.7884615384615384","0.6916666666666667","0.6747967479674797"
"Kinase Assay","Inhibition","Target (short name):LYN A (splice variant)","364","Smile Bernoulli NB classification","0.8283911884762003","Proportion","UP","8.694883897214963","0.75","0.5941176470588235","0.8211382113821138"
"Kinase Assay","Inhibition","Target (short name):LYN A (splice variant)","364","Weka RF on folded fp classification","0.8240731369969319","Proportion","UP","8.694883897214963","0.739010989010989","0.6555555555555556","0.4796747967479675"
"Kinase Assay","Inhibition","Target (short name):LYN A (splice variant)","364","Smile SVC Poly classification","0.8177984684411176","Proportion","UP","8.694883897214963","0.695054945054945","0.8333333333333334","0.12195121951219512"
"Kinase Assay","Inhibition","Target (short name):LYN A (splice variant)","364","Weka RF classification","0.8148972776034813","Proportion","UP","8.694883897214963","0.7362637362637363","0.6626506024096386","0.44715447154471544"
"Kinase Assay","Inhibition","Target (short name):LYN A (splice variant)","364","Smile SVC RBF classification","0.7903046250379516","Proportion","UP","8.694883897214963","0.739010989010989","0.7333333333333333","0.35772357723577236"
"Kinase Assay","Inhibition","Target (short name):KIT (V560G mutant)","364","Weka RF on folded fp classification","0.8707244160177962","Proportion","UP","4.453046976486576","0.8296703296703297","0.7872340425531915","0.6379310344827587"
"Kinase Assay","Inhibition","Target (short name):KIT (V560G mutant)","364","Smile Bernoulli NB classification","0.8666921579532796","Proportion","UP","4.453046976486576","0.7912087912087912","0.636986301369863","0.8017241379310345"
"Kinase Assay","Inhibition","Target (short name):KIT (V560G mutant)","364","Smile SVC Poly classification","0.859253337041157","Proportion","UP","4.453046976486576","0.7197802197802198","0.85","0.14655172413793102"
"Kinase Assay","Inhibition","Target (short name):KIT (V560G mutant)","364","Smile SVC Tanimoto classification","0.8557424916573949","Proportion","UP","4.453046976486576","0.8241758241758241","0.8170731707317073","0.5775862068965517"
"Kinase Assay","Inhibition","Target (short name):KIT (V560G mutant)","364","Weka RF classification","0.8519361790878754","Proportion","UP","4.453046976486576","0.782967032967033","0.7402597402597403","0.49137931034482757"
"Kinase Assay","Inhibition","Target (short name):KIT (V560G mutant)","364","Smile SVC RBF classification","0.8437152391546152","Proportion","UP","4.453046976486576","0.7637362637362637","0.75","0.3879310344827586"
"Kinase Assay","Inhibition","Target (short name):KIT (T6701 mutant)","364","Smile Bernoulli NB classification","0.817074539739559","Proportion","UP","4.925968264263949","0.7417582417582418","0.5273972602739726","0.7549019607843137"
"Kinase Assay","Inhibition","Target (short name):KIT (T6701 mutant)","364","Smile SVC Tanimoto classification","0.7983086364316717","Proportion","UP","4.925968264263949","0.8351648351648352","0.7916666666666666","0.5588235294117647"
"Kinase Assay","Inhibition","Target (short name):KIT (T6701 mutant)","364","Smile SVC Poly classification","0.7900014967819204","Proportion","UP","4.925968264263949","0.7307692307692307","0.75","0.058823529411764705"
"Kinase Assay","Inhibition","Target (short name):KIT (T6701 mutant)","364","Weka RF on folded fp classification","0.7835466247567723","Proportion","UP","4.925968264263949","0.8269230769230769","0.7671232876712328","0.5490196078431373"
"Kinase Assay","Inhibition","Target (short name):KIT (T6701 mutant)","364","Weka RF classification","0.7702813950007483","Proportion","UP","4.925968264263949","0.7884615384615384","0.7049180327868853","0.4215686274509804"
"Kinase Assay","Inhibition","Target (short name):KIT (T6701 mutant)","364","Smile SVC RBF classification","0.7590555306091906","Proportion","UP","4.925968264263949","0.7747252747252747","0.7631578947368421","0.28431372549019607"
"Kinase Assay","Inhibition","Target (short name):KIT (D816V mutant)","364","Weka RF classification","0.6077259178973042","Proportion","UP","3.8943075532957305","0.6593406593406593","0.4861111111111111","0.28688524590163933"
"Kinase Assay","Inhibition","Target (short name):KIT (D816V mutant)","364","Smile SVC RBF classification","0.5959897032922369","Proportion","UP","3.8943075532957305","0.6483516483516484","0.4","0.09836065573770492"
"Kinase Assay","Inhibition","Target (short name):KIT (D816V mutant)","364","Weka RF on folded fp classification","0.5609165424739195","Proportion","UP","3.8943075532957305","0.6565934065934066","0.4634146341463415","0.1557377049180328"
"Kinase Assay","Inhibition","Target (short name):KIT (D816V mutant)","364","Smile SVC Poly classification","0.5592399403874811","Proportion","UP","3.8943075532957305","0.6593406593406593","0.0","0.0"
"Kinase Assay","Inhibition","Target (short name):KIT (D816V mutant)","364","Smile SVC Tanimoto classification","0.5539561035090097","Proportion","UP","3.8943075532957305","0.6510989010989011","0.4358974358974359","0.13934426229508196"
"Kinase Assay","Inhibition","Target (short name):KIT (D816V mutant)","364","Smile Bernoulli NB classification","0.5288240075870478","Proportion","UP","3.8943075532957305","0.510989010989011","0.3390804597701149","0.48360655737704916"
"Kinase Assay","Inhibition","Target (short name):KIT","364","Weka RF on folded fp classification","0.9050777131585207","Proportion","UP","12.00063893649483","0.8489010989010989","0.8055555555555556","0.71900826446281"
"Kinase Assay","Inhibition","Target (short name):KIT","364","Smile Bernoulli NB classification","0.9040574091079141","Proportion","UP","12.00063893649483","0.8543956043956044","0.7361111111111112","0.8760330578512396"
"Kinase Assay","Inhibition","Target (short name):KIT","364","Smile SVC Tanimoto classification","0.8959629969730962","Proportion","UP","12.00063893649483","0.8489010989010989","0.7796610169491526","0.7603305785123967"
"Kinase Assay","Inhibition","Target (short name):KIT","364","Weka RF classification","0.8911675679352447","Proportion","UP","12.00063893649483","0.8296703296703297","0.8041237113402062","0.6446280991735537"
"Kinase Assay","Inhibition","Target (short name):KIT","364","Smile SVC Poly classification","0.881440669319455","Proportion","UP","12.00063893649483","0.7637362637362637","0.8301886792452831","0.36363636363636365"
"Kinase Assay","Inhibition","Target (short name):KIT","364","Smile SVC RBF classification","0.8671564126109575","Proportion","UP","12.00063893649483","0.7967032967032966","0.8405797101449275","0.4793388429752066"
"Kinase Assay","Inhibition","Target (short name):FLT3 (D835Y mutant)","364","Smile Bernoulli NB classification","0.8159763905562237","Proportion","UP","3.4673687111355207","0.7664835164835165","0.6413793103448275","0.7380952380952381"
"Kinase Assay","Inhibition","Target (short name):FLT3 (D835Y mutant)","364","Smile SVC Poly classification","0.8143924236361215","Proportion","UP","3.4673687111355207","0.6785714285714286","0.7142857142857143","0.11904761904761904"
"Kinase Assay","Inhibition","Target (short name):FLT3 (D835Y mutant)","364","Smile SVC Tanimoto classification","0.7996198479391746","Proportion","UP","3.4673687111355207","0.8021978021978022","0.7872340425531915","0.5873015873015873"
"Kinase Assay","Inhibition","Target (short name):FLT3 (D835Y mutant)","364","Weka RF on folded fp classification","0.7983526744030938","Proportion","UP","3.4673687111355207","0.7884615384615384","0.7578947368421053","0.5714285714285714"
"Kinase Assay","Inhibition","Target (short name):FLT3 (D835Y mutant)","364","Weka RF classification","0.7865312791783379","Proportion","UP","3.4673687111355207","0.7445054945054945","0.6813186813186813","0.49206349206349204"
"Kinase Assay","Inhibition","Target (short name):FLT3 (D835Y mutant)","364","Smile SVC RBF classification","0.7656729358410043","Proportion","UP","3.4673687111355207","0.7472527472527473","0.7575757575757576","0.3968253968253968"
"Kinase Assay","Inhibition","Target (short name):CDK2/cyclinE","364","Smile SVC Tanimoto classification","0.8187574809838218","Proportion","UP","5.999834012831322","0.8324175824175825","0.7647058823529411","0.5360824742268041"
"Kinase Assay","Inhibition","Target (short name):CDK2/cyclinE","364","Smile Bernoulli NB classification","0.8156106413375048","Proportion","UP","5.999834012831322","0.7527472527472527","0.5251798561151079","0.7525773195876289"
"Kinase Assay","Inhibition","Target (short name):CDK2/cyclinE","364","Weka RF on folded fp classification","0.7992972701648702","Proportion","UP","5.999834012831322","0.8076923076923077","0.7288135593220338","0.44329896907216493"
"Kinase Assay","Inhibition","Target (short name):CDK2/cyclinE","364","Smile SVC Poly classification","0.7947024981659524","Proportion","UP","5.999834012831322","0.7472527472527473","1.0","0.05154639175257732"
"Kinase Assay","Inhibition","Target (short name):CDK2/cyclinE","364","Weka RF classification","0.7921927487547783","Proportion","UP","5.999834012831322","0.8159340659340659","0.734375","0.4845360824742268"
"Kinase Assay","Inhibition","Target (short name):CDK2/cyclinE","364","Smile SVC RBF classification","0.7278273292405109","Proportion","UP","5.999834012831322","0.7802197802197802","0.7428571428571429","0.26804123711340205"
"Kinase Assay","Inhibition","Target (short name):CDK2/cyclinA","364","Weka RF on folded fp classification","0.8475836431226739","Proportion","UP","5.397132344611668","0.8131868131868132","0.6901408450704225","0.5157894736842106"
"Kinase Assay","Inhibition","Target (short name):CDK2/cyclinA","364","Smile SVC Tanimoto classification","0.8401095675992928","Proportion","UP","5.397132344611668","0.8324175824175825","0.717948717948718","0.5894736842105263"
"Kinase Assay","Inhibition","Target (short name):CDK2/cyclinA","364","Smile Bernoulli NB classification","0.8397573860301294","Proportion","UP","5.397132344611668","0.7747252747252747","0.5467625899280576","0.8"
"Kinase Assay","Inhibition","Target (short name):CDK2/cyclinA","364","Smile SVC Poly classification","0.8388964977499496","Proportion","UP","5.397132344611668","0.7554945054945055","0.8","0.08421052631578947"
"Kinase Assay","Inhibition","Target (short name):CDK2/cyclinA","364","Weka RF classification","0.8116219917824302","Proportion","UP","5.397132344611668","0.8186813186813187","0.6933333333333334","0.5473684210526316"
"Kinase Assay","Inhibition","Target (short name):CDK2/cyclinA","364","Smile SVC RBF classification","0.7570338485619253","Proportion","UP","5.397132344611668","0.782967032967033","0.6904761904761905","0.30526315789473685"
"Kinase Assay","Inhibition","Target (short name):PKC-beta2 (splice variant)","364","Smile SVC Tanimoto classification","0.8048690194972294","Proportion","UP","2.751235052009459","0.739010989010989","0.6097560975609756","0.4424778761061947"
"Kinase Assay","Inhibition","Target (short name):PKC-beta2 (splice variant)","364","Smile SVC Poly classification","0.7969361492084762","Proportion","UP","2.751235052009459","0.739010989010989","0.75","0.23893805309734514"
"Kinase Assay","Inhibition","Target (short name):PKC-beta2 (splice variant)","364","Weka RF on folded fp classification","0.7942566019109389","Proportion","UP","2.751235052009459","0.771978021978022","0.6923076923076923","0.4778761061946903"
"Kinase Assay","Inhibition","Target (short name):PKC-beta2 (splice variant)","364","Weka RF classification","0.7912068539999293","Proportion","UP","2.751235052009459","0.7527472527472527","0.6493506493506493","0.4424778761061947"
"Kinase Assay","Inhibition","Target (short name):PKC-beta2 (splice variant)","364","Smile Bernoulli NB classification","0.7891795649261348","Proportion","UP","2.751235052009459","0.7252747252747253","0.5408805031446541","0.7610619469026548"
"Kinase Assay","Inhibition","Target (short name):PKC-beta2 (splice variant)","364","Smile SVC RBF classification","0.7805062934104271","Proportion","UP","2.751235052009459","0.7417582417582418","0.7111111111111111","0.2831858407079646"
"Kinase Assay","Inhibition","Target (short name):PKC-beta1 (splice variant)","364","Smile Bernoulli NB classification","0.7681914582419191","Proportion","UP","2.6923674890833196","0.7307692307692307","0.53125","0.6415094339622641"
"Kinase Assay","Inhibition","Target (short name):PKC-beta1 (splice variant)","364","Weka RF on folded fp classification","0.764626298083954","Proportion","UP","2.6923674890833196","0.7554945054945055","0.6268656716417911","0.39622641509433965"
"Kinase Assay","Inhibition","Target (short name):PKC-beta1 (splice variant)","364","Weka RF classification","0.7613170981424602","Proportion","UP","2.6923674890833196","0.7664835164835165","0.6842105263157895","0.36792452830188677"
"Kinase Assay","Inhibition","Target (short name):PKC-beta1 (splice variant)","364","Smile SVC RBF classification","0.755302033055433","Proportion","UP","2.6923674890833196","0.7747252747252747","0.8","0.3018867924528302"
"Kinase Assay","Inhibition","Target (short name):PKC-beta1 (splice variant)","364","Smile SVC Tanimoto classification","0.7467456486763204","Proportion","UP","2.6923674890833196","0.7554945054945055","0.660377358490566","0.330188679245283"
"Kinase Assay","Inhibition","Target (short name):PKC-beta1 (splice variant)","364","Smile SVC Poly classification","0.7410048266783679","Proportion","UP","2.6923674890833196","0.75","0.7419354838709677","0.2169811320754717"
